=== МЕТАДАННЫЕ ===
{
  "original_filename": "ehaa605.pdf",
  "converted_date": "2026-01-31T14:47:04.535102",
  "file_size_bytes": 6073128,
  "original_format": "pdf",
  "document_type": "Guidelines",
  "source_folder": "Guidelines",
  "full_path": "00_RAW_CARDIOLOGY/Guidelines/ehaa605.pdf"
}

=== СОДЕРЖАНИЕ ===

--- Страница 1 ---
ESC GUIDELINES
EuropeanHeartJournal(2021)42,17(cid:2)96
doi:10.1093/eurheartj/ehaa605
2020 ESC Guidelines on sports cardiology and
exercise in patients with cardiovascular disease
The Task Force on sports cardiology and exercise in patients with
cardiovascular disease of the European Society of Cardiology (ESC)
Authors/Task Force Members: Antonio Pelliccia* (Chairperson) (Italy),
Sanjay Sharma* (Chairperson) (United Kingdom), Sabiha Gati (United Kingdom),
Maria Ba€ck (Sweden), Mats Bo¨rjesson (Sweden), Stefano Caselli (Switzerland),
Jean-Philippe Collet (France), Domenico Corrado (Italy), Jonathan A. Drezner
(United States of America), Martin Halle (Germany), Dominique Hansen (Belgium),
Hein Heidbuchel (Belgium), Jonathan Myers (United States of America),
Josef Niebauer (Austria), Michael Papadakis (United Kingdom),
Massimo Francesco Piepoli (Italy), Eva Prescott (Denmark),
Jolien W. Roos-Hesselink (Netherlands), A. Graham Stuart (United Kingdom),
Rod S. Taylor (United Kingdom), Paul D. Thompson (United States of America),
Monica Tiberi (Italy), Luc Vanhees (Belgium), Matthias Wilhelm (Switzerland)
DocumentReviewers:MarcoGuazzi(CPGReviewCoordinator)(Italy),Andre´ LaGerche(CPGReview
Coordinator)(Australia),VictorAboyans(France),PaoloEmilio Adami(Italy),JohannesBacks
(Germany),AaronBaggish(UnitedStatesofAmerica),CristinaBasso(Italy),AlessandroBiffi(Italy),
ChiaraBucciarelli-Ducci(UnitedKingdom),A.John Camm(UnitedKingdom),GuidoClaessen(Belgium),
VictoriaDelgado(Netherlands),PerryM.Elliott(UnitedKingdom),MaurizioGalderisi† (Italy),
ChrisP.Gale(UnitedKingdom),BelindaGray(Australia),KristinaHermann Haugaa(Norway),
BernardIung(France),HugoA.Katus(Germany),AndreKeren(Israel),ChristopheLeclercq(France),
*Correspondingauthors:AntonioPelliccia,DepartmentofMedicine,InstituteofSportMedicineandScience,Rome,Italy.Tel:þ390632759230,Email:antonio.pelliccia@coni.
it;ant.pelliccia@gmail.com.
SanjaySharma,CardiologyClinicalAcademicGroup,StGeorge’s,UniversityofLondon,London,UnitedKingdom.Tel:þ44(0)2087256878,Email:sasharma@sgul.ac.uk.
†WewouldliketopaytributetoProfessorGalderisiwhopassedawayinMarch2020.
ESCCommitteeforPracticeGuidelines(CPG),NationalCardiacSocietiesdocumentreviewersandAuthor/TaskForceMemberaffiliations:listedintheAppendix.
ESCentitieshavingparticipatedinthedevelopmentofthisdocument:
Associations:AssociationofCardiovascularNursing&AlliedProfessions(ACNAP),EuropeanAssociationofCardiovascularImaging(EACVI),EuropeanAssociationof
PreventiveCardiology(EAPC),EuropeanHeartRhythmAssociation(EHRA),HeartFailureAssociation(HFA).
WorkingGroups:AdultCongenitalHeartDisease.
ThecontentoftheseEuropeanSocietyofCardiology(ESC)Guidelineshasbeenpublishedforpersonalandeducationaluseonly.Nocommercialuseisauthorized.Nopartof
theESCGuidelinesmaybetranslatedorreproducedinanyformwithoutwrittenpermissionfromtheESC.Permissioncanbeobtaineduponsubmissionofawrittenrequestto
OxfordUniversityPress,thepublisheroftheEuropeanHeartJournalandthepartyauthorizedtohandlesuchpermissionsonbehalfoftheESC(journals.permissions@oup.com).
Disclaimer.TheESCGuidelinesrepresenttheviewsoftheESCandwereproducedaftercarefulconsiderationofthescientificandmedicalknowledgeandtheevidenceavailableat
thetimeoftheirpublication.TheESCisnotresponsibleintheeventofanycontradiction,discrepancyand/orambiguitybetweentheESCGuidelinesandanyotherofficialrecom-
mendationsorguidelinesissuedbytherelevantpublichealthauthorities,inparticularinrelationtogooduseofhealthcareortherapeuticstrategies.Healthprofessionalsareencour-
agedtotaketheESCGuidelinesfullyintoaccountwhenexercisingtheirclinicaljudgment,aswellasinthedeterminationandtheimplementationofpreventive,diagnosticor
therapeuticmedicalstrategies;however,theESCGuidelinesdonotoverride,inanywaywhatsoever,theindividualresponsibilityofhealthprofessionalstomakeappropriateand
accuratedecisionsinconsiderationofeachpatient’shealthconditionandinconsultationwiththatpatientand,whereappropriateand/ornecessary,thepatient’scaregiver.Nordo
theESCGuidelinesexempthealthprofessionalsfromtakingintofullandcarefulconsiderationtherelevantofficialupdatedrecommendationsorguidelinesissuedbythecompetent
publichealthauthorities,inordertomanageeachpatient’scaseinlightofthescientificallyaccepteddatapursuanttotheirrespectiveethicalandprofessionalobligations.Itisalsothe
healthprofessional’sresponsibilitytoverifytheapplicablerulesandregulationsrelatingtodrugsandmedicaldevicesatthetimeofprescription.
VC TheEuropeanSocietyofCardiology2020.Allrightsreserved.Forpermissions,pleaseemail:journals.permissions@oup.com.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 2 ---
18 ESCGuidelines
BasilS.Lewis(Israel),LluisMont(Spain),ChristianMueller(Switzerland),SteffenE.Petersen(United
Kingdom),AnnaSonia Petronio(Italy),MarcoRoffi(Switzerland),KaiSavonen(Finland),LuisSerratosa
(Spain),EvgenyShlyakhto(RussianFederation),IainA.Simpson(UnitedKingdom),MartaSitges(Spain),
ErikEkker Solberg(Norway),MiguelSousa-Uva(Portugal),EmelineVanCraenenbroeck(Belgium),
CarolineVanDeHeyning(Belgium),WilliamWijns(Ireland)
ThedisclosureformsofallexpertsinvolvedinthedevelopmentoftheseGuidelinesareavailableonthe
ESCwebsitewww.escardio.org/guidelines
FortheSupplementaryDatawhichincludebackgroundinformationanddetaileddiscussionofthedata
thathaveprovidedthebasisfortheGuidelinesseeEuropeanHeartJournalonline.
ClickheretoaccessthecorrespondingchapterinESCCardioMed-section55-Sportsandheartdisease
...................................................................................................................................................................................................
Keywords Guidelines (cid:129) adultcongenitalheartdisease (cid:129) aortopathies (cid:129) arrhythmias (cid:129) cancer (cid:129) cardiomyopathy (cid:129) car-
diovascularriskfactors (cid:129) chroniccoronarysyndromes (cid:129) exercise (cid:129) heartfailure (cid:129) pregnancy (cid:129) peripheral
vasculardisease (cid:129) recommendations (cid:129) riskstratification (cid:129) sport(cid:2) specialenvironments (cid:129) valvularheartdisease
.
Table of Contents .. 4.2.5.2Recommendationsforparticipationinexercisein
.
.
. individualswithdiabetesmellitus............................ 36
.
Abbreviationsandacronyms ....................................... 21 .. 4.2.5.3Cardiacevaluationbeforeexercisein
.
1Preamble ........................................................ 22 .. individualswithdiabetesmellitus............................ 36
.
2Introduction ..................................................... 24 .. 4.3Exerciseandsportsinageing ................................. 37
.
3Identificationofcardiovasculardiseaseandriskstratificationin ... 4.3.1Introduction ............................................ 37
.
individualsparticipatinginrecreationalandcompetitivesports ....... 25 .. 4.3.2Riskstratification,inclusion/exclusioncriteria ............. 37
.
3.1Introduction ................................................ 25 .. 4.3.3Exercisemodalitiesandrecommendationsforexerciseandsport
.
3.2Definitionsofrecreationalandcompetitiveathletes ........... 25 .. intheelderly .................................................... 37
.
3.3Exercise-relatedmajoradversecardiovascularevents ......... 25 .. 5Exerciseinclinicalsettings........................................ 38
.
3.4Incidenceofsuddencardiacdeathinathletes ................. 26 .. 5.1Exerciseprogrammesforleisure-timeandcompetitive
.
3.5Aetiologyofsuddencardiacdeathduringexercise ............ 26 .. sportparticipationinchroniccoronarysyndrome ................ 38
.
3.6Screeningmodalitiesforcardiovasculardiseaseinyoung .. 5.1.1Individualsatriskofatheroscleroticcoronaryartery
.
athletes......................................................... 26 .. diseaseandasymptomaticindividualsinwhomcoronary
. 3.7Screeningforcardiovasculardiseaseinolderathletes.......... 26 .. arterydiseaseisdetectedatscreening ......................... 39
. 4Physicalactivity,leisureexercise,andcompetitivesports .. 5.1.1.1Recommendationsforsportsparticipation ........... 39
.
participation ...................................................... 27 .. 5.1.2Established(long-standing)chroniccoronarysyndrome ... 40
.
4.1Generalintroduction ........................................ 27 .. 5.1.2.1Antithrombotictreatment........................... 42
.
4.1.1Definitionandcharacteristicsofexerciseinterventions.... 27 .. 5.1.3Myocardialischaemiawithoutobstructivediseasein .
4.1.1.1Typeofexercise .................................... 27 .. theepicardialcoronaryartery ................................. 42
.
4.1.1.2Exercisefrequency .................................. 28 .. 5.1.4Returntosportafteracutecoronarysyndrome .......... 42
.
4.1.1.3Exerciseintensity ................................... 28 .. 5.1.4.1Competitiveathletes ................................ 42
.
4.1.1.4Trainingvolume..................................... 28 .. 5.1.4.2Recreationalathletes ................................ 42
.
4.1.1.5Typeoftraining ..................................... 28 .. 5.1.5Anomalousoriginofcoronaryarteries ................... 42
.
4.1.2Classificationofexerciseandsports ...................... 29 .. 5.1.5.1Background ......................................... 42
.
4.2Exerciserecommendationsinindividualswithcardiovascular .. 5.1.5.2Eligibilityforsports .................................. 42
.
riskfactors...................................................... 30 .. 5.1.6Myocardialbridging...................................... 44
.
4.2.1Generalintroduction .................................... 30 .. 5.1.6.1Background ......................................... 44
.
.
4.2.2Obesity ................................................. 34 .. 5.1.6.2Eligibility ............................................ 44
.
4.2.3Hypertension ........................................... 35 . 5.2Exerciserecommendationsinindividualswithchronic
.
.
4.2.4Dyslipidaemia ........................................... 35 . heartfailure..................................................... 44
.
.
4.2.5Diabetesmellitus ........................................ 36 . 5.2.1Background:rationaleforexerciseinchronicheart
.
.
4.2.5.1Effectofexerciseondiabeticcontrol,riskfactors . failure ........................................................ 44
.
.
andoutcomes ............................................. 36 .. 5.2.2Riskstratificationandpreliminaryevaluation .............. 44
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 3 ---
ESCGuidelines 19
.
.
5.2.3Exercisemodalitiesandsportsparticipationinheart . 5.5.2.6Exercisetesting ..................................... 58
.
.
failure ........................................................ 45 . 5.5.2.7Genetictesting...................................... 58
.
.
5.2.3.1Aerobic/enduranceexercise ......................... 45 . 5.5.2.8Exerciserecommendations .......................... 58
.
.
5.2.3.2Resistanceexercise ................................. 45 . 5.5.2.9Specialconsiderations ............................... 58
.
.
5.2.3.3Respiratoryexercise ................................ 45 . 5.5.2.10Follow-up ......................................... 58
.
.
5.2.3.4Aquaticexercise .................................... 45 . 5.5.3Exerciserecommendationsinindividualswithleft
.
.
5.2.4Sportsparticipationandreturntosports ................. 46 . ventricularnon-compaction .................................. 59
.
.
5.2.4.1Competitivesports ................................. 46 . 5.5.3.1Riskstratification .................................... 59
.
.
5.2.4.2Recreationalsports ................................. 46 .. 5.5.3.2Follow-up .......................................... 59
.
5.2.5Heartfailurewithpreservedejectionfraction ............. 47 .. 5.5.4Exerciserecommendationsinindividualswith
.
5.2.5.1Exercisemodalitiesandsportsparticipation .......... 47 .. dilatedcardiomyopathy ....................................... 59
.
5.2.6Exerciseinindividualsafterhearttransplantation.......... 47 .. 5.5.4.1Baselineassessmentofpatientswithdilated
.
5.2.6.1Exercisemodalitiesandsportsparticipation .......... 47 .. cardiomyopathy ........................................... 60
.
5.3Exerciserecommendationsinindividualswithvalvular .. 5.5.4.2Specialconsiderations ............................... 60
.
heartdisease.................................................... 48 .. 5.5.5Exerciserecommendationsinindividualswith
.
5.3.1Introduction ............................................ 48 .. myocarditisandpericarditis ................................... 60
.
5.3.1.1Generalprinciplesinassessmentandrisk .. 5.5.5.1Myocarditis ......................................... 60
.
stratificationofindividualswithvalvularheartdisease .. 5.5.5.2Diagnosis ........................................... 61
. priortoleisureexerciseorcompetitivesports .............. 48 .. 5.5.5.3Riskstratification .................................... 61
.
5.3.1.2Surveillance ......................................... 48 .. 5.5.5.4Exerciserecommendationsforindividualswith
.
5.3.2Aorticvalvestenosis .................................... 48 .. myocarditis ............................................... 61
.
5.3.3Aorticvalveregurgitation ................................ 49 .. 5.5.6Pericarditis .............................................. 61
.
.
5.3.4Bicuspidaorticvalve ..................................... 50 . 5.5.6.1Diagnosis ........................................... 61
.
.
5.3.5Primarymitralregurgitation .............................. 51 . 5.5.6.2Riskstratification .................................... 61
.
.
5.3.5.1Mitralvalveprolapse ................................ 52 . 5.5.6.3Exerciserecommendationsforindividualswith
.
.
5.3.6Mitralstenosis .......................................... 52 . pericarditis ................................................ 62
.
.
5.3.7Tricuspidregurgitation .................................. 53 . 5.6Exerciserecommendationsinindividualswitharrhythmias
.
.
5.4Exerciserecommendationsinindividualswithaortopathy ..... 53 . andchannelopathies ............................................ 62
.
.
5.4.1Introduction ............................................ 53 . 5.6.1Ageneralmanagementframework ....................... 62
.
.
5.4.2Riskofdissection ........................................ 54 . 5.6.2Atrialfibrillation ......................................... 62
.
.
5.4.3Sportingdisciplines ...................................... 54 .. 5.6.2.1Patientswithoutatrialfibrillation ..................... 62
.
5.4.4Effectonaorticdiameterandwallstress .................. 54 .. 5.6.2.2PrognosticandsymptomaticrelevanceofAF
.
5.4.5Recommendations ...................................... 55 .. duringsports .............................................. 63
.
5.5Exerciserecommendationsinindividualswith .. 5.6.2.3Impactofcontinuingsportonthenatural
.
cardiomyopathies,myocarditis,andpericarditis................... 55 .. progressionofatrialfibrillationafterablation ................ 63
.
5.5.1Hypertrophiccardiomyopathy ........................... 55 .. 5.6.3SupraventriculartachycardiaandWolff-Parkinson-
.
5.5.1.1Riskstratificationinhypertrophiccardiomyopathy .... 55 .. Whitesyndrome ............................................. 64
.
5.5.1.2BaselineassessmentofpatientswithHCM ........... 55 .. 5.6.3.1Prognosticandsymptomaticrelevanceof
.
5.5.1.3History ............................................. 55 .. paroxysmalsupraventriculartachycardiawithout
.
5.5.1.4RestingandambulatoryECG ........................ 56 .. pre-excitation ............................................. 64
.
5.5.1.5Echocardiography ................................... 56 .. 5.6.3.2Prognosticandsymptomaticrelevanceof
.
5.5.1.6Cardiacmagneticresonanceimaging ................. 56 .. pre-excitation ............................................. 64
.
5.5.1.7Exercisetesting ..................................... 56 .. 5.6.4Prematureventricularcontractionsandnon-sustained
. 5.5.1.8Genetictesting...................................... 56 .. ventriculartachycardia........................................ 65
.
.
5.5.1.9ESCriskscoreinHCM .............................. 56 . 5.6.4.1Relationbetweennumberofpremature
.
.
5.5.1.10Exerciserecommendation ......................... 56 . ventricularcontractionsandrisk ............................ 65
.
.
5.5.1.11Specialconsiderations.............................. 56 . 5.6.4.2Morphologyofprematureventricularcontractions ... 65
.
.
5.5.1.12Follow-up ......................................... 56 . 5.6.4.3Prematureventricularcontractions:responseto
.
.
5.5.2Arrhythmogeniccardiomyopathy ........................ 57 . exercise ................................................... 65
.
.
5.5.2.1Riskstratificationinarrhythmogenic . 5.6.4.4Practicalmanagementofcardiacpatientswith
.
.
cardiomyopathy ........................................... 57 . prematureventricularcontractionsornon-sustained
.
.
5.5.2.2Baselineassessmentofpatientswitharrhythmogenic . ventriculartachycardiawhowanttoengageinsports ........ 66
.
.
cardiomyopathy ........................................... 57 .. 5.6.5LongQTsyndrome ..................................... 66
.
5.5.2.3History ............................................. 58 .. 5.6.6Brugadasyndrome ...................................... 67
.
5.5.2.4RestingandambulatoryECG ........................ 58 .. 5.6.7Followingdeviceimplantation............................ 68
.
5.5.2.5Echocardiographyandcardiacmagneticresonance .. 5.6.7.1Pacemakers ......................................... 68
.
imaging .................................................... 58 . 5.6.7.2Implantablecardioverterdefibrillators ............... 68
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 4 ---
20 ESCGuidelines
.
.
5.7Exerciserecommendationsinindividualswithadult . Figure2Sportingdisciplineinrelationtothepredominantcomponent
.
.
congenitalheartdisease ......................................... 69 . (skill,power,mixedandendurance)andintensityofexercise.Intensityof
.
.
5.7.1Introduction ............................................ 69 . exercisemustbeindividualizedaftermaximalexercisetesting,fieldtest-
.
.
5.7.2Theincreasingnumbersofathleteswithcongenital . ingand/oraftermuscularstrengthtesting ........................... 29
.
.
heartdisease ................................................. 69 . Figure3aand3bSCOREchartsforEuropeanpopulationsof
.
.
5.7.3Non-cardiacabnormalitiesincongenitalheartdisease . countriesatHIGHandLOWcardiovasculardiseaserisk ............ 31
.
.
andParalympicsport ......................................... 69 . Figure4Proposedalgorithmforcardiovascularassessmentin
.
.
5.7.4Generalconsiderationsinthecongenitalheart . asymptomaticindividualswithriskfactorsforandpossible
.
.
diseaseathlete ............................................... 69 .. subclinicalchroniccoronarysyndromebeforeengaginginsports
.
5.7.5Suddendeathduringsport ............................... 70 .. forindividualsaged>35years ...................................... 34
.
5.7.6Exerciseinathleteswithcongenitalheartdisease: .. Figure5Clinicalevaluationandrecommendationsforsports
.
currentguidelinesandrecommendations ...................... 70 .. participationinindividualswithestablishedcoronaryarterydisease .... 41
.
5.7.7Assessmentoftheathletewithcongenitalheartdisease ... 70 .. Figure6Schematicrepresentationofthemostfrequent
.
6Keymessages.................................................... 72 .. anomalousoriginofcoronaryarteriesandassociatedriskof
.
7Gapsinevidence ................................................ 73 .. suddencardiacdeath .............................................. 43
.
8Sexdifferences .................................................. 74 .. Figure7Schematicrepresentationofamyocardialbridge ........... 44
.
9‘Whattodo’and‘whatnottodo’messagesfromtheGuidelines ... 75 .. Figure8Specificmarkersofincreasedriskofsuddencardiac
.
10Supplementarydata ............................................ 78 .. deathwithmitralvalveprolapse .................................... 52
. 11Appendix ...................................................... 78 .. Figure9Pre-participationassessmentofindividualswithcongenital
.
12References ..................................................... 80 .. heartdisease....................................................... 55
.
.
.
.
.
List of tables .. Tables of recommendations
.
.
.
.
Table1Classesofrecommendations ............................... 23 . Generalrecommendationsforexerciseandsportsinhealthy
.
.
Table2Levelsofevidence ......................................... 23 . individuals ......................................................... 33
.
.
Table3Characteristicsofexercise ................................. 28 .. Recommendationsforcardiovascularevaluationandregular
.
Table4Indicesofexerciseintensityforendurancesportsfrom .. exerciseinhealthyindividualsaged>35years ....................... 34
.
maximalexercisetestingandtrainingzones ......................... 30 .. Specialconsiderationsforindividualswithobesity,hypertension,
.
Table5Cardiovascularriskcategories .............................. 33 .. dyslipidaemia,ordiabetes .......................................... 37
.
Table6Potentialrisksforolderpeopleduringexercise ............. 38 .. Recommendationsforexerciseinageingindividuals ................. 38
.
Table7Exerciseprescriptionintheelderly ......................... 38 .. Recommendationsforexerciseinindividualsatriskof
.
Table8Exerciseactivitiesforolderpeopleaccordingtoexercise .. atheroscleroticcoronaryarterydiseaseandasymptomatic
.
typeandintensity.................................................. 38 .. individualsinwhomcoronaryarterydiseaseisdetectedat
.
Table9BorderlineoruninterpretableECGfindings ................. 39 .. screening ......................................................... 40
.
Table10Factorsdeterminingriskofadverseeventsduring .. Recommendationsforexerciseinindividualswithlong-standing
.
intensiveexerciseandcompetitivesportsinasymptomatic .. chroniccoronarysyndrome ....................................... 41
.
individualswithlong-standingcoronaryarterydisease ............... 40 .. Recommendationsforreturntoexerciseafteracutecoronary .
Table11High-riskfeaturesforexercise-inducedadversecardiac .. syndrome ......................................................... 42
.
eventsinpatientswithatheroscleroticcoronaryarterydisease ...... 40 .. Recommendationsforexerciseinyoungindividuals/athletes
.
.
Table12Optimalexercisetrainingdoseforpatientswithchronic . withanomalousoriginsofcoronaryarteries ........................ 43
.
. heartfailure ....................................................... 45 . Recommendationsforexercise/sportsinindividualswith
.
.
Table13Factorsinfluencingdecreasedexercisecapacity . myocardialbridging ................................................ 44
.
.
(peakVO )andreducedcardiacoutputinindividualswithheart . Recommendationsforexerciseprescriptioninheartfailure
2 . .
transplants ........................................................ 47 . withreducedormid-rangeejectionfraction ........................ 46
.
.
Table14Classificationofrisktoperformsportsinpatientswith . Recommendationsforparticipationinsportsinheartfailure ......... 46
.
.
aorticpathology ................................................... 54 . Recommendationsforexerciseandparticipationinsportin
.
.
Table15Findingsduringaninvasiveelectrophysiologicalstudy . individualswithheartfailurewithpreservedejectionfraction ........ 47
.
.
(withtheuseofisoprenaline)indicatinganaccessory .. Recommendationsforexerciseandparticipationinsportin
.
pathwaywithincreasedriskofsuddendeath ........................ 48 .. hearttransplantrecipients ......................................... 48
.
Table16Baselineparametersforassessmentincongenital .. Recommendationsforexerciseandparticipationinrecreational/
.
heartdisease ...................................................... 55 .. leisure-timesportsinasymptomaticindividualswithaorticstenosis .... 49
.
.. Recommendationsforparticipationincompetitivesportsin
.
List of figures .. asymptomaticindividualswithaorticstenosis ....................... 49
.
.. Recommendationsforparticipationinrecreational/leisure-time
.
FigureCentralillustrationModeratephysicalactivityshouldbepromoted .. sportsinasymptomaticindividualswithaorticregurgitation ......... 50
.
inallindividualswithcardiovasculardisease ......................... 24 .. Recommendationsforparticipationincompetitivesportsin
.
Figure1Componentsforexpressionofphysicalfitness ............. 27 . asymptomaticindividualswithaorticregurgitation .................. 50
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 5 ---
ESCGuidelines 21
.
Recommendationsforparticipationinrecreational/leisure-time .. BP Bloodpressure
.
sportsinasymptomaticindividualswithmitralregurgitation ......... 51 .. BrS Brugadasyndrome
.
Recommendationsforparticipationincompetitivesportsin .. CAC Coronaryarterycalcium
.
asymptomaticindividualswithmitralregurgitation .................. 51 .. CAD Coronaryarterydisease
.
Recommendationsforparticipationinrecreational/leisure-time .. CCS Chroniccoronarysyndrome
.
sportsinindividualswithmitralstenosis ............................ 53 .. CCTA Coronarycomputedtomographyangiography
.
Recommendationsforparticipationincompetitivesportsin .. CHD Congenitalheartdisease
.
asymptomaticindividualswithmitralstenosis ....................... 53 .. CKD Chronickidneydisease
.
Recommendationsforexerciseandparticipationinsportsin .. CMD Coronarymicrovasculardysfunction
.
individualswithaorticpathology ................................... 55 .. CMR Cardiacmagneticresonance
.
Recommendationsforexerciseandsportsparticipationin .. CPET Cardiopulmonaryexercisetest
.
individualswithhypertrophiccardiomyopathy ...................... 57 .. CPR Cardiopulmonaryresuscitation
.
Recommendationsforexerciseandsportsparticipationin .. CT Computedtomography
.
individualswitharrhythmogeniccardiomyopathy ................... 58 .. CV Cardiovascular
.
Recommendationsforexerciseinindividualswithleftventricular .. CVA Cerebrovascularaccident
.
non-compactioncardiomyopathy .................................. 59 .. CVD Cardiovasculardisease
.
Recommendationsforexerciseinindividualswithdilated ... DBP Diastolicbloodpressure
cardiomyopathy ................................................... 60 ... DCM Dilatedcardiomyopathy
Recommendationsforexerciseinindividualswithmyocarditis....... 62 ... EACPR EuropeanAssociationforCardiovascularPrevention
Recommendationsforexerciseandsportsparticipationin ... andRehabilitation
.
individualswithpericarditis ........................................ 62 .. EAPC EuropeanAssociationofPreventiveCardiology
.
Recommendationsforexerciseinindividualswithatrialfibrillation ... 63 .. ECV Extracellularvolume
.
Recommendationsforexerciseandsportsparticipationin .. ECG Electrocardiogram
.
individualswithparoxysmalsupraventriculartachycardiaand .. EDS EhlersDanlossyndrome
.
pre-excitation ..................................................... 65 .. EF Ejectionfraction
.
Recommendationsforexerciseinindividualswithpremature .. EP Electrophysiological
.
ventricularcontractionsornon-sustainedventriculartachycardia .... 66 .. ESC EuropeanSocietyofCardiology
.
RecommendationsforexerciseinlongQTsyndrome ............... 67 .. Ex-R Exercise-related
.
RecommendationsforexerciseinBrugadasyndrome ............... 67 .. exCR Exercise-basedcardiacrehabilitation
.
Recommendationsforexerciseinindividualswithpacemakers .. FFR Fractionalflowreserve
.
andimplantablecardioverterdefibrillators .......................... 69 .. FITT Frequency,intensity,time,andtype
.
Recommendationsforexerciseinindividualswithcongenital .. HCM Hypertrophiccardiomyopathy
.
heartdisease ...................................................... 72 .. HDL High-densitylipoprotein
.
.
. HF Heartfailure
.
.
. HIIT High-intensityintervaltraining
Abbreviations and acronyms ..
. HR Heartrate .
.
. HFmrEF Heartfailurewithmid-rangeejectionfraction .
ACE Angiotensin-convertingenzyme .
. HFpEF Heartfailurewithpreservedejectionfraction
.
ACHD Adultswithcongenitalheartdisease .
.. HFrEF Heartfailurewithreducedejectionfraction
ACM Arrhythmogeniccardiomyopathy . .. HRmax Maximalheartrate
ACS Acutecoronarysyndromes . .. HRR Heartratereserve
AED Automaticexternaldefibrillator .
.. HTAD Hereditarythoracicaorticdisease
AHA AmericanHeartAssociation .
.. HTx Hearttransplant
AF Atrialfibrillation ...
ICD Implantablecardioverterdefibrillator
AFL Atrialflutter ...
IMT Intima(cid:2)mediathickness
AMI Acutemyocardialinfarction ...
INOCA Ischaemicandnon-obstructivecoronaryarterydisease
AN-SUD Autopsy-negativesuddenunexplaineddeath ...
LBBB Leftbundlebranchblock
AP Accessorypathway ...
LDL Low-densitylipoprotein
AOCA Anomalousoriginofcoronaryarteries ...
LEAD Lowerextremityarterydisease
AR Aorticvalveregurgitation ...
LGE Lategadoliniumenhancement
ARVC Arrhythmogenicrightventricularcardiomyopathy ..
. LV Leftventricular
AS Aorticvalvestenosis ..
. LVEDD Leftventricularend-diastolicdiameter
ASI Aorticsizeindex ..
. LVEF Leftventricularejectionfraction
AVNRT Atrioventricularnodalre-entranttachycardia ..
. LVNC Leftventricularnon-compaction
AVRT Atrioventricularre-entranttachycardia ..
. LVOT Leftventricularoutflowtract
.
BAV Bicuspidaorticvalve .
. LQTS LongQTsyndrome
.
BMI Bodymassindex .
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 6 ---
22 ESCGuidelines
.
.
MACE Majoradversecardiovascularevents .. and their recommendations should facilitate decision making of
.
MB Myocardialbridge/bridging .. healthprofessionalsintheirdaily practice.However, thefinaldeci-
.
MCE Moderatecontinuousexercise .. sionsconcerninganindividualpatientmustbemadebytheresponsi-
.
MET Metabolicequivalent .. ble health professional(s) in consultation with the patient and
.
MFS Marfansyndrome .. caregiverasappropriate.
.
MI Myocardialinfarction .. AgreatnumberofGuidelineshavebeenissuedinrecentyearsby
.
MR Mitralregurgitation .. theEuropeanSocietyofCardiology(ESC),aswellasbyothersoci-
.
MS Mitralstenosis .. etiesandorganizations.Becauseoftheirimpactonclinicalpractice,
.
MVA Mitralvalvearea .. quality criteria for the development ofguidelines have been estab-
.
MVP Mitralvalveprolapse .. lishedinordertomakealldecisionstransparenttotheuser.Therec-
.
NSVT Non-sustainedventriculartachycardia .. ommendations for formulating and issuing ESC Guidelines can be
.
NYHA NewYorkHeartAssociation .. found on the ESC website (http://www.escardio.org/Guidelines-&-
.
OAC Oralanticoagulants .. Education/Clinical-Practice-Guidelines/Guidelines-development/Wri .
PA Physicalactivity .. ting-ESC-Guidelines).TheESCGuidelinesrepresenttheofficialposi-
.
PAD Peripheralarterialdisease ... tionoftheESConagiventopicandareregularlyupdated.
PAP Pulmonaryarterypressure ... Inaddition to thepublication ofClinical PracticeGuidelines, the
PCI Percutaneouscoronaryintervention ... ESCcarriesouttheEurObservationalResearchProgrammeofinter-
PCSK-9 Proproteinconvertasesubtilisin/kexintype9 ... nationalregistriesofcardiovasculardiseasesandinterventionswhich
.
PET Positronemissiontomography .. are essential to assess, diagnostic/therapeutic processes, use of
.
PH Pulmonaryhypertension .. resourcesandadherencetoGuidelines.Theseregistriesaimatpro-
.
PM Pacemaker .. viding a better understanding of medical practice in Europe and
.
PSVT Paroxysmalsupraventriculartachycardia .. aroundtheworld,basedonhigh-qualitydatacollectedduringroutine
.
PVC Prematureventricularcontraction .. clinicalpractice.
.
PVI Pulmonaryveinisolation .. Furthermore,theESChasdevelopedandembedded,insomeof
.
RBBB Rightbundlebranchblock .. itsguidelines,asetofqualityindicators(QIs)whicharetoolstoevalu-
.
RM Repetitionmaximum .. atethelevelofimplementationoftheGuidelinesandmaybeusedby
.
RPE Ratingofperceivedexertion .. theESC,hospitals,healthcareprovidersandprofessionalstomeasure
.
RT-PCR Reversetranscriptasepolymerasechainreaction .. clinicalpracticeaswellasusedineducationalprogrammes,alongside
.
RV Rightventricular .. thekeymessagesfromtheGuidelines,toimprovequalityofcareand
.
RVOT Rightventricularoutflowtract .. clinicaloutcomes.
.
SBP Systolicbloodpressure .. TheMembersofthisTaskForcewereselectedbytheESC,includ-
.
SCA Suddencardiacarrest .. ing representation from its relevant ESC sub-specialty groups, in
.
SCAD Spontaneouscoronaryarterydissection .. order to representprofessionalsinvolved withthe medicalcare of
.
SCD Suddencardiacdeath .. patientswiththispathology.Selectedexpertsinthefieldundertooka
.
SCORE SystematicCoronaryRiskEvaluation .. comprehensivereviewofthepublishedevidenceformanagementof
.
sPAP Systolicpulmonaryarterypressure .. a given condition according to ESC Committee for Practice .
SPECT Single-photonemissioncomputedtomography .. Guidelines(CPG)policy.Acriticalevaluationofdiagnosticandthera- .
TIA Transientischaemicattack ... peutic procedures was performed, including assessment of the
TR Tricuspidregurgitation ... risk(cid:2)benefitratio.Thelevelofevidenceandthestrengthoftherec-
T2DM TypeIIdiabetesmellitus ... ommendationofparticularmanagementoptionswereweighedand
US UnitedStates ... gradedaccordingtopredefinedscales,asoutlinedbelow.
.
VA Ventriculararrhythmia .. Theexpertsofthewritingandreviewingpanelsprovideddeclaration
.
VAD Ventricularassistdevice .. ofinterestformsforallrelationshipsthatmightbeperceivedasrealor
.
VF Ventricularfibrillation .. potentialsourcesofconflictsofinterest.Theirdeclarationsofinterest
.
VT Ventriculartachycardia .. werereviewedaccordingtotheESCdeclarationofinterestrulesand
.
VO
2
Oxygenconsumption ... canbefoundontheESCwebsite(http://www.escardio.org/guidelines).
VO
2max
Maximumoxygenconsumption ... Thisprocessensurestransparencyandpreventspotentialbiasesinthe
VO
2peak
Peakoxygenconsumption ... development and review processes. Any changes in declarations of
WADA WorldAnti-DopingAgency .. interestthatariseduringthewritingperiodwerenotifiedtotheESC
.
WPW Wolff-Parkinson-White .. andupdated.TheTaskForcereceiveditsentirefinancialsupportfrom
.
. theESCwithoutanyinvolvementfromthehealthcareindustry.
.
.
1. Preamble
.. The ESC CPG supervises and coordinates the preparation of
.
.. new Guidelines. The Committee is also responsible for the
.
Guidelinessummarizeandevaluateavailableevidencewiththeaimof
... endorsement process of these Guidelines. The ESC Guidelines
assisting health professionals in proposing the best management
... undergoextensivereviewbytheCPGandexternalexperts.After
strategiesforanindividualpatientwithagivencondition.Guidelines
.. appropriate revisions the Guidelines are approved by all the
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 7 ---
ESCGuidelines 23
Table1 Classesofrecommendations
Wording to use
Class I Evidence and/or general agreement Is recommended or is indicated
that a given treatment or procedure is
Class II
Class IIa Weight of evidence/opinion is in Should be considered
Class IIb May be considered
established by evidence/opinion.
Class III Evidence or general agreement that the Is not recommended
given treatment or procedure is not
useful/effective, and in some cases
may be harmful.
Table2 Levelsofevidence
Level of Data derived from multiple randomized clinical trials
evidence A or meta-analyses.
Level of Data derived from a single randomized clinical trial
evidence B or large non-randomized studies.
Level of Consensus of opinion of the experts and/or small studies,
evidence C retrospective studies, registries.
.
.
experts involved in the Task Force. The finalized document is . moredetailedinformation,theusershouldalwaysaccesstothefull
.
.
approved by the CPG for publication in the European Heart .. textversionoftheGuidelines,whichisfreelyavailableviatheESC
.
Journal. The Guidelines were developed after careful considera- .. website and hosted on the EHJ website. The National Cardiac
.
tion of the scientific and medical knowledge and the evidence .. Societies of the ESC are encouraged to endorse, adopt, translate
.
availableatthetimeoftheirdating. .. and implement all ESC Guidelines. Implementation programmes
.
ThetaskofdevelopingESCGuidelinesalsoincludesthecreation .. areneededbecauseithasbeenshownthattheoutcomeofdisease
.
ofeducationaltoolsandimplementationprogrammesfortherec- .. maybefavourablyinfluencedbythethoroughapplicationofclinical
.
ommendations including condensed pocket guideline versions, .. recommendations.
.
summaryslides, booklets with essential messages,summary cards .. HealthprofessionalsareencouragedtotaketheESCGuidelines
.
fornon-specialistsandanelectronicversionfordigitalapplications .. fullyintoaccountwhenexercisingtheirclinicaljudgment,aswellasin
.
(smartphones, etc.). These versions are abridged and thus, for .. thedeterminationandtheimplementationofpreventive,diagnostic
snoitadnemmocer
fo
sessalC
0202
CSE©
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 8 ---
24 ESCGuidelines
.
ortherapeuticmedicalstrategies.However,theESCGuidelinesdo .. European Society of Cardiology (ESC) in 20051 and some aspects
.
not override inany waywhatsoever theindividualresponsibility of .. were subsequently updated in 2018 and 2019.2,3 The overarching
.
.
health professionalstomake appropriate and accurate decisions in . aimoftheserecommendationswastominimizetheriskofadverse
.
.
considerationofeachpatient’shealthconditionandinconsultation . eventsin highlytrainedathletes.Itisimportantto recognize,how-
.
.
withthatpatientorthepatient’scaregiverwhereappropriateand/or . ever,thatmostoftheexercisingpopulationengagesinleisuresport
.
.
necessary. Itis alsothehealth professional’s responsibility to verify . andsolorecreationalexerciseand,unlikeeliteathletes,theseindivid-
.
.
therulesandregulationsapplicableineachcountrytodrugsanddevi- . ualshaveahigherprevalenceofriskfactorsforatherosclerosisand
.
.
cesatthetimeofprescription. . establishedCVD.
.
.
. Regularphysicalactivity(PA),includingsystematicexercise,isan
.
.
. importantcomponentoftherapyformostCVDsandisassociated
.
.
2. Introduction . withreducedcardiovascular(CV)andall-causemortality.Inanera
.
.
.. wherethereisanincreasingtrendtowardsasedentarylifestyleanda
.
Exerciserecommendationsandeligibilitycriteriaforsportsparticipa- .. risingprevalenceofobesityandassociatedCVDs,thepromotionof
.
tionincompetitiveathleteswithcardiovasculardisease(CVD)were .. PAandregularexerciseismorecrucialthaneverandattheforefront
.
originally published by the Sports Cardiology Section of the . of priorities for all scientific CV societies. Even during routine
FigureCentralillustration Moderatephysicalactivityshouldbepromotedinallindividualswithcardiovasculardisease.Appropriateriskstratifi-
cationandoptimaltherapyareessentialforprovidingexerciseprescriptionformorevigorousactivity.Individualsshouldbeinvolvedinthedecisionmaking
processandarecordofthediscussionandexerciseplanshouldbedocumentedinthemedicalrecords.
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 9 ---
ESCGuidelines 25
.
consultationsforotherconsiderations,physiciansareencouragedto .. knownmalignancies.7(cid:2)16Despitethesubstantialhealthbenefitspro-
.
.
promoteexerciseinallpatients. . videdbyregularPA,intenseexercisemayparadoxicallyactasatrig-
.
.
Althoughproportionatelyscarce,exercisemayparadoxicallytrig- . gerforlife-threateningventriculararrhythmias(VAs)inthepresence
.
.
gersuddencardiacarrest(SCA)inindividualswithCVD,particularly . ofunderlyingCVD.Indeed,suddencardiacdeath(SCD)istheleading
.
thosewhowerepreviouslysedentaryorhaveadvancedCVD.4,5In .. cause ofsports and exercise-related mortalityin athletes.17(cid:2)19CV
.
parallel with the drive to promote exercise in all individuals,6 it is .. safetyduringsportsparticipationforindividualsatalllevelsandages
.
.
anticipatedthatphysicianswillbeconfrontedwithanincreasingnum- . isimperativetoavoidcatastrophicandoftenpreventableSCDand
.
.
berofenquiriesfromindividualswithestablishedriskfactorsforcor- . has become a common goal among medical and sports governing
.
.
onaryarterydisease(CAD)orestablishedCVDsaboutparticipation .. organizations.20(cid:2)24
.
inexerciseprogrammesandrecreationalsportsactivities.Suchcon- .. Pre-participationCVscreeningaimedatthedetectionofdisorders
.
sultationsneedtostrikeabalancebetweenthemultiplebenefitsof .. associatedwithSCDisuniversallysupportedbymajormedicalsoci-
.
exercise,thesmallriskofsuddendeath,andthepatient’sgoalsfor .. eties.20(cid:2)22,25,26 However, the best method for CV screening of
.
cardiorespiratoryfitnessandongoingparticipationinrelativelystren- .. young competitive athletes (<35 years old) remains controversial,
.
uousexercisefollowingaCVdiagnosis. .. andlimited data are availableto guide recommendations in master
.
The current Guidelines for exercise and sports participation in .. athletes(>_35yearsold)
.
individualswithCVDarethefirstofakindbytheESC.Sportscardiol- .. Screeningstrategiesmustbetailoredtothetargetpopulationand
.
ogy is a relatively novel and emerging sub-speciality, therefore the .. the specific disorders with highest risk. SCD in young athletes is
.
evidencebaseforthenaturalhistoryofdiseaseprogressionorriskof .. causedbyavarietyofstructuralandelectricaldisordersoftheheart,
. deathduringintensiveexerciseandcompetitivesportamongindivid- .. includingcardiomyopathies,ionchanneldisorders,coronaryanoma-
.
ualswithCVDisrelativelysparse.Thisisreflectedbythefactthata .. lies,and acquired cardiacconditions.17,27,28Inadultandseniorath-
.
.
disproportionatelylargenumberofrecommendationsarerelianton . letes,atheroscleroticCADistheprimaryconditionleadingtomajor
.
thewisdomandvastexperienceoftheconsensusgroupratherthan .. adversecardiovascularevents(MACE).28,29
.
.
onlargeprospectivestudies.Weacknowledgetheinherentdifficul- .
.
.
tiesinformulatingrecommendationsforallscenariosinaheteroge- . 3.2 Definitions of recreational and
.
.
neous population with a diverse spectrum of CVDs in light of the .. competitive athletes
.
limited availability of evidence. Therefore, these recommendations .
.. The ESC defines anathlete as ‘anindividual ofyoungoradult age,
shouldnotbeconsideredaslegallybindingandshouldnotdiscourage .
.. either amateur or professional, who is engaged in regular exercise
individualphysiciansfrompractisingoutsidetheremitofthisdocu- .
.. training and participates in official sports competition’.1,30 Similarly,
ment,basedontheirclinicalexperienceinsportscardiology. .
.
. theAmericanHeartAssociation(AHA)andothersdefineacompeti-
Wherepossible,theGuidelineshaveincludedthemostup-to-date .
.
. tiveathleteasanindividualinvolvedinregular(usuallyintense)train-
researchinexercisingindividualswithCVD.ThecurrentGuidelines ..
. ing in organized individual or team sports, with an emphasis on
also draw upon existing ESC Guidelines for the investigation, risk ...
competitionandperformance.31,32Athletesinvolvedincompetitive
assessment,andmanagementofindividualswithCVDstoaidphysi- ..
. sports span the age spectrum and can compete at the youth, high
cianswhenprescribingexerciseprogrammesorprovidingadvicefor ..
. school,academy,university,semi-professional,professional,national,
sportsparticipation.Wehopethatthedocumentwillserveasause- ..
. international,andOlympiclevels.Asadistinction,arecreationalath-
fulclinicalguidebutalsoasanincentiveforfutureresearchtochal- ..
. leteengagesinsportsforpleasureandleisure-timeactivity,whereas
lengeestablishedwisdom. ..
. acompetitiveathleteishighlytrainedwithagreateremphasisonper-
Inlinewithgoodclinicalpractice,thepresentdocumentencour- ..
. formanceandwinning.Inaproposedclassificationofathletesbased
agesshareddecisionmakingwiththeathletepatientandrespectsthe ..
. on the minimum volume of exercise, ‘elite’ athletes (i.e. national
autonomy of the individual after provision of detailed information ..
abouttheimpactofsportsandthepotentialrisksofcomplications
... team,Olympians,and professionalathletes)generallyexercise>_10
and/oradverseevents(Centralillustration).Similarly,allexercisepre-
... h/week; ‘competitive’ athletes [i.e. high school, college, and older
.. (master)club level athletes] exercise>_6 h/week;and ‘recreational’
scription and related discussions between the individual and the .
.. athletesexercise>_4h/week.33Thisdistinctionissomewhatarbitrary
physicianshouldbedocumentedinthemedicalreport. .
.. since some recreational athletes, such as long-distance cyclists and
.
.. runners,engageinexerciseathighervolumesthansomeprofessional
.
.. athletesparticipatinginskillsports.
3. Identification of cardiovascular .
.
.
.
disease and risk stratification in .. 3.3 Exercise-related major adverse cardi-
.
.
individuals participating in .. ovascular events
.
.
recreational and competitive
.. Exercise-relatedMACEincludeSCAandSCD;acutecoronarysyn-
.
.. dromes(ACS)suchasmyocardialischaemiaandmyocardialinfarc-
sports ...
tion (MI); transient ischaemic attacks (TIA) and cerebrovascular
.
.. accidents(CVA);andsupraventriculartachyarrhythmias.
3.1 Introduction ...
SCAisdefinedasanunexpectedcollapseduetoacardiaccausein
.
Higher levels of PA and fitness are associated with lower all-cause .. which cardiopulmonary resuscitation (CPR) and/or defibrillation is
.
mortality, lower rates of CVD, and lower prevalence of several . provided in an individual regardless of the survival outcome.17,27,32
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 10 ---
26 ESCGuidelines
.
SCDisdefinedasasuddenunexpecteddeathduetoacardiaccause, .. basketballplayershadariskof1in5300.17Basedonavailablestudies
.
.
orasuddendeathinastructurallynormalheartatautopsywithno . andasystematicreviewoftheliterature,agenerallyacceptedannual
.
.
other explanation for death and a history consistent with cardiac- . incidenceofallSCAisapproximately1in80000inhighschool-aged
.
relateddeath(i.e.requiringcardiacresuscitation).17,27,32Inorderto .. athletes and 1 in 50 000 in college-aged athletes.50 Male athletes,
.
.
comparepreviouslyreporteddataonSCAandSCDusingvariable . black athletes, basketball (US)and soccer (Europe) athletes repre-
.
.
definitions,thetimingoftheeventshouldbecategorizedasoccurring . senthigherriskgroups.Limitedestimatesareavailableforyouth,pro-
.
.
duringtheepisode,withinthefirsthourpost-exercise,orbetween1 . fessional,andmasterathletes.
.
.
to24hpost-exercise.30Theactivityatthetimeoftheeventcanbe .
.
.
furthercharacterizedasoccurringduringtrainingorcompetition,at .. 3.5 Aetiologyof sudden cardiac death
.
rest,orduringsleep.30 .. during exercise
.
Exercise-induced ACS are most likely to affect adult and senior ...
SCD in young athletes is usually caused by a genetic or congenital
athletesandresultfromatheroscleroticplaquedisruptionandcoro- ... structural cardiac disorder.17(cid:2)19,42,53,54 However, autopsy-negative
narythrombosisinmostcases.34,35Morethan50%ofpatientswho ...
sudden unexplained death (AN-SUD), also referred to as sudden
experienceacuteMI(AMI)andSCAdonothavepre-existingsymp- ...
arrhythmicdeathsyndrome,isreportedonpost-mortemexamina-
tomsoraknownhistoryofCAD.36,37Inlong-termenduranceath- ...
tioninupto44%ofpresumedSCDcasesdependingonthestudy
letes,SCAandmyocardialischaemiacanalsooccurfrom‘demand’ ... population.17,28,42,53(cid:2)56 In apparently healthy young athletes the
ischaemiaduetoanimbalancebetweenoxygensupplyanddemand ... prevalence of cardiac disorders associated with SCD is approxi-
resultingfromstablecalcifiedplaqueandafixedstenosis.38Inastudy ...
mately 0.3%, and this figure is supported by multiple studies using
ofUnitedStates(US)marathonandhalf-marathonraces,noneofthe ..
. non-invasiveevaluationtoolstodetectcardiacdisordersatelevated
runnerswithSCAwithserious(>80%coronaryarterystenosisina ... riskofSCD.20,57(cid:2)65
.
proximalleftcoronaryarteryorthree-vesseldisease)coronaryathe- .
. Inathletes>35yearsofage,morethan80%ofallSCDisdueto
.
rosclerosis had angiographic evidence of acute plaque rupture or .
. atherosclerotic CAD, and vigorous physical exertion is associated
thrombus.38 ...
withanincreasedriskofAMIandSCD.34,66(cid:2)70Theathletesatgreat-
.
.
. estriskarethosewithlittleornobackgroundinsystematictraining.
.
.
.
3.4 Incidence of sudden cardiac death in .
.
. 3.6 Screening modalities for
athletes ..
.. cardiovascular disease inyoung athletes
Currentestimates oftheincidence of SCD in competitiveathletes ..
rangefromalmost1inamillionto1in5000athletesperyear.17,39,40 ... Mostexpertsbelievethatearlydetectionofpotentiallylethaldisor-
Differencesincurrentestimatesarelargelyduetoinconsistentstudy
... ders in athletes can decrease CV morbidity and mortality through
methodologyandheterogeneouspopulationcomparisons.
... riskstratification,disease-specificinterventions,and/orexercisemod-
Because reporting of SCD in athletes is not mandatory in most
... ifications.22,57,58,71CVscreeningbyhistoryandphysicalexamination
countries, studies risk underestimating the true incidence due to
... orbyelectrocardiogram(ECG)presentsuniquechallengesandlimi-
incomplete case ascertainment. For instance, studies using media
... tations.Severalstudieshavedocumentedthelowsensitivityandhigh
reportsastheirmainsourcetodetectincidentsofSCDidentifyonly
... positive response rate of pre-participation history ques-
5-56% of cases, even in high-profile competitive athletes.41(cid:2)44 ... tionnaires.64,65,72(cid:2)75 In CV screening studies in which experienced
Similarly,useofcatastrophicinsuranceclaimsastheonlymethodfor
... clinicians use contemporary ECG interpretation standards, ECG
caseidentificationmissed83%ofSCDcasesand92%ofallSCAcases
... screeningoutperformshistoryandphysicalexaminationinallstatisti-
inMinnesotahighschoolathletes.40,45
... calmeasuresofperformance.58,59,62,64,65,74,76
.. Whileechocardiography mayidentify additionalstructuraldisor-
The athlete population being studied also needs to be precisely .
.
. ders,thereisinsufficientevidencetorecommendanechocardiogram defined. Census population statistics, cross-sectional surveys, and .
.. forroutinescreening.77
self-reportedathleteparticipationdataallproducelessreliablecalcu- .
.
.
lations. Other study details should also be considered. Does the .
.. 3.7 Screening forcardiovascular disease
studyincludeallcasesofSCA(survivorsplusdeaths)oronlySCD? .
.
. in older athletes
Doesthestudyincludecasesoccurringatanytime(i.e.duringexer- .
.
.
cise,rest,orsleep),oronlythosethatoccurduringsports?Studies . The recommendations and evidence base for CVscreeningin ath-
.
.
indicatethat56-80%ofSCAinyoungathletesoccursduringexer- . letes>35yearsofagearelimited.CVscreeninginadultandsenior
.
cisewiththeremaindernon-exertional.17,18,46 .. athletesmusttargetthehigherprevalenceofatheroscleroticCAD.
.
.
EvidencesupportsthatsomeathletesdisplayahigherriskforSCA . However, routine screening for ischaemia with exercise testing in
.
.
basedonsex,race,orsport.17,40,41,45(cid:2)50Incidenceratesareconsis- .. asymptomatic adults hasa low positive predictive value and a high
.
tentlyhigherinmaleathletesthaninfemaleathletes,witharelative .. numberoffalse-positivetestsandisnotrecommended.78(cid:2)80
.
riskrangingfrom3:1to9:1(male:female).17,45,47(cid:2)49,51,52Blackath- .. AscreeningECGmaystilldiscoverundiagnosedcardiomyopathies
.
letesofAfricanCaribbeandescentalsohaveahigherriskthanwhite .. and primary electrical disorders in older athletes, and risk factor
.
athletes.InUScollegeathletes,maleshadahigherriskthanfemales .. assessmentforCVDmayidentifyhigherriskindividualswhowarrant
.
(1in38000vs.1in122000),andblackathleteshada3.2timeshigher .. additionaltesting.Thus,consistentwitha2017ESCpositionpaper
.
riskthanwhiteathletes(1in21000vs.1in68000).17Malebasketball .. onpre-participationCVscreening,exercise ECGtestingshouldbe
.
playershadthehighestannualriskofSCD(1in9000),andmaleblack . reservedforsymptomaticathletesorthosedeemedathighriskof
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 11 ---
ESCGuidelines 27
.
CAD based on the ESC Systematic Coronary Risk Evaluation .. visceral fat, bone density, and flexibility);84 a muscular component
.
.
(SCORE)system(seechapters4and5).6,81 . (power or explosive strength, isometric strength, muscular endur-
.
.
Exercisetestingmayalsobeusefultoevaluatethebloodpressure .. ance);85amotorcomponent(agility,balance,coordination,speedof
.
(BP) response to exercise, the occurrence of exercise-induced .. movement);85 a cardiorespiratory component (endurance or sub-
.
arrhythmias,andtoassesssymptomsorphysicalperformanceandits .. maximal exercise capacity, maximal aerobic power, heart function,
.
relationtoexercisetraining.81Inadultandelderlyindividuals,espe- .. lung function, BP); and a metabolic component (glucose tolerance,
.
ciallythosena¨ıvetomoderatetovigorousPA,exercisetestingorcar- .. insulinsensitivity,lipidandlipoproteinmetabolism,substrateoxida-
.
diopulmonary exercise testing (CPET) is a useful means to assess .. tioncharacteristics).86
.
overall CV health and performance, allowing individualized recom- ..
.
mendationsregardingsportsandexercisetypeandintensity,aswill ..
.
bediscussedinsubsequentsections.82 .. 4.1.1Definitionandcharacteristicsofexercise
.
.. interventions
.
.. Thebasictenetsofexerciseprescriptionhavebeendescribedusing
.
4. Physical activity, leisure .. the‘FITT’concept(frequency,intensity,time,andtype).Themodeof
.
.
exercise, and competitive sports .. exercise(Table3)isalsoanimportantcharacteristic.Thefollowing
.
. sectionswilldescribeeachofthesecomponentsrelatedtoaerobic
.
participation .
. exercisefollowedbycomponentsofstrengthexercise. .
.
.
.
4.1 General introduction .
. 4.1.1.1Typeofexercise
.
.
Recommendationsforprescriptionofexerciserequireabasicknowl- . Traditionally,differentformsofexerciseareclassifiedinbinaryterms
.
.
edge of physiological responses to exercise, along with an under- . asenduranceorresistance(strength)exercise.However,thisclassifi-
.
.
standing of concepts and characteristics of PA, exercise . cationissomewhatoversimplified.Furtherclassificationsofexercise
.
.
interventions, and their implications for sports participation. . are metabolically related (aerobic vs. anaerobic exercise) or those
.
.
AlthoughexerciseandPAareoftenusedinterchangeably,itisimpor- . related to the type of muscle contraction: isotonic [contraction
.
.
tanttorecognizethatthesetermsdiffer.PAisdefinedasanybodily .. againstresistanceinwhichthelengthofthemuscleshortens(con-
.
movement produced by the skeletal muscle that results in energy .. centric) or lengthens (eccentric)] and isometric (static or without
.
expenditure.Exerciseorexercisetraining,ontheotherhand,bydefi- .. changeinlengthofthemuscle).
.
nition,isPAthatisstructured,repetitive,andpurposefultoimprove .. Aerobic exercise refersto activity performed at anintensitythat
.
ormaintainoneormorecomponentsofphysicalfitness.83 .. allowsmetabolismofstoredenergytooccurmainlythroughaerobic
.
Physical fitness may be expressed by five major components .. glycolysis.Besidestheglycolyticpathway,fatmetabolism(b-oxidation)
.
(Figure 1):83 a morphological component (body mass relative to .. is also involved during aerobic exercise. Aerobic exercise involves
.
height, body composition, subcutaneous fat distribution, abdominal . large muscle groups performing dynamic activities, resulting in
Figure1Componentsforexpressionofphysicalfitness.
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 12 ---
28 ESCGuidelines
.
Table3 Characteristicsofexercise .. (METs).84,88Relativeexerciseintensityreferstoafractionofanindi-
.
.
. vidual’smaximalpower(load)thatismaintainedduringexerciseand
.
.
. is usually prescribed as a percentage of maximal aerobic capacity
.
.. (VO ) on the basis of a CPET.88 Training intensity can also be
. 2max
.
. expressedasapercentageofmaximalheartrate(HR )recorded
. max
.. duringanexercisetest89orpredictedonthebasisoftheequation
.
.. [HR =220-age].90TheuseofpredictionequationsforHR is
. max max
.
. not recommended, because there is a large standard deviation
.
.. aroundtheregressionlinebetweenageandHR .91Alternatively,
. max
.
. exerciseintensitycanbeexpressedrelativetoapercentageofaper-
.
.
. son’sHRreserve(HRR),whichusesapercentageofthedifference
.
.
.. between HR
max
and resting HR and adds it to the resting HR
.
.. (Karvonenformula).92TherearecaveatstotheuseofHRforpre-
.
.. scribingandevaluatingexerciseintensityinpersonsusingbeta-block-
.
.. ers.93 Ideally, the HR derived for training should only be used if
.
.. functionalcapacitywasdetermined(anexercisetestwasperformed)
.
.. while taking the medication. Intensity is also commonly monitored
.
.. usingtherate ofperceivedexertionscale(e.g.12-14onthe Borg
. .. 6-20scale)or‘talktest’,e.g.‘tobeabletotalkwhileexercising’.91,94
.
.. GeneralzonesforvariousexerciseintensitiesareshowninTable4.
.
.
.
.
.. 4.1.1.4Trainingvolume
.
.. Exerciseintensityisinverselyrelatedtoexercisetime.Theirprod-
.
.
. uct(inkcalorkJ)definesthevolumeofeachtrainingunit,whichin
.
.
. turn multiplied by frequency provides an estimate of the energy
.
. . expenditure of the training bout or session. The frequency of
.
.
. training sessions and the duration of the training period provide
. .
. total energy expenditure of a training programme. Meeting the
.
.
. minimal activity guidelines equates to approximately 1000 kcal/
.
.
HR=heartrate;HRR=heartratereserve;RM=repetitionmaximum;VO2= .. week or about 10 MET/h/week (the product of MET level and
oxygenconsumption;VO2peak=peakoxygenconsumption. ... duration in hours per week). Training volume should increase
.. weeklyeitherby2.5%inintensity95or2mins’duration,95although
.
.
substantialincreasesinheartrateandenergyexpenditure.Examples . therateofprogressionshouldbeindividualizedaccordingtothe
.
.
ofaerobicexerciseincludecycling,running,andswimmingperformed .. biologicaladaptationoftheindividual.Trainingadaptationisalso
.
atlowtomoderateintensity.84Incontrast,anaerobicexerciserefers .. influenced by age, genetics,96 fitness, and environmental factors,
.
to movement performed at high intensity unsustainable by oxygen .. suchashydration,heat,cold,andaltitude.97
.
deliveryaloneandrequiringmetabolismofstoredenergytobeproc- ..
.
essed largely by anaerobic glycolysis. A sustained isometric muscle .. 4.1.1.5Typeoftraining
.
actionthatisnotworkingmaximallybutdoesnotnecessarilydepend ... Aerobictraining.Aerobicexercisetrainingcaneitherbecontinuous
entirelyuponoxygenduringthemusclecontractionisanexampleof .. orintervalbased.Thereisaplethoraofevidenceandmanyguidelines
.
anaerobicexercise.Anotherexampleofanaerobicexerciseisinter- .. on continuous aerobic exercise, but there is also strong evidence
.
mittenthigh-intensityexercise.85 ...
emerging about the benefits of interval-type training. The interval
.
.. design involves the completion of short bouts of exercise at high
4.1.1.2Exercisefrequency ... intensities, interspersed with recovery periods. When compared
.
Exercisefrequencyisusually expressed asthenumberoftimes an .. withcontinuoustraining,thisapproachprovidesagreaterchallenge
.
individualengagesinexerciseperweek.Guidelinessuggestthatmod- .. to the cardiopulmonary, peripheral, and metabolic systems and
.
erateexerciseshouldbeperformedmostdaysoftheweek,amount- .. resultsinamoreefficienttrainingeffect.98Intervaltraininghasbeen
.
ingtoaminimumof150min/week. .. reportedtobe motivating,since thetraditionalcontinuoustraining
.
.. canoftenbetedious.Intervaltrainingshouldbeemployedonlyinsta-
.
4.1.1.3Exerciseintensity .. blecardiacpatientsbecauseitplacesahigherstressontheCVsys-
.
Ofallthebasicelementsofexerciseprescription,exerciseintensityis .. tem.99Sinceintermittenttrainingexposessubjectstonearmaximal
.
generallyconsideredtobethemostcriticalforachievingaerobicfit- .. effort,restintervalsofappropriateduration,preferablyactiveones,
ness and to have the most favourable impact on risk factors.86,87 ... arerecommended.100Theexercisetorestratiovaries.101Thereare
.
Absolute intensity refers to the rate of energy expenditure during .. anumberofdifferentapproachesused,whichshouldbeindividual-
.
exerciseandisusuallyexpressedinkcal/minormetabolicequivalents .. izedaccordingtofitnessandcomorbidities.
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 13 ---
ESCGuidelines 29
.
.
Resistance training. Exercise intensity: The intensity of resistance . repetitions should be performed including flexion and extension
.
exerciseistypicallyprescribedintermsofonerepetitionmaximum .. ofeachmusclegroup.Multiplesetsaresuperiortoasingleset.105
.
.
(1RM).OneRMisdefinedasthemaximumamountofweightaper- . A variety of 8(cid:2)10 resistance exercises should be prescribed to
.
.
soncanliftthroughoutarangeofmotionwithonerepetition.Even . cover most of the muscular groups.88 Muscular power is best
.
.
thoughtheperformanceof1RMappearstobeasafeapproachfor .. maintainedwhen3(cid:2)5minrestintervalsareusedinsteadofshort
evaluating strength102 and no significant CV events have been ... restintervals(<1min).106
reported using this approach,103 for convenience and compliance ... Mode of training: Resistance training can either be isometric (i.e.
.
reasonsthe useofmultiple(usuallyfive) repetitions(5RM)issug- .. unchangedmusclelengthwithoutjointmovement)ordynamic(con-
.
gested.FiveRMisthemaximumamountofweightthatcanbeper- .. tractionwithchangeinlengthofthemuscleandmovementofthe
.
formedfivetimes.Ithasbeenreportedthat1RMcanbeaccurately .. jointthroughoutarangeofmotion).Isometric(static)muscleactions
.
estimatedfrommultiplerepetitionsandthat5RMisanappropriate .. mayinduceaValsalvamanoeuvreatmoderatetohighloads,ifitis
.
reflectionofmaximalstrength.104 .. notintentionallypreventedbyregularbreathing,andmayleadtoan
.
Exercisetrainingzones:Resistancetrainingusinglessthan20%1RMis .. unnecessaryfluctuationofBP.Dynamictrainingmayincludeconstant
.
generally considered aerobic endurance training. With more than .. orvariableresistancethroughtherangeofmotionusingeitherfree
.
20% 1 RM, the muscular capillaries become compressed during .. weightsorweightmachines.Inbothofthesemodes,thetypeofcon-
.
muscle contraction resulting in a hypoxic stimulus responsible for .. tractionandthevelocityofmovementvarythroughouttherangeof
.
trainingeffects.Thenumberofrepetitionsshouldbeinverselyrelated .. motion.Thistypeofmuscleactivitymirrorsmuscleloadingfacedin .
tothetrainingintensity.Amoderatetrainingintensityof30(cid:2)50%1 .. daily activity. Muscles can contract in a concentric fashion, in which
.
RMwith15(cid:2)30repetitionsisconsideredmuscularendurancetrain- .. muscle shortening is exhibited during the movement, or eccentric
.
ing.Highertrainingintensitiesof50(cid:2)70%1RMwith8(cid:2)15repeti- .. fashion,inwhichalengtheningofthemuscleoccurs.Resistancetrain-
.
tionsareoptimalforstrengthgains. .. ingisanadvancedapplicationinwhichparticipantscarryoutaseries
.
.
Training volume: Optimal strength gains occur when resistance . ofrapidconcentricandeccentricmuscleactionsoftenatarelatively
.
.
trainingisperformed2(cid:2)3timesperweek.Approachestoresist- . highload.
.
.
ancetrainingoftenfolloweitherastationoracircuitapproach.In .
.
.
theformerapproach,individualstypicallycompleteallofthesets .
.
.
foragivenexercisepermusclegroupbeforemovingtoanother .. 4.1.2Classificationofexerciseandsports
.
exerciseandmusclegroup.Inthelatterapproach,individualstypi- .. Apreciseclassificationofsportsbyusingthedifferentcomponentsof
.
callyperformonesetofagivenmusclegroupandthenrotateto .. FITT is difficult because of the differences in the type of muscular
.
anotherexerciseandmusclegroupuntilthefullsetofexercisesin .. work,themode,andthevolumeandintensityofexercise.Moreover,
.
completed per muscle group. One to three sets of 8(cid:2)15 . most sports consist of an isotonic and isometric muscular
Figure2 Sportingdisciplineinrelationtothepredominantcomponent(skill,power,mixed,andendurance)andintensityofexercise.Intensityofexer-
cisemustbeindividualizedaftermaximalexercisetesting,fieldtestingand/oraftermuscularstrengthtesting(Table2).
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 14 ---
30 ESCGuidelines
.
.
component.Forexample,resistanceactivitiescanbeperformedina . Percentage of these values, number of repetitions, and number of
.
.
predominantly dynamic manner or a predominantly static manner. . series will enable determination of the CV and muscular demand.
.
.
Somesportsrequireahighmotorcontrolcomponentandlevelof . Additionally,fieldtestswillfacilitateappropriateprescriptions,mainly
.
.
skill,whereasothersportsareperformedatalow,moderate,high, . forteamsports.
.
.
orveryhighintensity.Theseintensitiescanvarydependinguponthe . When prescribing power sports for individuals with CVD, one
.
.
type ofsport ortheprofessional, amateur, orrecreationallevel of . shouldalsoconsiderthetypeofmuscularwork:isometric(static)or
.
.
performingthesports. . isotonic (dynamic) strength exercises. Additionally, the type and
.
.
When providing advice regarding an exercise programme or . amount of exercise training, when preparing for a sport, is very
.
.
sports participation, the physician should indicate: (i) the type of . important.Theamountofexerciseworkshouldbeadaptedgradually
.
.
sport;(ii)frequencyanddurationoftheexerciseprogramme;and(iii) .. accordingtothesubject’sactualexercisetoleranceandtotheantici-
.
theintensitythatappearsmostappropriatetotheindividual. .. patedlevelofperformance.
.
.
.
(1) Regardingthechoiceofthemostconvenientsport,thephysician .. 4.2 Exercise recommendations in
.
mayindicatethetypeofsportasillustratedinFigure2(skill,power, ..
individuals with cardiovascular risk
.
mixed,orendurance),withspecificationofthefrequency,duration, ...
factors
andintensityofmuscularworktobepreferentiallymaintaineddur- ..
ingtheexerciseprogramme.
... 4.2.1Generalintroduction
(2) Inordertoadequatelyprescribetheindividualintensityofanendur- ... Exercisehasapositiveeffectonseveralriskfactorsforatherosclero-
anceormixedtypeofexerciseorsports,theindividualshouldper-
... sis.6Regularexercisereducestheriskofmanyadversehealthout-
.
form a maximal exercise test with 12-lead ECG recording or .. comes irrespective of age, sex, ethnicity, or the presence of
.
preferentially,ifpossible,withsimultaneousmeasurementofrespi- .. comorbidities.Indeed,thereis adose(cid:2)effectrelationship between
.
ratorygasexchange(CPET). .. exerciseandCVandall-causemortality,witha20(cid:2)30%reductionin
.. adverse events compared with sedentary individuals.107,108
.
Knowing a person’s maximal exercise capacity allows the health .. Consequently,EuropeanGuidelinesrecommendthathealthyadults
.
professionaltodetermineapersonallytailoredexerciseprogramme .. of all ages should perform a minimum of 150 min of moderate-
.
thatissafeandmostlikelytobeeffective.Theexercisetestpermits .. intensityenduranceexercisetrainingover5daysor75minofvigo-
.
the formulation of the appropriate exercise prescription based on .. rousexerciseperweekover3days,withadditionalbenefitderived
.
.
well-recognizedindicesincludingheartratereserve(HRR=HR max- .. bydoublingtheamountto300minofmoderate-intensityor150min
HR rest), VO
2
reserve, the ventilatory threshold, or percentage of ... ofvigorous-intensityaerobicPAperweek.6
.
workrateforagivenindividual. . WhileexerciseisalsobeneficialinpatientswithestablishedCVD,
.
.
TheexercisetestalsopermitsanassessmentofanyabnormalCV .. theriskassociatedwithvigorousexerciseandsportsintheseindivid-
.
responses that might not otherwise be apparent during usualdaily .. ualsisincreased.Importantly,CVDmaybesubclinicalandunrecog-
.
activities (including symptoms, ECG abnormalities, arrhythmias, or .. nized;therefore,considerationshouldbegiventopre-participation
.
abnormal BP response). Based on the exercise testing results, the .. assessment of risk in individuals with a higher likelihood of CVD.
.
physicianmayindicatetheintensity,mode,anddurationofexercise .. IndividualswithmultipleriskfactorsaremorelikelytodevelopCVD.
.
thatappearsmostsuitabletotheindividualpatient(seeTable4). .. Assessment of the individual likelihood of subclinical CVD may be
.
Forpowersportsorresistancetraining,additionallymaximalmus- .. performed by calculating the accumulated risk through established
.
cular testing is warranted in order to determine 1 RM or 5 RM. . riskscoressuchastheSCOREriskcharts(Figure3)andconsidering
Table4 Indicesofexerciseintensityforendurancesportsfrommaximalexercisetestingandtrainingzones
HRmax=maximumheartrate;HRR=heartratereserve;RPE=rateofperceivedexertion;VO2max=maximumoxygenconsumption.
aAdaptedfromrefs84,85usingtrainingzonesrelatedtoaerobicandanaerobicthresholds.Low-intensityexerciseisbelowtheaerobicthreshold;moderateisabovetheaerobic
thresholdbutnotreachingtheanaerobiczone;highintensityisclosetotheanaerobiczone;andveryintenseexerciseisabovetheanaerobicthreshold.Thedurationofexer-
cisewillalsolargelyinfluencethisdivisioninintensity.
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 15 ---
ESCGuidelines 31
SCORE Cardiovascular Risk Chart
10-year risk of fatal CVD
High-risk regions of Europe
WOMEN MEN
Non-smoker Smoker Age Non-smoker Smoker
180 12 13 14 15 17 19 20 21 24 26 30 33 33 36 40 45
160 10 11 12 13 14 15 16 18 20 22 25 28 27 31 34 39
70
140 8 9 10 10 12 13 14 15 16 18 21 24 23 26 29 33
120 7 7 8 9 10 10 11 12 13 15 17 20 19 22 25 28
180 7 8 8 9 11 12 13 15 15 17 20 23 23 26 30 34
160 5 6 6 7 9 9 10 11 12 14 16 18 18 21 24 27
65
140 4 4 5 5 7 7 8 9 9 11 12 14 14 16 19 22
120 3 3 4 4 5 5 6 7 7 8 10 11 11 13 15 17
180 4 4 5 5 7 8 9 10 10 11 13 15 16 19 22 25
160 3 3 3 4 5 6 6 7 7 8 10 11 12 14 16 19
60
140 2 2 2 3 4 4 4 5 5 6 7 8 9 10 12 14
120 1 1 2 2 3 3 3 3 4 4 5 6 6 7 9 10
180 2 2 3 3 5 5 6 7 6 7 9 10 11 13 16 18
160 1 2 2 2 3 3 4 4 4 5 6 7 8 9 11 13
55
140 1 1 1 1 2 2 2 3 3 3 4 5 5 6 7 9
120 1 1 1 1 1 1 2 2 2 2 3 3 4 4 5 6
180 1 1 2 2 3 3 4 4 4 5 6 7 8 9 11 13
160 1 1 1 1 2 2 2 3 2 3 3 4 5 6 7 9
50
140 0 0 1 1 1 1 1 2 2 2 2 3 3 4 5 6
120 0 0 0 0 1 1 1 1 1 1 1 2 2 2 3 4
180 0 0 1 1 1 1 2 2 2 2 2 3 4 4 5 7
160 0 0 0 0 1 1 1 1 1 1 1 2 2 2 3 4
40
140 0 0 0 0 0 0 0 1 0 1 1 1 1 1 2 2
120 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1
4 5 6 7 4 5 6 7 4 5 6 7 4 5 6 7
Total cholesterol (mmol/L)
<3% 3–4% 5–9% ≥10%
Figure3a SCOREchartsforEuropeanpopulationsathighcardiovasculardisease(CVD)risk109.The10-yearriskoffatalCVDinpopulationsathighCVDriskis
basedonthefollowingriskfactors:age,gender,smoking,systolicbloodpressure,andtotalcholesterol.ToconverttheriskoffatalCVDtoriskoftotal(fatalþnon-
fatal)CVD,multiplyby3inmenand4inwomen,andslightlylessinolderpeople.Note:theSCOREchartisforuseinpeoplewithoutovertCVD,diabetes(type1and
2),chronickidneydisease,familialhypercholesterolaemia,orveryhighlevelsofindividualriskfactorsbecausesuchpeoplearealreadyathighriskandneedintensiverisk
factoradvice.Cholesterol:1mmol/L¼38.67mg/dL.TheSCOREriskchartspresentedabovedifferslightlyfromthoseinthe2016ESC/EASGuidelinesforthemanage-
mentofdyslipidaemiasandthe2016EuropeanGuidelinesoncardiovasculardiseasepreventioninclinicalpractice,inthat:(i)agehasbeenextendedfrom
65to70years;(ii)theinteractionbetweenageandeachoftheotherriskfactorshasbeenincorporated,thusreducingtheoverestimationofriskinolderpersonsin
theoriginalSCOREcharts;(iii)thecholesterolbandof8mmol/Lhasbeenremovedsincesuchpersonswillqualifyforfurtherevaluationinanyevent.
SCORE=SystematicCoronaryRiskEvaluation.
)gHmm(
erusserp
doolb
cilotsyS
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 16 ---
32 ESCGuidelines
SCORE Cardiovascular Risk Chart
10-year risk of fatal CVD
Low-risk regions of Europe
WOMEN MEN
Non-smoker Smoker Age Non-smoker Smoker
180 7 8 8 9 11 11 12 13 12 14 15 17 18 20 22 24
160 6 6 7 7 9 9 10 11 10 11 13 14 15 16 18 20
70
140 5 5 6 6 7 8 8 9 8 9 10 12 12 13 15 17
120 4 4 5 5 6 6 7 7 7 8 9 10 10 11 12 14
180 4 4 5 5 7 7 8 9 8 9 10 12 12 14 16 18
160 3 3 4 4 5 6 6 7 6 7 8 9 9 11 12 14
65
140 2 3 3 3 4 4 5 5 5 5 6 7 7 8 9 11
120 2 2 2 2 3 3 3 4 3 4 5 5 5 6 7 8
180 2 3 3 3 4 5 5 6 5 6 7 8 8 10 11 13
160 2 2 2 2 3 3 4 4 4 4 5 5 6 7 8 9
60
140 1 1 1 2 2 2 3 3 3 3 3 4 4 5 6 7
120 1 1 1 1 2 2 2 2 2 2 2 3 3 4 4 5
180 1 1 2 2 3 3 3 4 3 4 4 5 6 7 8 9
160 1 1 1 1 2 2 2 3 2 2 3 3 4 4 5 6
55
140 1 1 1 1 1 1 1 2 1 2 2 2 3 3 3 4
120 0 0 0 1 1 1 1 1 1 1 1 2 2 2 2 3
180 1 1 1 1 2 2 2 3 2 2 3 3 4 5 5 6
160 0 0 1 1 1 1 1 2 1 1 2 2 2 3 3 4
50
140 0 0 0 0 1 1 1 1 1 1 1 1 1 2 2 3
120 0 0 0 0 0 0 0 1 0 1 1 1 1 1 1 2
180 0 0 0 0 1 1 1 1 1 1 1 1 2 2 3 3
160 0 0 0 0 0 0 0 1 0 0 1 1 1 1 1 2
40
140 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1
120 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
4 5 6 7 4 5 6 7 4 5 6 7 4 5 6 7
Total cholesterol (mmol/L)
<3% 3–4% 5–9% ≥10%
Figure3b SCOREchartforEuropeanpopulationsatlowcardiovasculardisease(CVD)risk.The10-yearriskoffatalCVDinpopulationsatlowCVD
riskisbasedonthefollowingriskfactors:age,gender,smoking,systolicbloodpressure,andtotalcholesterol.ToconverttheriskoffatalCVDtoriskof
total(fatalþnon-fatal)CVD,multiplyby3inmenand4inwomen,andslightlylessinolderpeople.Note:theSCOREchartisforuseinpeoplewithout
overtCVD,diabetes(type1and2),chronickidneydisease,familialhypercholesterolaemia,orveryhighlevelsofindividualriskfactorsbecausesuchpeople
arealreadyathighriskandneedintensiveriskfactoradvice.Cholesterol:1mmol/L=38.67mg/dL.TheSCOREriskchartspresentedabovedifferslightly
fromthoseinthe2016ESC/EASGuidelinesfortheManagementofDyslipidaemiasand2016EuropeanGuidelinesoncardiovasculardiseasepreventionin
clinicalpractice,inthat:(i)agehasbeenextendedfrom65to70years;(ii)theinteractionbetweenageandeachoftheotherriskfactorshasbeenincorpo-
rated,thusreducingtheoverestimationofriskinolderpersonsintheoriginalSCOREcharts;(iii)thecholesterolbandof8mmol/Lhasbeenremoved
sincesuchpersonswillqualifyforfurtherevaluationinanyevent.SCORE=SystematicCoronaryRiskEvaluation.
)gHmm(
erusserp
doolb
cilotsyS
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 17 ---
ESCGuidelines 33
.
individual risk factors such as very high total cholesterol and low- .. exercise as well as selected individuals planning to undertake
.
densitylipoprotein(LDL),diabetesmellitus,orastrongfamilyhistory .. moderate-intensityexerciseshouldundergoaphysicalexamination,
.
ofCVD.6BasedonthisassessmenttheindividualCVriskcanbecate- .. 12-leadECG,andexercisestresstest.Theaimoftheexercisetestis
.
gorizedfromlowtoveryhighrisk(Table5). .. toidentifyprognosticallyimportantCADandtoassessthepresence
.
Preliminaryevaluationshouldconsistofaself-assessmentrelating .. ofexercise-inducedarrhythmias.Individualswithsymptoms,abnor-
.
tosymptomsandcalculationofSCORE.Individualswhoarehabitu- .. mal findings on physical examination, abnormal ECG, or abnormal
.
.
allyactiveandatlowormoderateriskshouldnothaveanyrestric- . exercisetestshouldbeinvestigatedfurtheraccordingtocurrentESC
.
tionsforexerciseincludingcompetitivesports.Sedentaryindividuals .. Guidelines for chronic coronary syndromes.110 Following normal
.
.
andindividualsathighorveryhighriskmayengageinlow-intensity . investigations,thereshouldbenorestrictionstosportsparticipation.
.
.
exercise without further evaluation. Sedentary individuals and/or . Allindividualsshould,however,bethoroughlyinformedthatdevel-
.
.
thoseathighorvery highriskplanning to undertake high-intensity . opmentofsymptomsduringexerciseshouldpromptreassessment.
.
.
. Whileanormalexercisetestandahighexercisecapacityisassoci-
.
.
. atedwithagoodprognosis,thetesthaslimitedsensitivityindiagnos-
.
.. ingmildtomoderateobstructiveCAD.111,112Currentlythereisno
Table5 Cardiovascularriskcategories ..
. evidence for incorporating routine cardiac imaging in pre-
.
.
. participation screening among asymptomatic individuals aged >35
.
.
.. yearsoldwithanormalexercisestresstest.However,inasympto-
.
.. maticadultsconsideredtobeathighriskorveryhighrisk(diabetes,
. .. strong family history of CAD, previous risk assessment suggesting
.
.. highriskforCAD)afunctionalimagingtestorcoronarycomputed
.
.. tomography angiography(CCTA)shouldbe considered in the risk
.
.. assessment(Figure4).110IdentificationofatheroscleroticCADshould
.
.. promptaggressivemanagementofriskfactorsandpreventivemedi-
.
.. caltreatment.AmongindividualswithprovenobstructiveCAD,fur-
.
.. therassessmentandtreatmentisindicated.
.
.
.
.
.
.
.
.
.
.
.
Generalrecommendationsforexerciseandsportsin
healthyindividuals
Recommendations Classa Levelb
Atleast150min/weekofmoderate-intensity,or
75min/weekofvigorous-intensityaerobicexer-
I A
cise,oranequivalentcombinationthereofis
recommendedinallhealthyadults.113(cid:2)118
Agradualincreaseinaerobicexerciseto300
min/weekofmoderate-intensity,or150min/
weekofvigorous-intensityaerobicexercise,or I A
anequivalentcombinationisrecommendedfor
additionalbenefitsinhealthyadults.114,116
Regularassessmentandcounsellingtopromote
adherenceand,ifnecessary,tosupportan
I B
increaseinexercisevolumeovertimeare
recommended.119
Multiplesessionsofexercisespreadthroughout
theweek,i.e.on4(cid:2)5daysaweekandprefera-
I B
blyeverydayoftheweek,are
recommended.113,114
aClassofrecommendation.
bLevelofevidence. 0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 18 ---
34 ESCGuidelines
.
.
Recommendationsforcardiovascularevaluationand .. 4.2.2Obesity
regularexerciseinhealthyindividualsaged>35years ... Apersonwithabodymassindex(BMI)>30kg/m2or(preferentially)
.
. a waist circumference >94 cm for males and >80 cm for females
.
Recommendations Classa Levelb .. (bothforEuropeanCaucasians)isconsideredobese.120,121
.
.
. Europeanguidelinesforobeseindividualsrecommendthatamini-
AmongindividualswithlowtomoderateCVD ..
. mum of 150 min/week of moderate-intensity endurance exercise
risk,theparticipationinallrecreationalsports ..
IIa C . trainingshouldbecombinedwiththreeweeklysessionsofresistance
shouldbeconsideredwithoutfurtherCV ...
exercise.121Suchinterventionleadstoareductioninintra-abdominal
evaluation. ..
. fat mass, increments in muscle and bone mass, attenuation in the
.
Cardiacscreeningwithfamilyhistory,symptoms, .
.. weightloss-induceddeclineofrestingenergyexpenditure,reduction
physicalexamination,and12-leadrestingECG IIa C .
.. inBPandchronicinflammation,andimprovementinglucosetoler-
shouldbeconsideredforcompetitiveathletes. .
.. ance,insulinsensitivity,lipidprofile,andphysicalfitness.121,122There
Clinicalevaluation,includingmaximalexercise ...
isalsoapositiveinfluenceonthelong-termmaintenanceofweight
testing,shouldbeconsideredforprognosticpur- ...
reduction,generalwell-beingandself-esteem,andreductioninanxi-
posesinsedentarypeopleandindividualswith
IIa C
... etyanddepression.121Theimpactofexerciseinterventionaloneon
highorveryhighCVriskwhointendtoengagein ... fatmassismodest.123Accordingtoaseriesoflargerandomizedcon-
intensiveexerciseprogrammesorcompetitive ...
trolledtrialsahighendurance-typeexercisevolume,>225min/week,
sports. ... isrequiredtomaximizefatmasslossinobeseindividuals.124
. InselectedindividualswithoutknownCADwho .. Apre-participationCVassessmentiswarrantedinobeseindi-
.
haveveryhighCVDrisk(e.g.SCORE>10%,strong .. vidualswhointendtoengageinhigh-intensityexercise(Figure4),
.
familyhistory,orfamilialhypercholesterolaemia) .. duetoassociatedcomorbiditiessuchastype2diabetes,hyperten-
.
andwanttoengageinhigh-orveryhigh-intensity IIb B .. sion, dyslipidaemia, and CV and respiratory diseases.121 Obese
.
exercise,riskassessmentwithafunctionalimaging .. individuals with a normal CV assessment should not have any
.
test,coronaryCCTA,orcarotidorfemoralartery .. restrictions on exercise. There is evidence from healthy, non-
.
ultrasoundimagingmaybeconsidered. .. obese and non-athletic individuals that running, and abrupt
.
.
. increases in training volume, contribute to musculoskeletal
CCTA = coronary computed tomography angiography; CV = cardiovascular; .
CVD=cardiovasculardisease;SCORE=SystematicCoronaryRiskEvaluation. .. injuries.125(cid:2)127Therefore,itmaybe reasonableto considerthat
.
aClassofrecommendation. ..
obese individuals should limit high-volume weight-bearing exer-
bLevelofevidence. ..
. cises on a hard surface (i.e. <2 h/day) until a considerable
.
.
Figure4 Proposedalgorithmforcardiovascularassessmentinasymptomaticindividualsaged>35-years-oldwithriskfactorsforcardiovasculardiseaseand
possiblesubclinicalchroniccoronarysyndromebeforeengaginginsports.*ConsiderfunctionaltestorCCTAifexercisestresstestisequivocalortheECGis
uninterpretable.aSeetextforexamplesoffunctionalimaging.bSingle-photonemissioncomputedtomography:areaofischaemia>_10%oftheleftventricular
myocardium;stressechocardiography:>_3of16segmentswithstress-inducedhypokinesiaorakinesia;stresscardiovascularmagneticresonance:>_2of16seg-
mentswithstressperfusiondefectsor>_3dobutamine-induceddysfunctionalsegments;coronarycomputedtomographyangiography(CCTA):three-vessel
diseasewithproximalstenoses;leftmaindisease;proximalleftanteriordescendingdisease.110CVD=cardiovasculardisease;ECG=electrocardiogram;
SCORE=SystematicCoronaryRiskEvaluation.
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 19 ---
ESCGuidelines 35
.
reduction in body weight is achieved. Moreover, if high-volume .. inflammatory drugs for musculoskeletal pain may contribute to
.
exercise(>2h/day)isdesired,asufficientrecoverytimeshouldbe .. raisedBP.136
.
.
allowed for between periods of exercise (optimally 48 h). It is . WhenBPisuncontrolled,temporaryrestrictionfromcompetitive
.
important to emphasize that good physical and muscular fitness .. sportsisrecommended,withthepossibleexceptionofskillsports.131
.
.
and neuromuscular coordination may protect obese individuals . Inindividualswithahigh-riskprofile,includingthosewithendorgan
.
.
from musculoskeletal injuries, hence non-weight-bearing exer- . damage [left ventricular (LV) hypertrophy, diastolic dysfunction,
.
cises such as cycling or swimming128 may be beneficial. Finally, .. ultrasoundevidenceofarterialwallthickeningoratheroscleroticpla-
.
.
there is no compelling evidence that resistance training, when . que, hypertensive retinopathy, increased serum creatinine (men
.
.
executedproperly,willincreasetheriskformusculoskeletalinju- . 1.3(cid:2)1.5 mg/dL, women1.2(cid:2)1.4 mg/dL), and/or microalbuminuria]
.
.
ries or provoke musculoskeletal symptoms in obese . in whom BP is controlled, participation in all competitive sports is
.
individuals.129 .. possible,withtheexceptionofthemostintensivepowerdisciplines
.
.
. such as discus/javelin throwing, shot-putting, and weightlifting (see
.
.
. section4.1).131
.
.
4.2.3Hypertension .. During sports participation, regular follow-up is recommended
.
ApersonwithapersistentsystolicBP(SBP)>_140mmHgand/ordia- .. dependingontheseverityofhypertensionandthecategoryofrisk.In
.
stolic BP (DBP) >_90 mmHg is considered hypertensive.130,131 .. individuals with borderline BP readings, regular ambulatory assess-
.
Hypertensive individuals should participate in at least 30 min of .. mentofBPshouldbeconsidered.Inindividualswithlowormoderate
.
moderate-intensedynamicaerobicexercise(walking,jogging,cycling, .. CV riskand well-controlled BP,thereshouldbe norestrictions to
. orswimming)for5(cid:2)7daysperweek.132Suchexerciseintervention .. sportsparticipation,however,intensiveheavyweightlifting,especially
.
isassociatedwithameanreductioninSBPof7mmHgandDBPof5 .. when this includes substantial isometric (static) muscle work, can
.
mmHg.133Additionalresistancetrainingishighlyeffectiveinreducing .. have a marked pressor effect and should be avoided. In this
.
BP further and resistance training 2(cid:2)3 days per week is also ... context,avoidingtheValsalvamanoeuvreinparticulariswarranted
advised.132Indeed,theBP-loweringeffectofresistanceandisometric ... because breath holding during muscular contraction is associated
exercisemaybecomparableto,orevengreaterthan,thatofaerobic ... with a greater elevation in SBP and DBP.135 When executed cor-
.
exercise.134 .. rectly,high-intensedynamicresistancetraining(upto80%of1RM),
.
Ifhigh-intensitysportsparticipationisdesired,apre-participation .. withalownumberofrepetitions(n<10)doesnotinducegreater
.
CV assessment is warranted to identify athletes with exercise- .. increments in BP compared with low-intense dynamic resistance
.
induced symptoms, excessive BP response to exercise130, and the .. training (<50% of 1 RM) with a high number of repetitions (n >_
presenceofendorgandamage.Individualswithsymptomssuggestive
... 20).137(cid:2)142
.
ofCADrequirefurtherassessmentandoptimizationofmedicalther- .. Someindividualswhoarenormotensiveatrestwillhaveanexag-
.
apy beforeparticipationinsports. If arterialhypertensionis poorly .. gerated BP response to exercise. An exaggerated BP response to
.
controlled(restingSBP>160mmHg),amaximalexercisetestshould .. exerciseincreasestheriskforincidenthypertensioninhighlytrained
bepostponeduntiltheBPiscontrolled.
... andnormotensiveathletesoveramiddle-termperiod.143IfSBPrises
Non-pharmacological measures should be considered as the
... to>200mmHgataworkloadof100Wduringexercisetesting,144
.
firststepinthemanagementofhypertensioninathletes,includ- .. antihypertensive medical therapy should be optimized and clinical
.
ing: restriction of salt intake and alcohol consumption, weight .. evaluation,includingECGandechocardiography,shouldbeconsid- .
reduction if applicable, balanced diet (e.g. Mediterranean diet), .. ered, even if the athlete is normotensive at rest.131 Moreover, in
.
andcessationofsmoking.Aerobicexerciseprogrammesshould .. young Olympic athletes a peak SBP of >220 mmHg in males and
.
herein complement the individual’s training schedule.131 If such .. >200mmHginfemalesmeasuredduringcycleergometryarebeyond
.
lifestyle changes do not lower BP after 3 months, antihyperten- .. the95thpercentile.131
.
. sive drugs should be commenced if SBP remains >140 mmHg. .
.
.
Antihypertensive therapy alongside lifestyle intervention should . 4.2.4Dyslipidaemia
.
.
be considered in all individuals aged >65 years but <80 years, . Physicalactivityhasfavourableeffectsonlipidmetabolismbyreduc-
.
.
provided it is well tolerated.131,132 It is important to consider . ingserumtriglyceridesbyupto50%andincreasinghigh-densitylipo-
.
.
that beta-blockers are prohibited in certain competitive skill .. protein (HDL) cholesterol by 5(cid:2)10%.85,145 Exercise may also
.
sports such as shooting [see World Anti-Doping Association .. reduceLDLcholesterolbyupto5%andshiftthemoreatherogenic
.
(WADA)forcomplete list135], and can induce bradycardia and/ .. small, dense LDL fraction towards larger LDL particles in a dose-
.
orloweraerobicexercisecapacity.131Diureticsareprohibitedin .. dependent fashion.146 These metabolic improvements can be
.
all competitive sports.135Angiotensin-converting enzyme (ACE) .. achievedthrough3.5-7hofmoderatelyvigorousPAperweekor
.
inhibitors, angiotensin II receptor blockers, and calcium antago- .. 30-60minofexerciseonmostdays.
.
nistsarethepreferreddrugsofchoiceinexercisingindividuals.It .. In individuals with hypertriglyceridaemia or hypercholesterolae-
.
is noteworthy that the use of non-selective non-steroidal . mia, a higher intensity of exercise is recommended, as this may
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 20 ---
36 ESCGuidelines
.
improvethelipidprofileandreduceCVrisk.Beforeembarkingon .. Theeffectsonmuscleinsulinsensitivityareobservedwitharela-
.
high-intensity exercise, a clinical assessment should be performed .. tivelylowvolumeofexercise(400kcal/week)inpreviouslysedentary
.
including symptomatic status, and a maximal exercise stress test, .. adults,butincreasewithhighervolumesofexercise.164Theoptimal
.
functional imaging test, or CCTA may be considered in the risk .. combinationofdurationandintensityisnotwellestablished.High-
.
assessment110(Figure4),particularlyinindividualswithfamilialhyper- .. intensityintervaltrainingmaybesuperiortomoderateaerobictrain-
.
cholesterolaemia.Amongathleteswithhypercholesterolaemia,regu- .. ing in achieving metabolic effects and improvement in exercise
.
lar exercisewill rarelyreduceLDL cholesterol to normalornear- .. capacity; however, whether long-term results are superior is
.
normalvalues;therefore,guidelinesonpharmacologicaltreatmentin .. unknown.165,166
.
.
primary and secondary prevention should be followed strictly. . Diabetesisacauseofcoronarymicrovasculardysfunction(CMD),
.
.
Individualswithdyslipidaemiashouldbeassessedatleastevery2(cid:2)5 . which is associated with lower exercise capacity and adverse out-
.
yearsforprimarypreventionandannuallyforsecondaryprevention. .. comes167,168 and can be improved by exercise training.162,169(cid:2)171
.
.
Pharmacologicalintervention,particularlywithstatins,issuperior . Largerandomizedtrialshaveconfirmedthebeneficialeffectofexer-
.
.
toexerciseandlifestyleinterventionaloneforreducingLDLcholes- . ciseinterventiononglycaemiccontrolandriskfactors,butthishas
.
terolandimprovingprognosis.147Despitetheminoreffectsofendur- .. not translated into a significant improvement in survival, partly
.
ance exercise on serum LDL cholesterol, the clinically beneficial .. becauseofsuboptimallong-termmaintenanceoflifestylechanges.172
.
.
relationship between increased physical fitness and reduced CV . Duringanacuteboutofexercise,glucoseuptakeinthemusclesis
.
eventsremainsbeyondtheeffectsofstatins.147,148 .. increasedforupto2hafterwardsthroughmechanismsthatareinde- .
.
Physically active individuals with dyslipidaemia may experience . pendentofinsulin.Theexercise-inducedhypoglycaemiceffectcanbe
.
. musclepainandsorenessortendinopathyaccompaniedbyelevated .. diminished by performing resistance training or interval training in
.
muscleenzymes.149Inthesecases,measuressuchasstoppingmedi- .. patientswithtype1diabetes.173Thereisadose(cid:2)responserelation-
.
cationtemporarilyfollowedbyrepeatchallengewithanotherstatin .. shipbetweenintensityandvolumeofexerciseanddurationofglu-
.
drug,withorwithoutanalternatedayregimen,orintroducingother .. coseuptakebyskeletalmusclethatmaylastupto48hafterexercise.
.
lipid-lowering agents such as ezetimibe or proprotein convertase .. These factors mustbe considered in individualswith diabeteswho
.
subtilisin/kexintype9(PCSK-9)inhibitorsshouldbeconsidered.109 .. areundertakingintensiveexerciseorcompetitivesportsinorderto
.
Individuals who develop rhabdomyolysis due to a statin should be .. avoidhypoglycaemia.
.
prescribedanalternativelipid-loweringagent. ..
.
. 4.2.5.2Recommendationsforparticipationinexerciseinindividualswith
.
.
. diabetesmellitus
.
.
4.2.5Diabetesmellitus .. Bothaerobicandresistancetrainingareeffectiveforglycaemiccon-
.
Physical inactivity is a major cause of type 2 diabetes mellitus .. trol,BPreduction,weightloss,peakexercisecapacity,anddyslipide-
.
(T2DM).150TheriskofdevelopingT2DMis50(cid:2)80%higherinindi- .. mia.174Aprogrammecombiningaerobicandresistancetraininghas
.
vidualswhoarephysicallyinactivecomparedtotheiractivecounter- .. beenshowntobesuperiorintermsofglycaemiccontrol,whereas
.
parts.However,exercisedoesnotentirelycompensatefortheeffect .. theeffectonotheroutcomesisunproven.174(cid:2)176
.
ofobesity.151(cid:2)154Diabetesisalsoindependentlyassociatedwithan .. Theidealexerciseprogrammetoachievethefullpotentialofben-
.
accelerated decline in muscular strength and, partly because of .. efits inpatientswithdiabetesisdailyexerciseofatleastmoderate
.
hyperglycaemia,mayleadtoreducedjointmobility. .. intensity,e.g.briskwalking,foratleast30min,resistancetrainingfor
. .. 15minonmostdays,andlighter-intensityactivities(standing,walk-
.
4.2.5.1Effectofexerciseondiabeticcontrol,riskfactorsandoutcomes .. ing)every30min.Thiscanbesupplementedbyflexibilityandbalance
.
AerobicexerciseinpatientswithT2DMimprovesglycaemiccontrol .. exercise,particularlyinolderindividualsorpatientswithmicrovascu- .
andreducesvisceralfatandinsulinresistance.Exercisealsohasbene- .. larcomplicationsduetotheirdiabetes. .
.
ficial effects on BP and lipid profile, and leads to modest weight .
.
loss.155,156Bothaerobicandresistancetrainingpromoteprolonged .. 4.2.5.3Cardiacevaluationbeforeexerciseparticipationinindividuals
.
.
adaptationsinskeletalmuscle,adiposetissue,andtheliverassociated . withdiabetesmellitus
.
with enhanced insulin action.157 Observational studies have shown .. Individualswithdiabeteshaveaprioriahigherlikelihoodofsubclinical
.
.
lower mortality with exercise in both type 1 diabetes mellitus and . CAD; therefore, all individuals with diabetes should undergo CV
.
.
T2DM.158 .. assessmentasoutlinedinFigure4beforetakingupanexercisepro-
.
Inpatientswithpre-diabetesormetabolicsyndrome,bothaerobic .. grammeofhighintensity.Thisshouldbesupplementedbyanevalua-
.
andresistanceexercisemaypreventthedevelopmentofovertdia- .. tion of glycaemic status, including risk factors for hypoglycaemia,
.
betes.159(cid:2)162Intensityofexerciseseemstobeofgreaterimportance .. historyofhypoglycaemicepisodes,presenceofautonomicneuropa-
thanthevolumeofexercise;individualswhoexerciseatmoderateor ... thy,andantidiabetictreatment.177
.
highintensityhavealowerriskofdevelopingmetabolicimpairment .. AsymptomaticindividualswithdiabetesmellitusandanormalCV
.
compared with those who have a similar energy expenditure at a .. assessmentandmaximalexercise testmayengageinallsports but
.
lowerintensity.160,163 . should be warned about the potential risk of iatrogenic
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 21 ---
ESCGuidelines 37
.
.
hypoglycaemiaintheeventofinadequatecaloricintake.Importantly, . 4.3.2Riskstratification,inclusion/exclusioncriteria
.
.
allpatientswithdiabetesshouldbeawareofwarningsymptomsand . Moderate-intensityexerciseisgenerallysafeforolderhealthypeople
.
.
attentionshouldbegiventochestdiscomfortorunusualbreathless- . andmedicalconsultationbeforestartingorprogressingthelevelof
.
.
nessduringexerciseasthismaybeindicativeofCAD. . exerciseprogrammeisnotusuallyrequired.81,197Thegeneralrecom-
.
.
.. mendation for exercise implementation for the general population
.
.. alsoappliestohealthyelderlypeople.
.
Specialconsiderationsforindividualswithobesity, .. Nevertheless,duetopotentialrisksofexercisingamongtheeld-
hypertension,dyslipidaemia,ordiabetes ... erly (Table 6), the European Association of Preventive Cardiology
.
.. (EAPC) recommends self-assessment by a brief questionnaire81 to
Recommendations Classa Levelb .
.. determine the need for advice from health professionals, but this
.
Inobeseindividuals(BMI>_30kg/m2orawaistcir- .. approachhasnotbeentestedprospectively.
.
cumference>80cmforfemalesor>94cmfor .. Community-dwelling frail or sedentary older adults may have a
.
males)resistancetraining>_3timesperweek,in .. slightly increased riskof falls during exercise; however, there is no
additiontomoderateorvigorousaerobicexercise
I A ...
evidence of serious adverse outcomes, injury, or CV
.
(atleast30min,5(cid:2)7daysperweek)isrecom- .. events.195,196,198,199 Exercise interventions to improve balance in
.
mendedtoreduceCVDrisk.121 .. thosediagnosedwithdementiabringnumerousbenefitswithoutan
.
Inindividualswithwell-controlledhypertension,
... increasedriskofadverseoutcomes.200Resistanceexerciseinolder
resistancetraining>_3timesperweekinadditionto
... adultsisrarelyassociatedwithadverseevents.201,202Nomajorrisks
.
moderateorvigorousaerobicexercise(atleast30 I A .. have been reported in older individuals performing low- and
.
min,5(cid:2)7daysperweek)isrecommendedto .. moderate-intensityaerobicexercise,andevenmoreintenseaerobic
reducebloodpressureandCVDrisk.132 ... activitiesareassociatedwitharelativelysmallrisk.203(cid:2)205CVevents
.
. duringintense exercise occur ata rate ofaround 1 eventper 100
Amongindividualswithdiabetesmellitus,resistance .
.. years of vigorous activity.206 Risks are highest during the first few
training>_3timesperweekinadditiontomoderate .
.
. weeksofbeginningvigorousexercise;thereforebothexerciseinten-
orvigorousaerobicexercise(atleast30min,5(cid:2)7 .
I A .. sityand duration shouldbe increased gently (for example, every 4
daysperweek)isrecommendedtoimproveinsulin .
.
. weeks).81,197,207(cid:2)210Amongolderindividualswhoarewellprepared
sensitivityandachieveabetterCVDrisk .
.
profile.176,178 .. andaccustomedtointenseexercise,participationincompetitivevig-
.
Amongadultswithwell-controlledhypertension
... orous sports does not confer higher risk compared with younger
buthighriskand/ortargetorgandamage,high-inten- III C
... adults.38,211
.
sityresistanceexerciseisnotrecommended. ..
.
.
Inindividualswithuncontrolledhypertension .
.
(SBP>160mmHg)high-intensityexerciseisnotrec- .. 4.3.3Exercisemodalitiesandrecommendationsfor
ommendeduntilbloodpressurehasbeen
III C ...
exerciseandsportintheelderly
.
controlled. .. The physical exercises for elderly persons should be designed
.
.. according to their biological age, exercise experience, functional
.
CVD=cardiovasculardisease;SBP=systolicbloodpressure. .. capacity,safety,ageingtrajectories,comorbidity,lifestylehabits,and
aClassofrecommendation. .
. bLevelofevidence. .. previousexperienceofexercise.
.
. Elderlypeopleshouldperformenduranceandstrengthexercise,
.
.. and specific exercises for flexibility and balance (Table 7).201,212,213
.
.
. Enduranceexerciseexertsbeneficialeffectsonthecardiorespiratory
. 4.3 Exercise and sports in ageing .
. systemandresistanceexercisepreventsthedecreaseinmusclemass
.
4.3.1Introduction .. and sarcopenia.192 Achieving >150 min/week moderate-intensity
.
Theelderlyaredefinedasadultsagedabove65years.Similartothe .. aerobicexercise(i.e.walkingorothermoderateintensityaerobics- .
.
generalpopulation,higherexercisecapacityinthisagegroupisalso . typeactivities)isassociatedwithatleast30%lowerriskofmorbidity,
.
associated with reduced mortality.179 A physically active lifestyle .. mortality,disability,frailty,anddementiacomparedwithbeinginac-
.
maintained through middle and older age translates into better .. tive.212,214,215 The strength exercises for the major muscle groups
.
health180andlongevity.181(cid:2)185Commencinganewexerciseregimen ... shouldbeperformedatleasttwiceaweek(8(cid:2)10differentexercises,
.
among sedentary elderly individuals has shown significant health .. 10(cid:2)15repetitions).
improvements180,186 including cognitive capacity.187(cid:2)190 Moreover, ... Accustomedseniorathletesshouldcontinueperformingexercise
.
regularexerciseexertsbeneficialeffectsinreducingtheriskofdevel- .. and sports activities, without any predetermined age limit.38,211,216
.
opingCVandmetabolicdiseasethroughimprovedcontrolofCVrisk .. Sports activities for older people according to exercise type and
factors,191,192alsopreservingcognitivefunction.187(cid:2)190Importantly, ... intensityarereportedinTable8.Annualclinicalassessmentincluding
.
exercise helps to preserve neuromuscular competence,193,194 thus .. amaximalexercisetest(preferablywithsimultaneousCPET)isrec-
.
maintaining balance and coordination, which reduces the risk of .. ommendedinmasterathletesperformingahighlevelofsportsand
.
falling.195,196 . exerciseprogrammes.217
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 22 ---
38 ESCGuidelines
Recommendationsforexerciseinageingindividuals
Table8 Exerciseactivitiesforolderpeopleaccordingto
exercisetypeandintensity
Recommendations Classa Levelb
Amongadultsaged65yearsorolderwhoare
fitandhavenohealthconditionsthatlimit
theirmobility,moderate-intensityaerobic I A
exerciseforatleast150min/weekis
recommended.212,214,215
Inolderadultsatriskoffalls,strengthtraining
exercisestoimprovebalanceandcoordina-
I B
tiononatleast2daysaweekare
recommended.201,212,214,215
Afullclinicalassessmentincludingamaximal
exercisetestshouldbeconsideredinseden-
IIa C
taryadultsaged65yearsorolderwhowishto
participateinhigh-intensityactivity.
Continuationofhigh-andveryhigh-intensity
activity,includingcompetitivesports,maybe
IIb C
consideredinasymptomaticelderlyathletes
(masterathletes)atlowormoderateCVrisk.
CV=cardiovascular.
aClassofrecommendation.
bLevelofevidence.
Table6 Potentialrisksforolderpeopleduringexercise
.
.
. 5. Exercise in clinical settings
.
.
.
.
. .. 5.1 Exercise programmes for
.
.
. leisure-time and competitive sport
.
Table7 Exerciseprescriptionintheelderly ... participation in chronic coronary
.
.
. syndrome
.
.
.
. AtheroscleroticCADisthe predominantcauseofexercise-related
.
.
. (Ex-R)cardiaceventsincludingACS,AMI,andSCAinindividualswith .
.
. establishedchroniccoronarysyndrome(CCS),orSCDasaprimary
.
.. presentationinindividuals>35yearsofage.218Inadditiontoathero-
.
.
. scleroticCAD,otherentities,includingananomalousoriginofacor-
.
.. onary artery (AOCA),219 myocardial bridge (MB),220 and
.
.. spontaneouscoronaryarterydissection(SCAD),221arealsoassoci-
.
.
. atedwithmyocardialischaemia,andpotentiallywithEx-RSCD.
.
.
. PhysicalinactivityisariskfactorforCAD,butsomewhatparadoxi-
.
.
.. cally, vigorous physical exertion transiently increases the risk for
. .. AMI66andSCD.216Overall,thebenefitsofregularexercisegreatly
.
.. outweightheEx-Rrisk,eveninindividualswithCCS.Moderate-to
.
. vigorous-intensity exercise is strongly associated with a reduced
0202
CSE©
0202
CSE©
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 23 ---
ESCGuidelines 39
incidence of adverse outcomes from CAD, but prolonged, high- Table9 BorderlineoruninterpretableECGfindings
intensityenduranceexercisehasbeenassociatedwithincreasedcor-
onary artery calcium (CAC), a marker of atherosclerosis,58,222 and
coronary plaques58 but without an increase in mortality112 in the
mediumterm.Importantly,thediagnosisofmyocardialinjuryisalso
more complex in athletes because intense exercise may increase
serologic markersofmyocardialinjury,including cardiac troponinI
andT.223,224
5.1.1Individualsatriskofatheroscleroticcoronaryartery
diseaseandasymptomaticindividualsinwhomcoronary .
.
. lowerspecificityformyocardialischaemiathanotherfunctionaltests,
arterydiseaseisdetectedatscreening .
.
. especially in asymptomatic and low-risk individuals. It is recom- Athletes or individuals participating in sports or regular exercise .
training may have risk factors for CAD and/or subclinical CCS.225
... mendedthatatrulymaximalexercisetest232(withorwithoutCPET)
.
. shouldbeperformedwhenevaluatingindividualswithpossiblesub-
Such individuals may be identified by routine pre-participation .
.
screening as recommended by the ESC21 or by pre-evaluation of .. clinical(orclinical)CCSwhointendtoorareparticipatinginsystem-
.
. aticexerciseincludingrecreationalorcompetitivesports.Whether
master athletes, as suggested by the European Association for .
.
CardiovascularPreventionandRehabilitation(EACPR)2011207and ... the initial exercisetest includes imaging ornotdepends on factors
theAHA.226 ... suchasthebaselineECG(Table9)andfeasibilityofperformingfunc-
. tionalimagingtestsinagiveninstitute.
In addition to the SCORE risk stratification described earlier ..
.
(Table5),theincreasinguseofcardiacimagingtechniquesallowsthe .. • Iftheclinicalassessment,includingamaximalexercisetestisnor-
.
identificationofagreaternumber ofindividualswith asymptomatic .. mal, the presence of ‘relevant CAD’ is assumed to be unlikely
.
CCS,227includingcompetitivemasterathletes.227 ..
(Figure4).
.
Newerpredictivemeasures,suchashigh-sensitiveC-reactivepro- .. • Intheeventofaborderlineoruninterpretableexercisetestresult,
.
teinandcarotidintima(cid:2)mediathickness(IMT)addlittletothetradi- .. itisrecommendedthatamorespecificimagingstresstestisper-
.
tional risk factors.110 The exception is CAC, which provides .. formedsuchasstress-echocardiography,CMRperfusionimaging,
.
additionalpredictiveinformationinindividualswithamoderate-risk .. orSPECT.MaximalexerciseSPECTandexerciseechocardiogra-
.
profile,228dividingthemintolow-orhigh-riskindividuals.Themost .. phyornuclearperfusiontechniquesutilizingexerciseratherthan
.
prudentandcost-effectivemethodofutilizingCACmaythusbeaddi- .. pharmacologicalstressmaypreferentiallybeused,dependingon
.
tivetothetraditionalriskfactors,229assuggestedbytheEAPC.230 .. availabilityandlocalexpertise.
.
.
Clinicalevaluationofasymptomaticindividualswithpossiblesub- . • If the exercise test is positive, an invasive coronary angiogram
.
clinicalCCSshouldinclude(Figure4):112 .. should be performed to confirm the presence, extent, and
.
.
. severityofCAD(Figure4).
(1) AssessmentofriskofCVD110(Table5) ..
.
.
(2) Considerationofintensityofintendedexerciseprogramme .
.
.
(3) Clinicalevaluation,includingmaximalexercisestresstest .
. 5.1.1.1Recommendationsforsportsparticipation
.
(4) Furtherdiagnostictestinginselectedindividuals. . . IndividualsatriskofCADandasymptomaticindividualsinwhomCAD
.
.
Many middle-aged individuals in the general population can be .. isdetectedatscreeningshouldhaveaggressivemanagementofriskfac-
.
expected to have some level of subclinical CCS as assessed with
.. torsforatherosclerosis.6,131,132,202Consideringthebenefitsofexercise
.
imaging techniques. Anatomical coronary imaging alone does not
.. onprimaryandsecondarypreventionofCCS,6,234individualswithrisk
.
provideinformationrelatingtothecoronaryflowandreserve,which .. factorsshouldberestrictedfromcompetitivesportonlywhenthereis
.
is important in assessing the risk of Ex-R ischaemia or SCD/SCA; .. substantialriskofanadverseevent,asindicatedbyfunctionaltests,or
.
therefore functional evaluation is necessary. Several methods of .. when there is evidence of disease progression during serial evalua-
.
stresstesting(e.g.cycleergometryortreadmilltesting),stressecho- .. tions.233 Exercise recommendations should be individually tailored
.
cardiography,adenosineordobutaminestresscardiacmagneticreso- .. based on the intensity of the exercise and the sporting discipline.
.
nance(CMR),orpositronemissiontomography(PET)/single-photon ... Participationincompetitiveendurance,power,andmixeddisciplines
emission computed tomography (SPECT), can be used to detect ... (see sections 4.2 and 5.1.3) generally requires vigorous effort and is
induciblemyocardialischaemia231.Exercisestress-echoispreferred ... morelikelytoinducemyocardialischaemia,whereasleisuresportsor
in athletes because it is free from radiation and does not involve ... intentionalrecreationalexerciseallowsforgreatercontrolofphysical
administrationofdrugs. ... effort.IndividualswithahighriskofatheroscleroticCADandasympto-
.
Exercise testing is the most widely available functional test, and .. maticindividualsinwhomCADisdetectedatscreeningwhopartici-
.
provides information on exercise capacity, heart rate, and BP .. pateinintensiveexerciseshouldbeassessedwithamaximalexercise
.
response,anddetectionofexercise-inducedarrhythmias,2buthasa . testorfunctionalimagingtestonanannualbasis.
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 24 ---
40 ESCGuidelines
.
.
Recommendationsforexerciseinindividualsatriskof
.. (seeFigure2,section4.1.2)forolderpatients(>60yearsold)withCCS.
.
atheroscleroticcoronaryarterydiseaseandasympto- .. This is due to the fact that age is an additional, strong predictor of
.
maticindividualsinwhomcoronaryarterydiseaseis .. adverseeventsduringexercise.Therearenorestrictionsinlow-risk
.
detectedatscreening .. patientsforskillssportsregardlessofage(Figure2).
.
.. Individuals with inducible ischaemia during functional testing,
Recommendations Classa Levelb ...
despiteadequatetreatment,shouldundergocoronaryangiography;
.
AmongindividualswithasymptomaticCCS,defined .. those with high-risk lesions on coronary angiography (Table 11)
.
asCADwithoutinduciblemyocardialischaemiaon .. should have revascularization prior to considering high-intensity
.
afunctionalimagingorconventionalexercisestress .. exerciseprogrammesorcompetitivesport(Figure5).Individualswith
test,233participationinalltypesofexercise,includ-
IIa C ...
high-risk coronary features may gradually return to sport 3(cid:2)6
.
ingcompetitivesports,shouldbeconsideredbased .. monthsaftersuccessfulrevascularizationpendinganormalmaximal
.
.
onindividualassessment. . exerciseorfunctionalimagingtest.
.
.
. When ischaemia cannot be treated despite adequate therapy, .
CAD=coronaryarterydisease;CCS=chroniccoronarysyndrome. .
. including revascularization, the individual shouldbe restricted from
aClassofrecommendation. ..
bLevelofevidence. .. competitive sports, with the possible exception of individually rec-
.
. ommendedlow-intensityskillsports.Suchindividualsmayengagein
.
.
. regularrecreationalexerciseoflowandmoderateintensityprovided 5.1.2Established(long-standing)chroniccoronary ..
. riskfactorsandsymptomsaretreatedadequatelyandthereisregular
syndrome ..
. clinicalsurveillance.Theseindividualsmayalsoparticipateinleisure
All individuals with established (long-standing) CCS should be ..
. sports,2(cid:2)3times/week,inselectedcases,iftheintendedactivityis
.
encouragedtoperformtheminimalPArecommendationsforgen- .
. below(around10beats)theischaemicthresholdandbelowthelevel
eralandCVhealth.235Thisappliestoindividualswithstableangina, ..
. ofarrhythmias.231
asymptomatic and symptomatic individuals stabilized <1 year after
ACS,orindividualswithrecentrevascularization,andasymptomatic
andsymptomaticindividuals>1yearafterinitialdiagnosisorrevascu-
Table11 High-riskfeaturesforexercise-inducedadverse
larization.110Adviceonintensiveexerciseandparticipationinmost
cardiaceventsinpatientswithatheroscleroticcoronary
competitive sports in asymptomatic individuals with long-standing arterydisease233
CCS should be based on several factors, which are determined
throughclinicalhistory,exercisestresstesting,orfunctionalimaging
andechocardiography(Table10).
Individualswithlong-standingCCSwhodonotshowanyabnormal-
ities on a maximal exercise test or functional imaging test, or have
unimpairedLVfunction,maybeconsideredaslowriskforanexercise-
inducedadverseevent236(cid:2)238(Table11).Suchindividualsmayengage
inallcompetitivesportsonanindividualbasis(Figure5).Somerestric-
tionsmayapplyforhigh-intensitypower,mixed,andendurancesports
Table10 Factorsdeterminingriskofadverseeventsdur-
ingintensiveexerciseandcompetitivesportsinasympto-
maticindividualswithlong-standingcoronaryartery
disease ACS=acutecoronarysyndrome;FFR=fractionalflowreserve;iFR=instant
flowreserve;NSVT=non-sustainedventriculartachycardia;PCI=percutaneous
coronaryintervention.
5.1.2.1Antithrombotictreatment
Individuals with CAD should receive conventional antithrombotic
treatment for secondary prevention, according to published guide-
linesforthegeneralpopulation.233,239,240Individualstakingdualanti-
platelet agents should avoid sports with bodily collision, especially
whentheyarecombinedwithoralanticoagulants,duetotheriskof
haemorrhage.241
0202
CSE©
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 25 ---
ESCGuidelines 41
Figure5 Clinicalevaluationandrecommendationsforsportsparticipationinindividualswithestablishedcoronaryarterydisease.CCS=chroniccoro-
narysyndrome;LAD=leftanteriordescendingcoronaryartery;LM=leftmaincoronaryartery;LVEF=leftventricularejectionfraction.*Withdocu-
mentedischaemiaorahaemodynamicallyrelevantlesiondefinedbyFFR<0.8oriFR<0.9.
Recommendationsforexerciseinindividualswithlong-standingchroniccoronarysyndrome
Recommendations Classa Levelb
Riskstratificationforexercise-inducedadverseeventsisrecommendedinindividualswithestablished(long-standing)chroniccor-
I C
onarysyndrome(CCS)priortoengaginginexercise.233
Regularfollow-upandriskstratificationofpatientswithCCSisrecommended.233 I B
ItisrecommendedthatindividualsathighriskofanadverseeventfromCADaremanagedaccordingtothecurrentGuidelines
I C
onCCS.233
Competitiveorleisuresportsactivities(withsomeexceptionssuchasolderathletesandsportswithextremeCVdemands)
IIa C
shouldbeconsideredinindividualsatlowriskofexercise-inducedadverseevents(Table11).233
Leisure-timeexercise,belowtheanginaandischaemicthresholds,maybeconsideredinindividualsathighriskofexercise-
IIb C
inducedadverseevents(Table11),includingthosewithpersistingischaemia.233
Competitivesportsarenotrecommendedinindividualsathighriskofexercise-inducedadverseeventsorthosewithresidual
III C
ischaemia,withtheexceptionofindividuallyrecommendedskillsports.233
CAD=coronaryarterydisease;CCS=chroniccoronarysyndrome;CV=cardiovascular.
aClassofrecommendation.
bLevelofevidence.
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 26 ---
42 ESCGuidelines
5.1.3Myocardialischaemiawithoutobstructivediseasein
Recommendationsforreturntoexerciseafteracute
theepicardialcoronaryartery coronarysyndrome
Ischaemia and non-obstructive CAD (INOCA) is an under-
recognizedentityassociatedwithincreasedriskofadverseevents242 Recommendations Classa Levelb
thatisusuallydetectedduringevaluationofanginalsymptoms.Stress
Exercise-basedcardiacrehabilitationisrecom-
CMRandPETcandetectabnormalcoronaryflowreserveandsug-
mendedinallindividualswithCADtoreduce I A
gest coronary microvascular dysfunction with non-critical lesions.
cardiacmortalityandrehospitalization.234
There are no established treatments for microvascular angina.
Duringtheinitialperiod,motivationalandpsy-
However,thepanelsuggestsadheringtothesameexerciserecom-
chologicalsupport,andindividualizedrecom-
mendationsasforlong-standingCCS.
mendationsonhowtoprogresstheamountand IIa B
intensityofsportsactivities,shouldbeconsid-
eredinpatientswithCAD.
5.1.4Returntosportafteracutecoronarysyndrome
Allsportsactivitiesshouldbeconsidered,atan
Exercise-based cardiac rehabilitation (exCR) reduces cardiac
mortality, hospital readmission,234234 and anxiety.243 Individuals individuallyadaptedintensitylevelinlow-risk IIa C
individualswithCCS.
whohaveexperiencedanACS,cardiacsurgery,orpercutaneous
intervention should be referred to an early exCR pro- CAD=coronaryarterydisease;CCS=chroniccoronarysyndrome.
gramme,235,242 soon afterthe discharge,6,235,244for8(cid:2)12weeks aClassofrecommendation.
afterthecardiacevent.235,244Everyweekthatexerciseisdelayed bLevelofevidence.
requiresanadditionalmonthofexercisetoaccomplishthesame
levelofbenefit.245
.
.
Exercising individuals with CAD may start performing low- to . 5.1.5Anomalousoriginofcoronaryarteries
.
.
moderate-intensity recreational sporting activities in parallel with . 5.1.5.1Background
.
.
participationinthestructuredprogressiveexerciseprogrammes.All .. TheprevalenceofAOCA(leftandrightcoronaryartery)is0.44%in
typesofsportsactivitiesmaybeconsidered,atanappropriateinten- ... thegeneralpopulationofadolescents.246AOCAisconsideredtobe
.
sitylevel;however,carefulattentionshouldbepaidtothedevelop- .. a common cause of SCD in young athletes17,18,247,248 but is rarely
.
mentofnewsymptoms.218 .. implicatedinindividuals>40yearsofage.249,250
.
In general, structured outpatient exercise programmes, for 3(cid:2)6 .. Chestpain,exertionalsyncopeandSCDmaybethefirstmani-
.
months, are required to achieve the appropriate level of activity for .. festation of AOCA,251 however, over two thirds of patients are
.
sports participation in patients with CAD. In individuals with non-ST .. asymptomatic.252 Mechanisms leading to SCD likely include
.
segmentelevationMIorCCSwhohavehadcompleterevascularization .. repeatedburstsofischaemiawithconsequentincreaseinmyocar-
.
anddonothaveresidualischaemia,exercisetrainingcanbeprogressed .. dial fibrosis and a proclivity to develop VAs during exercise.
.
atafasterpaceuntiltherecommendedexerciselevelisreached. .. Ischaemiamayresultfromthecompressionoftheanomalousves-
.
.. selcoursingbetweentheaortaandthepulmonaryarteryand/or
.
5.1.4.1Competitiveathletes .. fromtheacuteangledtake-offfromtheaortaand/ortheproximal
.
Carefulindividualevaluationisrequiredbeforestartinghigh-intensity .. intramuralcourseoftheanomalousvessel(Figure6).253Bothleft
.
competitivesports.Incompetitiveathletes,anechocardiogram,max- .. andrightanomalouscoronaryoriginshavebeenimplicatedinEx- .
imal exercise test with 12-lead ECG recording or CPET is recom- .. RSCD,althoughtheriskhastraditionallybeenthoughttobecon-
.
mended for risk stratification before return to sports (see section .. siderablyhigherwithananomalousleftcoronaryarteryorigin.252
.
.
5.1.2).CPETspecificallyaddsinformationonaerobicandanaerobic . Exercise testing rarely reveals myocardial ischaemia and multi-
.
. thresholds, guiding exercise intensity prescription and progression . slicecontrast-enhancedCT,CCTA,orCMRarethemainstayof
.
.
(seesection4.2). . diagnosis.
.
.
.
. .
5.1.4.2Recreationalathletes . 5.1.5.2Eligibilityforsports
.
.
Forindividualsintendingtoparticipateinnon-competitive,recrea- . Eligibility for competitive sports is based on the anatomical
.
.
tional sports and leisure-time activity, similar principles apply . typeofAOCAandonthepresenceofischaemia.Ahighlyposi-
.
.
regardingriskstratification.Asymptom-limited/maximalexercise .. tive inotropic and positive chronotropic exercise stress test is
.
testshouldprecedethereturntosports.Higher-riskpatientswith .. thebestapproachtodemonstrateorruleoutischaemia.AOCA
.
CCS(Table11)arenoteligibleforcompetitivesports(seesection .. with acute angled take-off from the aorta resulting in a slit-like
.
5.1.2); however, low-intensity skill sports, such as golf, may be .. orificewithreducedlumenandanomalouscoursingbetweenthe
.
considered, at intensities below the angina threshold. If aerobic .. aorta and the pulmonary artery is associated with the greatest
.
exercise is not tolerated, predominantly strength-related sports .. risk for SCA/SCD whether or not the anomalous artery origi-
.
with a small amount of muscular work are recommended .. natesfromtheleftorrightsinusofValsalva,andstrongconsider-
.
(Figure2,section4.1.2). . ationshould be given to surgical correctionof such ananomaly
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 27 ---
ESCGuidelines 43
Figure6Schematicrepresentationofthemostfrequentanomalousoriginofcoronaryarteriesandassociatedriskofsuddencardiacdeath.RCA=right
coronaryartery;LMCA=leftmaincoronaryartery;LAD=leftanteriordescendingartery;LCCA=leftcircumflexcoronaryartery.
.
in symptomatic individuals. Prior to successful correction, .. (>40 years) with AOCA, due to the paucity of studies.
.
participation in sports, other than low-intensity skill sports, is .. However,recreationalexerciseofmoderateintensityseemsrea-
.
discouraged regardless of symptoms. We are unable to .. sonable, but a cautious approach is advised to more vigorous
.
provide exercise or sport recommendations for older patients .. exercise.
.
Recommendationsforexerciseinyoungindividuals/athleteswithanomalousoriginsofcoronaryarteries
Recommendations Classa Levelb
Whenconsideringsportsactivities,evaluationwithimagingteststoidentifyhigh-riskpatternsandanexercisestresstesttocheckfor
IIa C
ischaemiashouldbeconsideredinindividualswithAOCA.
Inasymptomaticindividualswithananomalouscoronaryarterythatdoesnotcoursebetweenthelargevessels,doesnothaveaslit-
likeorificewithreducedlumenand/orintramuralcourse,competitionmaybeconsidered,afteradequatecounsellingontherisks, IIb C
providedthereisabsenceofinducibleischaemia.
AftersurgicalrepairofanAOCA,participationinallsportsmaybeconsidered,attheearliest3monthsaftersurgery,iftheyareasympto-
IIb C
maticandthereisnoevidenceofinduciblemyocardialischaemiaorcomplexcardiacarrhythmiasduringmaximalexercisestresstest.
ParticipationinmostcompetitivesportswithamoderateandhighcardiovasculardemandamongindividualswithAOCAwithan
III C
acutelyangledtake-offorananomalouscoursebetweenthelargevesselsisnotrecommended.c
AOCA=anomalousoriginofcoronaryarteries.
aClassofrecommendation.
bLevelofevidence.
cThisrecommendationapplieswhethertheanomalyisidentifiedasaconsequenceofsymptomsordiscoveredincidentally,andinindividuals<40yearsofage.
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 28 ---
44 ESCGuidelines
5.1.6Myocardialbridging
Recommendationsforexercise/sportsinindividuals
5.1.6.1Background withmyocardialbridging
Myocardial bridging (MB) refers to a condition when some of the
myocardium overlies a segment of an epicardial coronary artery Recommendations Classa Levelb
(referred toasa tunnelled artery) and most commonlyaffects the
Participationincompetitiveandleisure-time
leftanteriordescendingartery(Figure7).TheprevalenceofMBvaries
sportsshouldbeconsideredinasymptomatic
from0.5(cid:2)12%andupto5(cid:2)75%accordingtodiagnosticangiogra-
individualswithmyocardialbridgingandwithout IIa C
phyorCTscanseries.254MBsaretraditionallyconsideredasbenign;
inducibleischaemiaorventriculararrhythmia
however, the association between myocardial ischaemia and MBs
duringmaximalexercisetesting.
has increased their clinical relevance. MB may be discovered at
Competitivesportsarenotrecommendedin
imaging after an abnormal exercise ECG and should also be sus-
individualswithmyocardialbridgingandpersis-
pectedinindividualswhopresentwithexertionalanginaorsyncope. III C
tentischaemiaorcomplexcardiacarrhythmias
Coronary artery compression together with a Venturi (suction)
duringmaximalexercisestresstesting.
effectarethepotentialunderlyingmechanismsforexercise-induced
ischaemia.248 aClassofrecommendation.
Evaluation of individuals with MB aims primarily at assessing the bLevelofevidence.
morphologiccharacteristicsoftheanatomicalanomaly(i.e.number
ofMB,depthandoveralllengthofthetunnelledvessel)andthepres-
.
enceofinducibleischaemia.Apositiveinotropicandpositivechrono- .
. 5.2 Exercise recommendations in
.
tropic stress test is the best approach to demonstrate myocardial .
.. individuals with chronic heart failure
ischaemia. MB without other underlying associated diseases [e.g. .
.
hypertrophiccardiomyopathy(HCM)]andwithnoevidenceofindu- .. 5.2.1Background:rationaleforexerciseinchronicheart
.
cible myocardial ischaemia has a good prognosis.255 However, in .. failure
.
adult/seniorindividuals,ithasbeenshownthatthearterialcompres- .. Mostoftheevidenceregardingexerciseinchronicheartfailure(HF)
.
sion in MB may be directly related to the atherosclerotic burden, .. isderivedfromstudiesimplementingexercisetrainingprogrammes
.
proximaltotheMB.256Theseindividualsshouldbeconsideredinthe .. thatareconsideredsafeandhighlyrecommendedinstablepatients
.
samecategoryasindividualswithCADandtreatedappropriatelyif .. on optimal medical therapy.257(cid:2)260Meta-analyses of these studies
.
necessary,althoughthevastmajorityofMBisclinicallysilent.Beta- ... havedemonstratedasignificantimprovementinexercisetolerance
blockersshouldbeusedwhenpatientsaresymptomaticormyocar- ... and quality oflife and a modesteffect on all-cause and HF-specific
dialischaemiaisestablished.Surgicalrepairmaybeconsidered,while
... mortalityandhospitalization.261(cid:2)267
.
coronarystentingisdiscouraged.255 ..
.
.
.
.
5.1.6.2Eligibility .. 5.2.2Riskstratificationandpreliminaryevaluation
.
Patients with MB and evidence of ischaemia should be restricted .. Exerciseinterventionshouldonlybeinitiatedinaclinicallystableindi-
.
fromparticipationincompetitivesportsandshouldreceiveappropri- .. vidualaftermedicaltherapyforHFhasbeenoptimized.Keycompo-
.
ateadviceregardingleisure-timeactivities. .. nents before commencing an exercise programme and sports
.
. participationinclude:
. .
.
.
. (1) Exclusionofcontraindicationstoexercise:Contraindicationstoinitiating
.
.
. an exercise programme in chronic HF include hypotension or
.
.
. hypertension at rest or during exercise, unstable cardiac disease,
. .
. deterioratingsymptomsofHF,myocardialischaemiadespitether-
.
.
. apy (exercise may be permitted up to ischaemic threshold), or
.
.
. severeandsuboptimallytreatedpulmonarydisease.258 .
.
.. (2) Performingabaselineassessment:Athoroughcardiologicalevaluation
.
.. isrequired,includingassessmentofcomorbiditiesandHFseverity
.
.. (e.g.byassessmentofbloodnatriureticpeptidesandechocardiogra-
.
.. phy). A maximal exercise test (preferably CPET) is important to
.
.. assessfunctionalcapacity,exercise-inducedarrhythmiasorhaemo-
.
.. dynamic abnormalities and for prescription of exercise intensity,
.
... basedonVO 2peak,oronrestingandmaximalheartrateduringexer-
.. cise[e.g.HRRorBorg’sratingofperceivedexertion(RPE)].265,266
.
.. (3) Optimizingmedicaltherapy:AllindividualswithHFshouldbetreated
.
Figure7 Schematicrepresentationofamyocardialbridge.LAD=left .. according to current Guidelines,257 including device implantation
.
anteriordescendingcoronaryartery. . whenrequired.267
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 29 ---
ESCGuidelines 45
The exercise session should be individually tailored for several
Table12 Optimalexercisetrainingdoseforpatients
weeks,accordingtosymptomsandobjectivefindingsduringexercise
withchronicheartfailure
testing such as maximal exercise capacity, heart rate response, or
arrhythmias.Inatrialfibrillation(AF),exercisecanonlybemonitored
bypowerorBorg’sRPE.
High-riskpatientsshouldbecounselledmorefrequentlyduringthe
initialphases.Ideallyexerciseshouldbesupervisedthroughanexercise-
based cardiac rehabilitation programme while non-supervised home-
basedsessionsshouldbegraduallyadded.260Whenallthesemeasures
are followed, the overall risk of exercise is low, even during higher-
intensityexercisesandinpatientswithmoresevereHF.268,269
Follow-upexaminationsfor exerciserecommendationsshould be
scheduledatleastevery3(cid:2)6months.Intervalsbetweenexaminations
should depend on disease severity and comorbidities, setting of the
sessions(supervisedvs.home-based),patient’sageandadherence.
5.2.3Exercisemodalitiesandsportsparticipationinheart
failure
Followingriskfactorcontrolandtherapyoptimization,theindividual
withHFshouldbeencouragedtostartexerciseprogrammeswithout
delay.242,244,270 Initially home-based exerciseprogrammes mayalso
beprescribedandmonitored.270,271
In uncomplicated cases low to moderate-intensity recreational
sporting activities may be considered in parallel to the structured
exerciseprogramme.Whenprescribed,maximalexerciseintensities
shouldbemonitored,forexample,byheartratemonitors.Ifmoni-
toring does not reveal any exercise-induced arrhythmias or other 1RM=onerepetitionmaximum;RPE=ratingofperceivedexertion;VO2peak=
peakoxygenconsumption.
abnormalities,thenalltypesofrecreationalsportsactivitiesareper-
mitted(seeFigure2,section4.1.2).
.
.
. atwhichthepatientcanperform10(cid:2)15repetitionsat15onBorg’s
5.2.3.1Aerobic/enduranceexercise .
.. RPE scale (Table 12).242,270 In patients with altered skeletal muscle
Aerobic exercise is recommended for stable patients [New York .
.
. function and muscle wasting, exercise trainingshould focus initially
Heart Association (NYHA) class I(cid:2)III], because of its well- .
demonstrated efficacy and safety.260 Recommendations on optimal
... onincreasingmusclemassbyusingresistanceprogrammes.275,276
.
. Resistance programmes may specifically be considered for low-
exercise dose have been previously described in ESC and AHA .
.
Guidelines.242,270(cid:2)272Themostcommonlyevaluatedexercisemode .. riskstablepatients,who want to returnto strength-relatedpower
.
is moderate continuous exercise (MCE).242,270(cid:2)272 In patients in .. sports, e.g. weightlifting (Figure 2, section 4.1.2). A meta-analysis .
. showed that resistance exercise as a single intervention has the
NYHAfunctionalclassIII,exerciseintensityshouldbemaintainedata .
.
alo nw de cr linin icte an lss tit ay tu( s< d4 u0 r% ino gf tV heO
f2 irp se tak
1) (cid:2),a 2cc wo erd ei kn sg .Tto hip se sr hc oe uiv lded besy fm olp lot wom eds ...... c lifa epa inci Hty Ft ro EFin pc are tia es ne tsm wu hsc ole ars etre un ng at bh le,a te oro pb ai rc ticc ia pp aa tc eit iy n, aa en rd oq bu ical eit xy eo r-f
b aty
e
Rda
e,
cg
u
er pa nd
t to
lu ya ,8l
5
hi %n igc hVr -e
iO
na ts
2
ee
p ne
si an
ik
tyain
s
it nte
h
tn ees ri
p
vt ay
r
limt to
a
rar5
y
in0
a
in(cid:2)
im
g7 .0
2
(H7%
0 I,2
ITV
71
)O
p2p re oa gk
r, aa mnd meif sto hl ae vr e-
.........
l
sc
o
mis we allp
e
mxro
e
ug
r
sr
c
ca
i
lsm
ee
gm
t ro
oe ls ue. p2 r7
a
s7
n
acA
re
el ,s to
r re
a, isi nn
is et
da ad
.n
2v
c
70a
e
,n
2e
7c 7xe ,2d
e 7r
8H cisF eo cr anin bp eat sie afn et ls yw apit ph liev der iy
f
.
been considered as an alternative exercise modality for low-risk ..
patients.269Themostrecentmeta-analysisshowedthatHIITwassupe- ... 5.2.3.3Respiratoryexercise
r (<io 4r 0t %o )M eC jeE ctii on nim frp ar co tiv oin ng (V HO
Fr2 Ep Fea )k
inin ti hn ediv shid ou ra tls tew ri mth .2H 73F Hw oi wth er ve ed ru ,c the id
s
...... sIn trs ep nir ga tt ho ,2ry 79m (cid:2)2u 8s 2cl ae nt dra ii tni tn yg pii cm alp lyro inve vos lV veO
s2 sp eea vk
e, rd ay ls sp en so sie oa n, san pd erm wus ec ele
k
superiority disappeared in subgroup analysis of isocaloric
... withintensityrangingfrom30%to60%ofmaximalinspiratorypres-
protocols.HITTprogrammesmayberecommendedinitiallytoprepare
... sure, and duration from 15(cid:2)30 min for an average of 10(cid:2)12
.. weeks.279 This training modality should be recommended to the
lowriskpatientswithstableHFwhowanttoreturntohighintensity .
.
. mostseverelydeconditionedindividualsasaninitialalternativewho
aerobicandmixedendurancesports(Figure2,section4.1.2). .
.
. maythentransitiontoconventionalexercisetrainingandsportspar-
.
5.2.3.2Resistanceexercise
... ticipation,tooptimizecardiopulmonarybenefits.280
.
Resistance exercise training may complement, but not substitute, ..
.
aerobic exercise training because it reverses skeletal muscle mass .. 5.2.3.4Aquaticexercise
.
lossanddeconditioningwithoutexcessivestressontheheart.270,274 .. Aquatic exercise has not been recommended for individuals
.
Thetrainingintensitycanpreferablybesetatthelevelofresistance . with HF, due to concerns that the increase in central blood
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 30 ---
46 ESCGuidelines
.
.
volume and cardiac preload as a consequence of hydrostatic . demands, especially in older patients. No restrictions should apply
.
pressuremaynotbetolerated.283However,arecentmeta-analysis .. forskill-relatedsports.
.
.
has shown that aquatic exercise training may be safe and clinically . Asymptomatic patients with HFrEF who are optimally treated
.
effective.284 .. mayonlybeconsideredsafetoperformspecificlow-intensityskill
.
.
. sportsatacompetitivelevel(Figure2).Higher-riskpatientsinclud-
.
.
. ing those who are suboptimally treated, those that remain in
.
.
5.2.4Sportsparticipationandreturntosports . NYHA II or III despite optimal therapy, and those with exercise-
.
.
Inadditiontoriskstratification(section5.2.3),theevaluationforpar- . inducedarrhythmiasorexercise-inducedhypotensionshouldnot
.
.
ticipationinsportsincludesintensityandtypeofsports(competitive . participate in competitive sports, particularly those sports with
.
.
vs.recreational),anddeterminingtheindividualfitnesslevel. . moderate to high cardiopulmonary strain during training or
.
.
.. competition.
.
.
5.2.4.1Competitivesports .
.
.
Participationin competitivesportsmaybe considered inagroup .. 5.2.4.2Recreationalsports
.
of selected low-risk individuals. A thorough individual evaluation .. For patients intending to participate in recreational sports and
.
using a maximal exercise test (or preferably CPET) is recom- .. leisure-timeactivity,similarprinciplesapplyregardingriskstratifica-
.
mended before returning to sports, particularly before starting .. tion.Aprogressiveincreaseinexercisedoseisrecommended.Low-
.
moderate- to high-intensity sports, mixed and power sports .. tomoderate-intensityskill,power,mixed,andendurancesportsmay
.
(Figure2,section4.1.2). .. beconsideredinallasymptomaticindividuals.
.
Asymptomaticindividualswithpreserved (>_50%)EF(HFpEF)or .. As with competitive sports, high-intensity recreational sports
.
withmid-range(>_40(cid:2)59%)EF(HFmrEF)whoareoptimallytreated .. shouldonlybeconsideredinasymptomaticindividualswithHFmrEF
.
may be eligible to participate in some competitive sports in the .. (EF 40(cid:2)49%) who do not have exercise-induced arrhythmias or
.
absenceofexercise-inducedarrhythmiasorexercise-inducedhypo- .. exercise-inducedhypotension.AsymptomaticindividualswithHFrEF
.
tension.Insuchcases,aprogressiveincreaseinexercisedoseisrec- .. whoareoptimallytreatedmayengageinlow-tomoderate-intensity
.
ommended. The duration of this process is dependent upon the .. skill-related recreational sports, and selectively in low-intensity
.
functionalcapacityandperceivedsymptoms.Somerestrictionsmay .. endurancesports(Figure2).
.
applytohigh-intensityendurance,mixedandpowersportswithhigh .. InpatientswithHFrEFwithverylowexercisetolerance,frequent
.
.
. decompensation, or patients with LV assist devices (see
.
.
Recommendationsforexerciseprescriptioninheart . SupplementaryData),participationinlow-intensityskill-relatedsports
.
failurewithreducedormid-rangeejectionfraction .. ispossible,iftolerated.Regularlow-intensityenduranceactivities,e.g.
.
.
. walking or cycling, should generally be recommended to improve
Recommendations Classa Levelb ..
. basicexercisecapacity.
.
.
Regulardiscussionaboutexerciseparticipation
Recommendationsforparticipationinsportsinheart
andprovisionofanindividualizedexercisepre-
I A failure
scriptionisrecommendedinallindividualswith
heartfailure.260,261,285 Recommendations Classa Levelb
Exercise-basedcardiacrehabilitationisrecom-
Beforeconsideringasportactivity,apreliminary
mendedinallstableindividualstoimproveexer-
I A optimizationofheartfailureriskfactorcontrol
cisecapacity,qualityoflife,andtoreducethe I C
andtherapy,includingdeviceimplantation(if
frequencyofhospitalreadmission.260,261,285
appropriate),isrecommended.
Beyondannualcardiacassessment,clinicalreas-
Participationinsportsactivitiesshouldbecon-
sessmentshouldbeconsideredwhentheinten- IIa C
sideredinindividualswithheartfailurewhoare
sityofexerciseisincreased.
atlowrisk,basedonacompleteassessmentand
Motivationalandpsychologicalsupportandindi- IIa C
exclusionofallcontraindications,instablecondi-
vidualizedrecommendationsonhowtoprogress
IIa C tionforatleast4weeks,optimaltreatment,and
theamountandintensityofsportsactivities
NYHAfunctionalclassIstatus.
shouldbeconsidered.
Non-competitive(low-tomoderate-intensityrec-
Low-tomoderate-intensityrecreationalsport-
reational)skill,power,mixed,orendurancesports
ingactivitiesandparticipationinstructuredexer- IIb C
IIb C maybeconsideredinstable,asymptomatic,and
ciseprogrammesmaybeconsideredinstable
optimallytreatedindividualswithHFmrEF.
individuals.
High-intensityrecreationalsports,adaptedto
High-intensityintervaltrainingprogrammesmay
thecapabilitiesoftheindividualpatient,maybe
beconsideredinlow-riskpatientswhowantto
IIb C consideredinselectedstable,asymptomatic,and
returntohigh-intensityaerobicandmixed IIb C
optimallytreatedindividualswithHFmrEFwith
endurancesports.
anage-matchedexercisecapacitybeyond
aClassofrecommendation. average.
bLevelofevidence.
Continued
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 31 ---
ESCGuidelines 47
.
Non-competitive(low-intensityrecreational
... 5.2.6Exerciseinindividualsafterhearttransplantation
skill-relatedsports)maybeconsidered(when
... The exercise capacity in heart transplantation (HTx) recipients is
tolerated)instable,optimallytreatedindividuals
IIb C ... reduced by 50(cid:2)60% compared with healthy age and sex-matched
withHFrEF.
... individuals in the general population,300(cid:2)302 due to several factors
.. (Table 13).303 Exercise reduces CV risk induced by post-
High-intensitypowerandendurancesportsare .
.. transplantation immunosuppressive medical therapy,304 and
notrecommendedinpatientswithHFrEFirre- III C .
.. increasesphysicalperformance,305enablingHTxpatientstoachieve
spectiveofsymptoms. .
.. levelscomparabletoage-matchedcontrols.306HTxrecipientspartic-
.
.
HFmrEF=heartfailurewithmid-rangeejectionfraction;HFrEF=heartfailure . ipatinginexercise-basedcardiacrehabilitationprogrammesreveala
.
withreducedejectionfraction;NYHA=NewYorkHeartAssociation. .
. favourableoutcomewithrespecttohospitalreadmissionandlong-
a bC Lela vs es lo of fr ee vc ido em nm cee .ndation. ....
termsurvival.305,307,308
.
. Improvementsinexercisecapacityareprimarilydependentonthe
.
.
. volumeofexercise.Increasedfunctionalcapacityisprimarilydueto .
5.2.5Heartfailurewithpreservedejectionfraction .
. peripheraladaptationsintheskeletalmuscleincludingincreasedoxi-
.
Exercise-basedcardiacrehabilitationprogrammesareacornerstone .
. dative capacity and capillary conductance. Cardiac allograft neural
intheholisticpreventionandmanagementofHFpEF.260,285Exercise ..
.. reinnervationalsocontributestoimprovedfunctionalcapacityinthe
interventionfor12(cid:2)24weeksincreasesfunctionalcapacityandqual- .
ity of life.286(cid:2)292 The beneficial effects seem to be mediated by
... firstyear.304,309,310Iftheseoccur,trainingcanbeperformedathigh
.. levels,enablingselectedHTxpatientstoperformmarathonrunsor
improvement in oxidative muscle metabolism and vascular func- .
tion.293Inobesepatients,weightreductionhasbeenshowntohave
... triathlons.304,309,310
.
similareffectstoexercisealone,288thereforeastableweightreduc- ..
.. 5.2.6.1Exercisemodalitiesandsportsparticipation
tionof10%over2(cid:2)4yearsisrecommended.294 .
.. A combination of endurance and resistance exercise is considered
.
.. to be the preferred exercise programme. Mean endurance
p5
H
e.2
ig
a.
h
k5 e.1
hr
eE
e
ax
n
re tdr
u
rc ai rs tae
en
,m
c
weo id
i
tna htli
e
3ti ne mss ita
ii
nen sd acss tup ivco ehrts
ra
ep
s
ca
H
ort vIi Ic eTi rp ya
(
)4ti ho (cid:3)n
ave4 rm evin eaa let d8 p5 o(cid:2) s9 it0 iv%
e
.........
e
aw
px
h
pe
ic
lr ic ehi ds ce
ia
ni nn tt he
la
en ts
e
mi rty
ab
js oeh ro itinu ycld
ore
fs at ea
s
xer et
d
ra ct
t io
sa em
8
in0o t%d ee rvor ea ft ne
V
tiOi on nt 2e
p
sn
e
tas uki dt ,y
ia
e( s6 r0
ie
n%
gi
HmV TeO
xn
.2 3p
l
0ee 5a vk
Ie) nl,
effectsonmyocardialfunction,butdataarelimitedtoasmallgroup ...
uncomplicatedcasestheseintensitiescanbeincreasedtomaximum
of patients with diabetes.295 HIIT performed over 4 weeks signifi- ..
. levels.
cantly improved VO
2peak
and LV diastolic function.296 Higher- ...
It is recommended that individuals should perform up to five
intensityexerciseshouldbelimitedtostablepatientsandcouldbe ..
. bouts of30 min ofexerciseper week;however,exerciseduration
graduallyintroducedafter4weeksofMCE. ..
. andfrequencyhaverangedfrom30minto90minfor2to5times
Exercise sessions should start with short phases of 10 min of ...
perweek,inpreviousHTxstudies.305,311Bothenduranceandresist-
enduranceand10minofresistanceexercises,whichshouldgradually ..
. ancetrainingisincludedinthesetrainingsessions;however,anaddi-
beextendedintimeoveraperiodof4weeks.Thefinalaimshould ..
. tional 2(cid:2)3 sessions of resistance training may be performed
.
be at least 30(cid:2)45 min for >_3 days per week. Depending on the .
. eachweek.
.
patient’s symptomatic status and functional capacity, intervals of .
. Resistance exercise should focus on large muscle groups using
. higherintensitymaybeintroduced. .
. ownbodyweightexercisesorexercisesonweightmachines.Upper
.
Durationofinterventionseemstobeimportantforinducingfunc- .
. bodyresistanceexerciseshouldstartatleast3monthsaftersurgery,
.
tionalandstructuralCVchangesinHFpEF.Interventionsover2years .
.. andintensityshouldgraduallyincreasefromlowtomoderatebutcan
in healthy individuals reversed early signs of diastolic dysfunc-
tion.297,298Regardingsportsparticipationrefertosection5.2.3.
Table13 Factorsinfluencingdecreasedexercisecapacity
Recommendationsforexerciseandparticipationin
(peakVO )andreducedcardiacoutputinindividualswith
sportinindividualswithheartfailurewithpreserved 2
hearttransplants
ejectionfraction
Recommendations Classa Levelb
Moderateenduranceanddynamicresistance
exercise,togetherwithlifestyleinterventionand
optimaltreatmentofcardiovascularriskfactors I C
(i.e.arterialhypertensionandtype2diabetes)
arerecommended.287,289(cid:2)292,299
Competitivesportsmaybeconsideredin
selectedstablepatientswithoutabnormalities IIb C
onmaximalexercisetesting.
aClassofrecommendation.
bLevelofevidence.
Referalsototherecommendationinsection5.2.5.
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 32 ---
48 ESCGuidelines
.
.
alsobeperformeduptosubmaximalintensities,incaseofuncompli- . 5.3.1.1Generalprinciplesinassessmentandriskstratificationofindivid-
.
.
cateddisease(seesection4.1.1). . ualswithvalvularheartdiseasepriortoleisureexerciseorcompetitive
.
.
Amajorlimitationofenduranceexerciseisthereducedchrono- . sports
.
.
tropicresponsetoexercisebecauseofallograftdenervation.Apart . Therearenoprospectivestudiesexaminingtheimpactofexercise
.
.
fromchronotropicincompetence,otherpathophysiologicalchanges . on the progression of valvular disease; therefore, general guidance
.
.
presentafterHTxshouldalsobeconsideredwhenprescribingand . presentedinthissectionisbasedonconsensusopinionsandlong-
.
.
conducting an exercise programme (Table 13). Exercise-induced . termfollow-upstudiesfromnon-athleticpopulations.Mostindividu-
.
.
ischaemiafromcardiacallograftvasculopathyshouldbeconsidered, . alswith valvular heart disease are asymptomaticormildly sympto-
.
.
particularly when performing higher-intensity exercise, which has .. matic and some may aspire to engage in regular exercise
.
beenadvocatedtohavesomesuperioreffectsonimprovingexercise .. programmesincludingleisureandcompetitivesports.Themanage-
.
capacityinthesepatients.311,312 .. ment of these individuals requires assessment of the symptomatic
.
Feasibilityandsafetyofsportsparticipationinstableasymptomatic .. status, functional capacity, the nature of the valvular lesion, and
.
HTx patients, after therapy optimization, has been reported. .. impact ofthe resultingloadingconditions oncardiac structure and
.
Therefore,participationincompetitivesports,avoidinghigh-intensity .. function. All individuals should be assessed with a clinical history,
.
power and endurance disciplines, may be considered in selected .. physical examination, ECG, echocardiography, and exercise stress
.
individuals. .. test.Theclinicalhistoryshouldenquireaboutcardiacsymptomsand
.
.. functionalcapacity.Echocardiographyshouldfocusonthevalvemor-
.
.. phologyandfunctionwithparticularattentiontotheseverityandthe
. Recommendationsforexerciseandparticipationin .. impactofcardiacchambersizeandfunction.Exercisetestingshould
sportinhearttransplantrecipients ...
resembletheintensityofthesportbeingengagedinandshouldfocus
.
Recommendations Classa Levelb
... oninducibilityofsymptoms,arrhythmias,myocardialischaemia,and
.
. thehaemodynamic(BP)responsetoexercise.Someindividualsmay
.
Regularexercisethroughcardiacrehabilitation, .. requireexerciseechocardiographytoassesstheseverityofthevalve
.
combiningmoderate-intensityaerobicandresist- .. defect.
.
anceexercise,isrecommendedtorevertpatho- .. Asymptomaticindividualswithmildtomoderatevalvulardysfunc-
.
physiologytopre-transplantationtime,reduce I B .. tionwhohavepreservedventricularfunctionandshowgoodfunc-
.
.
cardiovascularriskinducedbypost-transplanta- . tional capacity without exercise-inducible myocardial ischaemia,
.
.
tionmedicaltreatment,andimproveclinical . abnormal haemodynamic response, or arrhythmias are considered
.
outcome.305(cid:2)312 .. tobeatlowriskandmayparticipateinallsports.Indeed,mildvalvular
.
.
Recreational(low-intensityrecreational)sports . regurgitation(mostlytricuspidandpulmonary)arecommonamong
.
.
participationshouldbeconsideredandencour-
IIa C
... trainedathletesandlikelyrepresentafeatureoftheathlete’sheart.
agedinstable,asymptomaticindividualsafter .. Conversely, individuals with exertional symptoms, moderate or
.
therapyoptimization. .. severevalvulardysfunction,leftorrightventriculardysfunction,pul-
.
Eligibilityforcompetitivesportsinvolvinglow- .. monary hypertension, and exercise-induced cardiac arrhythmiasor
.
andmoderate-intensityexercisemaybeconsid- .. abnormalhaemodynamicresponseareconsideredtobeathighrisk
IIb C .
eredinselected,asymptomaticindividualswith .. andshouldbeconsideredforinvasiveintervention.
.
anuncomplicatedfollow-up.304,309,310 ..
.
.. 5.3.1.2Surveillance
a bC Lela vs es lo of fr ee vc ido em nm cee .ndation. ....
Allindividualswithvalvularheartdiseaseshouldbeassessedonareg-
.. ularbasis.Thefrequencyoftheassessmentmayvaryfrom6monthly
.
.. to2yearlydependingonsymptomaticstatusandtheseverityofvalve
.
.. dysfunction.
.
.
5.3 Exercise recommendations .. .
. 5.3.2Aorticvalvestenosis
in individuals with valvular heart ..
. Aortic valve stenosis (AS) is most frequently the result of an age-
.
disease .
. dependentdegenerativeprocesscausingprogressivethickening,cal-
.
5.3.1Introduction .. cification,andreducedmobilityofthecusps.313AScausesanincrease
.
Valvularheartdiseaseaffectsapproximately1(cid:2)2%ofyoungexer- .. intransvalvularpressuregradientandLVworkload,withconsequent
.
.
cisingindividualsinthegeneralpopulation.Reportsonthenatural . LVhypertrophy,fibrosis,andincreasedmyocardialoxygendemand.
.
.
history of valvular heart disease in athletes are sparse; however, .. Leftventricularejectionfraction(LVEF)isusuallypreserved.Affected
.
thereisatheoreticalpossibilitythatalargestrokevolume,coupled .. individualsmayhaveanormalcardiacoutputatrestandevenduring
.
with vigorous mechanical contractions of the heart, and an .. exercise, therefore, some individuals with AS are capable of good
.
increasedchronotropicstateinducedbyexercisemayaccelerate .. exercise performance. Nonetheless, severe AS is associated with
.
valve dysfunction. The ensuing effects on chronic stenotic or .. increased risk of heart failure and SCD from mechanical outflow
.
regurgitantlesionsmaycausecompensatorycardiachypertrophy, .. obstruction,malignantVAs,orcoronaryhypoperfusion.18,314
.
impaired ventricular function, myocardial ischaemia, cardiac .. ThediagnosisandgradingofASduringechocardiographyisbased
.
arrhythmias,andpossiblySCD. . onwell-establishedcriteria.315Specifically,severeASisdefinedby:(i)
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 33 ---
ESCGuidelines 49
atransvalvularDopplervelocity>_4.0m/s;(ii)ameangradient>_40
Recommendationsforparticipationincompetitive
mmHg;and(iii)acalculatedaorticvalvearea<1.0cm2oranindexed
sportsinasymptomaticindividualswithaorticstenosis
area(recommendedinathletes)<0.6cm2/m2.315Incaseswithalow
gradient(<40mmHg)andcalculatedvalvearea<1.0cm2,withEF< Aorticstenosisc
50% and stroke volume index <35 mL/m2, low-dose dobutamine
Recommendation Classa Levelb
stressechocardiographyisrecommendedtoidentifypseudo-severe
Mild Participationinallcompetitive
ASortruesevereAS.315,316Assessmentoftheaorticvalvecalcium I C
sports,ifdesired,isrecommended.
scorewithCTcanbeusefulinborderlinecaseswheretheseverityof
ASremainsunclear.313,316 Moderate Participationinallcompetitive
sportsinvolvinglowtomoderate
Exercise testingisparticularlyimportanttoassessthehaemody-
effort,ifdesired,maybeconsidered
namicresponseinASandtoserveasaguidetoexerciseprescription IIb C
inindividualswithLVEF>_50%,good
in cases of asymptomatic moderate and severe AS. A progressive
functionalcapacity,andnormalBP
dropinSBPwithexercise,orfailuretoincreaseSBPbyatleast20
mmHg,identifiessubjectsathigherrisk.317Exercise-inducedventricu- responseduringexercise.
lar tachycardia should also be considered a criterion for exercise Severe Participationinlow-intensityskill
restrictions. sportsmaybeconsideredinaselect IIb C
Asymptomatic individuals with mild AS may participate in all groupofindividualswithLVEF>_50%.
sports.AsymptomaticathleteswithsevereASshouldnotparticipate Participationinsportsorexerciseof
in any competitive or leisure sports with the exception of low- moderateorhighintensityisnot III C
intensityskillsports.However,low-intensityaerobicexercisecould recommended.
be encouraged in asymptomatic individuals to improve functional
BP=bloodpressure;LVEF=leftventricularejectionfraction.
capacityandgeneralwell-being. aClassofrecommendation.
Individuals with symptomatic AS should not participate in any bLevelofevidence.
cFor mixed valvular disease, the recommendation for the predominant lesion
competitivesportorrecreationalsport/exerciseandvalvereplace-
shouldbefollowed.
mentisrecommended.Mildexercise,thatdoesnotprovokesymp-
toms, may be considered in these individuals for general health
.
benefits. .. 5.3.3Aorticvalveregurgitation
.
.
. Aortic valve regurgitation (AR) is usually caused by a congenitally
.
.
Recommendationsforexerciseandparticipationinrec- .. abnormalvalve(i.e.bicuspidvalve),degenerationofatricuspidvalve,
reational/leisure-timesportsinasymptomaticindividu- .. or loss of coaptation due to aortic root enlargement.313,318 Less
.
alswithaorticstenosis .. common causes of AR include infective endocarditis or aortic
.
.
. dissection.
Aorticstenosisc ..
. The haemodynamicconsequence ofchronicARischaracterized
.
.
Recommendation Classa Levelb .. bya pressure and volumeoverloadthattypicallyleadstoadilated
.
. andhypertrophied LV. To accommodate theconcomitantforward
Mild Participationinallrecreational .
I C .. flow from the mitral valve and the backward flow from the aortic sports,ifdesired,isrecommended. .
.
Moderate Participationinallrecreational
... valveduringdiastole,theLVprogressivelyincreasesinsizeandmass.
sportsinvolvinglowtomoderate
... Thisremodellingmayoccasionallybedifficulttodistinguishfromcar-
intensity,ifdesired,shouldbecon-
... diacadaptationinathletes,especiallyinmaleswithalargebodysize
sideredinindividualswith
IIa C ... whoengageinenduranceactivities,andthereforeLVsizeshouldbe
LVEF>_50%,goodfunctional
... interpretedinthecontextofthesportparticipatedin,andthegender
capacity,andnormalexercisetest.
... and body surface area of the individual.319 Males with a LV end-
.. diastolic diameter >35 mm/m2 or a LV end-systolic diameter >50
Severe Participationinallrecreational .
.. mm,andfemaleswithaLVend-diastolicdiameter>40mm/m2ora
sports/exerciseinvolvinglowinten- .
.. LV end-systolic diameter >40 mm, should be considered to have
sity,ifdesired,maybeconsideredin IIb C .
.. pathological LV enlargement, irrespective of the level of physical
individualswithLVEF>_50%andnor- .
.. training.Theseindividualsshouldbecloselymonitoredforaprogres-
malBPresponseduringexercise. .
.. siveincreaseinLVend-systolicdiameter.
Participationincompetitiveorrec- ..
. Inindividualswithsuboptimalechocardiographicimages,CMRhas
reationalsports/exerciseofmoder- ..
III C . the advantages of providing an accurate assessment of LV volume
ateandhighintensityisnot ..
. andEF,flowcalculations and detectingthe presence ofmyocardial
recommended. ...
scar,319inindividualswithsevereAR.Furthermore,thewholethora-
.
.
BP=bloodpressure;LVEF=leftventricularejectionfraction. .. cicaortacanbevisualizedduringthesameexamination.
aClassofrecommendation. .. AsymptomaticindividualswithmildandmoderateARmaypartici-
bLevelofevidence. ..
. pateinallsports.AsymptomaticindividualswithsevereAR,moder-
cFor mixed valvular disease, the recommendation for the predominant lesion ..
(stenoticorregurgitant)shouldbefollowed. .. ately dilated LV, and good LV systolic function may participate in
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 34 ---
50 ESCGuidelines
.
sportsinvolvinglowandmoderateintensityandmaybeconsidered .. syndrome,theriskofaortopathyislower;nonethelessBAVismuch
.
for more intensive exercise on an individual basis. Such individuals .. more frequent, and the relative risk of aortic dissection has been
.
requiremorefrequentsurveillanceona6-monthlybasistoassessLV .. reported to be eight times greater than with a tricuspid aortic
.
function. In asymptomatic individuals with severe AR and reduced .. valve.321 BAV may not be identified during physical examination in
.
LVEF,surgicalvalvereplacement/repairisindicated,andtheyshould .. the absence of valve dysfunction;58,322 however, the outcome of
.
not participate in competitive sports but may participate in leisure .. youngindividualswithoutvalvulardysfunctionisgood.323,324
.
.
sportsinvolvingonlylow-intensityexercise.Surgeryisrecommended . Itisunclearwhetherintensiveexerciseacceleratesaorticdilatation
.
.
insymptomaticindividualswithsevereAR.Theseindividualsshould . in the long term. A previous study comparing athletes with BAV,
.
.
not participate in competitive or leisure sports; however, low- . non-athletes with BAV, and athletes with a normal aortic valve
.
.
intensity aerobic exercise activity is encouraged to improve func- . reported that athletes with BAV showed a 0.11 ± 0.59 mm/year
.
.
tionalcapacityandgeneralwell-being. . increaseinaorticsizeatthesinusesofValsalvaand0.21±0.44mm/
.
.
. year for the proximal ascending aorta, which was not dissimilar to
.
.. non-athletes with a BAV.325 Currently, expert consensus panels
.
.
5.3.4Bicuspidaorticvalve .. advise a cautious approach to sports activities when the ascending
.
Bicuspidaorticvalve(BAV)isacommoncongenitalabnormalitywith .. aortaisabovethenormallimits(seesection5.4).Intheabsenceof
.
a prevalence of 1(cid:2)2% in the general population.320 BAV may be .. aortopathy,exerciserecommendationsforindividualswithBAVare
.
associated with AS or AR and increased risk for ascending aortic .. identical to those in individuals with tricuspid aortic valve
.
aneurysm or dissection, and SCD.28,321 Compared with Marfan . dysfunction.
Recommendationsforparticipationinrecreational/leisure-timesportsinasymptomaticindividualswithaortic
regurgitation
Aorticregurgitationc
Recommendation Classa Levelb
Mild Participationinallrecreationalsports,ifdesired,isrecommended. I C
Moderate Participationinallrecreationalsports,ifdesired,shouldbeconsideredinasymptomaticindi-
IIa C
vidualswithanon-dilatedLVwithLVEF>50%andnormalexercisestresstest.
Severe Participationinallrecreationalsportsinvolvinglowandmoderateintensity,ifdesired,may
beconsideredwithamildormoderatelydilatedLVwithLVEF>50%andnormalexercise IIb C
stresstest.
Participationinanymoderate-orhigh-intensityrecreationalexerciseisnotrecommended
III C
withLVEF<_50%and/orexercise-inducedarrhythmias.
LV=leftventricle;LVEF=leftventricularejectionfraction.
aClassofrecommendation.
bLevelofevidence.
cFormixedvalvulardisease,therecommendationforthepredominantlesionshouldbefollowed.
Recommendationsforparticipationincompetitivesportsinasymptomaticindividualswithaorticregurgitation
Aorticregurgitationc
Recommendation Classa Levelb
Mild Participationinallcompetitivesports,ifdesired,isrecommended. I C
Moderate Participationinallcompetitivesports,ifdesired,shouldbeconsideredinindividualswith
IIa C
LVEF>50%andnormalexercisetest.
Severe Participationinmostcompetitivesportsinvolvinglowtomoderateintensitymaybeconsid-
eredinindividualswithamildormoderatelydilatedLVwithLVEF>50%andnormalexercise IIb C
stresstest.
Participationinanymoderate-orhigh-intensitycompetitivesportsisnotrecommendedin
III C
individualswithsevereARand/orLVEF<_50%and/orexercise-inducedarrhythmias
AR=aorticregurgitation;LV=leftventricle;LVEF=leftventricularejectionfraction.
aClassofrecommendation.
bLevelofevidence.
cFormixedvalvulardisease,therecommendationforthepredominantlesionshouldbefollowed.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 35 ---
ESCGuidelines 51
.
.
5.3.5Primarymitralregurgitation . Asymptomatic individuals with mild or moderate MR may com-
.
.
Mostindividualswithmitralvalvediseasehaveprimarymitralregurgi- . peteinallsportsiftheyhavegoodfunctionalcapacity,preservedLV
.
tation(MR)frommyxomatousdisease.326MRisconfirmedandquan- .. function,sPAP<50mmHgandabsenceofcomplexarrhythmiasdur-
.
.
tified by echocardiography. General recommendations regarding . ingexercise.IndividualswithsymptomaticMRandreducedexercise
.
.
exerciseandsportsarebasedonsymptomaticstatus,severityofMR, . capacity or individuals with MR with exercise-induced complex
.
.
LVfunction,systolicpulmonaryarterypressure(sPAP),andthepres- . arrhythmias should not participate in competitive or leisure sport;
.
.
enceorabsenceofarrhythmiasduringexercise.Bothathletictraining . however, low-intensity aerobic exercise should be encouraged to
.
.
andMRmaybeassociatedwithanenlargedLVcavity;however,an . improve functional capacity and general well-being. Individuals on
.
.
enlargedLVthatisdisproportionatetothelevelofexercisemaybe .. long-termanticoagulationtherapyforAFshouldnotengageincon-
.
suggestiveofsevereMRandanindicationtorefrainfromcompetitive .. tact/collisionsport.
.
orleisuresportsinvolvingmoderate-orhigh-intensityexercise. .
Recommendationsforparticipationinrecreational/leisure-timesportsinasymptomaticindividualswithmitral
regurgitation
Mitralregurgitationc,d
Recommendation Classa Levelb
Mild Participationinallsports,ifdesired,isrecommended. I C
Moderate Participationinallrecreationalsports,ifdesired,shouldbeconsideredinindividualsfulfillingthefollowing:
• LVEDD<60mm327or<35.3mm/m2inmenand<40mm/m2inwomen
• LVEF>_60% IIa C
• RestingsPAP<50mmHg
• Normalexercisetest
Severe Participationinallrecreationalsportsinvolvinglowandmoderateintensity,ifdesired,maybeconsideredin
individualsfulfillingthefollowing:
• LVEDD<60mm327or<35.3mm/m2inmenand<40mm/m2inwomen
IIb C
• LVEF>_60%
• RestingsPAP<50mmHg
• Normalexercisetest
LVEDD=leftventricularend-diastolicdiameter;LVEF=leftventricularejectionfraction;MR=mitralregurgitation;sPAP=systolicpulmonaryarterypressure.
aClassofrecommendation.
bLevelofevidence.
cFormixedvalvulardisease,therecommendationforthepredominantvalvelesionshouldbefollowed.
dNocollisionorbodycontactsportsifanticoagulatedforatrialfibrillation.
Recommendationsforparticipationincompetitivesportsinasymptomaticindividualswithmitralregurgitation
Mitralregurgitationc,d
Recommendation Classa Levelb
Mild Participationinallcompetitivesports,ifdesired,isrecommended. I C
Moderate Participationinallcompetitivesports,ifdesired,shouldbeconsideredinindividualsfulfilling
thefollowing:
• LVEDD<60mm327or<35.3mm/m2inmenand<40mm/m2inwomen
IIa C
• LVEF>_60%
• RestingsPAP<50mmHg
• Normalexercisetest
Severe Participationincompetitivesportsinvolvinglowexerciseintensity,ifdesired,maybeconsideredinindividuals
fulfillingthefollowing:
• LVEDD<60mm327or<35.3mm/m2inmenand<40mm/m2inwomen
IIb C
• LVEF>_60%
• RestingsPAP<50mmHg
• Normalexercisetest
ParticipationincompetitivesportsisnotrecommendedinindividualswithaLVEF<60% III C
LVEDD=leftventricularend-diastolicdiameter;LVEF=leftventricularejectionfraction;MR=mitralregurgitation;sPAP=systolicpulmonaryarterypressure.
aClassofrecommendation.
bLevelofevidence.
cFormixedvalvulardisease,therecommendationforthepredominantvalvelesionshouldbefollowed.
dNocollisionorbodycontactsportsifanticoagulatedforatrialfibrillation.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 36 ---
52 ESCGuidelines
.
5.3.5.1Mitralvalveprolapse .. ventricular premature beats arising from the LV should undergo a
.
Mitral valve prolapse (MVP) is characterized by fibro-myxomatous .. CMRimagingscantocheckspecificallyformyocardialfibrosisaffect-
.
changes of the mitral valve leaflets and has a prevalence of .. ingtheinfero-basalwall.Otherpotentiallyhigh-riskmarkersinclude
.
1(cid:2)2.4%.328,329ThediagnosisofMVPisdefinedas>2mmdisplace- .. evidence of mechanical dispersion detected by speckled tracking
.
mentofoneorbothleafletsofthemitralvalvebeyondtheannulus .. echocardiography,338coexistingprolongationoftheQTintervaland
.
withintheleftatriuminend-systole.330MVPisgenerallybenignwith .. mitralannulardisjunction.333
.
a10-yearmortalityriskof5%.331Themajorityofindividualsareiden- .. GiventherelativelybenignnatureofMVP,asymptomaticpatients
.
.
tifiedincidentallyduringcardiacauscultation,orechocardiography. . withmildormoderateMRcanparticipateinallcompetitivesports
.
.
The most common complication of MVP is the progression to . andleisuresportsintheabsenceoftheaforementionedriskfactors
.
.
chronicsevereMR,in5(cid:2)10%ofindividualswithMVP.Othercompli- . (Figure8).Asymptomatic patients withsevereMRbut none ofthe
.
.
cationsincludeHFfromchronicMR,pulmonaryhypertension,infec- . abovehigh-riskmarkersmaycompeteinlow-tomoderate-intensity
.
.
tive endocarditis, supraventricular and VAs, and, occasionally, . sportsafterdetaileddiscussionwiththeirspecialistinthepresenceof
.
SCD.313IntheItaliancardiacpathologyregistryof650SCDsinyoung .. LV end-diastolic diameter (LVEDD) <60 mm (or <35.5 mm/m2 in
.
adults,7%wereattributedtoMVP.332Mostdecedentsshowedscar- .. menand<40mm/m2inwomen)withLVEF>_60%,restingsPAP<
.
.
ringintheinfero-basalwallandpapillarymusclesandbi-leafletpro- . 50mmHg,andnormalexercisetest.
.
.
lapse. Myocardial scarring, mitral valve annular disjunction (i.e. an . Symptomatic patients with MVP and any of the aforementioned
.
.
abnormal atrial displacement of the mitral valve leaflet hinge point .. high-risk features (Figure 8) should not participate in recreational
.
duringsystole),333T-waveinversionintheinferiorleadsandVAsaris- .. or competitive sports; however, low-intensity aerobic exercise
. ing from the LV [right bundle branch block (RBBB) morphology] .. should be encouraged to improve functional capacity and general
.
werehigh-riskfeaturesforSCD.334ThemechanicalstrainofMVPon .. well-being.
.
papillarymusclesandadjacentmyocardiumisthoughttoberesponsi- ..
.
bleforthemyocardialscarring,whichmaybeapossiblemechanism .. 5.3.6Mitralstenosis
.
forlife-threateningarrhythmiasinsomeindividuals.335,336 ..
Although rheumatic valve disease is uncommon in the western
.
Ingeneral,exercisingindividualswithMVPhaveanexcellentprog- .. world, the increase in emigration patterns means that cardiologists
.
nosis. In a recent Italian study of 7449 young competitive athletes, ... mayencounterindividualswithrheumaticmitralstenosis(MS)who
MVPwasidentifiedin2.9%.Duringafollow-upperiodof8±2years ... aspiretoexercise.IndividualswithadvancedMSareusuallysympto-
therewerenofatalities.337Adverseevents,includingprogressiveMR ...
maticandincapableofengaginginexerciseregimenswithahighCV
with LV dilatation, ischaemic stroke, and AF occurred at a rate of ... demand. The risk stratification of exercising individuals with MS is
.
0.5%perannumandweremorecommoninolderathleteswithbase- .. basedlargelyonadetailedechocardiogramwithspecificinterestin
.
linemitralvalvedisjunctionorVAs. .. theseverityofthelesionandaccompanyingsystolicPAP.Inaddition,
.
IndividualswithMVPshouldbeevaluatedwithanexercisetestand .. assessmentshouldincludeamaximalexercisestresstesttoidentify
.
24-hour ECG. Individuals with inferior T-wave inversion or . concealedsymptomsandfunctionalcapacity.
Figure8 Specificmarkersofincreasedriskofsuddencardiacdeath(SCD)withmitralvalveprolapse.LV=leftventricular;MR=mitralregurgitation;
MV=mitralvalve.AdaptedfromGatietal.336
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 37 ---
ESCGuidelines 53
.
AsymptomaticindividualswithmildMS[mitralvalvearea(MVA) .. MildTRiscommoninathletesandaccompaniedbyphysiological
.
1.5(cid:2)2.0cm2]andmoderateMS(MVA1.0(cid:2)1.5cm2)whoareinsinus .. dilatation of the inferior vena cava, which is easily collapsible with
.
rhythmanddemonstrategoodfunctionalcapacityonexercisetesting .. inspiration.SevereTRischaracterizedbyincreasingtricuspidannular
.
and a normal sPAP may participate in all competitive and leisure .. dilatationandRVremodellingthateventuallyleadstoRVdysfunction
.
sports. Mildlysymptomaticindividualswithsevere MS (MVA< 1.0 .. andanon-reactiveinferiorvenacava.IndividualswithsevereTRmay
.
cm2)mayonlyparticipateinleisureexerciseinvolvingphysicaleffort .. alsohaveareducedexercisecapacityduetoanimpairedcardiacout-
.
oflowintensity.IndividualswithsymptomaticMSshouldbereferred .. put response with exercise.339 Furthermore, they may experience
.
.
forinterventionandadvised toabstainfromparticipationinsports . increasedright-andleft-sidedfillingpressuresduringexercise,thelat-
.
and recreationalexercise ofmoderateorhighintensity. Individuals .. terbeingduetodiastolicventricularinteraction.340
.
.
withAFshouldbeanticoagulatedandavoidcontact/collisionsport.In . Ingeneral, asymptomaticpatientswithTRwho have goodfunc-
.
.
casesofballoonmitralvalvuloplastywithgoodresults(i.e.MVA>2.0 . tionalcapacity,non-dilatedrightventricle,preservedventricularfunc-
.
cm2) regular exercise and competitivesport may be considered in .. tion, sPAP<40 mmHg, and absence of complex arrhythmias may
.
.
asymptomaticindividualswithgoodfunctionalcapacity. . competeinallcompetitiveandrecreationalsports.
.
Recommendationsforparticipationinrecreational/leisure-timesportsinindividualswithmitralstenosis
Mitralstenosisc,d
Recommendation Classa Levelb
Mild(MVA1.5(cid:2)2.0cm2) Participationinallrecreationalsports,ifdesired,isrecommendedinindividualswitharesting
I C
sPAP<40mmHgandnormalexercisetest.
Moderate(MVA1.0(cid:2)1.5cm2) Participationinallrecreationalsportsinvolvinglowandmoderateintensity,ifdesired,maybe
IIb C
consideredinindividualswithrestingsPAP<40mmHgandanormalexercisetest.
Severe(MVA<1cm2) Participationinleisuresportsofmoderateorhighintensityisnotrecommended. III C
MVA=mitralvalvearea;sPAP=systolicpulmonaryarterypressure.
aClassofrecommendation.
bLevelofevidence.
cFormixedvalvulardisease,therecommendationforthepredominantvalvelesionshouldbefollowed.
dNocollisionorbodycontactsportsifanticoagulatedforatrialfibrillation.
Recommendationsforparticipationincompetitivesportsinasymptomaticindividualswithmitralstenosis
Mitralstenosisc,d
Recommendation Classa Levelb
Mild(MVA1.5(cid:2)2.0cm2) Participationinallcompetitivesports,ifdesired,isrecommendedinindividualswitharesting
I C
sPAP<40mmHgandanormalexercisetest.
Moderate(MVA1.0(cid:2)1.5cm2) Participationinallcompetitivesportsinvolvinglowintensitymaybeconsideredinindividuals
IIb C
witharestingsPAP<40mmHgandnormalexercisetest.
Severe(MVA<1.0cm2) Participationincompetitivesportsisnotrecommended. III C
MVA=mitralvalvearea;sPAP=systolicpulmonaryarterypressure.
aClassofrecommendation.
bLevelofevidence.
cFormixedvalvulardisease,therecommendationforthepredominantvalvelesionshouldbefollowed.
dNocollisionorbodycontactsportsifanticoagulatedforatrialfibrillation.
5.4 Exercise recommendations in
5.3.7Tricuspidregurgitation
Tricuspidregurgitation(TR)isusuallysecondarytoleftheartdisease, individuals with aortopathy
pulmonary hypertension, or right ventricular (RV) dysfunction. In 5.4.1Introduction
mostpatientswithsecondaryTR,exerciselimitationsrelatetothe Thoracicaorticaneurysmsare largelyasymptomaticuntil a sudden
underlyingpathology. andcatastrophicevent,includingaorticruptureordissection,occurs,
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 38 ---
54 ESCGuidelines
.
.
whichcanberapidlyfatal.Advancedage,malesex,long-termhistory . effects of a 3-week rehabilitation training programme in 19 MFS
.
.
ofarterialhypertension,andthepresenceofaorticaneurysmconfer . patientswithameanageof47years.Duringthe1-yearfollow-up,
.
.
the greatest population attributable risk for aortic dissection. . therewerenoadverseeventsbuttherewasimprovementinphysical
.
.
However,patientswithgeneticconnectivetissuedisorderssuchas . fitness and reduction in psychological distress. These effects were
.
.
Marfan (MFS), Loeys Dietz, Turner, or Ehlers Danlos (EDS) syn- . detectable after 3 weeks of rehabilitation, and mostly persisted
.
.
dromes, and patients with BAV are at increased risk at a much .. through the 1-year follow-up. Unfortunately, no information on
.
younger age. BAV has a prevalence of about 1(cid:2)2% in the general .. aorticdiameterswasprovided.348
.
population.Thesepatientshavearelativelylowriskforaorticdissec- ..
.
tionincomparisonwithpatientswithhereditarythoracicaorticdis- ..
. 5.4.3Sportingdisciplines
ease(HTAD).Havingafamilyhistoryofaorticdissectionorsudden ..
. Exercise-related acute thoracic aortic dissections are described in
deathisariskfactorandalargerdiameteroftheaortacarriesahigher ..
. theliteratureinatotalof49casereports.Ofthese,42patientssuf-
risk,althoughdissectioncanoccuratanydiameterandespeciallyin ..
. feredStanfordtypeAthoracicaorticdissections.Inthemajority(26/
EDS patients there is no clear association with aortic ...
49) weightlifting was associated with aortic dissection.349
diameter.341(cid:2)343 ..
. Furthermore,arecentlypublishedretrospectivecohortstudyof615
Adilatedaorticroot(>40mm)isnotafeatureofathlete’sheart, ..
. patients with acute type A aortic dissection found that 4.1% cases
withonlyasmallminorityofyoungathletes(0.3%)havinganenlarged ..
. were related to sports activities. The type of sports most often
aortic root diameter.344(cid:2)347 During follow-up no progressive ..
.. reportedwasgolf(32%),butthiswasnotcorrectedforthepercent-
enlargementoftheaorticdiameterwasobservedintheseathletes, .
andnoaorticeventsoccurredduringa5-yearperiod.347 ... ageofparticipantsinthesportandprobablyreflectsthatgolfersare
.. frequently older with an increased risk of hypertension and hence
.
.. thepotentialfordissection.350
.
.
.
5.4.2Riskofdissection .
.
.
BecauseoftheincreaseinBPandwallstressassociatedwithintensive . 5.4.4Effectonaorticdiameterandwallstress
.
.
exerciseandsports,suchactivitiesarepotentiallyassociatedwithan . One cross-sectional study, which included 58 competitive athletes
.
.
enhancedriskofexpansionoftheaortaandacuteaorticdissection. . with BAV, showed no correlation between aortic dimensions and
.
However,dailyexerciseisimportantinmaintaininganidealBP,heart .. durationoftraining.351Twostudiescomparedathletesandsedentary
.
.
rate,andbodyweightandasedentarylifestyleisanimportantmodifi- . individuals with BAV and reported no difference in aortic growth
.
.
able risk factor for CV disease and mortality. Physical activity is . ratebetweenthetwogroups.
.
.
advisedinallpatientswithaorticpathology,evenwhentheaortais .. Two MFS mouse models investigating the effects of mild-
.
dilated. .. moderatedynamicexerciseontheaorticwallshowedareductionin
.
Therearenorandomizedcontrolledtrialsoncompetitivesports .. the growth rate oftheaortic diameter in mice with MFSthatper-
.
in patients with thoracic aortic disease, or any prospective data .. formedmildtomoderatedynamicexercisecomparedtosedentary
.
regardingtherisksofcompetitiveathleticsinpatientsaftersurgical .. micewithMFS.352,353Amongexercisingmice,theaorticwallbecame
.
correction; however, even after aortic root replacement, patients .. strongerandalargermechanicalstresswasrequiredtoinduceaortic
.
with MFS and other HTAD remain at risk of aortic complications. .. rupture.Anoptimumprotectiveeffectwasfoundatatraininginten-
.
One small prospective cohort study evaluated the feasibility and . sitylevelof55(cid:2)65%ofmaximumoxygenuptake(VO ).
2max
Table14 Classificationofrisktoperformsportsinpatientswithaorticpathology
ASI=aorticsizeindex;BAV=bicuspidaorticvalve;HTAD=hereditarythoracicaorticdisease;MFS=Marfansyndrome.
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 39 ---
ESCGuidelines 55
.
.
5.4.5Recommendations . 5.5.1Hypertrophiccardiomyopathy
.
.
Regularexercisehasawell-documentedbenefitforfitness,psycho- . ThediagnosisofHCMisbasedonthepresenceofunexplainedLV
.
.
logicalwell-being,andsocialinteraction,aswellasapositiveeffecton . hypertrophy,definedasamaximumend-diastolicwallthickness>_15
.
.
hypertensionandconcomitantfutureriskofdissection.Mostindivid- . mm,inanymyocardialsegmentonechocardiography,CMR,orCT
.
uals with aortic pathology benefit from a certain minimal exercise .. imaging.355HCMmayalsobeconsideredinindividualswithalesser
.
.
programme and can at least participate in recreational sports . degreeofLVhypertrophy(wallthickness>_13mm)inthecontextof
.
.
(Table14).Somelesionsarenotcompatiblewithendurancetraining . afamilyhistoryofdefiniteHCMorapositivegenetictest.355
.
.
and athletic sports, due to their high risk of dissection or rupture. ..
.
Recommendationsfor exerciseand sportsshould be individualized .. 5.5.1.1Riskstratificationinhypertrophiccardiomyopathy
.
andbasedontheunderlyingdiagnosis,theaorticdiameter,familyhis- .. Circumstantial evidence and a large systematic collection of young
.
toryfordissectionorsuddendeath(riskfactor),andthepre-existing .. SCDsinsportsintheUSsuggestthatexerciseincreasestheriskof
.
fitnessandexperience.Anexercisetestwithanassessmentofblood .. SCD/SCAinindividualswithHCM.18Consistently,previousconsen-
.
pressureresponseisrecommendedbeforeengaginginsports. .. sus recommendations have restricted all athletes with HCM from
.
.. competitivesports.1,356,357
.
.. Morerecently,relativelysmalllongitudinalclinicalstudiesindicate
.
Recommendationsforexerciseandparticipationin ... thattheriskofSCDduringexercisemaybeconsiderablylowerthan
sportsinindividualswithaorticpathology .. initially considered. Lampert et al. reported that individuals with
.
.. HCMwhocontinuedparticipatinginsportsafterimplantablecardi-
. Recommendations Classa Levelb .. overterdefibrillator(ICD)implantationdidnotrevealanincreased
.
.. numberofshocksduringexercise.358,359Inacross-sectionalstudyof
Priortoengaginginexercise,riskstratification, .
.
. 187patientswithHCM,vigorousexercisewasnotassociatedwith
withcarefulassessmentincludingadvancedimag- .
.. the occurrence of VAs.358 Pelliccia et al. reported outcomes in a
ingoftheaorta(CT/CMR)andexercisetesting I C .
.
. cohort of35 athletes withHCM, engaged in training and competi-
withbloodpressureassessmentis .
.
. tions for 5 to 31 years (mean 15 ± 8). During a 9-year follow-up
recommended. ..
. period,therewerenodifferencesintheincidenceofsymptomsor
Regularfollow-upincludingriskassessmentis ..
I C . majoreventsbetweenathleteswhoceasedexercise(n=20)com-
recommended. ...
paredwithathleteswhocontinuedcompetitivesports(n=15).360In
.
Dynamicexerciseshouldbeconsideredmore .
IIa C .. apost-mortemseries,only23%of194deathsfromHCMoccurred
suitablethanstaticexercise. .. during sport, and affected males with a mean age of 30 years.361
.
Participationincompetitiveorleisure-time ...
Finally,individualswithHCMwhoparticipatedinrehabilitationpro-
sportsactivities(exceptpowersports)should IIa C ...
grammes demonstrated a significant improvement in functional
beconsideredinlow-riskindividuals(Table14). ... capacitywithoutadverseevents.362,363
.
Participationinindividualizedleisureexercise .. Inconclusion,thereislimitedevidencetoindicatethatallindividu-
programmesmaybeconsideredinhigh-riskindi- IIb C ... alswithHCMarevulnerabletofatalarrhythmiasduringexerciseand
.
viduals(Table14). .. sportparticipation.In thisregard, systematicrestriction fromcom-
.
Competitivesportsarenotrecommendedin
III C
... petitivesportsinallaffectedindividualsisprobablyunjustifiedanda
individualswhoareathighrisk(Table14). .. moreliberalapproachtosportsparticipationisreasonableinsome
.
.. individualsaftercarefulevaluation.3Thisisparticularlyimportantfor
CMR=cardiacmagneticresonance;CT=computedtomography. .
aClassofrecommendation. ... themajorityofindividualswithHCMwhowishtoparticipateinama-
bLevelofevidence. .. teur sports or leisure-time exercise to maintain their physical and
.
.. psychologicalwell-being.
.
.
.
.
.
. 5.5.1.2BaselineassessmentofpatientswithHCM
. .
. Asystematicapproachisrequiredwhenassessinganindividualwith
5.5 Exercise recommendations in .
.
. HCMwhorequestsexerciseadvice.Thebaselineevaluationshould
individuals with cardiomyopathies, ..
. includeacomprehensivepersonalandfamilyhistorywithconsidera-
.
myocarditis, and pericarditis .. tionoftheageoftheindividualandyearsofexercisepriortodiagno-
.
.
CardiomyopathiesareanimportantcauseofSCD/SCAinyoungindi- . sis, assessment of the severity of the HCM phenotype, and the
.
.
viduals and exercise has been implicated as a trigger for fatal . presence of any conventional risk factors for SCD/SCA. In older
.
.
arrhythmias.17(cid:2)19,28Thedetectionofacardiomyopathyinanindivid- .. patientswithHCM,thephysicianshouldreviewthepresenceofcar-
.
ualhasimportantimplicationswithrespecttoongoingparticipation .. diaccomorbiditiessuchashypertensionandischaemicheartdisease,
.
inexercise.TheadventofpreventivestrategiesforSCDhasledtoa .. whichmayconferaworseprognosisinHCM.364,365
.
significantexpansioninthenumberofpredominantlyasymptomatic ..
.
youngpatientswithcardiomyopathieswhoaspiretoexercise.When .. 5.5.1.3History
.
advising such individuals, it is essential to strike a balance between .. ThepresenceofsymptomsattributedtoHCMshouldpromptmore
.
protecting patientsfromthe potentially adverse effects ofexercise .. conservativeexerciserecommendations.Individualswithahistoryof
.
anddeprivingthemofthemultiplebenefitsofexercise. . cardiacarrestorunheraldedsyncopeandindividualswithexercise-
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 40 ---
56 ESCGuidelines
.
inducedsymptomsshouldbeadvisedtoengageinlow-intensityrec- .. diameter, LV outflow obstruction, NSVT) to assess the risk
.
reationalsportsonly. .. of SCD of patients with HCM.355,373 This information can be
.
.. inserted into an online calculator (https://doc2do.com/hcm/
.
5.5.1.4RestingandambulatoryECG .. webHCM.html) to estimate individualized 5-year risk to provide
.
The resting 12-lead ECG has limited value in risk stratification. .. guidance on whether a prophylactic ICD is indicated. For
.
Ambulatory ECG monitoring, preferably for 48 h, is important for .. thepurposesoftheseGuidelinestheriskofSCDisdefinedaslow
.
.
detectingventricularandsupraventriculararrhythmias.Themonitor- . if <4%, moderate if between >_4% and <6%, and high if >_6% in
.
.
ing period should include an exercise session. Asymptomatic non- . 5years.
.
.
sustainedventriculartachycardia(NSVT)confersconsiderableriskof .
.
SCDinyoungerindividuals(<_35years).355Paroxysmalsupraventric- .. 5.5.1.10Exerciserecommendation
.
.
ular arrhythmias may pose significant implications for functional . Oncompletionofthebaselineevaluation,thephysicianshouldcon-
.
capacityand,inthecaseofAF,forstrokeprevention.366 .. sider:(i)thepresenceofsymptoms;(ii)ESCriskscore;(iii)presence
.
.
. of resting or inducible LVOT obstruction during exercise; (iv) the
.
.
5.5.1.5Echocardiography . haemodynamic (BP) response to exercise; and (v) the presence of
.
.
InrelationtoriskstratificationforSCDtheclinicianshouldassessthe . resting or exercise-induced arrhythmias before recommending the
.
.
followingechocardiographicindices:(i)LVwallthickness;(ii)LVout- . appropriateformandintensityofexercise.
.
.
flowtract(LVOT)gradient;and(iii)leftatrialdiameter.355Allindivid- . AlthoughtheseGuidelinesadvocateforamoreliberalapproach .
.
uals should have the LVOT gradient assessed at rest, during the .. tosportsparticipation,itisindisputablethateventheabsenceof
. Valsalvamanoeuvre,onstandingsuddenly,andafterlightexerciseon .. allmajorriskfactorsdoesnotconveyimmunitytoSCD.374Inaddi-
.
thespot,suchasrepeatedsquats.Byconvention,LVOTobstruction .. tion,theESCriskscorereliesonevidencederivedfrompredomi-
.
isdefinedasapeakpressuregradient>_30mmHgatrestorduring .. nantly non-athletic cohorts.373 Whereas there are no data to
.
physiologicalprovocation.Agradient>_50mmHgisconsideredtobe .. suggestthatthisapproachtoriskestimationislessvalidinathletic
.
haemodynamically important. Exercise stress echocardiography .. individuals,onehastoconsiderthatitmaynotaccuratelyreflect
.
shouldbe considered inindividualswithexertionalsymptomswho .. theriskofSCDinindividualsexposedtothehaemodynamicand
.
haverestingsystolicanteriormotionofthemitralvalveleafletsbut .. metabolicstressesofhigh-intensitysports.Therefore,whenadvis-
.
whodonotrevealLVOTobstructionorshowonlymildtomoderate .. inganindividualwithHCMregardingparticipationinhigh-intensity
.
LVOTobstructionwiththeaforementionedmanoeuvres. .. exercise programmes and competitive sports, this consideration
.
.. should be an integral part of the discussion during the shared
.
5.5.1.6Cardiacmagneticresonanceimaging .. decision-makingprocess.
.
.
CMRimagingisincreasinglyrecognizedasanecessarytoolforcon- .
.
.
firming diagnosis and to assess risk stratification in individuals with . 5.5.1.11Specialconsiderations
.
.
HCM.Lategadoliniumenhancement(LGE),indicativeofmyocardial . Theageofanindividualmayhaveanimpactonrisk.Themeanage
.
.
fibrosis,maybepresentinupto75%ofpatientswithHCMand,by . of death in the largest series of SCD from the US was 18 years,
.
itself,isapoordiscriminatorofoutcomes.However,thepresenceof .. with 65% of deaths occurring in athletes <_17 years.354 Although
.
.
extensive(>_15%ofLVmyocardium)LGEmayidentifyindividualsat . young age should not exclude an individual from high-intensity
.
increasedriskofventriculartachyarrhythmiasandSCD.367(cid:2)370 .. exerciseintheabsenceofadditionalriskfactors,itshouldbecon-
. .
. sidered in the discussion with the individual and the parents or
.
.
5.5.1.7Exercisetesting . guardians. In addition, specific sports may pose a higher risk for
.
.
Exercisetesting(orCPET)shouldbepartoftheroutineevaluation .. SCD,suchashighlydynamic,start(cid:2)stopsportslikebasketballand
.
toassessfunctionalcapacityinanindividualwithHCMwhointends .. football.17,58
.
to exercise. In addition, an abnormal BP response to exercise .. Individualswhohaveapositivegenotypebutwhodonotreveal
.
(defined as<20 mmHgincrease inSBPfrombaseline,orexercise- .. anyphenotypicstructuralorarrhythmiafeaturesofHCMmayengage
.
induced hypotension)371,372 and the presence of exercise-induced .. inallsports.Suchindividualsshouldbeassessedannuallyforpheno-
.
symptomsorarrhythmiasaremarkersofhighriskandshouldresult .. typicfeaturesandriskstratificationpurposes.
.
inmoreconservativeexerciserecommendations. ..
.
.. 5.5.1.12Follow-up
.
5.5.1.8Genetictesting .. Annual follow-up is recommended for most individuals with HCM
.
Currentlygenetictestingisreservedforfamilialcascadescreening.It .. whoexerciseonaregularbasis.Morefrequent(6-monthly)follow-
.
doesnotinformdecisionsrelatingtotheriskofSCD/SCAandshould .. upshouldbeconsideredinadolescentindividualsandyoungadults
.
notbeperformedforexerciseriskstratification. .. whosephenotype,andthereforeriskofSCD,maystillbeevolving
.
.. andwhoaremorevulnerabletoexercise-relatedSCD.58,239Follow-
.
.
5.5.1.9ESCriskscoreinHCM . upevaluationshouldfocusonassessmentofdiseaseprogressionand
.
.
The ESC risk score uses seven variables (age, syncope, family . risk stratification. New symptoms should prompt interruption of
.
.
historyofSCD fromHCM,maximalLVwallthickness,leftatrial . exerciseandre-evaluation.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 41 ---
ESCGuidelines 57
.
.
. beagreed,itcanbeconsideredasanumbrellatermforafamilyofdis-
Recommendationsforexerciseandsportsparticipation .
.
inindividualswithhypertrophiccardiomyopathy .. eases that are characterized by biventricular myocardial abnormal-
.
. ities, including fibro-fatty infiltration and scarring, identified by
.
Recommendations Classa Levelb .. pathologicalexaminationand/orcardiacimagingandVA.
.
.
. The term arrhythmogenic cardiomyopathy (ACM) is used
Exerciserecommendations ..
. throughouttheserecommendations;however,itisimportanttorec-
.
Participationinhigh-intensityexercise/competitive .
. ognizethatmostoftheliteratureontheinfluenceofexerciseondis-
.
sports,ifdesired(withtheexceptionofthose .
. ease progression and risk of SCD is derived from cohorts with
.
whereoccurrenceofsyncopemaybeassociated .
IIb C .. classicalARVC.Thisisreflectedintherecommendationsprovidedin
withharmordeath),maybeconsideredforindi- .
.. theseGuidelines.Itispossiblethereforethattherecommendations
vidualswhodonothaveanymarkersofincreased .
riskcfollowingexpertassessment.
... maynotaccuratelyreflectpredominantlyLVdisease,whichconsti-
.. tutesasmallproportionofthediseasespectrumwheretheimpactof
Participationinlow-ormoderate-intensityrecrea- ...
exerciseondiseasephenotypeandriskislessclarifiedthantheRV
tionalexercise,ifdesired,maybeconsideredfor
IIb C
...
variant. Where appropriate, guidance is provided for other condi-
individualswhohaveanymarkersofincreased ...
tionsthatcanbereasonablyconsideredundertheumbrellaofACM
riskcfollowingexpertassessment. ...
[includingsubtypesofdilatedcardiomyopathy(DCM)].
.
Participationinallcompetitivesports,ifdesired, .
.
.
maybeconsideredforindividualswhoaregene IIb C .. 5.5.2.1Riskstratificationinarrhythmogeniccardiomyopathy
. positiveforHCMbutphenotypenegative. .. ACMaccountsforasignificantproportionofSCDsinyoungandath-
.
Participationinhigh-intensityexercise(including .. letic individuals.28 Established risk factors for SCD that should
.
recreationalandcompetitivesports)isnotrecom- .. promptconsiderationforanICDincludeabortedSCD,unheralded
III C .
mendedforindividualswhohaveANYmarkersof .. syncope,ventriculartachycardia,andimpairedRVand/orLVsystolic
.
increasedriskc. .. function.379AnovelriskpredictionmodelforVAshasrecentlybeen
.
Follow-upandfurtherconsiderationsrelatingtorisk .. proposed but is yet to be validated.380 Regular and high-intensity
.
.
Annualfollow-upisrecommendedforindividuals . exerciseprogrammesareassociatedwithaccelerationofthedisease
whoexerciseonaregularbasis.
I C ...
processandworseoutcomes.381(cid:2)389
.
.
Six-monthlyfollow-upshouldbeconsideredin .. In an experimental model of heterozygous plakoglobin-deficient
.
adolescentindividualsandyoungadultswhoare IIa C .. mice, exercise training accelerated RV dysfunction and arrhyth-
morevulnerabletoexercise-relatedSCD.
... mias.382Similarresultshavebeenconfirmedinhumandesmosomal
.
. mutationcarriersparticipatinginvigorous(>70%VO )endurance
Annualassessmentshouldbeconsideredforgen- . 2max
.
otype-positive/phenotype-negativeindividualsfor
.. sports.384SimilarfindingswerereportedinpatientswithACMand
phenotypicfeaturesandriskstratification
IIa C ...
asymptomaticgene-positivefamilymembers,despiteamoreconser-
.
purposes.
.. vative definitionofathletic status(exercise withintensity>_6METs
.
.. for>_4h/weekfor>_6years).386Recently,theresultsfromtheNorth
.
BP=bloodpressure;ESC=EuropeanSocietyofCardiology;HCM=hypertro- .. American multidisciplinary study reported that patients engagingin
phiccardiomyopathy;LVOT=leftventricularoutflowtractobstructioncardio- .
myopathy;SCD=suddencardiacdeath.
... competitive sports were at two-fold increased risk of ventricular
aClassofrecommendation. .. tachyarrhythmias or death and earlier presentation of symptoms,
bLevelofevidence. ...
comparedwithpatientswhoparticipatedinrecreationalsportsand
acM rra er sk te or rs uo nf exin pc lr ae ina ese dd syr nis ck opin ec ;l (u iid )e m: o(i d) ec ra ar td eia Ec SCsy rm isp kt so cm ors eo (r >_4h %is )to ar ty 5o yf eac ra sr ;d (i ia iic
)
....
sedentary individuals.385 Among patients engaging in competitive
LVOTgradientatrest>30mmHg;(iv)abnormalBPresponsetoexercise;(v) .. sports,earlyageofsportsinitiationwasassociatedwithpremature
.
exercise-inducedarrhythmias. .. presentationofsymptomsandadverseclinicalprofile.Reducingexer-
RefertoTable4fordifferentindicesofexerciseintensityandtrainingzones. ...
ciseintensitywasassociatedwithasubstantialdecreaseintheriskof
.
.
. ventriculartachyarrhythmiasordeath,tothesamelevelasinactive
. 5.5.2Arrhythmogeniccardiomyopathy .. patients.385Finally,inamultinationalregistryof393competitiveath-
.
.
Arrhythmogenicrightventricularcardiomyopathy(ARVC)isdefined . letesimplantedwithanICDwhocontinuedtoparticipateinregular
.
.
pathologicallybythepresenceoffibro-fattyreplacementoftheright . competitions, 20% of athletes with ACM received a shock during
.
.
ventricleandclinicallybylife-threateningVAs.Theconditionwasini- . exertioncomparedto10%atrest,duringamedianfollow-upof44
.
.
tiallyrecognizedasapredominantlyRVdisease,anddiagnosisiscur- . months.ThediagnosisofACMwastheonlyvariableassociatedwith
.
rently based on probabilistic Task Force Criteria that encompass .. receivingappropriateshocksduringcompetition.359,389
.
.
electrophysiological, anatomical, functional, and clinical features of .
.
.
thedisease.375Since its firstdescription, theconceptofARVChas .. 5.5.2.2Baselineassessmentofpatientswitharrhythmogenic
.
evolvedtoincludeconcealedorsubclinicalphenotypesandbiventric- .. cardiomyopathy
.
ular disease. It is now well established that both ventricles are .. A systematic approach is required when assessing individuals with
.
affectedinmostcases.376(cid:2)378Thishasledtothedevelopmentofa .. ACM who requestexerciseadvice. Thebaselineevaluationshould
.
newterm,arrhythmogeniccardiomyopathy,thatembracesanarray .. includeacomprehensivehistoryofsymptomsandfamilyhistoryof
.
ofdiagnostictermsfordifferent(geneticandacquired)pathologies. .. ACM or SCD, assessment of the severity of the ACM phenotype,
.
Althoughthedefinitionof‘arrhythmogeniccardiomyopathy’isyetto . andthepresenceofanyconventionalriskfactorsforSCD/SCA.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 42 ---
58 ESCGuidelines
.
.
5.5.2.3History .. 5.5.2.9Specialconsiderations
.
Syncopeduetopresumedarrhythmiaisanimportantriskmarker .. Young age of presentation and male sex are associated with
.
for SCD/SCA and a predictor of future appropriate ICD .. increasedriskofmalignantarrhythmiasinACM.379Althoughyoung
.
therapies.390(cid:2)394 The presence of symptoms attributed to ACM .. ageshouldnotexcludeanindividualfrommoderate-intensityexer-
.
should reinforce the conservative exercise recommendations. .. ciseintheabsenceofhigh-riskfeatures,ageshouldbeconsideredin
.
Individualswithahistoryofcardiacarrestorunheraldedsyncope .. the discussion with the patient and the parents. In addition, one
.
and individuals with exercise-induced symptoms should be .. shouldconsiderthatspecifichighlydynamic,start(cid:2)stopsports,such
.
advised to engage only in low-intensity recreational exercise .. asbasketballandfootball,mayposeahigherriskofSCDparticularly
.
programmes. .. inathleteswhocompeteatthehighestlevel.17,365
.
.
.
.
5.5.2.4 RestingandambulatoryECG .. 5.5.2.10 Follow-up
.
Apart from its diagnostic utility, the 12-lead ECG may provide useful .. An annual follow-up is recommended for most individuals
.
.
informationrelatingtoriskstratificationinACM.Thepresenceofexten- . with ACM who exercise on a regular basis. More frequent (6- .
.
siveT-waveinversionaffecting>_3precordialleadsorT-waveinversion . monthly) follow-up should be considered for adolescent and
.
.
intwoofthethreeinferiorleadsconferssomeadditionalriskforSCD/ . youngadultswhoseACMphenotype,andthereforeriskofSCD,
.
SCA.395,396 .. may still be evolving, particularly if they engage in moderate- to
.
.
Ambulatory ECG monitoring is important for detecting VAs. . high-intensity exercise. More frequent follow-up should also be .
.
Every effort should be made for the monitoring period to . consideredinindividualswithhigharrhythmicriskgenotypessuch
.
.
includetheproposedexercisesession.ThepresenceofNSVTor . as DSP, TMEM43, and carriers of multiple pathogenic variants.
.
.
significant burden of ventricular ectopy (>_1000/24 h), even in . New symptoms should prompt interruption of exercise and re-
.
.
asymptomatic individuals, confers an increased risk of fatal . evaluation.
arrhythmias.392,393,397
Recommendationsforexerciseandsportsparticipation
inindividualswitharrhythmogeniccardiomyopathy
5.5.2.5 Echocardiographyandcardiacmagneticresonanceimaging
In relation to risk stratification for SCD, the clinician should Recommendations Classa Levelb
assesstheseverityofRVandLVinvolvementintermsofventric-
ulardilatationandsystolicdysfunction.CMRimagingismoreuse- Exerciserecommendations
ful than echocardiography for assessing RV wall motion Participationin150minoflow-intensityexercise
IIa C
abnormalitiesandcanalsoquantifythedegreeofmyocardialfat perweekshouldbeconsideredforallindividuals.
infiltration and/or scar. The more extensive the disease the Participationinlow-tomoderate-intensityrecrea-
higherthearrhythmicrisk.398,399 tionalexercise/sports,ifdesired,maybeconsid-
eredforindividualswithnohistoryofcardiac
IIb C
5.5.2.6 Exercisetesting arrest/VA,unexplainedsyncope,minimalstruc-
Exercisetesting should be part of the routineassessment of every turalcardiacabnormalities,<500PVCs/24hand
individualwithACMwhowishestoexercise,asitcanprovideinfor- noevidenceofexercise-inducedcomplexVAs.
mationregarding functionalcapacityand riskstratification. Exercise Participationinhigh-intensityrecreationalexercise/
testinginpatientswith ACM shouldnot beperformedduring‘hot sportsoranycompetitivesportsisnotrecom-
III B
phases’.Thepresenceofexercise-inducedsymptomsorarrhythmias mendedinindividualswithACM,includingthose
shouldresultinmoreconservativerecommendations. whoaregenepositivebutphenotypenegative.384,386
Follow-upandfurtherconsiderationsrelatingtorisk
5.5.2.7 Genetictesting
Annualfollow-upisrecommendedforindividuals
Genotype mayalsobe ofprognostic value. IntheARVCvariant,a I C
whoexerciseonaregularbasis.
numberofstudieshavereportedthatcarriersofmultiplepathogenic
Six-monthlyfollow-upshouldbeconsideredin
variantsinthesamedesmosomalgeneormutationsin>_2genesmay
adolescentindividualsandyoungadultswhoare IIa C
haveanalmostfour-foldhigherarrhythmicriskthanthosewithasin-
morevulnerabletoexercise-relatedSCD.
glemutation.400ParticulargenotypessuchasDSPandTMEM43,but
Annualassessmentshouldbeconsideredforgeno-
alsoLMNAandFLNC,associatedwithotherACMphenotypes(see
type-positive/phenotype-negativeindividualsfor IIa C
section5.5.4)haveapropensityforhigharrhythmicburdenthatcan
phenotypicfeaturesandriskstratificationpurposes.
pre-datethestructuralphenotype.401,402
Six-monthlyfollow-upshouldalsobeconsidered
inindividualswithhigharrhythmicriskgenotypes
5.5.2.8 Exerciserecommendations IIa C
suchasDSP,TMEM43,andcarriersofmultiple
Theoverallscientificevidencesupportstheconceptthatinpatients
pathogenicvariants.
with ACM participation in high-intensity sports should be discour-
aged, becauseitis associated with accelerated disease progression, ACM=arrhythmogeniccardiomyopathy;PVC=prematureventricularcontrac-
greaterriskofVAsandmajorevents.Thisrecommendationisalso tion;SCD=suddencardiacdeath;VA=ventriculararrhythmia.
aClassofrecommendation.
applicabletogeneticcarriersofpathogenicvariantsforACMevenin
bLevelofevidence.
theabsenceofovertdiseasephenotype. RefertoTable4fordifferentindicesofexerciseintensityandtrainingzones.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 43 ---
ESCGuidelines 59
5.5.3Exerciserecommendationsinindividualswithleft
ventricularnon-compaction Participationinhigh-orveryhigh-intensityexer-
LVnon-compaction(LVNC)isanunclassifiedcardiomyopathychar- ciseincludingcompetitivesports,ifdesired,may
acterized by prominenttrabeculation and deep recesses thatcom- beconsideredforindividualswhoaregeneposi- IIb C
municate with the LV cavity.403,404 Clinical presentation of LVNC tiveforLVNCbutphenotypenegative(withthe
includes progressive LV systolic dysfunction, ventricular tachyar- exceptionoflaminA/CorfilaminCcarriers).
rhythmias,andthromboembolicevents.404 Participationinhigh-intensityexerciseorcompeti-
AthletesoftendemonstrateLVhypertrabeculationandupto8%fulfil tivesportsisnotrecommendedinindividualswith
theechocardiographiccriteriaforadiagnosisofLVNC.405Itishypothe- anyofthefollowing:symptoms,LVEF<40%and/or III C
sizedthatanincreasedcardiacpreloadmayunmaskLVtrabecularmor- frequentand/orcomplexVAsonambulatory
phology.406 Therefore, among athletic individuals, the suspicion of Holtermonitoringorexercisetesting.
LVNCshouldonlybeconsideredinthosewhofulfilechocardiographic Follow-upandfurtherconsiderations
criteria for LVNC but also have either LV systolic dysfunction (EF < Annualassessmentforriskstratificationisrecom-
50%),symptomssuggestiveofcardiacdisease,orapositivefamilyhis- mendedforindividualswithLVNCandgenotype-
I C
tory of LVNC.407(cid:2)409 Additional echocardiographic criteria include a positive/phenotype-negativeindividualswhoexer-
verythincompactedepicardiallayer(5mminend-diastoleonCMR,or ciseonaregularbasis.
<8mminsystole)andabnormalmyocardialrelaxation(averageE’<9
cm/sontissueDopplerimaging).404,405,410,411Suchathleteswillrequire CMR =cardiacmagnetic resonance; ECG =electrocardiogram;EF=ejection
fraction;LV=leftventricular;LVEF=leftventricularejectionfraction;LVNC=
furtherassessmentwithCMR,exerciseechocardiography,andHolter leftventricularnon-compaction;VA=ventriculararrhythmia.
monitortoassessthepresenceofLVfibrosis,cardiacthrombi,contrac- aClassofrecommendation.
tilereserve,andexercise-inducedcomplexarrhythmias.405,406
bLevelofevidence.
5.5.3.1Riskstratification
TheclinicaloutcomesofLVNCaredeterminedbythepresenceof .
.
. 5.5.4Exerciserecommendationsinindividualswith
symptoms, severity of LV dysfunction, and the nature of the VAs. .
.
. dilatedcardiomyopathy
TherearenoreportedadversecardiaceventsintheabsenceofLV .
.
dysfunctionregardlessoftheseverityofLVtrabeculation.405(cid:2)409 .. DCMischaracterizedbyLVorbiventricularsystolicdysfunctionwith
.
. orwithoutdilatationthatarenotexplainedbyabnormalloadingcon-
.
.
. ditionsorCAD.Possiblecausesincludegeneticpredisposition,myo-
5.5.3.2Follow-up .
.
. carditis, drugs, toxins, peripartum cardiomyopathy, and, in some
Regularfollow-upisrecommendedforindividualswithLVNC.New ...
cases,thecumulativeeffectofmorethanonefactor.412
symptomsshouldpromptinterruptionofexerciseandre-evaluation. ..
. Theclinicalspectrumofdiseasemayrangefromamildphenotypic
.
.
. expressioncharacterizedbyabsenceofsymptoms,isolatedLVdilata-
Recommendationsforexerciseinindividualswithleft ..
. tionandnormalorlow-normalsystolicfunction,toanovertdisease
ventricularnon-compactioncardiomyopathy .
.
.. phenotype with limiting symptoms and significant systolic dysfunc-
.
Recommendationfordiagnosis Classa Levelb .. tion. Ventricular arrhythmias are common in DCM, particularly in
. .. individuals withprevious myocarditis,orwith lamin A/C mutations
AdiagnosisofLVNCinathleticindividualsshould ... andfilaminCmutations.413,414TheriskofSCDinDCMis2(cid:2)3%per
beconsiderediftheyfulfilimagingcriteria,inasso- ... yearandincreaseswithlowerEFandhigherNYHAclass.415Exercise
ciationwithcardiacsymptoms,familyhistoryof ...
trainingimprovesfunctionalcapacity,ventricularfunction,andquality
LVNCorcardiomyopathy,LVsystolic(EF<50%)
IIa B
...
oflifeinpatientswithDCMandshouldthereforebeconsideredas ordiastolic(E’<9cm/s)dysfunction,athincom- ... an integral part of the management of affected individuals.416,417
pactedepicardiallayer(<5mminend-diastoleon ...
However,intensiveexerciseandcompetitivesportsarereportedas
CMR,or<8mminsystoleonechocardiography), ... acauseofSCDinDCM.28,46,58,413,418
orabnormal12-leadECG.404,405,410,411 ...
LV cavity enlargement in trained individuals that is not associated
.
Exerciserecommendations .. withsystolicdysfunctionandoutsidethecontextofafamilialdisease,
.
Participationinhigh-intensityexerciseandall .. representsabenignphysiologicaladaptationifitisconsistentwiththe
.
competitivesports,ifdesired,withtheexception .. typeofsportsparticipated(usually,endurancesports)andthebodysize
.
wheresyncopemaycauseseriousharmordeath, .. oftheathlete.Conversely,amildlyreducedEF(45(cid:2)50%)inanathlete
IIb C .
maybeconsideredinasymptomaticindividuals .. withanenlargedLVcavityshouldnotmerelybeconsideredasanormal
.
withLVNCandLVEF>_50%andabsenceoffre- .. adaptation.InsuchcasesassessmentofLVfunctionduringexercisemay
.
quentand/orcomplexVAs. .. provide important diagnostic clues.319 Failure to increase EF at peak
.
.
Participationinrecreationalexerciseprogrammesof . exercise by >10% compared with the baseline value may suggest a
.
lowtomoderateintensity,ifdesired,maybeconsid- .. pathological condition.319,419,420 The presence of diastolicdysfunction
.
.
eredinindividualswithLVEF40(cid:2)49%intheabsence IIb C . orreducedpeakoxygenconsumptiononCPETmayalsoprovidesup-
.
.
ofsyncopeandfrequentorcomplexVAsonambula- . portinginformationforthedifferentialdiagnosis.CMRhasemergedas
.
.
toryHoltermonitoringorexercisetesting. .. an important tool for the diagnosis and risk stratification of DCM.
Continued
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 44 ---
60 ESCGuidelines
Specifically,thepresenceofLGE,withthetypicalmid-walldistribution,
Participationinallcompetitivesportsmaybecon-
hasbeenassociatedwithincreasedriskofVAsandSCD.319,419,421(cid:2)424
sideredinindividualswithDCMwhoaregeno-
typepositiveandphenotypenegative,withthe IIb C
5.5.4.1Baselineassessmentofpatientswithdilated
exceptionofcarriersofhigh-riskmutations(lamin
cardiomyopathy
A/CorfilaminC).
Clinicalevaluationofaffectedindividualswhorequestexerciseadvice
Participationinhigh-orveryhigh-intensityexer-
shouldaimto:(i)ascertainthepotentialaetiology;(ii)assesstheclini-
ciseincludingcompetitivesportsisnotrecom-
cal status including exercise history and functional capacity; (iii)
mendedforindividualswithaDCMandanyofthe
review the degree of LV dilatation and dysfunction; (iv) assess the
following:(i)symptomsorhistoryofcardiac
haemodynamicresponsetoexercise;and(v)assessthepresenceof
arrestorunexplainedsyncope;(ii)LVEF<45%;(iii) III C
exercise-inducedsymptomsorarrhythmias.
frequentand/orcomplexVAsonambulatory
Ingeneral,symptomaticindividualswithDCMshouldabstainfrom
Holtermonitoringorexercisetesting;(iv)exten-
mostcompetitiveandleisuresportsorrecreationalexerciseassociated
siveLGE(>20%)onCMR;or(v)high-riskgeno-
withmoderateorhighexerciseintensity.Aselectgroupofasympto-
type(laminA/CorfilaminC).
matic individuals with DCM who have mildly impaired LV function
Follow-uprecommendations
(LVEF 45(cid:2)50%) without exercise-induced arrhythmias or significant
Annualfollow-upisrecommendedforindividuals
myocardialfibrosismayparticipateinmostcompetitivesports. I C
withDCMwhoexerciseonaregularbasis.
Six-monthlyfollow-upshouldbeconsideredin
5.5.4.2Specialconsiderations
individualswithhigh-riskmutationsandadolescent
Althoughthenaturalhistoryofmostpathogenicvariantsisunknown,it
individualsandyoungadultswhoseDCMpheno- IIa C
would be reasonable to permit intensive exercise and competitive
typemaystillbeevolvingandwhoaremorevul-
sportsinmostindividualswithpathogenicvariantsimplicatedinDCMin
nerabletoexercise-relatedSCD.
theabsenceofovertfeaturesofDCM.Specialconsideration,however,
shouldbegiventoindividualswithpathogenicvariantsthatareassoci- Annualassessmentshouldbeconsideredforgen-
atedwithanincreasedriskoflife-threateningarrhythmiassuchaslamin otype-positive/phenotype-negativeindividualsfor
IIa C
A/CorfilaminCmutations.Thereisemergingevidencethatexercise phenotypicfeaturesandriskstratification
mayhaveanadverseeffectoncardiacfunctionandriskforpotentially purposes.
fatalarrhythmiasinindividualsharbouringpathogenicvariantsinlamin
CMR=cardiacmagneticresonance;DCM=dilatedcardiomyopathy;EF=ejec-
A/C.425(cid:2)427Affectedindividualsshouldnotengageinanycompetitive
tionfraction;LGE=lategadoliniumenhancement;SCD=suddencardiacdeath;
sportsorrecreationalexerciseofhighorveryhighintensityirrespective VA=ventriculararrhythmia.
oftheseverityofLVdysfunctionanddilatation.428,429
aClassofrecommendation.
bLevelofevidence.
5.5.4.3Follow-up. .
Regularfollow-upisrecommendedformostindividualswithDCM.New
... 5.5.5Exerciserecommendationsinindividualswith
symptomsshouldpromptinterruptionofexerciseandre-evaluation
... myocarditisandpericarditis
.. 5.5.5.1Myocarditis
. .. Myocarditisisanon-ischaemicinflammatorydiseaseofthemyocar-
. Recommendationsforexerciseinindividualswith .. dium, which may cause cardiac dysfunction and arrhythmias.
dilatedcardiomyopathy ..
. Myopericarditis is defined as a primary pericarditis with associated
.
.
. myocardial inflammation and biomarker evidence of myocyte
Recommendations Classa Levelb .
.. necrosis.430,431 The aetiology of myocarditis is heterogenous, but .
.
Participationinlow-tomoderate-intensityrecrea- . viral infection is the most common cause in the developed world.
.
.
tionalexerciseshouldbeconsideredinallindividu- . Enterovirus,CoxsackieBvirus,parvovirusB-19,andhumanherpesvi-
alswithDCM,regardlessoftheEF,intheabsence
IIa C ...
rus6arethemostfrequentlyresponsibleinfectiouspathogens.432,433
.
.
oflimitingsymptoms,andexercise-inducedVAs. . In the context of young individuals, toxins such as cocaine and
.
.
Participationinhigh-orveryhigh-intensityexer- .. amphetamine-based supplements should also be evaluated in the
ciseincludingcompetitivesports(withtheexcep- ... clinicalhistory.430
.
tionofthosewhereoccurrenceofsyncopemay .. Theclinicalpresentationishighlyvariableandthediagnosiscanbe
.
beassociatedwithharmordeath)maybeconsid- .. challenging.Theillnessmaybeproceededbycoryzalsymptomsand
.
eredinasymptomaticindividualswhofulfilallof .. athleticindividualsmaypresentwithnon-specificfeaturesofgeneral
.
thefollowing:(i)mildlyreducedLVsystolicfunc- .. malaise,fatigue,ordiarrhoea.430,431Attheotherextreme,myocarditis
IIb C .
tion(EF45(cid:2)50%);(ii)absenceoffrequentand/or .. may simulate MI or present with symptomatic supraventricular and
.
complexVAsonambulatoryHoltermonitoring .. VAsunexplainedbyothercauses,HF,cardiogenicshock,orSCD.
.
orexercisetesting;(iii)absenceofLGEonCMR; .. Approximately50%ofindividualsrevealfullresolutionofLVfunc-
.
(iv)abilitytoincreaseEFby10(cid:2)15%duringexer- .. tion within 30 days, 25% show persistent cardiac dysfunction, and
.
cise;and(v)noevidenceofhigh-riskgenotype .. 12(cid:2)25% progresstofulminant HF.LVdysfunctionis animportant
.
(laminA/CorfilaminC). .. prognosticfactorinthelongterm.28,434
Continued
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 45 ---
ESCGuidelines 61
.
.
5.5.5.2Diagnosis . presenceofinflammationonT2-weightedimagesandLGEuptake
.
.
Serumcardiactroponinisusuallyelevatedinmyopericarditisandisa . onCMR.3,461
.
.
sensitive marker of cardiac inflammation-induced myocyte .. Individualswithmyocarditisshouldhaveacomprehensiveevaluation
.
necrosis.435 .. after complete recovery to assess the risk of exercise-related SCD.
.
The ECG has low sensitivity and electrical anomalies are non- .. Imagingstudies,exercisestresstest,andHoltermonitorprovideessen-
.
specific. ECG patterns vary from non-specific T-wave and ST- .. tialinformationforriskstratification.DepressedLVfunction,presence
.
changes to ST-segment elevation mimicking MI, left bundle branch .. of LGE and complex VAs during exercise or Holter monitoring are
.
block(LBBB),orfrequentand/orcomplexventricularandsupraven- .. recognizedriskmarkersforadverseoutcomes.455,462,463
.
triculararrhythmias,oratrioventricularblock,orlowQRSvoltagesin .. Repeatevaluationshouldconsistofmeasurementoftroponinand
.
thepresenceofapericardialeffusion.436 .. biomarkersofinflammation,echocardiography,andprolongedECG
.
Recognized echocardiographic features of overt myocarditis .. monitoring. Individuals without evidence of ongoing inflammation
.
includeanon-dilatedLVcavitywithincreasedmyocardialwallthick- .. shouldundergoanexercisestresstest.ACMRshouldberepeatedif
.
ness (when oedema is present), or mildly dilated LV cavity with a .. myocardial oedema or LGE was present during the acute illness.
.
thinnedmyocardialwall,usuallywithregionalwallmotionabnormal- .. Returntosportingactivitiesshouldbeconsidered,inasymptomatic
.
ities.437TheglobalLVsystolicfunctionmayrangefrombeingalmost .. individuals, with normal troponin and biomarkers of inflammation,
.
.
normal to severely depressed. Regional wall motion abnormalities . normalLVsystolicfunctiononechocardiographyandCMR,noevi-
.
maybepresent.438 .. denceofongoinginflammationormyocardialfibrosisonCMR,good .
.
CMRisthemostusefuldiagnostictoolandhasexcellentsensitivity . functionalcapacity,andabsenceofcomplexarrhythmiasduringexer-
.
for detectingmyocardial hyperaemia,inflammation, oedema and/or .. ciseonprolongedECGmonitoring.430,434,453,459,460,464
.
focalscar.439,440TheLakeLouiseCriteriaandLGEarenowcomple- .. Individualswithpreviousmyocarditisareatriskofrecurrenceand
.
.
mentedbyCMRtechniquesofT1/T2mappingandextracellularvol- . silentclinicalprogression,andthepresenceofLGEduringtheacute
.
umefraction(ECV).440(cid:2)442TheextentanddistributionofLGEwith .. presentationisassociatedwithincreasedincidenceofmajoradverse
.
.
non-ischaemicpatternareindependentpredictorsofCVeventsdur- . cardiac events; therefore, periodic re-evaluation is advised on an
.
ingfollow-up.439,440,443(cid:2)447Namely,a10%increaseofLGEvolume .. annualbasis.443,445,454,463
.
conveysa79%increaseintheriskofmajorCVevents.448,449 ... Among individuals with healed myocarditis with persistence of
.
Endomyocardialbiopsyisthegoldstandardforthediagnosisof .. LGEonCMRbutnomyocardialoedemaat3(cid:2)6months,thosewho
.
myocarditis.450,451 A histological diagnosis allows distinction .. areasymptomatic,withnormaltroponinandbiomarkersofinflam-
.
betweenthedifferenttypesofinflammatoryprocesses,(i.e.giant .. mation,normalLVsystolicfunction,noevidenceofongoinginflam-
.
cellmyocarditis),andguidestreatmentinlife-threateningpresen- .. mation on CMR, and absence of complex arrhythmias during
.
tations.430,445,452 The diagnostic yield of endomyocardial biopsy .. exerciseonprolongedECGmonitoring(48hHolterECGandexer-
.
can be improved by analysing the viral genome through DNA- .. cisestresstesting),shouldbeevaluatedonacasebycasebasisand
.
RNAextractionandreversetranscriptasepolymerasechainreac- .. mayreturntocompetitivesportsonanindividualbasis.Incontrast,
.
tion(RT-PCR)amplification,whichhastheadvantageofidentify- .. individualswithextensivemyocardialscar(>20%LGE)andpersistent
.
ingthedisease-causingpathogen.445 .. LVdysfunctionshouldabstainfromexerciseprogrammesandsports
.
.. activitiesinvolvingmoderateorhighphysicalintensity.
.
5.5.5.3Riskstratification ..
.
Case series have established myocarditis as a risk factor for SCD, ..
.
.
which accounts for up to 2(cid:2)20% of sudden death in ath- . 5.5.6Pericarditis
.
letes.17,18,28,430,453,454Murinemodelshaveshownthatdailyexercise .. Pericarditis is defined as an inflammatory disorder of the pericar-
.
in mice infected with Coxsackie virus is associated with increased .. dium,430,465whichmaybeprecededbyupperrespiratoryorgastroin-
.
viraltitres,fulminantmyocarditis,andsuddendeath.455Theseanimal .. testinalsymptoms.Aswithmyocarditis,viralpathogensarethemost
.
.
modelsprovidesomeinsightintothemechanismsofSCDwithexer- . commonlyimplicatedpathogensinthewesternworld.
.
.
cise,whichappearstocauseanacceleratedandprogressiveinflam- .
. matoryresponse.455(cid:2)458 .. 5.5.6.1Diagnosis
.
.
. The ECGisnon-specificbutmayrevealcharacteristicconcave ST-
.
.
5.5.5.4Exerciserecommendationsforindividualswithmyocarditis . segmentelevationinmostleadsand/orPQdepressionintheacute
.
.
Athleticindividualswithaprobableordefinitivediagnosisofrecent . phase. Echocardiography may reveal a pericardial effusion. CMR
.
.
myocarditisshouldbeadvisedtoabstainfromcompetitivesportsor . shouldbeconsideredinindividualswithraisedcardiactroponinlevels
.
.
leisuresportswhileactiveinflammationispresent,regardlessofage, .. to assess for concomitant myocardial inflammation. Furthermore,
.
sex,orextentofLVsystolicdysfunction.459,460 .. CMRwillidentifyactiveinflammationofthepericardium,thickened
.
Thedurationofmyocardialinflammationcanbehighlyvariable .. pericardiallayers,andanysignsofpericardialconstriction.
.
andmaytakeseveralmonthsforfullresolution.BoththeESCand ..
.
AHA recommend abstinence from moderate- to high-intensity .. 5.5.6.2Riskstratification
.
exerciseforaperiodof3(cid:2)6months,459,460althoughtheprecise .. Pericarditisisgenerallyassociatedwithanexcellentprognosis.430,465,466
.
timing for return to competitive or recreational sports involving .. However,thereareasubsetofpatientswhomaybeatgreaterriskof
.
moderate- or high-intensity exercise may be guided by the . recurrenceandtheseincludeindividualswithatemperature>38(cid:4)Cat
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 46 ---
62 ESCGuidelines
presentation,largepericardialeffusion,andthosewhoareresistantto
Recommendationsforexerciseinindividualswith
therapywithnon-steroidalanti-inflammatorydrugs.465,466
pericarditis
5.5.6.3Exerciserecommendationsforindividualswithpericarditis Recommendations Classa Levelb
Exercise should be avoided in individuals during active pericarditis.
Returntoallformsofexerciseincludingcompeti-
Individuals can return to exercise after complete resolution of the
tivesportsisrecommendedafter30daysto3
activedisease.467 Individuals witha milderclinical courseand rapid
monthsforindividualswhohaverecoveredcom- I C
resolutioncanreturntosportingactivitieswithin30days.However,
pletelyfromacutepericarditis,dependingonclini-
inmoreseverecases,itmaybenecessarytowaitforaperiodof3
calseverity.459,460
months for complete resolution followed by re-evaluation before
Participationinleisure-timeorcompetitivesports
returningtosports.
isnotrecommendedforindividualswithaprob-
Asymptomatic individuals with a small pericardial effusion occa-
ableordefinitivediagnosisofrecentpericarditis
sionallydetectedonechocardiographyintheabsenceofclinicalcor- III C
whileactiveinflammationispresent,regardlessof
relates should be monitored with periodic surveillance, but should
age,sex,orextentofLVsystolic
notberestrictedfromsportsparticipation.Competitivesportsand/
dysfunction.459,460
or moderate- to high-intensity leisure-time activities should be
Participationinmoderate-tohigh-intensityexer-
avoided in individuals with constrictive pericarditis. Individuals with
cise,includingcompetitivesports,isnotrecom-
myopericarditisshouldbemanagedaccordingtotherecommenda- III C
mendedforindividualswithconstrictive
tionsformyocarditis.
pericarditis.
LV=leftventricle.
Recommendationsforexerciseinindividualswith
aClassofrecommendation.
myocarditis
bLevelofevidence.
Recommendations Classa Levelb ..
. 5.6 Exercise recommendations in
.
.
Comprehensiveevaluation,usingimagingstudies, .. individuals with arrhythmias and
.
exercisestresstestandHoltermonitoring,isrec- .
. channelopathies
.
ommendedfollowingrecoveryfromacutemyo- I B .
.
. 5.6.1Ageneralmanagementframework
carditistoassesstheriskofexercise-related .
.
. When individuals with known arrhythmias or with a potentially
SCD.455,462,463 .
.
. arrhythmogenic condition want to engage in sports activity, three
Returntoallformsofexerciseincludingcompeti- ..
. principle questions should guide management: (1) is there an
tivesportsshouldbeconsideredafter3(cid:2)6 ..
. increased risk for life-threatening arrhythmias?; (2) how does one
monthsinasymptomaticindividuals,withnormal ..
. control symptoms due to arrhythmias, during sports, but also at
troponinandbiomarkersofinflammation,normal ..
. rest?;and(3)whatistheimpactofsportsonthenaturalprogression
LVsystolicfunctiononechocardiographyand ..
IIa C . ofthearrhythmogeniccondition?Thegeneralviewontheassocia-
CMR,noevidenceofongoinginflammationor ..
. tionbetweensportsandarrhythmiasisthatexercisesetsthestage
myocardialfibrosisonCMR,goodfunctional ..
.. for an arrhythmia in the context of an underlying and pre-existing
capacity,andabsenceoffrequentand/orcomplex .
.. condition,beitstructural,electrical,inherited,oracquired.Moreover,
VAsonambulatoryHoltermonitoringorexercise .
testing.430,434,453,459,460,464 ... regularexerciseprogrammesmayinduceoracceleratetheprogres-
.. sion of ARVC,382,384 even among those without underlying muta-
Amongindividualswithaprobableordefinitive ...
tions.383,387,468Conceptually,allthestructuralandfunctionalcardiac
diagnosisofrecentmyocarditis,participationin ...
adaptationstoregularintensiveexercisemaycontributetothedevel-
leisure-timeorcompetitivesportswhileactive III C ... opment of arrhythmias, at the atrial, nodal, and ventricular level.469
inflammationispresentisnot ...
Thisconceptexplainswhyrecommendationsforsportsparticipation
recommended.459,460 ...
inindividualswitharrhythmogenicconditionsaresocomplex.
.
Participationinmoderate-tohigh-intensityexer- .
.
ciseforaperiodof3(cid:2)6monthsafteracutemyo- III B ..
. 5.6.2Atrialfibrillation
carditisisnotrecommended.459(cid:2)461,467 ..
. 5.6.2.1Patientswithoutatrialfibrillation
.
Participationinleisureexerciseorcompetitive .
.. Moderate, regular PA is a cornerstone in the prevention of AF
sportsinvolvinghighintensityinindividualswith III C ... through modifying many of its predisposing factors.297,470(cid:2)473
residualmyocardialscarandpersistentLVdys- ...
PatientsatriskofAFshouldthereforebemotivatedtoexercise(see
functionisnotrecommended. ...
section4.2).Conversely,AFismoreprevalentinactiveandformer
.
CMR=cardiovascularmagneticresonance;LV=leftventricular;SCD=sudden .. malemasterathletesandthoseperforminghigh-intensityendurance
.
cardiacdeath;VA=ventriculararrhythmia. .. sports,suggestingaU-shapedrelationshipbetweenhabitualexercise
a bC Lela vs es lo of fr ee vc ido em nm cee .ndation. .... andAF.471,474(cid:2)477478(cid:2)481Thisassociationhasnotbeenconfirmedin
. women.474
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 47 ---
ESCGuidelines 63
5.6.2.2PrognosticandsymptomaticrelevanceofAFduringsports
Recommendationsforexerciseinindividualswithatrial
Underlyingstructuralheartdiseaseorpre-excitationshouldalways fibrillation
beexcludedbeforeadvisingsportsactivityinindividualswithrecog-
nized AF. It is also important to exclude hyperthyroidism, alcohol Recommendations Classa Levelb
abuse,and(illicit)druguse.Intensivesportsparticipationshouldbe
Regularphysicalactivityisrecommendedtopre-
temporarilystoppeduntilanidentifiedunderlyingcauseiscorrected. I A
ventAF.297,470(cid:2)473
RapidatrioventricularnodalconductionofAFduringexercisemay
Evaluationandmanagementofstructuralheart
lead to symptoms, including dizziness, syncope, fatigue, or impaired
disease,thyroiddysfunction,alcoholordrug
physicalperformance.Therefore,theindividualshouldbeinstructedto I A
abuse,orotherprimarycausesofAFisrecom-
stopPAontheemergenceofsymptomsandratecontrolshouldbe
mendedbeforeengaginginsports.485
optimized. Rapid 1: 1 conduction can occur, especially during atrial
Counsellingabouttheeffectoflong-lastingintense
tachycardia or atrial flutter (AFL); therefore, if AFL has been docu-
sportsparticipationon(recurrenceof)AFisrec-
mented,prophylacticcavo-tricuspidisthmusablationshouldbeconsid-
ommendedinindividualswithAFwhoexercise I B
ered.IfthereisevidenceforadequateratecontrolwhileinAFthrough
vigorouslyforprolongedperiods,especiallyin
anexercisestresstestorECGmonitoringduringtrainingorcompeti-
middle-agedmen.471,475,481,490
tion,allsportsparticipationispossibleinasymptomaticindividuals.
Achieving adequate rate control can be difficult, however. Beta- AFablationisrecommendedinexercising
blockersarethelogicalchoicebutmaynotbetoleratedduetotheir individualswithrecurrentsymptomaticAF,and/
I B
impactonphysicalperformance.Calcium-channelblockersanddigi- orinthosewhodonotwantdrugtherapy,
talisareusuallynotpotentenoughwhenusedalone.Oftenacombi-
givenitsimpactonathleticperformance.488,489
nation of individually titrated negatively chronotropic agents is TheventricularratewhileexercisingwithAF
needed, while avoiding sinus bradycardia at rest or chronotropic shouldbeconsideredineveryexercisingindi-
incompetenceduringexercise. vidual(bysymptomsand/orbyECGmonitor- IIa C
Rhythmcontrolisequallycomplicated.ClassIIIantiarrhythmicdrugs ing),andtitratedratecontrolshouldbe
areusuallyinsufficientforcontrol(sotalol)orrelativelycontraindicated instituted.
inayoungpopulation(amiodarone).AlthoughclassIdrugsmaybeable Participationinsportswithoutantiarrhythmic
topreventrecurrencesofAF,theyshouldnotbeusedinmonotherapy, therapyshouldbeconsideredinindividualswith-
IIa C
sincethesemayincreasethepropensitytodevelopAFL(‘classIAFL’), outstructuralheartdisease,andinwhomAFis
whichintheabsenceofadequateratecontrolmayleadto1:1atrioven- welltolerated.
tricularconduction,highventricularrates,andveryprofoundintraven- Cavo-tricuspidisthmusablationshouldbeconsid-
tricular conduction slowing, with haemodynamic compromise.482,483 eredinthosewithdocumentedflutterwhowant
IIa C
Therefore,prophylacticcavo-tricuspid-isthmusablationshouldbecon- toengageinintensiveexercise,topreventatrial
sideredifclassIdrugsareprescribedinmonotherapyinathletes. flutter1:1atrioventricularconduction.
InpatientswithsporadicAF,classIdrugsmaybeconsideredonly Prophylacticcavo-tricuspidisthmusablationto
foracutecardioversion,i.e.asa‘pill-in-the-pocket’approach.These preventfluttershouldbeconsideredinindividu-
patientsshouldrefrainfromsportsaslongasAFpersists,anduntil alswithAFwhowanttoengageinintensive IIa C
twohalf-livesoftheantiarrhythmicdrughavepassed.484
exerciseandinwhomclassIdrugtherapyis
Prescriptionof oral anticoagulants (OAC) depends onthe clinical initiated.
riskprofile(mainlyCHA DS-VAScscore).485Sportswithdirectbodily 2 2 TheuseofclassIantiarrhythmicdrugsasmono-
contactorpronetotraumashouldbeavoidedinpatientsonOAC.486 therapy,withoutproofofadequateratecontrol
Catheterablationbypulmonaryveinisolation(PVI)shouldbeconsid- III C
ofAF/AFLduringvigorousexercise,isnot
eredifdrug therapyfails oras first-line therapyif drugtherapyisnot recommended.482,483
desired.487SeveralsmallserieshaveshownthattheoutcomeofPVIin
Afteringestionofpill-in-the-pocketflecainideor
athletes with paroxysmal AF is similar to that in non-athletic
propafenone,participationinintensivesportsis
patients.488,489
notrecommendeduntiltwohalf-livesoftheanti- III C
arrhythmicdrughaveelapsed(i.e.upto2
5.6.2.3Impactofsportscontinuationonthenaturalprogressionofatrial
days).484
fibrillationafterablation
Sportswithdirectbodilycontactorproneto
IftherearenorecurrencesofAFwithin1monthofasuccessfulabla-
traumaarenotrecommendedinexercisingindi- III A
tion procedure, sports activity may be resumed. It is unknown
vidualswithAFwhoareanticoagulated.485
whether continuationofsports aftersuccessful PVI might progress
thediseaseprocessandleadtorecurrenceofnon-pulmonaryvein- AF=atrialfibrillation;AFL=atrialflutter;ECG=electrocardiogram.
dependentAFinthefuture.Therefore,nofirmrecommendationcan
aClassofrecommendation.
bLevelofevidence.
bemadeaboutthe‘safe’doseofsportsafterablation.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 48 ---
64 ESCGuidelines
.
.
5.6.3SupraventriculartachycardiaandWolff-Parkinson- .. excludesnon-intermittentlatentpre-excitation.Pre-excitationmaybe
.
Whitesyndrome .. intermittent,whichusuallyindicateslowriskpropertiesofthepathway.
.
The term paroxysmal supraventricular tachycardia (PSVT) includes .. However,someaccessorypathwaysmaybepotentiatedbyadrenergic
.
(i)atrioventricularnodalre-entranttachycardia(AVNRT;mostcom- .. stimuli. Therefore, exercise testing excluding pre-excitation at peak
.
mon);(ii)atrioventricularre-entranttachycardia(AVRT)involvingan .. exerciseisrecommendedbeforeclearanceforsports.
.
accessorypathway;or(iii)atrialtachycardia. .. Ablation of the AP is recommended in competitive and recrea-
.
Ventricularpre-excitationontherestingECGisduetoanacces- .. tionalathletes withpre-excitation and documented arrhythmias. In
.
sory pathway (AP) with antegrade conduction. The prevalence of .. the event of transient, infrequent well-tolerated arrhythmia (even
.
pre-excitationinthegeneralpopulationvariesfrom0.1(cid:2)0.3%.491,492 .. during exercise), good anticipation of an ablation procedure with
.
Wolff-Parkinson-White(WPW)syndromeisdefinedasthepresence .. increasedrisk(e.g.anteroseptalAP),orreluctanceoftheathleteto
.
ofparoxysmalarrhythmiasinapatientwithpre-excitation. .. undergo ablation, management should be guided by assessment of
.
.
. theantegradeconductioncharacteristicsoftheAPusingeithernon-
.
.
5.6.3.1Prognosticandsymptomaticrelevanceofparoxysmalsupraven- . invasivetestsoraninvasiveelectrophysiological(EP)study. .
.
triculartachycardiawithoutpre-excitation . Non-invasive investigation examines for intermittent pre-
.
.
PSVTwithoutpre-excitationandwithoutassociatedstructuralheart . excitation on ECG or Holter, for abrupt disappearance of pre-
.
.
diseaseisnotlife-threatening,althoughthearrhythmiamayresultin . excitationafteradministrationofalowdoseofclassIdrugs,orforits
.
dizzinessandexhaustionthatrequirescessationofexercise.Syncope .. abrupt disappearance during an exercise test.497 In cases of a long .
.
isuncommon.Pre-excitation,however,maybeassociatedwithsud- . refractoryperiodandhencelowriskforsuddendeath,continuation
.
.
dendeath(seelater);therefore,itisimportanttoexcludethepres- . ofsportsactivityispermittedwithoutablationontheunderstanding
.
.
enceoflatentpre-excitation,byperformingcarotidsinusmassageor . thatsportingactivityshouldbestoppedintheeventofrecurrenceof
.
.
anadenosine-testinsinusrhythm.493 .. palpitations.
.
AthleteswithPSVTshouldstopexerciseintheeventofpalpita- .. In competitive athletes with asymptomatic pre-excitation an EP
.
tionssincerapidheartratesmaycause(pre)syncope.Individualswith .. studyiswarrantedtoevaluatetheriskforsuddendeath.Intheevent
.
provenPSVTwithoutpre-excitationshouldbeeducatedonhowto .. ofahigh-riskfinding(Table15),ablationoftheAPisrecommended.
.
safelyperformvagalmanoeuvres(suchascarotidsinusmassageor, .. For athletes who refuse ablation, or if the procedure is associated
.
preferably, Valsalva manoeuvre) to facilitate termination of the .. withhighrisk,suchasananteroseptalaccessorypathway,participa-
.
arrhythmia.494 Exercise may be resumed after termination of the .. tionincompetitivesportsactivitiescanbediscussedonanindividual
.
arrhythmia. Prophylactic drug treatment with beta-blockers orcal- .. case by case basis including the use of pharmacological therapy,
.
ciumantagonistswithatrioventricularnodalblockingpropertiescan .. although there are currently no data about its efficacy. Sports in
.
beconsidered,althoughithaslimitedefficacy.ClassIdrugshaveno .. which the potential loss of consciousness could be fatal should be
.
role in the management of PSVT, since they can cause life- .. discouraged.
.
threateningarrhythmias(seeearlier). .. In recreational athletes with asymptomatic pre-excitation, risk
.
If competitive athletic activity is desired, curative treatment by .. assessmentmayfirstbepursuedvianon-invasivetesting.497Thesen-
.
.
ablationshouldbeconsidered.Ablationoutcomeisequallysafeand . sitivityofnon-invasivescreeningforAPpropertiesthatfacilitateafast
.
hassimilaracutesuccessratesinathletesandnon-athletes.495Ifthe .. ventricularresponsetoAF/AFLisgood,butitsspecificityislow.498
.
.
PSVTisonlysporadicandtransientandnotassociatedwithhaemo- . Ofnote,inchildrenyoungerthan12years,theriskofAF-induced
.
.
dynamicconsequences,evenwhenitdevelopsduringexercise,orin . VFandsuddendeathisverylow.Generally,aconservativeapproach
.
.
caseswhereablationisnotdesiredorunsuccessful,sportsactivityis
permissiblewhenthereisnoincreasedriskofafatalityfromapoten-
tial loss of consciousness (such as motorsports drivers, parachute
jumpers,divers,andsoon). Table15 Findingsduringaninvasiveelectrophysiological
study(withtheuseofisoprenaline)indicatinganaccessory
pathwaywithincreasedriskofsuddendeath
5.6.3.2Prognosticandsymptomaticrelevanceofpre-excitation
IthasbeenestimatedthatonethirdofpatientswithWPWsyndrome
maydevelopAFand,insuchcases,rapidconductionovertheAPcan
leadtoventricularfibrillation(VF)andsuddendeath.Giventhefact
that AF is more common in athletes, pre-excitation constitutes a
prognosticconcerninathletes.Theriskforsuddendeathinpatients
with pre-excitation varies in population-based studies from
0.15(cid:2)0.20%, and usually presents during exercise or emotional
stress.496
Evaluation of the athlete with ventricular pre-excitation should
excludeassociatedstructuralcardiacdisease,suchasHCMorEbstein
anomaly.Minimalor‘latent’pre-excitationcanbeunmaskedona12-
lead ECG during sinus rhythm by vagal manoeuvres or intravenous
administrationofadenosine.ProlongationofthePRintervalwithouta AF=atrialfibrillation;AVRT=atrioventricularre-entranttachycardia.
change in the QRS morphology, or transient atrioventricular block,
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 49 ---
ESCGuidelines 65
.
isrecommendedinthisagegroup,althoughonestudy499suggested .. apexorfreewalloftheLVorRV),highburden,complexity(e.g.cou-
.
.
thatprophylacticassessmentandablationreducestheriskofsudden . plets, triplets, or non-sustained runs), multifocal origin, and/or
.
.
death. There is a knowledge gap in the benefit/risk ratio of this . increasingfrequencywithexerciseshouldalerttothepossibilityof
.
approachandlarge-scalestudiesarerequiredtoaddresstheissue. .. electrical,ischaemic,orstructuralheartdisease.505,506
.
.
Leisure-timeandlow-tomedium-intensityexerciseprogrammes . ThereisnoabsolutethresholdofthenumberofPVCsthatcanbe
.
.
cangenerallyberesumed1weekafterablationifthereisnoparticu- . usedasacut-offforunderlyingdisease.Onestudyhasshownthatin
.
.
larriskofrecurrenceofarrhythmia. . asymptomaticathleteswith>2000PVCsperday,therewasa30%
.
.
Resumingcompetitivesportsispossibleafter1(cid:2)3months,with .. chance of finding an underlying structural or cardio-genetic
.
furtherECGfollow-upat6monthsand1year(giventheverysmall .. disease.503
.
riskforlaterecurrenceofpre-excitation). ..
.
Althoughtheremaybeanassociationbetween(typeof)AVNRT .. 5.6.4.2Morphologyofprematureventricularcontractions
.
andhistoryofsports,therearenodataabouthigherrecurrencerate .. The morphology of the PVCs may provide important prognostic
.
postablationwhensportsareresumedornot,andhencenoreason .. informationsincesomefocioforiginarerecognizedasbenign.The
.
tolimitexerciseprogrammesforsuchreason. .. mostprevalententityinthisrespectarePVCsoriginatingfromthe
.
.. right or left ventricular outflow regions (RVOT/LVOT), showing a
.
.. clearinferioraxiswithhighvoltagesintheinferiorlimbleads.Early
.
Recommendationsforexerciseandsportsparticipation .. precordialtransition(inV2,andcertainlywhenV1showsarightbun-
inindividualswithparoxysmalsupraventriculartachy- ... dlebranchmorphology)suggestsaleft-sidedorigin.507RVOT/LVOT
cardiaandpre-excitation . .. PVCsarethoughttobetheresultoftriggeredactivity,i.e.alocalcel-
.
Recommendations Classa Levelb ... lularcause,whichhasnonegativeprognosticimplications.Although
.
. theseRVOT/LVOTarrhythmiasusuallyoccurinstructurallynormal
.
Inindividualswithpalpitations,acomprehensive .. hearts,theymaybetheexpressionofsubclinicalarrhythmogeniccar-
.
assessmenttoexclude(latent)pre-excitation, .. diomyopathy.Cardiacimagingtestscanhelpexcludestructuralheart
I B .
structuralheartdisease,andVAsis .. diseaseinsuchathletes.
.
recommended.500 ..
LesscommonlocationsoffocalPVCsarearoundthemitralortri-
.
.
Participationinallsportsactivitiesisrecom- . cuspidannulus,mostofteninapostero-septallocation.Thesehavea
.
mendedinindividualsPSVTwithoutpre- I C .. superioraxiswithLBBBorRBBBmorphology.ThePVCsoriginating
.
excitation.500 .. from the His-Purkinje system typically have relatively narrow QRS
.
.
Ablationoftheaccessorypathwayisrecom- .. complexwithRBBBmorphologyandeitherleftanteriororleftpos-
.
mendedincompetitiveandrecreationalathletes
I C
... terior hemi-block. Lastly, intramyocardial foci may occur, often
withpre-excitationanddocumented .. relatedtothepapillarymusclesormoderatorband.508
.
arrhythmias.500 .. PVCsofdifferingmorphologiesfromtheRV(i.e.,wideLBBBand
.
Incompetitive/professionalathleteswithasymp- .. superioraxis)inindividualswithnormalLVfunctionshouldprompt
.
tomaticpre-excitation,anEPstudyisrecom- .. investigationstoexcludearrhythmogeniccardiomyopathyorsarcoi-
I B .
mendedtoevaluatetheriskforsudden .. dosis.Similarly,wideRBBBpattern,withsuperioraxisandmultifocal
.
death.497,500 .. PVCs of LV origin should trigger investigations for non-ischaemic
.
IncompetitiveathleteswithPSVTbutwithout ... cardiomyopathy.
pre-excitation,curativetreatmentbyablation IIa C ... Veryrarely,otherwise‘benign’PVCsarisingfromthePurkinjenet-
shouldbeconsidered. ... workmaygive rise topolymorphicventriculartachycardia(VT) or
.. VF due to their short coupling interval.509,510 In such patients, the
.
EP=electrophysiological;PSVT=paroxysmalsupraventriculartachycardia;VA= .. malignant electrical presentation mandates aggressive treatment.
v aCen lat sr sic ou fla rr ea cr or mhy mth em ndia a.
tion.
....
Finally, frequent but otherwise benign PVCs (usually defined as
bLevelofevidence. .. >10(cid:2)15%ofthetotalnumberofbeatsper24h)canimpairLVfunc-
. .
. tionovertime(PVC-inducedcardiomyopathy),whichmayberever-
.
.. siblewithmedicaltreatmentorcatheterablation.511,512
.
.
.
.
.
5.6.4Prematureventricularcontractionsand .. 5.6.4.3Prematureventricularcontractions:responsetoexercise
.
non-sustainedventriculartachycardia .. ReductionorresolutionofPVCswithincreasingexerciseloadistypi-
.
5.6.4.1Relationbetweennumberofprematureventricularcontractions .. calofidiopathicandbenignVAs,particularlythosewithanoutflow
andrisk
... tractmorphology.513,514PVCsinducedbyexerciseshouldbeconsid-
.
OnlyaminorityofathletesexhibitfrequentorcomplexVAwitha .. eredasa‘redflag’,becauseVAsassociatedwithheartdiseasesare
.
prevalence similar to that of their sedentary counterparts.502(cid:2)505 .. often made worse by adrenergic stimulation.19,502,511,512,515(cid:2)520 A
.
Premature ventricular contractions (PVCs) may be a marker of .. higherprevalenceofmyocardialsubstrates(mainlymid-wallorsube-
.
underlying heart disease, the presence of which would confer an .. picardialnon-ischaemicLVscars)wasfoundinaCMRstudyamong
.
unfavourable prognosis even in asymptomatic individuals. Specific .. athletes with exercise-induced PVCs compared to those with
.
characteristics of the PVCs, including morphology (origin from the
.. exercise-suppressedVAs(56%vs.21%).516
.
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 50 ---
66 ESCGuidelines
.
.
Ofnote,exercise-inducedisolatedorrepetitivePVCswithmulti- .. 5.6.5LongQTsyndrome
.
plemorphologies,especiallywithbeat-to-beatalternatingmorpholo- .. The QT and corrected QTc intervals vary by sex and
.
gies (so-called ‘bi-directional’ pattern), may be the expression of .. physical training. Congenital long QT syndrome (LQTS) should be
.
catecholaminergic polymorphic VT, which can degenerate into .. distinguishedfromacquiredforms,i.e.duetocircumstances,which
.
VF.518,521 .. canbereversedandprevented.OnceacquiredLQTSisestablished,
.
.. sports activity should be prohibited until the underlying cause is
.
5.6.4.4Practicalmanagementofcardiacpatientswithprematureven- .. corrected.
.
tricularcontractionsornon-sustainedventriculartachycardiawhowant .. A definitive diagnosis of congenital LQTS is often difficult.523
.
toengageinsports .. CongenitalLQTSshouldbesuspectedonaroutineECGor4min
.
The most important task in individuals with PVCs or NSVT who .. intorecoveryafteranexercisestresstest,524ifthecorrectedQTc
.
.
wanttoengageinsportsistoexcludeunderlyingstructuralorfamilial . interval according to Bazett’s formula is >_470 ms or >_480 ms in
.
arrhythmogenicconditions,sincesportsactivitymaytriggersustained .. asymptomaticmale orfemaleathletes,respectively.525 A QTc of
.
VT.Ithasbeensuggestedthatthepresenceof>_2PVCsonabaseline .. >_500 ms is diagnostic.526 In the case of a borderline long QTc .
.
ECG(oreven>_1PVCinthecaseofhigh-enduranceathletes)should . interval and a negative personal and familial history, subclinical
.
prompt a more thorough evaluation.522Work-up includes a family .. arrhythmiasshouldbeexcludedbyexercisetestingandlong-term
.
.
history,assessmentofthenumber,morphology,andcomplexityof . ECGrecording.
.
.
PVCsbyHolterand12-leadECG,inducibilitybyexertion(viaexer- . Since the risk of cardiac events during sports activities is largely .
.
cise test or long-term ECG recording during sports activities), and . gene-specific,genetictestingandcascadescreeningoffamilymembers
.
tailored additional imaging.1 Further diagnostic evaluation with .. shouldbeperformedfollowingaclinicaldiagnosisofLQTS.Individuals
.
.
moleculargenetictestingmaybeindicatedinselectedcasesifthesus- .. withLQT1areathighestriskduringstressfulexercise.527,528
.
picion for familial disease is high. Finally, repeat evaluation may be .. Symptomaticathletesshouldnotengageincompetitivesports.
.
neededafter6monthsto2years.Recommendationsforsportspar- .. IndividualswithLQT1shouldnotengageinsportsthatinvolvediv-
.
ticipation of athletes with PVC should be individualized based on .. ing into cold water since this is associated with increased risk of
.
evaluationforunderlyingcardiacconditionsasdescribedearlier,and .. arrhythmias. General precautions include avoidance of QT-
.
oftenrequiresshareddecisionmaking. .. prolonging drugs, dehydration, and electrolyte imbalance. Beta-
.
.. blocker therapy is extremely effective in LQT1 and additional
.
.. therapiesareonlyneededtocontrolmoreseverecasesorspecific
Recommendationsforexerciseinindividualswithpre- .
matureventricularcontractionsornon-sustainedven-
... genotypes.529
triculartachycardia .. Survivors of SCA (certainly while taking beta-blocker therapy)
.
.. shouldbereferredforanICD.Similarly,individualswhohaveexperi-
.
Recommendations Classa Levelb .. encedsuddensyncopedespitebeta-blockertherapyshouldalsobe
.
.. referred for an ICD or sympathetic cardiac denervation.530 ICD
Inexercisingindividualswith>_2PVCsonabase- ..
. implantationdoesnotconstituteclearanceforintensiveorcompeti-
lineECG(or>_1PVCinthecaseofhigh-endur- ..
. tivesports.ContinuedsportsparticipationwithanICDispossible,
anceathletes)thoroughevaluation(includinga
I C
...
but specific recommendations apply (see section 5.5.6). American
detailedfamilyhistory)toexcludeunderlying ..
. guidelinesaremorelenientwithrespecttoparticipationincompeti-
structuralorarrhythmogenicconditionsis ..
. tivesport(exceptforLQT1),providedthatprecautionsincludethe
recommended.503,522 ..
. presenceofanautomaticexternaldefibrillator(AED)‘aspartofthe
.
AmongindividualswithfrequentPVCsandnon- .. athlete’spersonalsportssafetygear’.531Weconsidersuchobligation .
sustainedVTathoroughinvestigationwith .
I C .. tobeimpractical(e.g.wintersports,watersports),anditplacesan
Holtermonitoring,12-leadECG,exercisetest, .
. addedresponsibilityonclubsorotherbystanders,whichcannotbe
andsuitableimagingisrecommmended.503 ..
. justified by a medical recommendation for an individual athlete.
.
Itisrecommendedthatallcompetitiveandlei- ...
Moreover,althoughLQTS-relatedcardiacarrestisuncommon,even
sure-timesportsactivitiesarepermitted,with I C ... during competitive sports,527 AED efficacy is not 100% in such
periodicre-evaluationinindividualswithoutfam- ... cases.532
ilialorstructuralunderlyingdisease.503 ...
InasymptomaticLQTSmutationcarrierswithoutaprolongedQT
.
ECG=electrocardiogram;PVC=prematureventricularcontractions;VT=ven-
.. interval,i.e.<470msinmenand<480msinwomen(‘genotypeposi-
.
triculartachycardia. .. tive/phenotypenegative’),shareddecisionmakingisrequired,balanc-
a bC Lela vs es lo of fr ee vc ido em nm cee .ndation. ....
ingtheriskforarrhythmiaswithpsychologicalwell-being.Anegative
. exercisestresstesthasnopredictivevalue.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 51 ---
ESCGuidelines 67
.
.
RecommendationsforexerciseinlongQTsyndrome
... pattern,preventivemeasuresarerecommended,suchasavoidance
.. of triggering drugs (www.brugadadrugs.org), electrolyte imbalance,
.
Recommendations Classa Levelb .. andincreasesincoretemperature>39(cid:4)C(e.g.byminimizingimmer-
.
.. sion in hot tubs, saunas, and steam rooms; by avoiding sports in
Itisrecommendedthatallexercisingindividuals ...
warm/humidconditions;orbyabstainingfromprolongedendurance
withLQTSwithpriorsymptomsorprolonged
I B
...
eventssuchastriathlonsandmarathons).Duringfebrileillness,fever
QTcbeontherapywithbeta-blockersattarget ... shouldbetreatedaggressively.247,511
dose.529 ...
Onecouldspeculatethatanenhancedvagalreactionduringrecov-
.
Itisrecommendedthatexercisingindividuals .. ery550andapredominantvagaltoneatrest551mayincreasethesus-
.
withLQTSshouldavoidQTprolongingdrugs .. ceptibilityofhighlytrainedindividualstodeveloparrhythmiasduring
.
(www.crediblemeds.org)andelectrolyteimbal- I B .
. recoveryoratrest.However,therearenoreportsdirectlylinking
.
ancesuchashypokalaemiaand .
. exerciseorsportstrainingtocardiaceventsandtherearenolarge
hypomagnesaemia.529 ..
. prospective studies evaluating the effect of exercise and sports in .
Shareddecisionmakingshouldbeconsidered .. BrS.
.
regardingsportsparticipationinpatientswith .. AsymptomaticpatientswiththespontaneoustypeIBrSECGpat-
.
genotype-positive/phenotype-negativeLQTS .. ternmaycompeteinallsportsexceptendurancesportsassociated
.
(i.e.<470/480msinmen/women).Typeandset- IIa C .. withanincreaseincoretemperature>39(cid:4)C(e.g.marathonrunning .
tingofsports(individualvs.team),typeofmuta- .. and triathlons). Similar rules apply to asymptomatic genotype-
.
tion,andextentofprecautionarymeasures .. positive/phenotype-negativeindividualsandthosewiththeconcealed
.
shouldbeconsideredinthiscontext. .. formofBrS.
.
.
Participationinhigh-intensityrecreationaland .. IftreatedwithanICD,providedprecautionarymeasuresaretaken
.
competitivesports,evenwhenonbeta-blockers, .. andthepatienthasbeenasymptomaticfor>_3months,resumption
.
isnotrecommendedinindividualswitha
III B
... of all sport, including competitive sport, may be considered, after
QTc>500msorageneticallyconfirmedLQTS .. shareddecisionmaking,andalsotakingintoconsiderationthefindings
.
withaQTc>_470msinmenor>_480msin .. fromtheICDregistry(seelater).
.
women. ..
.
Participationincompetitivesports(withorwith- .
outICD)isnotrecommendedinindividualswith RecommendationsforexerciseinBrugadasyndrome
III C
LQTSandpriorcardiacarrestorarrhythmic
Recommendations Classa Levelb
syncope.
ICDimplantationisrecommendedinpatients
ICD=implantablecardioverterdefibrillator;LQTS=longQTsyndrome.
aClassofrecommendation. withBrSwithepisodesofarrhythmicsyncope I C
bLevelofevidence. and/orabortedSCD.247
FollowingimplantationofanICD,resumptionof
5.6.6Brugadasyndrome leisureorcompetitivesportsshouldbeconsid-
TheBrugadasyndrome(BrS)isaninheritedcardiacionchanneldis- eredaftershareddecisionmakinginindividuals IIa C
orderwithanelevatedriskofVFandSCDinindividualswithastruc- whohavenotexperiencedrecurrentarrhyth-
turallynormalheart.533,534AlthoughBrSwasinitiallydescribedasa miasover3monthsafterICDimplantation.
purely electrical disease, minor structural RV abnormalities have InasymptomaticindividualswithBrS,asympto-
beendescribed,535(cid:2)538suggestingthatthediseasemaybetheresult maticmutationcarriersandasymptomaticath-
ofearlyrepolarizationordelayeddepolarization.509Thediagnosisis leteswithonlyaninducibleECGpattern,
basedonthepresenceofthetype1Brugadapatternonthe12-lead participationinsportsactivitiesthatarenot
IIb C
ECG(coved-typeST-segmentelevation>_2mmfollowedbyanega- associatedwithanincreaseincoretemperature
tiveT-wavein>_1mmoftherightprecordialleadspositionedinthe >39(cid:4)C(e.g.enduranceeventsunderextremely
fourth,third, or second intercostalspace),eitherspontaneouslyor hotand/orhumidconditions)maybe
followingprovocationbyasodiumionchannelblocker.523,539,540 considered.
MostindividualswithBrSremainasymptomaticthroughouttheir PrescriptionofdrugsthatmayaggravateBrSc,
lives.Inthemajorityofcases,eventsoccurduringsleeporrest,dur- electrolyteabnormalities,andsportspractice
ingfebrilestates or, occasionally, from heat stroke.541(cid:2)549 Patients thatincreasescoretemperature>39(cid:4)Carenot III C
whohavesufferedaSCAoranarrhythmicsyncopeshouldundergo recommendedinindividualswithovertBrSor
ICDimplantation.247,511Riskstratificationintheasymptomaticpopu- phenotypicallynegativemutationcarriers.
lation with spontaneous type 1 ECG pattern is more challeng-
BrS=Brugadasyndrome;ECG=electrocardiogram;ICD=implantablecardi-
ing.247,511 There is controversial evidence that exercise testing
overterdefibrillator;SCD=suddencardiacdeath.
showinganaggravatingphenotypeduringexerciseorearlyrecovery, aClassofrecommendation.
orEP study, are efficient at detecting individualsat risk ofSCD. In
bLevelofevidence.
cForexample,www.brugadadrugs.org.
asymptomatic patients with only inducible type 1 Brugada ECG
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 52 ---
68 ESCGuidelines
.
5.6.7Followingdeviceimplantation .. However,threeimportantconsiderationscomeintoplay.First,if
.
5.6.7.1Pacemakers .. sportiscontraindicatedbecauseitcancontributetotheprogression
.
Pacemaker (PM) implantation is common. Generally, individuals .. oftheunderlyingdisease(suchasinarrhythmogeniccardiomyopathy
.
implantedwithaPMhavelessseverediseaseandcomorbiditiesthan .. or lamin A/C mutations),384,425 an ICD cannot be considered as a
.
patientswithanICD.Moreover,thereislessriskofmalfunctionfora .. substituteforsportsrestriction,andparticipationinmoderate-and
.
PMthanforanICDduringsports.552Forallthesereasons,recom- .. high-intensityexerciseshouldbediscouraged.Recommendationsin
.
.
mendationsforsportspracticearemoreliberalinpatientswithaPM . suchcircumstancesshouldhavealifetimeperspectiveandbebased
.
.
thaninpatientswithanICD.PatientswithaPMmayparticipatein . ontheoptimalpreservationofstructuralcardiacintegrity.TheICD,
.
.
competitive or recreational sports in the absence of structural or . however,mayallowforlighttomoderateexercisewithoutconcerns
.
.
otherheartdiseaseforwhichexercisemaybeprohibited. . aboutriskofarrhythmiaorshocks,andmayhelpindividualstoregain
.
.
In the first weeksafter device implantation, sports activities that . autonomyandovercomefearsrelatingtoexercisingunattended.
.
.
increase the risk of lead dislocation (e.g. strong upper extremity . The second consideration is that ICD shocks in general, even
.
.
movements)shouldbeavoided.Exercisetestingand/orHoltermoni- . whenappropriateandsafe,willhaveapsychologicalimpactonthe .
.
toringduringsportsmayimproveindividualizedprogrammingofthe . athlete;30(cid:2)40%oftheathleteswhoexperiencedshocksinthemul-
.
.
upper sensor and the tracking rate and exclude inappropriate rate . tinationalICDSportsSafetyRegistrystopped participation,atleast
.
.
accelerationinothercircumstances(e.g.horseriding).553 .. temporarily,outoffearofrepeatshocks.389Moreover,thepropor-
.
Forallpatientswithcardiacdevices(PM,cardiacresynchronization .. tion of athletes with appropriate and inappropriate shocks during
.
therapy, and ICD), sports activities associated with a risk of chest .. exercise was higher in competitive than in recreational sports,
. traumashouldbeavoided.554(cid:2)557Somesportssuchassoccer,bas- .. emphasizingtheknowntriggeringeffectofhigh-intensityexercise.562
.
ketball,andbaseballmaybepossiblewhilewearingappropriatepad- .. ConsideringthatICDtherapyislifelong,wherequalityoflifeisnot
.
ding.Itisnoteworthythatsportswithpronouncedarmmovements .. onlydependentontheabilitytoperformsportsactivities,butalso
.
suchasvolleyball,basketball,tennis,golf,andclimbingmayincrease .. and mostly on continued trust in the device, physicians should be
.
theriskforlateleaddamageduetosubclaviancrush(withinsulation .. aware that their own belief in the effectiveness and safety of ICD
.
orconductorfailure).554,558,559Implantationonthecontralateralside .. therapyduringsportsshouldnotimplicitlyputpressureontheath-
.
of the dominant arm, fixation within the pocket, or submuscular .. letetocontinuesports.Again,informeddecisionmakingneedstore-
.
placement may improve durability of the system. It is not known .. evaluate alloptions of theathlete aftershocks, includingcontinuing,
.
whether subcostal or epicardial implant techniques provide long- .. reducing,orstoppingsports.563,564
.
.
term benefit. Electromagnetic interference is unlikely with modern . Third,situationswherelossoffocusorlossofconsciousnesscould
.
.
devices,and no cases have beenreported,butit should always be . causeharmtoathirdpartyortheathlete(suchasinmotorsports,
.
.
suspected and closely evaluated in specific athletic environments . diving,mountainclimbing,evencycling)shouldbeavoided.
.
.
withelectronicequipment(e.g.fencing).Myopotentialinhibitionmay . Theathletemustbeawareoftheprogrammeddetectionratecut-
.
.
resultininhibitionofpacing,aproblemthatismorecommonwith . offstobeabletoavoidreachingthoseduringexercise.Conversely,
.
.
unipolarelectrodes,althoughitcanusuallybecorrectedwithappro- . detectionzonesneedtobeprogrammedsufficientlyhightoallowfor
.
priatereprogrammingofthedevice.560,561Bipolarleadsarelesssen- .. adequatelyhighheart rates duringthe desired exercise levels. This
.
.
sitivetothisproblem,butmayhaveareducedlongevity. . practice proved safe and reduced the occurrence of shocks in the
.
.. ICDSportsSafetyDatabase.565Themostcommoncauseofinappro-
. .
5.6.7.2Implantablecardioverterdefibrillators . priate shocks in individualswith anICD is the occurrence ofsinus
.
.
AlargemultinationalICDSportsSafetyRegistryhasshownthatafter .. tachycardiaandsupraventriculararrhythmias.566,567Underlyingheart
.
amedianfollow-upof44months,therewerenodeathsorarrhyth- .. diseaseandendurancesportitselfcarriesahigherriskfordeveloping
.
miaorshock-relatedphysicalinjuryin440athleteswhocontinued .. AF.474,480,568ImplantationofadualsystemICDforthesolereasonof
.
organized competitive or high-risk sports after ICD implanta- .. atrial arrhythmia detection and discrimination is not warranted
.
tion.359,389Anadditionalanalysisin82non-professionalrecreational .. becauseitisusuallynoteffective.565,569(cid:2)572Giventhefactthatmany
.
athletes confirmedthese reassuring outcomes,562 which isrelevant .. oftheseathletesareyoung,thereisahigherriskforlong-termlead
.
for the many ICD recipients who want to continue recreational .. complicationswhenmoreleadsareimplanted;therefore,implanta-
.
sportsactivitiesafterimplantation.Therefore,shareddecisionmaking .. tionofmorecomplexICDsystems,andtheirindication,shouldbe
.
isappropriatewhendecidingwhetherornottocontinuesportsand .. weighed in every patient. Routine inclusion of athletes in remote
.
thelevelofparticipationwithanICD. .. monitoringprogrammesishighlyrecommended.
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 53 ---
ESCGuidelines 69
.
.
Recommendationsforexerciseinindividualswithpace-
.. defect, its physiological consequences, and the effect of surgical or
.
makersandimplantablecardioverterdefibrillators .. transcatheterintervention.
.
.
.
.
Recommendations Classa Levelb .. 5.7.2Theincreasingnumbersofathleteswithcongenital
.
.. heartdisease
Itisrecommendedthatindividualswith .
.
. AthleteswithCHDincludethosewithminorunoperatedlesionsand
implanteddeviceswith/withoutresynchroniza- .
.
. palliated and repaired CHD. Some athletes will be diagnosed with
tionandunderlyingdiseasefollowtherecom- I B .
.
. CHD for the first time during pre-participation screening.
mendationspertainingtotheunderlying .
.
disease.384,425 .. Approximately1in150adultshaveacongenitalheartdefect.Thisisan
.
. increaseofover50%inthelast10yearsandreflectsimproveddiagno-
Participationinsportsandexercise(exceptcolli- ...
sisandlong-termsurvival.575Overall90%ofadultswithCHDarein
sionsports)shouldbeconsideredinindividuals
IIa C
...
NYHAfunctionalclassIorII.576Thenumberofprofessionalandrec-
withpacemakertherapywhodonothavepatho- ..
. reationalathleteswithCHDisunknownbuttheeliteathletepopula- logicalsubstratesforfatalarrhythmias. ..
. tionislikelytobesmall.Inastudyof2352Olympianathletes,onlynine
.
Preventionofdirectimpacttotheimplanted .
. (0.4%)hadacongenitalheartdefect.577However,manymoreCHD
.
devicebyadaptingthesiteofleadand/ordevice .
IIa C .. patientscompeteatarecreationallevel.Itislikelythatthenumberof
implantation,padding,orrestrictingdirectimpact .
.. athletes with CHD is increasing due to improved survival, better
sportsshouldbeconsidered. .
.. understandingofthebenefitsofexercise,andtheincreasednumberof
Holterrecordingsanddeviceinterrogationdur- ...
professionalathletesfromcountrieswherepoorlydevelopedhealth-
ingandafterresumingsportsshouldbeconsid- ... caresystemsareassociatedwithunder-diagnosisofCHD.573,574
eredtoallowappropriatetailoringofrate- ..
IIa C .
responsivepacingparameters,exclusionofmyo- ..
. 5.7.3Non-cardiacabnormalitiesincongenitalheartdis-
potentialorelectromagneticinhibition,and ..
. easeandParalympicsport
detectionofVAs. ..
. CHDhasamultifactorialaetiology,butthereisasignificantgenetic
.
Shareddecisionmakingshouldbeconsidereddur- .. component and a recurrence risk of 2(cid:2)5%.578 The genetic origin
.
ingdecisionsrelatingtocontinuationofintensive .
. maybeduetoachromosomeanomaly,aheritablesyndromewith
.
orcompetitivesportsparticipationinindividuals .. Mendelian pattern, or sporadic with variable penetrance.578
.
withanICD,takingintoaccounttheeffectof .
. Approximately 14% of patients with CHD have additional non-
.
sportsontheunderlyingsubstrate,thefactthat IIa C .. cardiac abnormalities.579 Thus, 44% of ACHD patients have lung
.
intensivesportswilltriggermoreappropriateand .. functionabnormalities.580Thiscanmakeadvisingsportsparticipation
.
inappropriateshocks,thepsychologicalimpactof ..
fortheACHDathletemoredifficult.Thereisnospecificclassification
.
shocksontheathlete/patient,andthepotential ...
forCHDinParalympicsport.
riskforthirdparties. ..
.
AnICDisnotrecommendedasasubstitutefor ...
5.7.4Generalconsiderationsinthecongenitalheart
disease-relatedrecommendationswhenthese III C ...
diseaseathlete
.
mandatesportsrestrictions. .. There is considerable variation in the haemodynamic consequences
.
.
ICD=implantablecardioverterdefibrillator;VA=ventriculararrhythmia. .. andprognosisofdifferentCHDlesions.Furthermore,theconsequen-
aClassofrecommendation. .. cesofanyindividuallesioncanvaryhugelybetweenindividuals.Thus,
.
bLevelofevidence. .. Ebstein’sanomalymaypresentininfancywithpulmonaryhypoplasia
.
. . duetocompressionbyagiantrightatriumormaypresentinlatemid-
.
.
. dleagewithsupraventriculartachycardiaandminimalhaemodynamic
.
5.7 Exercise recommendations in .. consequences.Similarly,aventricularseptaldefectmaybesmalland
.
.
individuals with adult congenital heart . asymptomatic,orlargepresentingwithHFininfancy,ormaypresent .
.
disease .. with extreme cyanosis, reduced exercise capacity, and Eisenmenger
.
. syndrome in the adult. Consequently, these recommendations are
5.7.1Introduction ..
. basedonaphysiologicalassessmentratherthanunderlyinganatomic
Congenitalheartdisease(CHD)hasaprevalenceof8(cid:2)9per1000 ..
. diagnosis.Anunderstandingoftherangeofseverityandalesion-based
live births and is the most common birth defect.573 Most children ..
.. knowledge of potential complications is essential. The cardiologist
withCHD surviveto adulthood,including over85% with complex .
.. shouldworkinconjunctionwithaCHDspecialist.AthleteswithCHD
disease.Regularexerciseisimportantforadultswithcongenitalheart .
.. who participate in regular training and competitive sports should
disease (ACHD) and exercise participation should be discussed at .
everypatientencounter.574However,CHDrepresentsaspectrum
... undergo a comprehensive annual assessment that includes clinical
.. examination, ECG, echocardiogram, and exercise stress test, ideally
of conditions with widely varying physiological consequences. .
.. CPET.
Individualizedassessmentisessentialbeforeadvisingonsportspartic- .
.. ManyathleteswithCHDwillhaveundergonecorrectiveorpallia-
ipation.Thisrequiresdetailedunderstandingofthecongenitalheart .
. tive surgery. In young adults with post-surgical CHD, valve
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 54 ---
70 ESCGuidelines
.
.
incompetence and arrhythmias are common problems, but with . Stage1.Afullhistoryandphysicalexaminationarecarriedout.
.
.
increasingagearrhythmiasandHFpredominate.Inmasterathletes, . ThisshouldincludedetailsofunderlyingCHDdiagnosis,anytrans-
.
.
problemsrelatedtopreviouscorrectiveorpalliativesurgerybecome . catheterorsurgicalinterventions,currentmedicationsandCVsymp-
.
.
prevalent. These include cardiac arrhythmias, systemic ventricular . toms (at rest and on exercise). Attention should be paid to any
.
.
dysfunction, valvar incompetence, and prosthetic conduit obstruc- . associatednon-cardiacdiagnosesincludingpulmonarydysfunction.A
.
.
tion.Redovalveorconduitsurgeryandarrhythmiaablationdueto . fullexerciseandsportsparticipationhistoryshouldbetakenincluding
.
.
re-entryarrhythmias(secondarytosurgicalscar)arefrequentinthis . precise details of current training schedule and any dietary supple-
.
.
age group. In addition, with increasing age, acquired CVD may . ments. Details of the planned or current sports activity should be
.
.
develop.581,582Thisisofparticularrelevanceintheassessmentofthe .. established to include an assessment of the static component and
.
masterathletewithCHD. .. intensityasdescribedinsection4.1(seeFigure2).Ifnecessary,advice
.
.. should be sought from a sports fitness coach or sports medicine
.
.. specialist.
5.7.5Suddendeathduringsport ...
Stage2.The followingfive baseline parametersshouldthenbe
SCDinCHDisrare(<0.1%peryear)583andonly8%ofdeathsoccur ...
evaluated597(Table16).
during exercise.584 Many complex CHD patients at highest risk of ..
.
SCDhavereducedexercisetoleranceandcannotparticipateinsig- .. (1) Ventricularfunction
.
nificantathleticactivity.However,somediagnosticgroups,e.g.post .. Assessment of ventricular function can usually be achieved using
.
tetralogyofFallotrepair,carryariskofSCDbutcanstillcompetein .. echocardiography. The aim is to establish whether function is
.
elitesport.585Otherhigh-riskcongenitallesionssuchasanomalous .. reduced (EF < 55%), and if so, is it mild (45(cid:2)55%), moderate
.
.
coronaryorigin,mitralvalveprolapse,andaortopathyaredescribed . (30(cid:2)45%), or severe (<30%).This isusedfor baseline assessment
.
.
insections5.1,5.3,and5.4,respectively.Inalargepopulation-based . and subsequent monitoring of the effects of exercise training.
.
.
studyofSCDinCHDpatientsunder35years,87%ofSCDwasdue . Echocardiographycanalsoevaluateinflowandoutflowabnormalities,
.
.
toapresumedarrhythmiaand41%occurredinpatientswithundiag- . whichmaybecomemoresevereduringacuteexercise(e.g.LVout-
.
nosed CHD.586Activity-related SCD was more common in the .. flow obstruction or systemic atrioventricular valve regurgitation).
.
.
undiagnosedgroup(18% vs.4%),whichsupportsthecase forpre- . CMRscanningmaybeapreferablemodalityincomplexdisease.This
.
participationathleticscreening.586Itisnotknownwhetherexercise ... hastheadditionalbenefitofevaluatingintracardiacscar,whichmay
.
intensityis a riskfactorfor SCD in CHD. Thereis reasonableevi- .. informtheassessmentofarrhythmiarisk.599,600
.
dence that moderate to vigorous exercise is safe in most ACHD .
.. (2) Pulmonaryarterypressure
patientsevenwhensymptomatic(NYHAII(cid:2)III).576,587,588However, ..
cardiac arrhythmias are a common cause of hospital admission in
... Pulmonary hypertension (PH) is diagnosed when the mean PAP is
ACHD and extreme exercise may expose a latent arrhythmic
... >20mmHg.601PHmayoccurinthecontextofachronicleft(cid:2)right
substrate.589,590 ... shunt(e.g.atrialseptaldefect,ventricularseptaldefect,patentductus
.. arteriosus) that allows unrestricted volume/pressure overload.
.
.. Eventuallythiscanresultinsupra-normalPAPwithreversalofshunt-
.
5.7.6Exerciseinathleteswithcongenitalheartdisease: .. ing and elevated pulmonary vascular resistance (Eisenmenger syn-
.
currentguidelinesandrecommendations .. drome). An increased RV afterload limits the ability to increase
.
Regular structured exercise is safe and effective therapy for most .. cardiacoutputbyincreasingstrokevolumeandcanimpairLVfunc-
.
patientswithCHD.Thisistrueformostdiagnosticgroups,including .. tionthroughdisruptionofnormalRV(cid:2)LVinteraction.
.
symptomaticpatients,andincludesaerobicandstrength-basedexer- .. FewCHDpatientswithsignificantPHwilltakepartincompetitive
.
cise.588,591(cid:2)596ExerciseintoleranceinCHDisastrongpredictorof .. sports due to reduced exercise capacity. However, some athletes
.
both outcome and SCD.576 Specific precautions are necessary in .. withCHDwillhavemildelevationofpulmonaryvascularresistance
. extremeenvironmentsincludingunderwatersportsandthisiscon- .. thatmaybeexacerbatedbyfactorssuchasaltitudetraining.602PAP
.
.
sideredbelow(seeSupplementaryData,section4).Thisisparticularly . risesduringexercise.Thisriseisaccentuatedwithincreasingageand
.
.
trueifthereisapotentialforarighttoleftshunt.Guidelinesareavail- . maybeexaggeratedinCHDathletesduetoelevatedpulmonaryvas- .
ablefor exerciseassessmentand prescriptionin bothchildrenand .. cular resistance.603 In addition, valvar pulmonary stenosis or distal
.
.
adultswithCHD,althoughthesearenotspecificallydesignedforthe . stenoses in branch pulmonary arteries may cause exercise-related
.
athlete.597,598 The paediatric guidelines are based primarily on the .. RVhypertension.Thenon-invasiveassessmentofPHcanbedifficult
.
.
underlying anatomical diagnosis, but the teenage and young adult . and full assessment guidelines have been published.604,605 Further
.
.
CHDguidelineshavetakenafunctionalapproachbasedonunderly- ... informationcanbegainedbyCPETandaVO 2of>25.2mL/min/kg
inghaemodynamicsandarrhythmiarisk.Thislatterapproachisbetter .. makessignificantPHunlikely.606AsPHcanalsobealatepostopera-
.
suitedforassessmentoftheACHDathlete(Figure9). .. tivecomplicationaftersurgicalcorrectionofCHD607theassessment
.
.. ofPAPshouldbepartofeveryechocardiographicexaminationinath-
.
.. leteswithCHD.Althoughexercisetrainingisgenerallyregardedas
5.7.7Assessmentoftheathletewithcongenitalheart ... safeinPH,competitivesportisnotrecommended.1,608
disease ..
The guidelines for exercise prescription in adolescents and adults
... (3) Aorticassessment
.
withCHDuseastructuredmethodologydescribedbyBudtsetal.597 .. Many CHD patients are at risk of aortic dilatation, in particular,
.
ThiscanbemodifiedforuseintheassessmentofathleteswithCHD. . patientswithtetralogyofFallot,coarctationoftheaortaandcertain
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 55 ---
ESCGuidelines 71
Table16 Baselineparametersforassessmentincongeni- syndromes such as 22q11 microdeletion and Turner syndrome.
talheartdisease However, aortic dissection is very rare in CHD.609 Athletes have
mildlyincreasedaorticdimensionsincomparisontosedentarycon-
trols,butitisnotknownifthishasacumulativeeffectinCHDath-
letes with aortic dilatation.345 The presence of ascending aorta
dilatationshouldleadtoassessmentforcoarctationoftheaortaas
thiscanbeassociatedwithseverecoarctation,whichmaybemissed
onclinicalassessmentbutmaycausesevereexercise-relatedhyper-
tension.610Exerciserisksinaortopathyaredescribedindetailinsec-
tion 5.4. Contact sports should be avoided in patients with dilated
aortas>5cm.
(4) Arrhythmiaassessment
Arrhythmias are responsible for 25% of CHD hospital admissions.
Over 80% are atrial but life-threatening VAs can occur.611
Independentriskfactorsincludeincreasingage,malegender,double
outlet right ventricle, atrioventricularseptal defect, HF, obstructive
sleep apnoea, transposition of the great arteries, congenitally cor-
rected transposition, and tetralogy of Fallot.599 Assessment of the
CHD athlete should include a symptom history with evaluation of
palpitations, presyncope and syncope, particularly during exercise.
CMR=cardiacmagneticresonance;ECG=electrocardiogram.
Figure9 Pre-participationassessmentofindividualswithcongenitalheartdisease.598CPET=cardiopulmonaryexercisetest;HR=heartrate;MHR=
maximumheartrate;RPE=rateofperceivedexertion.A(cid:2)Erepresentpathwayslinkingstaticandintensitycomponentsforeachcolumn.Afterassess-
mentofCPETandthefivevariables(Table16),anindividualrecommendationcanbegiven(solidarrow).Ifahigherstaticlevelsportischosen,thenalower
intensitylevelisadvised(dottedarrow).
0202
CSE©
0202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 56 ---
72 ESCGuidelines
.
Arrhythmiasmaybethefirstsignofunderlyinghaemodynamicdete- .. the age-related changes that occur in the CHD athlete and the
.
.
riorationandnew-onsetarrhythmiasshouldleadtoafullhaemody- . potentialforonsetofdegenerativeCVD.
.
namic assessment. Detailed guidelines for the assessment and
treatment of arrhythmias in CHD are available.612 In the athlete,
Exerciserecommendationsforindividualswithcongeni-
arrhythmiatherapymaybecomplicatedbytheneedtominimizethe
talheartdisease
negative chronotropic effects of antiarrhythmic treatment, which
mayaffectperformance.Ifsymptomaticarrhythmiasarepresentthen Recommendations Classa Levelb
anexerciseECG,prolongedECGmonitoring,looprecorderimplan-
tation, and even electrophysiology testing might be required. This Participationinregularmoderateexerciseisrec-
should be coordinated by an electrophysiologist with expertise in ommendedinallindividualswith I B
CHD.
CHD.588,591(cid:2)594,619
(5) Assessmentofsaturations/lungfunction Adiscussiononexerciseparticipationandprovi-
sionofanindividualizedexerciseprescriptionis
CHDathletesshouldbeassessedforthepotentialofanunderlying I B
recommendedateveryCHDpatient
intracardiacrighttoleftshunt.Thiscanbeassessedusingpulseoxi-
encounter.574,597,598,617
metry, but a resting saturation >95% does not exclude exercise-
Assessmentforventricularfunction,pulmonary
related central cyanosis, and exercise assessment is essential. The
arterypressure,aorticsize,andarrhythmiarisk potentialforapulmonarycauseofcyanosismustbeconsideredand I C
isrecommendedinallathleteswith
lungfunctionshouldbeassessedaspartofacardiopulmonaryexer-
CHD.342,348,573,597
cise test. Even after surgical correction of the cardiac defect there
mayberesidualintracardiacshunting. Competitivesportsparticipationshouldbecon-
Stage3.Cardiopulmonaryexercisetesting sideredforCHDathletesinNYHAclassIorII
CPETisinvaluableinriskstratifyingtheadultwithCHDandcan whoarefreefrompotentiallyseriousarrhyth- IIa C
predictoutcome.613,614Itisalsoextremelyusefulintheevaluationof miasafterindividualtailoredevaluationand
theathletewithCHDasitallowsanassessmentofPAP,respiratory
shareddecisionmaking.573,595,597,598
problems, cardiac output, exercise-related haemodynamics, and Competitivesportsarenotrecommendedfor
arrhythmias.Thisshouldbeusedinconjunctionwithanevaluationof individualswithCHDwhoareinNYHAclass
III C
effortsuchastheBorgscale.615NormalCPETvaluesareavailablefor III(cid:2)IVorwithpotentiallyserious
non-athlete CHD patients.616 CPET should be carried out in con- arrhythmias.605,608
junctionwitha12-leadECGtoallowdetectionofarrhythmiasand
CHD=congenitalheartdisease;NYHA=NewYorkHeartAssociation.
evaluate chronotropic incompetence. Reduced VO 2max and peak aClassofrecommendation.
oxygen pulsemay reflect reduced strokevolume and are found in bLevelofevidence.
complexCHDaswellasinotherformsofCHD,includingrepaired
tetralogyofFallot,aorticregurgitation,andcoarctationoftheaorta.
In CHD, ventilatory anaerobic threshold may be reduced and this 6. Key messages
impairs gas exchange efficiency in dynamic and endurance sports.
Thismayrelatetopreviousthoracotomyorlungdisease.Similarly, CV screening before participation in recreational and competitive
theremaybeanelevatedminuteventilation/carbondioxideproduc- sports is aimed at the detection of disorders associated with SCD
tion(VE/VCO )slope,601indicatinganinadequatepulmonaryvascu- andhasthepotentialtolowerCVriskthroughdisease-specificand
2
lar bed.610,611,613(cid:2)616 Reduced skeletal muscle mass is common in individualizedpatientmanagement.
adults with CHD and can contribute to decreased tissue oxygen CVscreeninginadultandseniorathletesshouldtargetthehigher
uptake.TheextenttowhichthisismodifiedinathleteswithCHD prevalenceofatheroscleroticCADincludinganassessmentofCVD
hasnotbeenevaluated.However,evenincomplexdisease,regular riskfactorsandexercisestresstest.CACscoringmaybeperformed
resistanceexerciseparticipationimprovesmusclemassandregular in asymptomatic athletes with a moderate atherosclerotic risk
exerciseparticipationisadominantfactorindetermininglong-term profile.
outcome.593,617 Healthyadultsofallagesandindividualswithknowncardiacdis-
Stage4.Exerciseintensityandprescription easeshouldexerciseonmostdays,totallingatleast150min/weekof
An assessment of the athlete’s sports and exercise participation moderate-intensityexercise.
should take place as discussed in the introduction (Table 16). This Individuals with CAD, at low risk for exercise-induced adverse
shouldincludeanassessmentoftheintensity,aerobicandresistance events,shouldbeconsideredeligibleforcompetitiveorleisuresports
components (isometric and dynamic), and the overall volume of activities,withfewexceptions.
exercise,whichshouldincludetrainingandcompetition.Thehaemo- Competitive sports are not recommended in individuals with
dynamic consequences should be considered in light of an under- CAD,athighriskofexercise-inducedadverseeventsorthosewith
standing of known lesion-specific consequences and individual residual ischaemia, with the exception for individually low-intensity
athlete-specificchangesidentifiedonassessment. skillsports.
Stage5.Follow-upandrepeatassessment ExerciseprogrammesinHFimproveexercisetoleranceandqual-
IntheCHDathlete,serialassessmentshouldbecarriedout—usu- ityoflifeandhaveamodesteffectonall-causeandHF-specificmor-
allyonanannualbasis—whileparticipatinginsport.Thisrecognizes tality,andall-causehospitalizationandHF-specifichospitalization.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 57 ---
ESCGuidelines 73
.
.
Asymptomaticindividualswithmildvalvularheartdiseasemaypar- . Prospective outcomes data, including the occurrence of major CV
.
.
ticipateinallsportingactivitiesincludingcompetitivesports. . eventsandotherCVmorbidity,isneededtobetterguideriskstratifi-
.
.
A select groupofasymptomatic individualswithmoderatevalve . cation, management, and eligibility recommendations for athletes
.
.
diseasewhohavegoodfunctionalcapacityandnoevidenceofmyo- . diagnosedwithCVD.
.
.
cardialischaemia,complexarrhythmias,orhaemodynamiccompro- . Cardiovascular evaluation in master athletes. Current
.
.
mise on a maximal exercise stress test may be considered for . methodsforscreeningindividualsforatheroscleroticCADarebased
.
.
competitive sports after careful discussion with an expert . on symptoms and a maximal exercise test; however, they do not
.
.
cardiologist. . identify individuals with mild to moderate atherosclerotic plaques.
.
.
Implementationofhealthylifestylebehavioursincludingsportspar- .. More knowledge on the optimal pre-participation screening algo-
.
ticipationdecreasestheriskofCVeventsandmortalityinindividuals .. rithmforidentifyingindividualsatriskofadversecardiaceventsdur-
.
withaortopathies. .. ingexerciseisrequired.
.
Individuals with acute myocarditis or pericarditis should abstain .. Safetyofhigh-intensityexerciseincardiovasculardisease.
.
fromallsportswhileactiveinflammationispresent. .. Therearelimiteddataonthesafetyofhigh-intensityexercisetraining
.
Individualswithcardiomyopathyorresolvedmyocarditisorperi- .. andsportsparticipationinhealthyindividualswithahighburdenof
.
carditis, who wish to participate in regular sports, should undergo .. risk factors; more information can be gained through high-quality
.
comprehensive evaluation, including an exercise test, to assess the .. prospectivestudiesinthefuture.
.
riskofexercise-inducedarrhythmias. .. Risk of anomalous origins of the coronary arteries in
.
Individualswhoaregenotypepositive/phenotypenegativeorhave .. older individuals. Although AOCA from the opposite sinus of
. amildcardiomyopathyphenotypeandabsenceofsymptomsorany .. Valsalvaarearecognizedcauseofmortalityinyoungathletes,more
.
riskfactors,maybeabletoparticipateincompetitivesports.Anota- .. knowledgeisrequiredontheriskofhigh-intensityexerciseinolder
.
.
ble exception is arrhythmogenic cardiomyopathy where high- . individuals(>40yearsold),withthiscongenitalabnormality.
.
.
intensityexerciseandcompetitivesportsshouldbediscouraged. . Riskof myocardial bridge. The precise significance of MB in
.
.
Managing sports participation in individuals with arrhythmogenic . causingMIorsuddendeathduringexerciseisunknown.
.
.
conditionsisguidedbythreeprinciples:(i)preventinglife-threatening . Benefit of regular exercise on survival in chronic heart
.
.
arrhythmias during exercise; (ii) symptom management to allow . failure.Althoughexerciseimprovesfunctionalcapacityandquality
.
.
sports;and(iii)preventingsports-inducedprogressionofthearrhyth- . oflifeinindividualswithHF,strongevidenceonthebenefitofregular
.
.
mogeniccondition.Ineachcase,thesethreebasicquestionsneedto . exerciseonsurvivalisstilllacking.
.
.
beaddressed. . Role of high-intensity exercise in chronic heart failure.
.
.
Pre-excitationshouldbe excluded in all athletes with PSVT, and . The impact of high-intensity exercise in asymptomatic individuals
.
.
ablationoftheaccessorypathwayisrecommendedifpresent. . with HF with reduced and preserved systolic function is unknown
.
.
InindividualswithPVCswhowanttoengageinsports,underlying .. andlargemulticentrestudiesarerequiredtofacilitateexercisepre-
.
structural or familial arrhythmogenic conditions must be excluded, .. scriptioninthefuture.
.
sincesportsactivitymaytriggermoremalignantarrhythmiasifthose .. Initiation of an exercise programme after decompen-
.
underlyingconditionsarepresent. .. satedheartfailure.Thestarttimeofanexerciseprogrammeof
.
Athleteswithelectricalabnormalitiesofgeneticorigin,suchasthe .. moderate-highintensityandreturntosportsafteranacuteeventin
.
inherited ionchannelopathies,requireassessmentand shared deci- .. HFisunknown.
.
sionmakinginwhichcardiogeneticistsareinvolved,giventhecom- .. Aquaticexerciseinheartfailure.Thesafetyofaquaticexer-
.
plex interplay of genotype, phenotype, potential modifiers, and .. ciseinHFneedstobeconfirmedbylargertrials.
.
exercise. .. Effectofexerciseonthenaturalhistoryofvalvularheart
.
Individualswithpacemakersshouldnotbediscouragedfrompar- .. disease.Thereisapaucitydataontheeffectsofregularintensive
.
ticipation in sport because of the device but need to tailor their .. exerciseinindividualswithvalvularheartdisease.Large-scalelongitu-
.
sportsparticipationaccordingtotheunderlyingdisease. .. dinalstudiesarerequiredtoprovidemoreevidence-basedguidelines
.
.
Participationinleisure-timeandcompetitivesportinpatientswith . onexerciseprescriptioninindividualswithvalvularheartdisease.
. .
an ICD may be considered, but requires shared and individualized . Effectofexerciseonthenaturalhistoryofaortopathies.
.
.
decisionmaking,basedonahigherlikelihoodofappropriateandinap- . Thereisalackofknowledgeontheimpactofsportonprogression
.
.
propriate shocks during sports, and the potential consequences of . ofaorticdiseaseandriskofdissectionoraorticruptureamongindi-
.
.
shortepisodesoflossofconsciousness. . vidualswithaortopathy.Theimpactofbeta-blockersonprogression
.
.
PatientswithCHDshouldbeencouragedtoexerciseandshould . ofaorticdiseaseamongindividualswithaortopathywhoparticipate
.
.
begivenapersonalizedexerciseprescription. . in regular exercise is unknown and should be investigated in a
.
.
. randomizedcontrolledtrial.
.
.
. Optimal safe exercise dose in cardiomyopathy. With an
.
.
7. Gaps in evidence . exception for arrhythmogenic cardiomyopathy, current practice
.
.
. relatingtoexerciserecommendationsinindividualswithcardiomy-
.
.
Outcomesinexercisingindividualswithcardiovasculardis- .. opathyorfollowingmyopericarditisarelargelybasedoncircumstan-
.
eases.Thenaturalhistoryandabsoluteriskofconditionsassociated .. tial evidence. Large, adequately powered randomized prospective
.
with SCD in athletes identified through CV screening is largely .. studiesarenecessarytoprovideevidence-basedrecommendations
.
unknown, making it difficult to quantify short- and long-term risk. . foroptimalexerciseprescriptionwithoutcompromisingsafety.Such
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 58 ---
74 ESCGuidelines
.
.
studiesshouldalsoproveusefulforvalidatingcurrentriskstratifica- . HCM.IntheUSNationalRegistry,femalescomprisedonly3%ofthe
.
tionprotocolsderivedfromarelativelysedentarypopulation. .. 302 individuals who died from HCM.621 Potential determinants of
.
.
Exerciseandatrialfibrillation.Thethresholdlifetimesports . this disproportionate prevalence of death in males may include a
.
.
activityforincreasingtheriskofdevelopingAFisunknown.Itisalso . lowerabsolutevolumeandintensityoftrainingloadinfemales,which
.
.
unknownwhetherongoingparticipationinvigorousexerciseatthe . could make them less susceptible to ventricular tachyarrhythmias.
.
.
sameintensityaftersuccessfulAFablationisassociatedwithahigher . However,itisalsoplausiblethatcertainprotectivemetabolicorhor-
.
.
riskofAFrecurrence. . monalmechanismscouldreducethearrhythmicriskduringintense
.
.
Benefitofinvasiveelectrophysiologicalstudiesinadoles- . physicalexertioninfemaleswithHCM.Thisobservationisrelevant
.
.
cents with accessory pathways. The benefit/risk ratio of early .. toprescriptionofintensiveexerciseorcompetitivesportsinHCM,
.
invasiveEPevaluationofAPconductionpropertiesinyoungathletes .. which is relatively conservative, but could be of less concern and
.
withasymptomaticpre-excitation(<12(cid:2)14yearsold),andprophy- .. moreliberalinaffectedfemalesinthefuture.ThediagnosisofHCM
.
lactic ablation, remains unclear and requires large-scale studies for .. inanathleteisalsorelevantinthisregard,becausemaleathletes,par-
.
clarification. .. ticularly those competing in endurance sports, show quantitatively
.
Exercisingwithanimplantablecardioverterdefibrillator. .. greatstructuralchangeswithintheheartincludingLVhypertrophy.
.
Although an international registry has shown absence of sports- .. Approximately2%ofwhitemaleathletesand13%ofblackmaleath-
.
relatedsuddendeathorinjuryinindividualswithanICDwhoper- .. letesshowaLVwallthicknessof12(cid:2)15mmthatoverlapswithmor-
.
form competitive, high-intensive recreational or high-risk sports, .. phologically mild HCM and can pose a diagnostic dilemma. In
.
manydataaresparseandhavenotexaminedspecificathleticpopula- .. contrastfemaleathletesrarelyrevealaLVwallthickness>12mmor
. tionswithreducedLVfunction,catecholaminergicpolymorphicVT. .. concentricLVremodelling,hencethediagnosisofHCMisclear-cut.3
.
Moreover,thelong-termphysicalandpsychologicalimpactofappro- .. In contrast, a different scenario is represented in females with
.
.
priateandinappropriateshocks,whichbecomemorefrequentwith . MVP,whererecommendationforparticipationinintensiveexercise
.
.
increasingsportsintensity,isunknown. . warrants a more detailed risk stratification. In the Italian pathology
.
.
Arrhythmicriskofexerciseinadultcongenitalheartdis- . registry of 650 SCDs, 7% were attributed to MVP. Of these, the
.
.
ease. The relationship between intensity of exercise and risk of . majority(60%)werefemalewhopresentedamarkedelongationof
.
arrhythmiasinindividualswithCHDisunknownandfurtherresearch .. bothleafletsduetoanextensivemyxomatousdegeneration.332
.
.
isneeded.AlthoughexerciseprescriptionisrecommendedinCHD . Itisalsonoteworthythatthemajorityofexercise-relatedSCDsin
.
.
patients,furtherstudiesarenecessarytoidentifytheoptimalmethod . young females are associated with a structurally normal heart at
.
.
ofimprovingadherencetoanexerciseprescription. . autopsy.Thisobservationfromseveralregistriessuggeststhatgenetic
.
.
. electricaldiseases(namely,LQTS,Brugadasyndrome,orcatechola-
.
.
. minergicpolymorphicVT)arelikelyresponsibleforasignificantpro-
.
.
8. Sex differences .. portion of these deaths. Differences in cardiac repolarization
.
.. between men and women have been reported in healthy subjects
.
For many years sportsparticipation,especiallyatthe highest eche- .. andinindividualswithLQTS.622Healthyfemalesalsohavealonger
.
lons,hasbeendominated bymales, butthe lastfourdecadeshave .. QTcintervalcomparedwithmales.Therefore,theyaremoreoften
.
witnessed an increasing number of females participating in a large .. clinicallyaffectedbythesyndromethanmen,despitetheequalsex
.
varietyofsportingdisciplinesatelitelevel.Femalesconstituted45% .. distributionofthediseasegenotype.Femalesarealsoatahigherrisk
.
ofallathletesatthe2016RioOlympicsandparticipatedin26ofthe .. thanmalesofdevelopingarrhythmiasinresponsetoQT-prolonging .
28differentsportingdisciplinesincludingthosethatweretraditionally .. drugs, and electrolyte disturbances compared with males.
.
considered to be ‘male sports’, such as footfall, rugby, and boxing. .. Furthermore, female sex is an independent risk factor for cardiac
.
Although the guidelines in this document are applicable to both .. eventsinLQTS.623Unfortunately,littleisknownabouttheinfluence
.
sexes, there are some pertinent sex-based differences relative to .. of sex hormones on cardiac repolarization, except that androgens
.
exerciseandsportincluding:(i)theincidenceofSCDduringexercise; .. may shorten the QTc interval. Based on these considerations, we
.
.
(ii) quantitative differences in CV adaptation to regular intensive . recommendparticularcaution whenadvisingcompetitive sports in
. .
exerciseandtheoverlapwithcardiomyopathy;(iii)thepredilection . womenwithaprobableordefinitediagnosisofLQTS.
.
.
ofadverseeventswithspecificCVDsinwomen;and(iv)theadditive . Pregnancyisassociatedwitha50%increaseinplasmavolumeand
.
.
haemodynamiceffectsofexerciseinpregnantwomenwithastruc- . cardiac output. The stresses of exercise in pregnant women with
.
.
turallyabnormalheart. . structuralheartdiseasehavethepotentialtocausehaemodynamic
.
.
Current evidence suggests a significantly lower prevalence of . compromise. Moderate aerobic exercise is generally safe in all
.
.
exercise-relatedSCDinfemaleswhorepresentasmallminorityof . womenandisassociatedwithalowerprevalenceofexcessiveweight
.
.
athletesdyingsuddenlywithamaletofemaleratiorangingfrom3to .. gain, post-partum obesity, gestational diabetes, and pre-eclampsia.
.
10:1.17,18,46,49,52,620ThisdisproportionatelylowerincidenceofSCD .. Femaleathletesmaycontinuetrainingintensivelyduringpregnancy,
.
amongyoungcompetitivefemaleathletesalsoholdstrueforolder .. although it is recommended that women do not exceed a heart
.
recreationalathleteswheredeathsinmalesare20-foldgreaterthan .. rateof>90%ofthemaximumpredictedforagetoreducetherisk
.
infemales. .. offoetalbradycardia.Pregnantwomenwithknownstructuralheart
.
Apart from a lower incidence of exercise-related SCD, there .. disease require evaluation before embarking on intensive exercise
.
appeartobesexdifferencesrelatedtothediseasespredisposingto .. programmes.Exerciseor sports involvingforceful physicalcontact,
.
SCD. Unlike males, female athletes rarely succumb to SCD from . risk of falling or abdominal trauma, heavy lifting, scuba diving, and
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 59 ---
ESCGuidelines 75
.
exercising at high altitude in an unacclimatized state are not .. cardiovascularcomplicationsanddeathcomparedwithmen.Inthis
.
recommended. .. regardallwomenshouldbeincentivizedtoengageinregularPAand
.
Finally,femalesrepresentthelargestpopulationofobeseindividu- .. exercise programmes irrespective of age, ethnicity, and CV
.
alsworldwideandfemaleswithT2DMhaveahigherprevalenceof .. morbidities.
.
9. ‘What to do’ and ‘what not to do’ messages from the Guidelines
Recommendations:Whattodoandwhatnottodoforexerciseandsportsinhealthyindividuals Classa Levelb
Generalrecommendationsforexerciseandsportsinhealthyindividuals
Atleast150min/weekofmoderate-intensity,or75min/weekofvigorous-intensityaerobicexerciseoranequivalentcombination
I A
thereofisrecommendedinallhealthyadults.
Regularassessmentandcounsellingtopromoteadherenceand,ifnecessary,tosupportanincreaseinexercisevolumeovertimeare
I B
recommended.
Multiplesessionsofexercisespreadthroughouttheweek,i.e.on4(cid:2)5daysaweekandpreferablyeverydayoftheweek,are
I B
recommended.
Specialconsiderationsforindividualswithobesity,hypertension,dyslipidaemia,ordiabetes
Inobeseindividuals(BMI>_30kg/m2orawaistcircumference>80cmforfemalesor>94cmformales)resistancetraining>_3times
perweek,inadditiontomoderateorvigorousaerobicexercise(atleast30min,5(cid:2)7daysperweek)isrecommendedtoreduce I A
CVDrisk.
Inindividualswithwell-controlledhypertension,resistancetraining>_3timesperweekinadditiontomoderateorvigorousaerobic
I A
exercise(atleast30min,5(cid:2)7daysperweek)isrecommendedtoreducebloodpressureandCVDrisk.
Amongindividualswithdiabetesmellitus,resistancetraining>_3timesperweek)inadditiontomoderateorvigorousaerobicexercise
I A
(atleast30min,5(cid:2)7daysperweek)isrecommendedtoimproveinsulinsensitivityandachieveabetterCVDriskprofile.
Inindividualswithuncontrolledhypertension(SBP>160mmHg)high-intensityexerciseisnotrecommendeduntilBPhasbeen
III C
controlled.
Recommendationsforexerciseinageingindividuals
Amongadultsaged65yearsorolderwhoarefitandhavenohealthconditionsthatlimittheirmobility,moderate-intensityaerobic
I A
exerciseforatleast150min/weekisrecommended.
Inolderadultsatriskoffalls,strengthtrainingexercisestoimprovebalanceandcoordinationonatleast2daysaweekare
I B
recommended.
Recommendationsforexerciseinindividualswithcoronaryarterydisease
Recommendationsforexerciseinindividualswithlong-standingchroniccoronarysyndrome
Riskstratificationforexercise-inducedadverseeventsisrecommendedinindividualswithestablished(long-standing)CCSpriorto
I C
engaginginexercise.
Competitivesportsarenotrecommendedinindividualsathighriskofexercise-inducedadverseeventsorthosewithresidualischae-
III C
mia,withtheexceptionofindividuallyrecommendedskillsports.
Recommendationsforreturntoexerciseafteracutecoronarysyndrome
Exercise-basedcardiacrehabilitationisrecommendedinallindividualswithCADtoreducecardiacmortalityandrehospitalization. I A
Recommendationsforexerciseinyoungindividuals/athleteswithanomalousoriginsofcoronaryarteries
ParticipationinmostcompetitivesportswithamoderateandhighCVdemandamongindividualswithAOCAwithanacutelyangled
III C
take-offorananomalouscoursebetweenthelargevesselsisnotrecommended.
Recommendationsforexercise/sportsinindividualswithmyocardialbridging
Competitivesportsarenotrecommendedinindividualswithmyocardialbridgingandpersistentischaemiaorcomplexcardiac
III C
arrhythmiasduringmaximalexercisestresstesting.
Recommendationsforexerciseinchronicheartfailure
Recommendationsforexerciseprescriptioninheartfailurewithreducedormid-rangeejectionfraction
Regulardiscussionaboutexerciseparticipationandprovisionofanindividualizedexerciseprescriptionisrecommendedinallindivid-
I A
ualswithHF.
Exercise-basedcardiacrehabilitationisrecommendedinallstableindividualstoimproveexercisecapacityandqualityoflifeandto
I A
reducethefrequencyofhospitalreadmission.
Continued
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 60 ---
76 ESCGuidelines
Recommendationsforparticipationinsportsinheartfailure
Beforeconsideringasportactivity,apreliminaryoptimizationofHFriskfactorcontrolandtherapy,includingdeviceimplantation(if
I C
appropriate),isrecommended.
High-intensitypowerandendurancesportsarenotrecommendedinpatientswithHFrEFirrespectiveofsymptoms. III C
Recommendationsforexerciseandparticipationinsportsinindividualswithheartfailureandpreservedejectionfraction
Moderateenduranceanddynamicresistanceexercise,togetherwithlifestyleinterventionandoptimaltreatmentofCVriskfactors
I C
(i.e.arterialhypertensionandtype2diabetes)arerecommended.
Recommendationsforexerciseandparticipationinsportsinindividualswithhearttransplantrecipients
Regularexercisethroughcardiacrehabilitationcombiningmoderate-intensityaerobicandresistanceexerciseisrecommendedto
revertpathophysiologytopre-transplantationtime,reduceCVriskinducedbypost-transplantationmedicaltreatment,andimprove I B
clinicaloutcome.
Recommendationsforexerciseinasymptomaticindividualswithvalvularheartdisease
Participationincompetitiveorrecreationalsports/exerciseofmoderateandhighintensityisnotrecommendedinindividualswith
III C
severeaorticstenosis.
Participationincompetitiveorrecreationalsports/exerciseofmoderateandhighintensityisnotrecommendedinindividualswith
III C
severeaorticregurgitationwithLVEF<_50%and/orexercise-inducedarrhythmias.
ParticipationincompetitivesportsisnotrecommendedinindividualswithseveremitralregurgitationwithaLVEF<60%. III C
Participationinanycompetitivesport,orleisuresports/exerciseofmildtomoderateintensity,isnotrecommendedinindividuals
III C
withsevere(MVA<1cm2)mitralstenosis.
Recommendationsforexerciseinindividualswithaorticpathology
Priortoengaginginexercise,riskstratification,withcarefulassessmentincludingadvancedimagingoftheaorta(CT/CMR)andexer-
I A
cisetestingwithBPassessment,isrecommended.
Competitivesportsarenotrecommendedinindividualswhoareathighrisk(Table14). III C
Recommendationsforexerciseinindividualswithcardiomyopathy
Generalrecommendation
Annualassessmentforriskstratificationisrecommendedinallindividualswithcardiomyopathywhoexerciseregularly. I C
Recommendationsforexerciseandsportsparticipationinindividualswithhypertrophiccardiomyopathy
Participationinhigh-intensityexercise(includingrecreationalandcompetitivesports)isnotrecommendedinindividualswhohave
ANYmarkersofincreasedrisk[(i)cardiacsymptomsorhistoryofcardiacarrestorunexplainedsyncope;(ii)moderateESCrisk
III C
score(>_4%)at5years;(iii)LVOTgradientatrest>30mmHg;(iv)abnormalBPresponsetoexercise;(v)exercise-induced
arrhythmias].
Recommendationsforexerciseandsportsparticipationinindividualswitharrhythmogeniccardiomyopathy
Participationinhigh-intensityrecreationalexercise/sportsoranycompetitivesportsisnotrecommendedinindividualswithACM
III C
includingthosewhoaregenotypepositiveandphenotypenegative.
Recommendationsforexerciseandsportsparticipationinindividualswithleftventricularnon-compactioncardiomyopathy
Participationinhigh-intensityexerciseorcompetitivesportsisnotrecommendedinindividualswithsymptoms,LVEF<40%and/or
III C
frequentand/orcomplexVAsonambulatoryHoltermonitoringorexercisetesting.
Recommendationsforexerciseandsportsparticipationinindividualswithdilatedcardiomyopathy
Participationinhigh-orveryhigh-intensityexerciseincludingcompetitivesportsisnotrecommendedforindividualswithaDCMand
anyofthefollowing:(i)symptomsorhistoryofcardiacarrestorunexplainedsyncope;(ii)LVEF<45%;(iii)frequentand/orcomplex
III C
VAsonambulatoryHoltermonitoringorexercisetesting;(iv)extensiveLGE(>20%)onCMR;or(v)high-riskgenotype(laminA/C
orfilaminC).
Recommendationsforexerciseinindividualswithmyocarditisandpericarditis
Comprehensiveevaluation,usingimagingstudies,exercisestresstest,andHoltermonitoring,isrecommendedfollowingrecovery
I B
fromacutemyocarditistoassesstheriskofexercise-relatedSCD.
Returntoallformsofexerciseincludingcompetitivesportsisrecommendedafter30daysto3monthsofrestforindividualswho
I C
haverecoveredcompletelyfromacutepericarditis,dependingonclinicalseverity.
Amongindividualswithaprobableordefinitivediagnosisofrecentmyocarditisorpericarditis,participationinleisure-timeorcom-
III C
petitivesportswhileactiveinflammationispresentisnotrecommended.
Participationinmoderate-tohigh-intensityexerciseforaperiodof3(cid:2)6monthsafteracutemyocarditisisnotrecommended. III B
Participationinmoderate-tohigh-intensityexercise,includingcompetitivesports,isnotrecommendedforindividualswithconstric-
III C
tivepericarditis.
Continued
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 61 ---
ESCGuidelines 77
Recommendationsforexerciseinindividualswitharrhythmiasandimplantablecardiacdevices
Exerciserecommendationsinindividualswithatrialfibrillation
RegularphysicalactivityisrecommendedtopreventAF. I A
Evaluationandmanagementofstructuralheartdisease,thyroiddysfunction,alcoholordrugabuse,orotherprimarycausesofAFis
I A
recommendedbeforeengaginginsports.
AFablationisrecommendedinexercisingindividualswithrecurrent,symptomaticAFand/orinthosewhodonotwantdrugtherapy,
I B
givenitsimpactonathleticperformance.
SportswithdirectbodilycontactorpronetotraumaarenotrecommendedinexercisingindividualswithAFwhoareanticoagulated. III C
Recommendationsforexerciseandsportsparticipationinindividualswithparoxysmalsupraventriculartachycardiaandpre-excitation
Inindividualswithpalpitations,acomprehensiveassessmenttoexclude(latent)pre-excitation,structuralheartdisease,andVAsis
I B
recommended.
Ablationoftheaccessorypathwayisrecommendedincompetitiveandrecreationalathleteswithpre-excitationanddocumented
I C
arrhythmias.
Incompetitive/professionalathleteswithasymptomaticpre-excitation,anEPstudyisrecommendedtoevaluatetheriskforsudden
I B
death.
Exerciserecommendationsinindividualswithprematureventricularcontractionsornon-sustainedventriculartachycardia
Inexercisingindividualswith>_2PVCsonabaselineECG(or>_1PVCincaseofhigh-enduranceathletes)athoroughevaluation I C
(includingadetailedfamilyhistory)toexcludeunderlyingstructuralorarrhythmogenicconditionsisrecommended.
AmongindividualswithfrequentPVCsandnon-sustainedVTathoroughinvestigationwithHoltermonitoring,12-leadECG,exercise
I C
test,andsuitableimagingisrecommended.
ExerciserecommendationsinlongQTsyndrome
ItisrecommendedthatallexercisingindividualswithLQTSwithpriorsymptomsorprolongedQTcbeontherapywithbeta-block-
I B
ersattargetdose.
ItisrecommendedthatexercisingindividualswithLQTSshouldavoidQT-prolongingdrugs(www.crediblemeds.org)andelectrolyte
I B
imbalancesuchashypokalaemiaandhypomagnesaemia.
Participationinhigh-intensityrecreationalandcompetitivesports,evenwhenonbeta-blockers,isnotrecommendedinindividuals
III B
withaQTc>500msorageneticallyconfirmedLQTSwithaQTc>_470msinmalesor>_480msinfemales.
Participationincompetitivesports(withorwithoutICD)isnotrecommendedinindividualswithLQTSandpriorcardiacarrestor
III C
arrhythmicsyncope.
ExerciserecommendationsinBrugadasyndrome
ICDimplantationisrecommendedinpatientswithBrSwithepisodesofarrhythmicsyncopeand/orabortedSCD. I C
PrescriptionofdrugsthatmayaggravateBrS,electrolyteabnormalities,andsportspracticesthatincreasecoretemperature>39(cid:4)C
III C
arenotrecommendedinindividualswithovertBrSorphenotypicallynegativemutationcarriers.
Exerciserecommendationsinindividualswithimplantablecardiacelectronicdevices
Itisrecommendedthatindividualswithimplanteddeviceswith/withoutresynchronizationandunderlyingdiseasefollowtherecom-
I B
mendationspertainingtotheunderlyingdisease.
AnICDisnotrecommendedasasubstitutefordisease-relatedrecommendationswhenthesemandatesportsrestrictions. III C
Recommendationsforpatientswithcongenitalheartdisease
ParticipationinregularmoderateexerciseisrecommendedinallindividualswithCHD. I B
AdiscussiononexerciseparticipationandprovisionofanindividualizedexerciseprescriptionisrecommendedateveryCHDpatient
I B
encounter.
CompetitivesportisnotrecommendedforindividualswithCHDwhoareinNYHAclassIII(cid:2)IVorwithpotentiallyserious
III C
arrhythmias.
Recommendationsforexerciseinpregnancy
Amongpregnantwomenwithoutmedicalorobstetriccontraindications,participationinatleast150min/weekofmoderate-intensity
I B
aerobicexercisebefore,during,andafterpregnancyisrecommended.
Re-evaluationbeforecontinuingexerciseortrainingisrecommendedinpregnantwomaniftheyexperienceexcessiveshortnessof
I A
breath,severechestpain,dizzinessorsyncope,regularpainfulcontractions,vaginalbleeding,oramnioticfluidleakage.
AmongwomenwithCVDwhowerehabituallyengagedinstrengthtrainingorpowersportdisciplinesbeforepregnancy,discussing
I A
theoptionwiththemedicalteambeforecontinuingandavoidingtheValsalvamanoeuvreisrecommended.
Exerciseorsportinvolvingforcefulphysicalcontact,riskoffallingorabdominaltrauma,heavylifting,scubadiving,orexercisingat
III C
highaltitudewhenunacclimatizedarenotrecommended.
Continued
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 62 ---
78 ESCGuidelines
Vigorousexerciseassociatedwithamaximalpredictedheartrate>90%ofthepredictedheartrateisnotrecommendedduring
III B
pregnancy.
Exercisingwhilelyingsupineonahardsurfaceisnotrecommendedafterthefirsttrimesterduetotheriskofdecreasedvenous
III B
returnanduterinebloodflow.
Recommendationsforexerciseinchronickidneydisease
Low-tomoderate-intensityaerobicexercisetraining(upto150min/week),andlow-tomoderate-intensityresistanceexercisetrain-
I A
ing(2dayperweek,8(cid:2)12exercises,12(cid:2)15repetitions),andflexibilityexercisesarerecommendedinallindividualswithCKD.
Amongpatientswithestablishedosteodystrophy/osteoporosis,orcoagulopathies,participationincontactsportsisnot
III C
recommended.
Participationinsportisnotrecommendedinthefollowingcircumstances:electrolyteabnormalities,recentchangestotheECG,
excessinter-dialysisweightgain,changingortitrationofmedicationregimen,pulmonarycongestion,andincreasingperipheral III C
oedema.
Recommendationsforexerciseinindividualswithcancer
Regularexerciseduringandaftercancertherapyisrecommendedtoreducecancer-relatedfatigue,andimprovequalityoflife,physi-
I A
calfitness,andprognosis.
Amongindividualstreatedwithcardiotoxicmedications,echocardiographybeforeparticipationinhigh-intensityexerciseis
I A
recommended.
Recommendationsforexerciseinindividualswithspinalcordinjury
Inadultswithspinalcordinjuryparticipationin20minofmoderate-tovigorous-intensityaerobicexerciseatleast3timesaweek,
alongwithmoderate-intensityresistancetraining2(cid:2)3timesperweek,isrecommendedforcardiorespiratoryfitness,cardiometabolic I A
health,andmusclestrengthbenefits.
Artificialmethodsofinducingautonomicdysreflexiabycausingintentionalpaintothelowerhalfofthebody(‘boosting’)through
obstructionofanindwellingurinarycatheter,overlytightlegstrapsandelectricalshocksorothermethodsofpaintothegenitaliaor III C
lowerlimbscanbelife-threateningandarenotrecommended.
Recommendationsforexerciseinindividualswithventricularassistdevices
Regularexercise,throughcardiacrehabilitation,combiningmoderate-intensityaerobicandresistanceexercise,isrecommendedin
I A
individualswithaventricularassistdevice(VAD).
SportsthatmaypotentiallyaffectanyoftheVADcomponents(e.g.withbodycontact)arenotrecommended. III C
Physicalactivityandsportsrecommendationsinpatientsandathleteswithperipheralarterialdisease
ItisrecommendedthatpatientswithatheroscleroticPADperformregularexercise(atleast150min/weekofmoderateaerobic
I A
exerciseor75min/weekofvigorousaerobicexerciseoracombinationthereof)aspartofthesecondarypreventionstrategy.
InpatientswithsymptomaticLEAD,supervisedexercisetrainingprogrammesincludingwalkingtothemaximalorsubmaximaldis-
I A
tanceforatleast3h/weekareindicated.
Continuationofcompetitivesportsisrecommendedinathleteswithtraumaticornon-traumaticPADfollowingrecoveryaftersuc-
I C
cessfulopensurgeryorpercutaneousrevascularization.
ACM=arrhythmogeniccardiomyopathy;AF=atrialfibrillation;AOCA=anomalousoriginofcoronaryarteries;BP=bloodpressure;BMI=bodymassindex;BrS=Brugada
syndrome;CAD=coronaryarterydisease;CCS=chroniccoronarysyndrome;CHD=congenitalheartdisease;CKD=chronickidneydisease;CMR,cardiovascularmagnetic
resonance;CT=computedtomography;CV=cardiovascular;CVD=cardiovasculardisease;EEG=electrocardiogram;EP=electrophysiological;ESC=EuropeanSocietyof
Cardiology;EP=electrophysiological;HF=heartfailure;HFrEF=heartfailurewithreducedejectionfraction;ICD=implantablecardioverterdefibrillator;LEAD=lower
extremityarterydisease;LQTS=longQTsyndrome;LVEF=leftventricularejectionfraction;LVOT=leftventricularoutflowtract;MVA=mitralvalvearea;NYHA=New
YorkHeartAssociation;PAD=peripheralarterialdisease;PVC=prematureventricularcontractions;SCD=suddencardiacdeath;SBP=systolicbloodpressure;VA=ven-
triculararrhythmia;VAD=ventricularassistdevice;VT=ventriculartachycardia.
aClassofrecommendation.
bLevelofevidence.
.
10. Supplementary data ... 11. Appendix
.
.
.
.
SupplementaryDatawithadditionalSupplementaryFigures,Tables, .. Author/TaskForceMemberAffiliations:SabihaGati,Faculty
.
andtextcomplementingthefulltextareavailableontheEuropean .. of Medicine, National Heart & Lung Institute, Imperial College,
.
HeartJournalwebsiteandviatheESCwebsiteatwww.escardio.org/ .. London, United Kingdom and Cardiology, Royal Brompton &
.
guidelines. . HarefieldHospitalNHSFoundationTrust,London,UnitedKingdom;
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 63 ---
ESCGuidelines 79
.
Maria Ba€ck, Unit of Physiotherapy, Department of Health, .. (Switzerland), Steffen E. Petersen (United Kingdom), Anna Sonia
.
.
Medicine and Caring Sciences, Linko¨ping University, Linko¨ping, . Petronio (Italy), Dimitrios J. Richter (Greece), Marco Roffi
.
.
Sweden, and Department of Molecular and Clinical Medicine, . (Switzerland), Evgeny Shlyakhto (Russian Federation), Iain A.
.
.
Institute of Medicine, Sahlgrenska Academy, University of . Simpson(UnitedKingdom),MiguelSousa-Uva(Portugal),andRhian
.
.
Gothenburg, and Sahlgrenska University Hospital, Gothenburg, . M.Touyz(UnitedKingdom).
.
.
Sweden; Mats Bo¨rjesson, Department of Molecular and Clinical .
.
.
Medicine,InstituteofMedicine,SahlgrenskaAcademy,Universityof . ESCNationalCardiacSocietiesactivelyinvolvedinthereview
.
.
Gothenburg, and Sahlgrenska University Hospital, Gothenburg, . process of the 2020 ESC Guidelines on Sports Cardiology and
.
.
Sweden, and Center for Health and Performance, Department of .. ExerciseinPatientswithCardiovascularDisease:Algeria:Algerian
.
Food, Nutrition and Sports Science, Gothenburg University, .. Society of Cardiology, Mohamed Tahmi; Armenia: Armenian
.
Gothenburg, Sweden; Stefano Caselli, Cardiovascular Center .. CardiologistsAssociation,ParounakH.Zelveian;Austria:Austrian
.
Zurich, Hirslanden Klinik im Park, Zurich, Switzerland; Jean- .. Society of Cardiology, Thomas Berger; Azerbaijan: Azerbaijan
.
Philippe Collet, Sorbonne Universite´, Institut de Cardiologie, .. Society of Cardiology, Rahima Gabulova; Belarus: Belorussian
.
Hoˆpital Pitie´-Salp^etrie`re (APHP), Paris, France; Domenico .. Scientific Society of Cardiologists, Svetlana Sudzhaeva; Belgium:
.
Corrado, Cardiac, Thoracic and Vascular Sciences, University of .. Belgian Society of Cardiology, Patrizio Lancellotti; Bosnia and
.
Padova, Padova, Italy; Jonathan A. Drezner, University of .. Herzegovina: Association of Cardiologists of Bosnia and
.
Washington, Seattle, United States of America; Martin Halle, .. Herzegovina, (cid:2)Sekib Sokolovi(cid:3)c; Bulgaria: Bulgarian Society of
.
PreventionandSportsMedicine,KlinikumrechtsderIsar,Technical .. Cardiology,IvanGruev;Croatia:CroatianCardiacSociety,Vedran
. University of Munich, Munich, Germany; Dominique Hansen, .. Velagic;Cyprus:CyprusSocietyofCardiology,EvagorasNicolaides;
.
Hasselt University, BIOMED/REVAL/Heart Centre Hasselt, Jessa .. Czech Republic: Czech Society of Cardiology, Vladimir Tuka;
.
.
Hospital, Hasselt, Belgium; Hein Heidbuchel, Cardiology, . Denmark:DanishSocietyofCardiology,HanneRasmusen;Egypt:
.
.
University Hospital Antwerp and Antwerp University, Antwerp, . Egyptian Society of Cardiology, Hazem Khamis; Estonia: Estonian
.
.
Belgium; Jonathan Myers, Cardiology Division, VA Palo Alto . Society of Cardiology, Margus Viigimaa; Finland: Finnish Cardiac
.
.
HealthCareSystem,PaloAlto,California,UnitedStatesofAmerica . Society, Jari A. Laukkanen; France: French Society of Cardiology,
.
.
and Cardiology Division, Stanford University, Palo Alto, California, . Gilles Bosser; Germany: German Cardiac Society, Rainer
.
.
United States of America; Josef Niebauer, University Institute of . Hambrecht; Greece: Hellenic Society of Cardiology, Alexandros
.
.
Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical . Kasiakogias; Hungary: Hungarian Society of Cardiology, Be´la
.
.
University, Salzburg, Austria and Ludwig Boltzmann Institute for . Merkely; Iceland: Icelandic Society of Cardiology, Gunnar Thor
.
.
Digital Health and Prevention, Salzburg, Austria; Michael . Gunnarsson; Ireland: Irish Cardiac Society, Brendan McAdam;
.
.
Papadakis, Cardiology Clinical Academic Group, St George’s, . Israel:IsraelHeartSociety,AndreKeren;Italy:ItalianFederationof
.
.
University of London, London, United Kingdom; Massimo .. Cardiology, Pasquale Perrone-Filardi; Kosovo (Republic of):
.
Francesco Piepoli, Heart Failure Unit, Cardiology, Guglielmo da .. KosovoSocietyofCardiology,GaniBajraktari;Kyrgyzstan:Kyrgyz
.
Saliceto Hospital and University of Parma, Piacenza, Italy; Eva .. SocietyofCardiology,ErkinMirrakhimov;Latvia:LatvianSocietyof
.
Prescott, Department of Cardiology, Bispebjerg University .. Cardiology, Sandra Rozen(cid:2)stoka; Lithuania: Lithuanian Society of
.
Hospital, Copenhagen, Denmark; Jolien W. Roos-Hesselink, .. Cardiology, Germanas Marinskis; Luxembourg: Luxembourg
.
Department of Cardiology, Erasmus MC, Rotterdam, Netherlands; .. Society of Cardiology, Cristiana Banu; Malta: Maltese Cardiac
.
A.GrahamStuart,CongenitalHeartUnit,BristolHeartInstitute, .. Society,MarkAbela;Moldova(Republicof):MoldavianSocietyof
.
Bristol, United Kingdom; Rod S. Taylor, University of Glasgow, .. Cardiology,EleonoraVataman;Montenegro:MontenegroSociety
.
Glasgow,Scotland,UnitedKingdom;PaulD.Thompson,Division .. of Cardiology, Natasa Belada; Morocco: Moroccan Society of
.
of Cardiology, Hartford Hospital, Hartford, Connecticut, United .. Cardiology,HasnaaBelghiti;Netherlands:Netherlands Societyof
.
States of America; Monica Tiberi, Department of Health-Sport .. Cardiology, Harald Thune Jorstad; North Macedonia: North
.
Medicine, Azienda Unica Regionale Marche, Area Vasta 1, Pesaro, .. MacedonianSocietyofCardiology, Elizabeta SrbinovskaKostovska;
.
.
Italy; Luc Vanhees, Rehabilitation Sciences, Kuleuven, Leuven, . Norway: Norwegian Society of Cardiology, Kristina Haugaa;
. Belgium; and Matthias Wilhelm, Department of Cardiology, .. Poland: Polish Cardiac Society, Renata Gło(cid:3)wczy(cid:3)nska; Portugal:
.
.
Inselspital, University Hospital Bern, University of Bern, Bern, . Portuguese Society of Cardiology, Helder Dores; Romania:
.
.
Switzerland. . RomanianSocietyofCardiology,FlorinMitu;RussianFederation:
.
.
. RussianSocietyofCardiology,AndreySmolensky;SanMarino:San
.
.
ESC Committee for Practice Guidelines (CPG): Stephan . Marino Society of Cardiology, Marina Foscoli; Serbia: Cardiology
.
.
Windecker (Chairperson) (Switzerland), Victor Aboyans (France), . Society of Serbia, Ivana Nedeljkovic; Slovakia: Slovak Society of
.
.
Colin Baigent (United Kingdom), Jean-Philippe Collet (France), . Cardiology, Stefan Farsky; Slovenia: Slovenian Society of
.
.
Veronica Dean (France), Victoria Delgado (Netherlands), Donna . Cardiology, Zlatko Fras; Spain: Spanish Society of Cardiology,
.
.
Fitzsimons (United Kingdom), Chris P. Gale (United Kingdom), . Araceli Boraita; Sweden: Swedish Society of Cardiology, Peder
.
.
Diederick E. Grobbee (Netherlands), Sigrun Halvorsen (Norway), . So¨renssen; Switzerland: Swiss Society of Cardiology, Christian
.
.
Gerhard Hindricks (Germany), Bernard Iung (France), Peter Ju¨ni .. Schmied; Syrian Arab Republic: Syrian Cardiovascular
.
(Canada), Hugo A. Katus (Germany), Ulf Landmesser (Germany), .. Association, Walid Bsata; Tunisia: Tunisian Society of Cardiology
.
Christophe Leclercq (France), Maddalena Lettino (Italy), Basil S. .. and Cardio-Vascular Surgery, Lilia Zakhama; Turkey: Turkish
.
Lewis (Israel), Be´la Merkely (Hungary), Christian Mueller . Society of Cardiology, Mehmet Uzun; Ukraine: Ukrainian
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 64 ---
80 ESCGuidelines
.
.
Association of Cardiology, Elena Nesukay; United Kingdom of . FoundationforthePhysicalActivityGuidelinesforAmericans,2ndEdition.JPhys
.
Great Britain and Northern Ireland: British Cardiovascular .. ActHealth2018;1(cid:2)11.
.. 16. KyuHH,BachmanVF,AlexanderLT,MumfordJE,AfshinA,EstepK,Veerman
Society,DhruboRakhit. ..
JL, Delwiche K, Iannarone ML, Moyer ML, Cercy K, Vos T, Murray CJL,
.
.. ForouzanfarMH.Physicalactivityandriskofbreastcancer,coloncancer,diabe-
12. References
... tes,ischemicheartdisease,andischemicstrokeevents:systematic reviewand
. dose-responsemeta-analysisfortheGlobalBurdenofDiseaseStudy2013.BMJ
.
1. PellicciaA,FagardR,BjornstadHH,AnastassakisA,ArbustiniE,AssanelliD,Biffi .. 2016;354:i3857.
A,BorjessonM,CarreF,CorradoD,DeliseP,DorwarthU,HirthA,Heidbuchel .. 17. HarmonKG,AsifIM,MaleszewskiJJ,OwensDS,PrutkinJM,SalernoJC,Zigman
H,HoffmannE,MellwigKP,Panhuyzen-GoedkoopN,PisaniA,SolbergEE,van- .. ML,EllenbogenR,RaoAL,AckermanMJ,DreznerJA.Incidence,cause,andcom-
.
BuurenF,VanheesL,Blomstrom-LundqvistC,DeligiannisA,DugmoreD,Glikson . parativefrequencyofsuddencardiacdeathinnationalcollegiateathleticassocia-
.
M, HoffPI,HoffmannA,HoffmannE,Horstkotte D,NordrehaugJE,Oudhof J, .. tionathletes:adecadeinreview.Circulation2015;132:10(cid:2)19.
McKennaWJ,PencoM,PrioriS,ReybrouckT,SendenJ,SpataroA,ThieneG. .. 18. MaronBJ,DoererJJ,HaasTS,TierneyDM,MuellerFO.Suddendeathsinyoung
.
Recommendationsforcompetitivesportsparticipationinathleteswithcardiovas- . competitiveathletes:analysisof1866deathsintheUnitedStates,1980(cid:2)2006.
.
culardisease:aconsensusdocumentfromtheStudyGroupofSportsCardiology .. Circulation2009;119:1085(cid:2)1092.
oftheWorkingGroupofCardiacRehabilitationandExercisePhysiologyandthe .. 19. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity
WorkingGroupofMyocardialandPericardialDiseasesoftheEuropeanSociety .. enhance the risk of sudden death in adolescents and young adults? J Am Coll .
ofCardiology.EurHeartJ2005;26:1422(cid:2)1445. . Cardiol2003;42:1959(cid:2)1963.
.
2. BorjessonM,DellborgM.Exercisetestingpost-MI:stillworthwhileintheinter- .. 20. MaronBJ,FriedmanRA,KligfieldP,LevineBD,ViskinS,ChaitmanBR,OkinPM,
ventionalera.EurHeartJ2005;26:105(cid:2)106. .. SaulJP,SalbergL,VanHareGF,SolimanEZ,ChenJ,MatherneGP,BollingSF,
3. PellicciaA,SolbergEE,PapadakisM,Adami PE,BiffiA,CaselliS,LaGercheA, .. MittenMJ,CaplanA,BaladyGJ,ThompsonPD.Assessmentofthe12-leadelec-
.
Niebauer J, Pressler A, Schmied CM, Serratosa L, Halle M, Van Buuren F, . trocardiogram as a screening test for detection of cardiovascular disease in
. Borjesson M, Carre F, Panhuyzen-Goedkoop NM, Heidbuchel H, Olivotto I, .. healthygeneralpopulationsofyoungpeople(12(cid:2)25yearsofage):ascientific
CorradoD,SinagraG,SharmaS.Recommendationsforparticipationincompeti- .. statementfromtheAmericanHeartAssociationandtheAmericanCollegeof
.
tive and leisure time sport in athletes with cardiomyopathies, myocarditis, and . Cardiology.JAmCollCardiol2014;64:1479(cid:2)1514.
.
pericarditis:positionstatementoftheSportCardiologySectionoftheEuropean .. 21. Corrado D, Pelliccia A, Bjornstad HH, Vanhees L, Biffi A, Borjesson M,
AssociationofPreventiveCardiology(EAPC).EurHeartJ2019;40:19(cid:2)33. .. Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP,
4. Marijon E, Uy-Evanado A, Reinier K, Teodorescu C, Narayanan K, Jouven X, .. AssanelliD,DeliseP,van-BuurenF,AnastasakisA,HeidbuchelH,HoffmannE,
.
GunsonK,JuiJ,ChughSS.Suddencardiacarrestduringsportsactivityinmiddle . FagardR,PrioriSG,BassoC,ArbustiniE,Blomstrom-LundqvistC,McKennaWJ,
.
age.Circulation2015;131:1384(cid:2)1391. .. ThieneG.Cardiovascularpre-participationscreeningofyoungcompetitiveath-
5. ChughSS,WeissJB.Suddencardiacdeathintheolderathlete.JAmCollCardiol .. letesforpreventionofsuddendeath:proposalforacommonEuropeanproto-
2015;65:493(cid:2)502. .. col. Consensus statement of the Study Group of Sport Cardiology of the
.
6. PiepoliMF,HoesAW,AgewallS,AlbusC,BrotonsC,CatapanoAL,CooneyM- . Working Group of Cardiac Rehabilitation and Exercise Physiology and the
.
T,CorraU,CosynsB,DeatonC,GrahamI,HallMS,HobbsFDR,LochenM-L, .. WorkingGroupofMyocardialandPericardialDiseasesoftheEuropeanSociety
Lollgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, .. ofCardiology.EurHeartJ2005;26:516(cid:2)524.
.
SmuldersY,TiberiM,vanderWorpHB,vanDisI,VerschurenWMM,BinnoS. . 22. DreznerJA,O’ConnorFG,HarmonKG,FieldsKB,AsplundCA,AsifIM,Price
.
2016EuropeanGuidelinesoncardiovasculardiseasepreventioninclinicalprac- .. DE,DimeffRJ,BernhardtDT,RobertsWO.AMSSMpositionstatementoncar-
tice:theSixthJointTaskForceoftheEuropeanSocietyofCardiologyandOther .. diovascularpreparticipationscreeninginathletes:currentevidence, knowledge
Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J .. gaps,recommendationsandfuturedirections.BrJSportsMed2017;51:153(cid:2)167.
.
2016;37:2315(cid:2)2381. . 23. LjungqvistA,JenoureP,EngebretsenL,AlonsoJM,BahrR,CloughA,DeBondt
.
7. MandsagerK,HarbS,CremerP,PhelanD,NissenSE,JaberW.Associationof .. G,DvorakJ,MaloleyR,MathesonG,MeeuwisseW,MeijboomE,MountjoyM,
cardiorespiratoryfitnesswithlong-termmortalityamongadultsundergoingexer- .. Pelliccia A, Schwellnus M, Sprumont D, Schamasch P, Gauthier J-B, Dubi C,
.
cisetreadmilltesting.JAMANetwOpen2018;1:e183605. . Stupp H, Thill C. The International Olympic Committee (IOC) Consensus
.
8. Shiroma EJ, Lee I-M. Physical activity and cardiovascular health: lessons learned .. Statementonperiodichealthevaluationofeliteathletes,March2009.BrJSports
from epidemiological studies across age, gender, and race/ethnicity. Circulation .. Med2009;43:631(cid:2)643.
2010;122:743(cid:2)752. .. 24. Hainline B, Drezner JA, Baggish A, Harmon KG, Emery MS, Myerburg RJ,
.
9. RadfordNB,DeFinaLF,LeonardD,BarlowCE,WillisBL,GibbonsLW,Gilchrist . Sanchez E, Molossi S, Parsons JT, Thompson PD. Interassociation consensus
.
SC,KheraA,LevineBD.Cardiorespiratoryfitness,coronaryarterycalcium,and .. statement on cardiovascular care of college student-athletes. J Am Coll Cardiol
cardiovascular disease events in a cohort of generally healthy middle-age men: .. 2016;67:2981(cid:2)2995.
results from the Cooper Center Longitudinal Study. Circulation .. 25. PreparticipationPhysicalEvaluation,4thEdition[online].AmericanAcademyof
.
2018;137:1888(cid:2)1895. .. FamilyPhysiciansetaletal;2010.Availablefrom:https://ebooks.aappublications.
10. ShahRV,MurthyVL,ColangeloLA,ReisJ,VenkateshBA,SharmaR,AbbasiSA, .. org/content/9781581104882/9781581104882.
Goff DCJ, Carr JJ, Rana JS, Terry JG, Bouchard C, Sarzynski MA, Eisman A, .. 26. Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS.
.
NeilanT,DasS,Jerosch-HeroldM,LewisCE,CarnethonM,LewisGD,Lima . Eligibilityanddisqualificationrecommendationsforcompetitiveathleteswithcar-
.
JAC.Associationoffitnessinyoungadulthoodwithsurvivalandcardiovascular .. diovascularabnormalities:TaskForce2:Preparticipationscreeningforcardiovas-
risk:theCoronaryArteryRiskDevelopmentinYoungAdults(CARDIA)study. .. culardiseaseincompetitiveathletes:ascientificstatementfromtheAmerican
JAMAInternMed2016;176:87(cid:2)95. .. HeartAssociation.Circulation2015;132:e267(cid:2)72.
. 11. HussainN,GershBJ,GonzalezCartaK,SydoN,Lopez-JimenezF,KopeckySL, . 27. Peterson DF, Siebert DM, Kucera KL, Thomas LC, Maleszewski JJ, Lopez-
.
ThomasRJ,AsirvathamSJ,AllisonTG.Impactofcardiorespiratoryfitnessonfre- .. AndersonM,SuchslandMZ,HarmonKG,DreznerJA.Etiologyofsuddencardiac
quency of atrial fibrillation, stroke, and all-cause mortality. Am J Cardiol .. arrest and death in US competitive athletes: a 2-year prospective surveillance
.
2018;121:41(cid:2)49. . study. Clin J Sport Med; doi:10.1097/JSM.0000000000000598. Published online
.
12. Juraschek SP, Blaha MJ, Whelton SP, Blumenthal R, Jones SR, Keteyian SJ, .. aheadofprint,2018Apr9.
Schairer J, Brawner CA, Al-Mallah MH. Physical fitness and hypertension in a .. 28. Finocchiaro G, Papadakis M, Robertus J-L, Dhutia H, Steriotis AK, Tome M,
populationat riskforcardiovasculardisease:theHenryFord ExercIseTesting .. MellorG,MerghaniA,MalhotraA,BehrE,SharmaS,SheppardMN.Etiologyof
.
(FIT)Project.JAmHeartAssoc2014;3:e001268. . suddendeathinsports:insightsfromaUnitedKingdomregionalregistry.JAm
.
13. Juraschek SP, Blaha MJ, Blumenthal RS, Brawner C, Qureshi W, Keteyian SJ, .. CollCardiol2016;67:2108(cid:2)2115.
SchairerJ,EhrmanJK,Al-MallahMH.Cardiorespiratoryfitnessandincidentdia- .. 29. Eckart RE, Shry EA, Burke AP, McNear JA, Appel DA, Castillo-Rojas LM,
betes: the FIT (Henry Ford ExercIse Testing) Project. Diabetes Care .. AvedissianL,PearseLA,PotterRN,TremaineL,GentleskPJ,HufferL,ReichSS,
.
2015;38:1075(cid:2)1081. . StevensonWG.Suddendeathinyoungadults:anautopsy-basedseriesofapop-
.
14. VainshelboimB,MullerJ,LimaRM,NeadKT,ChesterC,ChanK,KokkinosP, .. ulationundergoingactivesurveillance.JAmCollCardiol2011;58:1254(cid:2)1261.
Myers J. Cardiorespiratory fitness and cancer incidence in men. Ann Epidemiol .. 30. Solberg EE, Borjesson M, Sharma S, Papadakis M, Wilhelm M, Drezner JA,
.
2017;27:442(cid:2)447. . HarmonKG,AlonsoJM,HeidbuchelH,DugmoreD,Panhuyzen-GoedkoopNM,
.
15. Powell KE, King AC, Buchner DM, Campbell WW, DiPietro L, Erickson KI, .. Mellwig K-P, Carre F, Rasmusen H, NiebauerJ, BehrER, Thiene G, Sheppard
HillmanCH,JakicicJM,JanzKF,KatzmarzykPT,KrausWE,MackoRF,Marquez .. MN,BassoC,CorradoD.Suddencardiacarrestinsports(cid:2)needforuniform
DX, McTiernan A, Pate RR, Pescatello LS, Whitt-Glover MC. The Scientific . registration:apositionpaperfromtheSportCardiologySectionoftheEuropean
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 65 ---
ESCGuidelines 81
.
.
AssociationforCardiovascularPreventionandRehabilitation.EurJPrevCardiol . 55. UllalAJ,AbdelfattahRS,AshleyEA,FroelicherVF.Hypertrophiccardiomyopathy
.
2016;23:657(cid:2)667. . as a cause of sudden cardiac death in the young: a meta-analysis. Am J Med
.
31. MaronBJ,ThompsonPD,AckermanMJ,BaladyG,BergerS,CohenD,DimeffR, .. 2016;129:486(cid:2)496.e2.
Douglas PS, Glover DW, Hutter AMJ, Krauss MD, Maron MS, Mitten MJ, .. 56. ThieneG,RizzoS,SchiavonM,MaronMS,ZorziA,CorradoD,MaronBJ,Basso
.
RobertsWO,PufferJC.Recommendationsandconsiderationsrelatedtoprepar- . C.Structurallynormalheartsareuncommonlyassociatedwithsuddendeathsin
.
ticipation screening for cardiovascular abnormalities in competitive athletes: .. athletesandyoungpeople.JAmCollCardiol2019;73:3031(cid:2)3032.
2007update:ascientificstatementfromtheAmericanHeartAssociationCouncilon .. 57. CorradoD,BassoC,PaveiA,MichieliP,SchiavonM,ThieneG.Trendsinsud-
.
Nutrition,PhysicalActivity,andMetabolism.Circulation2007;115:1455(cid:2)1643. . dencardiovasculardeathinyoungcompetitiveathletesafterimplementationofa
.
32. Drezner JA, Peterson DF, Siebert DM, Thomas LC, Lopez-Anderson M, . preparticipationscreeningprogram.JAMA2006;296:1593(cid:2)1601.
.
Suchsland MZ,Harmon KG, Kucera KL. Survival after exercise-related sudden .. 58. MalhotraA,DhutiaH,FinocchiaroG,GatiS,BeasleyI,CliftP,CowieC,Kenny
cardiacarrestinyoungathletes:canwedobetter?SportsHealth2019;11:91(cid:2)98. .. A,MayetJ,OxboroughD,PatelK,PielesG,RakhitD,RamsdaleD,ShapiroL,
.
33. McKinneyJ,VelgheJ,FeeJ,IsserowS,DreznerJA.Definingathletesandexer- . Somauroo J, Stuart G, Varnava A, Walsh J, Yousef Z, Tome M, Papadakis M,
.
cisers.AmJCardiol2019;123:532(cid:2)535. .. SharmaS.Outcomesofcardiacscreeninginadolescentsoccerplayers.NEnglJ
34. GiriS,ThompsonPD,KiernanFJ,CliveJ,FramDB,MitchelJF,HirstJA,McKay .. Med2018;379:524(cid:2)534.
.
RG, Waters DD. Clinical and angiographic characteristics of exertion-related . 59. Fuller CM, McNulty CM, Spring DA, Arger KM, Bruce SS, Chryssos BE,
.
acutemyocardialinfarction.JAMA1999;282:1731(cid:2)1736. . DrummerEM,KelleyFP,NewmarkMJ,WhippleGH.Prospectivescreeningof
.
35. ThompsonPD.Exerciseprescriptionandproscriptionforpatientswithcoronary .. 5,615highschoolathletesforriskofsuddencardiacdeath.MedSciSportsExerc
arterydisease.Circulation2005;112:2354(cid:2)2363. .. 1997;29:1131(cid:2)1138.
.
36. Marijon E, Uy-Evanado A, Dumas F, Karam N, Reinier K, Teodorescu C, . 60. Wilson MG, Basavarajaiah S, Whyte GP, Cox S, Loosemore M, Sharma S.
.
NarayananK,GunsonK,JuiJ,JouvenX,ChughSS.Warningsymptomsareasso- . Efficacyofpersonalsymptomandfamilyhistoryquestionnaireswhenscreening
.
ciatedwithsurvivalfromsuddencardiacarrest.AnnInternMed2016;164:23(cid:2)29. .. forinheritedcardiacpathologies:theroleofelectrocardiography.BrJSportsMed
37. NehmeZ,BernardS,AndrewE,CameronP,BrayJE,SmithK.Warningsymp- .. 2008;42:207(cid:2)211.
.
toms preceding out-of-hospital cardiac arrest: do patient delays matter? . 61. BessemB,GrootFP,NieuwlandW.TheLausannerecommendations:aDutch
.
Resuscitation2018;123:65(cid:2)70. .. experience.BrJSportsMed2009;43:708(cid:2)715.
38. KimJH,MalhotraR,ChiampasG,d’HemecourtP,TroyanosC,CiancaJ,Smith .. 62. Hevia AC, Fernandez MM, Palacio JMA, Martin EH, Castro MG, Reguero JJR.
.
RN,WangTJ,RobertsWO,ThompsonPD,BaggishAL.Cardiacarrestduring . ECG as a part of the preparticipation screening programme: an old and still
.
long-distancerunningraces.NEnglJMed2012;366:130(cid:2)140. . presentinternationaldilemma.BrJSportsMed2011;45:776(cid:2)779.
.
39. DreznerJA,RaoAL,HeistandJ,BloomingdaleMK,HarmonKG.Effectivenessof .. 63. Baggish AL, Hutter AMJ, Wang F, Yared K, Weiner RB, Kupperman E, Picard
emergency response planning for sudden cardiac arrest in United States high .. MH, Wood MJ. Cardiovascular screening in college athletes with and without
.
schoolswithautomatedexternaldefibrillators.Circulation2009;120:518(cid:2)525. . electrocardiography:across-sectionalstudy.AnnInternMed2010;152:269(cid:2)275.
.
40. RobertsWO,StovitzSD.IncidenceofsuddencardiacdeathinMinnesotahigh . 64. FudgeJ,HarmonKG,OwensDS,PrutkinJM,SalernoJC,AsifIM,HarutaA,Pelto
.
schoolathletes1993(cid:2)2012screenedwithastandardizedpre-participationeval- .. H,RaoAL,ToresdahlBG,DreznerJA.Cardiovascularscreeninginadolescents
.
uation.JAmCollCardiol2013;62:1298(cid:2)1301. . andyoungadults:aprospectivestudycomparingthePre-participationPhysical
.
41. HarmonKG,AsifIM,KlossnerD,DreznerJA.Incidenceofsuddencardiacdeath . Evaluation Monograph 4th Edition and ECG. Br J Sports Med
.
in National Collegiate Athletic Association athletes. Circulation .. 2014;48:1172(cid:2)1178.
2011;123:1594(cid:2)1600. .. 65. DreznerJA,PrutkinJM,HarmonKG,O’KaneJW,PeltoHF,RaoAL,Hassebrock
.
42. Holst AG, Winkel BG, Theilade J, Kristensen IB, Thomsen JL, Ottesen GL, . JD, Petek BJ, Teteak C, Timonen M, Zigman M, Owens DS. Cardiovascular
.
Svendsen JH, Haunso S, Prescott E, Tfelt-Hansen J. Incidence and etiology of . screeningincollegeathletes.JAmCollCardiol2015;65:2353(cid:2)2355.
.
sports-relatedsuddencardiacdeathinDenmark(cid:2)implicationsforpreparticipa- .. 66. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE.
tionscreening.HeartRhythm2010;7:1365(cid:2)1371. .. Triggeringofacutemyocardialinfarctionbyheavyphysicalexertion.Protection
.
43. RisgaardB,WinkelBG,JabbariR,GlingeC,Ingemann-HansenO,ThomsenJL, . against triggering by regular exertion. Determinants of Myocardial Infarction
.
OttesenGL,HaunsoS,HolstAG,Tfelt-HansenJ.Sports-relatedsuddencardiac .. OnsetStudyInvestigators.NEnglJMed1993;329:1677(cid:2)1683.
deathinacompetitiveandanoncompetitiveathletepopulationaged12to49 .. 67. SiscovickDS,WeissNS,FletcherRH,LaskyT.Theincidenceofprimarycardiac
.
years: data from an unselected nationwide study in Denmark. Heart Rhythm . arrestduringvigorousexercise.NEnglJMed1984;311:874(cid:2)877.
.
2014;11:1673(cid:2)1681. . 68. Waller BF, Roberts WC. Sudden death while running in conditioned runners
.
44. RisgaardB,Tfelt-HansenJ,WinkelBG.Sports-relatedsuddencardiacdeath:how .. aged40yearsorover.AmJCardiol1980;45:1292(cid:2)1300.
to prove an effect of preparticipation screening? Heart Rhythm .. 69. Noakes TD, Opie LH, Rose AG, Kleynhans PH, Schepers NJ, Dowdeswell R.
.
2016;13:1560(cid:2)1562. . Autopsy-proved coronary atherosclerosis in marathon runners. N Engl J Med .
45. Drezner JA, Harmon KG, Marek JC. Incidence of sudden cardiac arrest in . 1979;301:86(cid:2)89.
. Minnesotahighschoolstudentathletes:thelimitationsofcatastrophicinsurance .. 70. MarijonE,TaffletM,CelermajerDS,DumasF,PerierM-C,MustaficH,Toussaint
claims.JAmCollCardiol2014;63:1455(cid:2)1456. .. J-F, Desnos M, Rieu M, Benameur N, Le Heuzey J-Y, Empana J-P, Jouven X.
.
46. Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S. Incidence and . Sports-related sudden death in the general population. Circulation
.
causes of sudden death in U.S. college athletes. J Am Coll Cardiol .. 2011;124:672(cid:2)681.
2014;63:1636(cid:2)1643. .. 71. MaronBJ,ZipesDP,KovacsRJ.Eligibilityanddisqualificationrecommendations
.
47. Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during . forcompetitiveathleteswithcardiovascularabnormalities:preamble,principles,
.
competitivesportsactivitiesinMinnesotahighschoolathletes.JAmCollCardiol . and general considerations: a scientific statement from the American Heart
.
1998;32:1881(cid:2)1884. .. Association and American College of Cardiology. J Am Coll Cardiol
48. Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG. Nontraumatic .. 2015;66:2343(cid:2)2349.
.
sports death in high school and college athletes. Med Sci Sports Exerc . 72. ZeltserI,CannonB,SilvanaL,FenrichA,GeorgeJ,SchleiferJ,GarciaM,Barnes
.
1995;27:641(cid:2)647. .. A,RivenesS,PattH,RodgersG,ScottW.Lessonslearnedfrompreparticipation
49. MaronBJ,HaasTS,AhluwaliaA,Rutten-RamosSC.Incidenceofcardiovascular .. cardiovascular screening in a state funded program. Am J Cardiol
.
sudden deaths in Minnesota high school athletes. Heart Rhythm . 2012;110:902(cid:2)908.
.
2013;10:374(cid:2)377. . 73. Dunn TP, Pickham D, Aggarwal S, Saini D, Kumar N, Wheeler MT, Perez M,
.
50. Harmon K, Asif I, Ellenbogen R, Drezner J. The incidence of sudden cardiac .. AshleyE,FroelicherVF.LimitationsofcurrentAHAguidelinesandproposalof
arrestanddeathinUnitedStateshighschoolathletes.BrJSportsMed[Internet] .. newguidelinesforthepreparticipationexaminationofathletes.ClinJSportMed
.
2014;48:605. . 2015;25:472(cid:2)477.
.
51. ToresdahlBG,RaoAL,HarmonKG,DreznerJA.Incidenceofsuddencardiac . 74. DreznerJA,OwensDS,PrutkinJM,SalernoJC,HarmonKG,ProsiseS,ClarkA,
.
arrest in high school student athletes on school campus. Heart Rhythm .. AsifIM.Electrocardiographicscreeninginnationalcollegiateathleticassociation
2014;11:1190(cid:2)1194. .. athletes.AmJCardiol2016;118:754(cid:2)759.
.
52. MaronBJ.Suddendeathinyoungathletes.NEnglJMed2003;349:1064(cid:2)1075. . 75.WilliamsEA,PeltoHF,ToresdahlBG,PrutkinJM,OwensDS,SalernoJC,Harmon
.
53. de Noronha SV, Sharma S, Papadakis M, Desai S, Whyte G, Sheppard MN. .. KG,DreznerJA.PerformanceoftheAmericanHeartAssociation(AHA)14-point
AetiologyofsuddencardiacdeathinathletesintheUnitedKingdom:apatholog- .. evaluation versus electrocardiography for the cardiovascular screening of high
.
icalstudy.Heart2009;95:1409(cid:2)1414. . schoolathletes:aprospectivestudy.JAmHeartAssoc2019;8:e012235.
.
54. Suarez-MierMP,AguileraB,MosqueraRM,Sanchez-de-LeonMS.Pathologyof . 76. Price DE, McWilliams A, Asif IM, Martin A, Elliott SD, Dulin M, Drezner JA.
.
sudden death during recreational sports in Spain. Forensic Sci Int .. Electrocardiography-inclusivescreeningstrategiesfordetectionofcardiovascular
2013;226:188(cid:2)196. . abnormalitiesinhighschoolathletes.HeartRhythm2014;11:442(cid:2)449.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 66 ---
82 ESCGuidelines
.
.
77. RizzoM,SpataroA,CecchetelliC,QuarantaF,LivrieriS,SperandiiF,CifraB, . 96. ThomaesT,ThomisM,OnkelinxS,GoetschalckxK,FagardR,LambrechtsD,
.
BorrioneP,PigozziF.Structuralcardiacdiseasediagnosedbyechocardiography . VanheesL.Geneticpredispositionscoresassociatewithmuscularstrength,size,
.
in asymptomatic young male soccer players: implications for pre-participation .. andtrainability.MedSciSportsExerc2013;45:1451(cid:2)1459.
screening.BrJSportsMed2012;46:371(cid:2)373. .. 97. GibsonOR,TaylorL,WattPW,MaxwellNS.Cross-adaptation:heatandcold
.
78. FletcherGF,AdesPA,KligfieldP,ArenaR,BaladyGJ,BittnerVA,CokeLA,Fleg . adaptation to improve physiological and cellular responses to hypoxia. Sports
.
JL, Forman DE, Gerber TC, Gulati M, Madan K, Rhodes J, Thompson PD, .. Med2017;47:1751(cid:2)1768.
WilliamsMA.Exercisestandardsfortestingandtraining:ascientificstatement .. 98. TjonnaAE,LeeSJ,RognmoO,StolenTO,ByeA,HaramPM,LoennechenJP,Al-
.
fromtheAmericanHeartAssociation.Circulation2013;128:873(cid:2)934. . ShareQY,SkogvollE,SlordahlSA,KemiOJ,NajjarSM,WisloffU.Aerobicinter-
.
79. Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A, . valtrainingversuscontinuousmoderateexerciseasatreatmentforthemeta-
.
McArthurD,Froelicher V.Exercise-inducedSTdepressioninthediagnosisof .. bolicsyndrome:apilotstudy.Circulation2008;118:346(cid:2)354.
coronaryarterydisease.Ameta-analysis.Circulation1989;80:87(cid:2)98. .. 99. ArenaR,MyersJ,FormanDE,LavieCJ,GuazziM.Shouldhigh-intensity-aerobic
.
80. CorradoD,SchmiedC,BassoC,BorjessonM,SchiavonM,PellicciaA,Vanhees . interval training become the clinical standard in heart failure? Heart Fail Rev
.
L,ThieneG.Riskofsports:doweneedapre-participationscreeningforcom- .. 2013;18:95(cid:2)105.
petitiveandleisureathletes?EurHeartJ2011;32:934(cid:2)944. .. 100.MacDonaldMJ,CurrieKD.Intervalexerciseisapathtogoodhealth,buthow
.
81. MontL,PellicciaA,SharmaS,BiffiA,BorjessonM,BrugadaTerradellasJ,Carre . much,howoftenandforwhom?ClinSci(Lond)2009;116:315(cid:2)316.
.
F,GuaschE,HeidbuchelH,LaGercheA,LampertR,McKennaW,PapadakisM, . 101.Helgerud J, Hoydal K, Wang E, Karlsen T, Berg P, Bjerkaas M, Simonsen T,
.
Priori SG, Scanavacca M, Thompson P, Sticherling C, Viskin S, Wilson M, .. HelgesenC,HjorthN,BachR,HoffJ.Aerobichigh-intensityintervalsimprove
CorradoD,LipGY,GorenekB,BlomstromLundqvistC,MerkelyB,Hindricks .. VO2maxmorethanmoderatetraining.MedSciSportsExerc2007;39:665(cid:2)671.
.
G,Hernandez-MadridA,LaneD,BorianiG,NarasimhanC,MarquezMF,Haines . 102.RatamessNA,FalvoMJ,MangineGT,HoffmanJR,FaigenbaumAD,KangJ.The
.
D,MackallJ,ManuelMarques-VidalP,CorraU,HalleM,TiberiM,NiebauerJ, . effectofrestintervallengthonmetabolicresponsestothebenchpressexer-
.
PiepoliM.Pre-participationcardiovascularevaluationforathleticparticipantsto .. cise.EurJApplPhysiol2007;100:1(cid:2)17.
preventsuddendeath:positionpaperfromtheEHRAandtheEACPR,branches .. 103.GordonNF,KohlHW3rd,PollockML,VaandragerH,GibbonsLW,BlairSN.
.
oftheESC.EurJPrevCardiol2017;24:41(cid:2)69. . Cardiovascularsafetyofmaximalstrengthtestinginhealthyadults.AmJCardiol
.
82. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, .. 1995;76:851(cid:2)853.
FletcherGF,FormanDE,KitzmanDW,LavieCJ,MyersJ.EACPR/AHAscientific .. 104.ReynoldsJM,GordonTJ,RobergsRA.Predictionofonerepetitionmaximum
.
statement.Clinicalrecommendationsforcardiopulmonaryexercisetestingdata . strength from multiple repetition maximum testing and anthropometry. J
.
assessmentinspecificpatientpopulations.Circulation2012;126:2261(cid:2)2274. . StrengthCondRes2006;20:584(cid:2)592.
.
83. CaspersenCJ,PowellKE,ChristensonGM.Physicalactivity,exercise,andphysi- .. 105.Rhea MR, Alvar BA, Burkett LN. Single versus multiple sets for strength: a
calfitness:definitionsanddistinctionsforhealth-relatedresearch.PublicHealth .. meta-analysistoaddressthecontroversy.ResQExercSport2002;73:485(cid:2)488.
.
Rep1985;100:126(cid:2)131. . 106.PetersonMD,RheaMR,AlvarBA.Applicationsofthedose-responseformus-
.
84. VanheesL,DeSutterJ,GeladaSN,DoyleF,PrescottE,CornelissenV,KouidiE, . cularstrengthdevelopment:areviewofmeta-analyticefficacyandreliabilityfor
.
DugmoreD,VanuzzoD,BorjessonM,DohertyP.Importanceofcharacteristics .. designingtrainingprescription.JStrengthCondRes2005;19:950(cid:2)958.
.
andmodalitiesofphysicalactivityandexerciseindefiningthebenefitstocardio- . 107.WahidA,ManekN,NicholsM,KellyP,FosterC,RobertsN,ScarboroughP.
.
vascular health within the general population: recommendations from the . Quantifyingtheassociationbetweenphysicalactivityandcardiovasculardisease
.
EACPR.PartI.EurJPrevCardiol2012;19:670(cid:2)686. .. and diabetes: a systematic review and meta-analysis. J Am Heart Assoc
85. VanheesL,GeladasN,HansenD,KouidiE,NiebauerJ,ReinerZ,CornelissenV, .. 2016;5:e002495.
.
AdamopoulosS,PrescottE,BorjessonM,Bjarnason-WehrensB,BjornstadHH, . 108.Lear SA, Hu W, Rangarajan S, Gasevic D, Leong D, Iqbal R, Casanova A,
.
Cohen-Solal A, Conraads V, Corrado D, De Sutter J, Doherty P, Doyle F, . SwaminathanS,AnjanaRM,KumarR,RosengrenA,WeiL,YangW,Chuangshi
.
Dugmore D, Ellingsen O, Fagard R, Giada F, Gielen S, Hager A, Halle M, .. W,HuaxingL,NairS,DiazR,SwidonH,GuptaR,MohammadifardN,Lopez-
HeidbuchelH,JegierA,MazicS,McGeeH,MellwigKP,MendesM,MezzaniA, .. JaramilloP,OguzA,ZatonskaK,SeronP,AvezumA,PoirierP,TeoK,YusufS.
.
PattynN,PellicciaA,PiepoliM,RauchB,Schmidt-TrucksassA,TakkenT,van . The effect of physical activity on mortality and cardiovascular disease in130
.
BuurenF,VanuzzoD.Importance ofcharacteristicsandmodalitiesofphysical .. 000 people from 17 high-income, middle-income, and low-income countries:
activityandexerciseinthemanagement ofcardiovascularhealth inindividuals .. thePUREstudy.Lancet2017;390:2643(cid:2)2654.
.
withcardiovascularriskfactors:recommendationsfromtheEACPR.PartII.EurJ . 109.MachF,BaigentC,CatapanoAL,KoskinasKC,CasulaM,BadimonL,Chapman
.
PrevCardiol2012;19:1005(cid:2)1033. . MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A,
.
86. TjonnaAE,StolenTO,ByeA,VoldenM,SlordahlSA,OdegardR,SkogvollE, .. LandmesserU,MihaylovaB,PedersenTR,RiccardiG,RichterDJ,SabatineMS,
Wisloff U. Aerobic interval training reduces cardiovascular risk factors more .. Taskinen M-R, Tokgozoglu L, Wiklund O. 2019 ESC/EAS Guidelines for the
.
than a multitreatment approach in overweight adolescents. Clin Sci (Lond) . managementofdyslipidaemias:lipidmodificationtoreducecardiovascularrisk:The .
2009;116:317(cid:2)326. . TaskForceforthemanagementofdyslipidaemiasoftheEuropeanSocietyof
. 87. Schjerve IE, Tyldum GA, Tjonna AE, Stolen T, Loennechen JP, Hansen HEM, .. Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J
Haram PM, Heinrich G, Bye A, Najjar SM, Smith GL, Slordahl SA, Kemi OJ, .. 2020;41:111(cid:2)188.doi:10.1093/eurheartj/ehz455.
.
WisloffU.Bothaerobicenduranceandstrengthtrainingprogrammesimprove . 110.Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C,
.
cardiovascularhealthinobeseadults.ClinSci(Lond)2008;115:283(cid:2)293. .. PrescottE,StoreyRF,DeatonC,CuissetT,AgewallS,DicksteinK,Edvardsen
88. Shephard RJ, Balady, GJ. Exercise as cardiovascular therapy. Circulation .. T,EscanedJ,GershBJ,SvitilP,GilardM,HasdaiD,HatalaR,MahfoudF,Masip
.
1999;99:963(cid:2)972. . J,MunerettoC,ValgimigliM,AchenbachS,BaxJJ.2019ESCGuidelinesforthe
.
89. LavieCJ,ThomasRJ,SquiresRW,AllisonTG,MilaniRV.Exercisetrainingand . diagnosisandmanagementofchroniccoronarysyndromes:TheTaskForcefor
.
cardiacrehabilitationinprimaryandsecondarypreventionofcoronaryheartdis- .. thediagnosisandmanagementofchroniccoronarysyndromesoftheEuropean
ease.MayoClinProc2009;84:373(cid:2)383. .. SocietyofCardiology(ESC).EurHeartJ2020;41:407(cid:2)477.
.
90. Franckowiak SC, Dobrosielski DA, Reilley SM, Walston JD, Andersen RE. . 111.Braber TL,Halle NHJPM,Velthuis SSBK.Cardiacimagingtodetectcoronary
.
Maximalheartratepredictioninadultsthatareoverweightorobese.JStrength . arterydiseaseinathletesaged35yearsandolder.Ascopingreview.ScandJ
.
CondRes2011;25:1407(cid:2)1412. .. MedSciSports2018;1036(cid:2)1047.
.
91. VanheesL,StevensA.Exerciseintensity:amatterofmeasuringoroftalking?J . 112.DeFinaLF,RadfordNB,BarlowCE,WillisBL,LeonardD,HaskellWL,Farrell
.
CardiopulmRehabil2006;26:78(cid:2)79. . SW,PavlovicA,AbelK,BerryJD,KheraA,LevineBD.Associationofall-cause
.
92. MyersJ,HadleyD,OswaldU,BrunerK,KottmanW,HsuL,DubachP.Effects .. andcardiovascularmortalitywithhighlevelsofphysicalactivityandconcurrent
ofexercisetrainingonheartraterecoveryinpatientswithchronicheartfailure. .. coronaryarterycalcification.JAMACardiol2019;4:174.
.
AmHeartJ2007;153:1056(cid:2)1063. . 113.AremH,MooreSC,PatelA,HartgeP,BerringtondeGonzalezA,Visvanathan
.
93.TabetJ-Y,MeurinP,BenDrissA,ThabutG,WeberH,RenaudN,OdjinkemN, . K,CampbellPT,FreedmanM,WeiderpassE,AdamiHO,LinetMS,LeeI-M,
.
SolalAC.Determinationofexercisetrainingheartrateinpatientsonbeta-blockers .. Matthews CE. Leisure time physical activity and mortality: a detailed
aftermyocardialinfarction.EurJCardiovascPrevRehabil2006;13:538(cid:2)543. .. pooled analysis of the dose-response relationship. JAMA Intern Med
.
94. O’DonovanG,BlazevichAJ,BorehamC,CooperAR,CrankH,EkelundU,Fox . 2015;175:959(cid:2)967.
.
KR,GatelyP,Giles-CortiB,GillJMR,HamerM,McDermottI,MurphyM,Mutrie .. 114.LeeD-C,PateRR,LavieCJ,SuiX,ChurchTS,BlairSN.Leisure-timerunning
N,ReillyJJ,SaxtonJM,StamatakisE.TheABCofphysicalactivityforhealth:a .. reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol
.
consensus statement from the British Association of Sport and Exercise . 2014;64:472(cid:2)481.
.
Sciences.JSportsSci2010;28:573(cid:2)591. . 115.LollgenH,BockenhoffA,KnappG.Physicalactivityandall-causemortality:an
.
95. WarburtonDER,NicolCW,BredinSSD.Healthbenefitsofphysicalactivity:the .. updated meta-analysis with different intensity categories. Int J Sports Med
evidence.CMAJ2006;174:801(cid:2)809. . 2009;30:213(cid:2)224.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 67 ---
ESCGuidelines 83
.
.
116. Sattelmair J, Pertman J, Ding EL, Kohl HW 3rd, Haskell W, Lee I-M. Dose . Society of Hypertension (ESH) and of the European Society of Cardiology
.
responsebetweenphysicalactivityandriskofcoronaryheartdisease:ameta- . (ESC).EurHeartJ2013;34:2159(cid:2)2219.
.
analysis.Circulation2011;124:789(cid:2)795. .. 131.NiebauerJ,BorjessonM,CarreF,CaselliS,PalatiniP,QuattriniF,SerratosaL,
117. MooreSC,PatelAV,MatthewsCE,BerringtondeGonzalezA,ParkY,Katki .. AdamiPE,BiffiA,PresslerA,SchmiedC,vanBuurenF,Panhuyzen-Goedkoop
.
HA,LinetMS,WeiderpassE,VisvanathanK,HelzlsouerKJ,ThunM,Gapstur . N, Solberg E, Halle M, La Gerche A, Papadakis M, Sharma S, Pelliccia A.
.
SM,HartgeP,LeeI-M.Leisuretimephysicalactivityofmoderatetovigorous .. Recommendationsforparticipationincompetitivesportsofathleteswitharte-
intensity and mortality: a large pooled cohort analysis. PLoS Med .. rial hypertension:apositionstatementfrom thesports cardiology section of
.
2012;9:e1001335. . the European Association of Preventive Cardiology (EAPC). Eur Heart J
.
118. SamitzG,EggerM,ZwahlenM.Domainsofphysicalactivityandall-causemor- . 2018;39:3664(cid:2)3671.
.
tality:systematicreviewanddose-responsemeta-analysisofcohortstudies.IntJ .. 132.WilliamsB,ManciaG,SpieringW,AgabitiRoseiE,AziziM,BurnierM,Clement
Epidemiol2011;40:1382(cid:2)1400. .. DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J,
.
119. ElleyCR,KerseN,ArrollB,RobinsonE.Effectivenessofcounsellingpatients . RuilopeL,ZanchettiA,KerinsM,KjeldsenSE,KreutzR,LaurentS,LipGYH,
.
onphysicalactivityingeneralpractice:clusterrandomisedcontrolledtrial.BMJ . McManusR,NarkiewiczK,RuschitzkaF,SchmiederRE,ShlyakhtoE,TsioufisC,
.
2003;326:793. .. Aboyans V, Desormais I. 2018 ESC/ESH Guidelines for the management of
.
120. RydenL,GrantPJ,AnkerSD,BerneC,CosentinoF,DanchinN,DeatonC, . arterialhypertension.EurHeartJ2018;39:3021(cid:2)3104.
.
EscanedJ,HammesH-P,HuikuriH,MarreM,MarxN,MellbinL,OstergrenJ, . 133.Wen H, Wang L. Reducing effect of aerobic exercise on blood pressure of
.
Patrono C, Seferovic P, Uva MS, Taskinen M-R, Tendera M, Tuomilehto J, .. essential hypertensive patients: a meta-analysis. Medicine (Baltimore)
Valensi P, Zamorano JL, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, .. 2017;96:e6150.
.
BuenoH,DeanV,DeatonC,ErolC,FagardR,FerrariR,HasdaiD,HoesAW, . 134.MacDonald HV, Johnson BT, Huedo-Medina TB, Livingston J, Forsyth KC,
.
Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, . KraemerWJ,FarinattiPTV,PescatelloLS.Dynamicresistancetrainingasstand-
.
PiepoliMF,PonikowskiP,SirnesPA,TamargoJL,TenderaM,TorbickiA,Wijns .. alone antihypertensive lifestyle therapy: a meta-analysis. J Am Heart Assoc
W,WindeckerS,DeBackerG,SirnesPA,EzquerraEA,AvogaroA,Badimon .. 2016;5.
.
L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck- . 135.TheWorldAnti-DopingCodeInternationalStandard,2019.https://www.wada-
.
BrentanoC,GulbaDC,HasdaiD,HoesAW,KjekshusJK,KnuutiJ,KolhP,Lev .. ama.org/sites/default/files/wada_2019_english_prohibited_list.pdf
E,MuellerC,NeysesL,NilssonPM,PerkJ,PonikowskiP,ReinerZ,SattarN, .. 136.RuschitzkaF,BorerJS,KrumH,FlammerAJ,YeomansND,LibbyP,Luscher
.
SchachingerV,ScheenA,SchirmerH,StrombergA,SudzhaevaS,TamargoJL, . TF,SolomonDH,HusniME,GrahamDY,DaveyDA,WisniewskiLM,Menon
.
Viigimaa M, Vlachopoulos C, Xuereb RG. ESC Guidelines on diabetes, pre- . V,FayyadR,BeckermanB,IorgaD,LincoffAM,NissenSE.Differentialblood
.
diabetes, and cardiovascular diseases developed in collaboration with the .. pressureeffectsofibuprofen,naproxen,andcelecoxibinpatientswitharthritis:
EASD:theTaskForceondiabetes,pre-diabetes,andcardiovasculardiseasesof .. the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib
.
theEuropeanSocietyofCardiology(ESC)anddevelopedincollaboratio.Eur . IntegratedSafety VersusIbuprofenorNaproxenAmbulatoryBloodPressure
.
HeartJ2013;34:3035(cid:2)3087. . Measurement).EurHeartJ2017;38:3282(cid:2)3292.
.
121. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, Toplak H. .. 137.deSousaNMF,MagossoRF,DippT,PlentzRDM,MarsonRA,MontagnolliAN,
.
European Guidelines for obesity management in adults. Obes Facts . MartinsRAS,PerezSEA,BaldisseraV.Continuousbloodpressureresponseat
.
2015;8:402(cid:2)424. . differentintensitiesinlegpressexercise.EurJPrevCardiol2014;21:1324(cid:2)1331.
.
122. YouT,ArsenisNC, DisanzoBL,Lamonte MJ. Effectsof exercisetrainingon .. 138.deSouzaNeryS,Gomides RS,daSilvaGV,deMoraesForjaz CL,MionDJ,
chronic inflammation in obesity: current evidence and potential mechanisms. .. TinucciT.Intra-arterialbloodpressureresponseinhypertensivesubjectsduring
.
SportsMed2013;43:243(cid:2)256. . low-andhigh-intensityresistanceexercise.Clinics(SaoPaulo)2010;65:271(cid:2)277.
.
123. Keating SE, Johnson NA, Mielke GI, Coombes JS. A systematic review and . 139.LamotteM,NisetG,vandeBorneP.Theeffectofdifferentintensitymodalities
.
meta-analysisofintervaltrainingversusmoderate-intensitycontinuoustraining .. ofresistancetrainingonbeat-to-beatbloodpressureincardiacpatients.EurJ
onbodyadiposity.ObesRev2017;18:943(cid:2)964. .. CardiovascPrevRehabil2005;12:12(cid:2)17.
.
124. SwiftDL,JohannsenNM,LavieCJ,EarnestCP,ChurchTS.Theroleofexercise . 140.Sardeli AV, do Carmo Santos L, Ferreira MLV, Gaspari AF, Rodrigues B,
.
and physical activity in weight loss and maintenance. Prog Cardiovasc Dis .. Cavaglieri CR, Chacon-Mikahil MPT. Cardiovascular responses to different
2014;56:441(cid:2)447. .. resistanceexerciseprotocolsinelderly.IntJSportsMed2017;38:928(cid:2)936.
.
125. AlmeidaSA,WilliamsKM,ShafferRA,BrodineSK.Epidemiologicalpatternsof . 141.GjovaagT,HjelmelandAK, OygardJB,VikneH,MirtaheriP.Acutehemody-
.
musculoskeletal injuries and physical training. Med Sci Sports Exerc . namicandcardiovascularresponsesfollowingresistanceexercisetovoluntary
.
1999;31:1176(cid:2)1182. .. exhaustion. Effects of different loadings and exercise durations. J Sports Med
126. Gilchrist J, Jones BH, Sleet DA, Kimsey CD. Exercise-related injuries among .. PhysFitness2016;56:616(cid:2)623.
.
women: strategies for prevention from civilian and military studies. MMWR . 142.HansenD,AbreuA,DohertyP,VollerH.Dynamicstrengthtrainingintensityin .
RecommRep2000;49:15(cid:2)33. . cardiovascularrehabilitation:isittimetoreconsiderclinicalpractice?Asystem-
. 127. Hootman JM, Macera CA, Ainsworth BE, Martin M, Addy CL, Blair SN. .. atic review. Eur J Prev Cardiol 2019;26:1483(cid:2)1492. doi: 10.1177/
Associationamongphysicalactivitylevel,cardiorespiratoryfitness,andriskof .. 2047487319847003.Epub2May2019.
.
musculoskeletalinjury.AmJEpidemiol2001;154:251(cid:2)258. . 143.CaselliS,SerdozA,MangoF,LemmeE,VaquerSeguiA,MilanA,Attenhofer
.
128. LismanPJ,delaMotteSJ,GribbinTC,JaffinDP,MurphyK,DeusterPA.Asys- .. Jost C, Schmied C, Spataro A, Pelliccia A. High blood pressure response to
tematicreviewoftheassociationbetweenphysicalfitnessandmusculoskeletal .. exercise predicts future development of hypertension in young athletes. Eur
.
injury risk: Part 1-Cardiorespiratory endurance. J Strength Cond Res . HeartJ2019;40:62(cid:2)68.
.
2017;31:1744(cid:2)1757. . 144.KjeldsenSE,MundalR,SandvikL,ErikssenG,ThaulowE,ErikssenJ.Supineand
.
129. VincentHK,GeorgeSZ,SeayAN,VincentKR,HurleyRW.Resistanceexercise, .. exercise systolic blood pressure predict cardiovascular death in middle-aged
disability,andpaincatastrophizinginobeseadultswithbackpain.MedSciSports .. men.JHypertens2001;19:1343(cid:2)1348.
.
Exerc2014;46:1693(cid:2)1701. . 145.FletcherB,BerraK,AdesP,BraunLT,BurkeLE,DurstineJL,FairJM,Fletcher
.
130. ManciaG,FagardR,NarkiewiczK,RedonJ,ZanchettiA,BohmM,Christiaens . GF,GoffD,HaymanLL,HiattWR,MillerNH,KraussR,Kris-EthertonP,Stone
.
T,CifkovaR,DeBackerG,DominiczakA,GalderisiM,GrobbeeDE,Jaarsma .. N, Wilterdink J, Winston M. Managing abnormal blood lipids:a collaborative
.
T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, . approach.Circulation2005;112:3184(cid:2)3209.
.
SchmiederRE,SirnesPA,SleightP,ViigimaaM,WaeberB,ZannadF,RedonJ, . 146.KrausWE,HoumardJA,DuschaBD,KnetzgerKJ,WhartonMB,McCartneyJS,
.
DominiczakA,NarkiewiczK,NilssonPM,BurnierM,ViigimaaM,AmbrosioniE, .. BalesCW,HenesS,SamsaGP,OtvosJD,KulkarniKR,SlentzCA.Effectsofthe
Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, .. amount and intensity of exercise on plasma lipoproteins. N Engl J Med
.
ZamoranoJL,AchenbachS,BaumgartnerH,BaxJJ,BuenoH,DeanV,Deaton . 2002;347:1483(cid:2)1492.
.
C,ErolC,FagardR,FerrariR,HasdaiD,HoesAW,KirchhofP,KnuutiJ,Kolh . 147.Lloyd-JonesDM,MorrisPB,BallantyneCM,BirtcherKK,DalyDDJ,DePalma
.
P,LancellottiP,LinhartA,NihoyannopoulosP,PiepoliMF,PonikowskiP,Sirnes .. SM, Minissian MB, Orringer CE, Smith SCJ. 2017 Focused update of the
PA,TamargoJL,TenderaM,TorbickiA,WijnsW,WindeckerS,ClementDL, .. 2016 ACC Expert Consensus Decision Pathway on the role of non-statin
.
Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, . therapiesforldl-cholesterolloweringinthemanagementofatheroscleroticcar-
.
BauersachsJ,HitijJB,CaulfieldM,DeBuyzereM,DeGeestS,DerumeauxGA, .. diovascular disease risk: a report of the American College of Cardiology
ErdineS,FarsangC,Funck-BrentanoC,GercV,GermanoG,GielenS,Haller .. Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol
.
H,HoesAW,JordanJ,KahanT,KomajdaM,LovicD,MahrholdtH,OlsenMH, . 2017;70:1785(cid:2)1822.
.
OstergrenJ,ParatiG,PerkJ,PoloniaJ,PopescuBA,ReinerZ,RydenLetaletal . 148.KokkinosPF,FaselisC,MyersJ,PanagiotakosD,DoumasM.Interactiveeffects
.
2013 ESH/ESC Guidelines for the management of arterial hypertension: the .. offitnessandstatintreatmentonmortalityriskinveteranswithdyslipidaemia:
Task Force for the management of arterial hypertension of the European . acohortstudy.Lancet2013;381:394(cid:2)399.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 68 ---
84 ESCGuidelines
.
.
149. StroesES,ThompsonPD,CorsiniA,VladutiuGD,RaalFJ,RayKK,RodenM, . 165.daSilvaDE,GrandeAJ,RoeverL,TseG,LiuT,Biondi-ZoccaiG,deFariasJM.
.
SteinE,TokgozogluL,NordestgaardBG,BruckertE,DeBackerG,KraussRM, . High-intensityintervaltraininginpatientswithtype2diabetesmellitus:asys-
.
Laufs U, Santos RD, Hegele RA, Hovingh GK, Leiter LA, Mach F, Marz W, .. tematicreview.CurrAtherosclerRep2019;21:8.
NewmanCB,WiklundO,JacobsonTA,CatapanoAL,ChapmanMJ,Ginsberg .. 166.MagalhaesJP,JudicePB,RibeiroR,AndradeR,RaposoJ,DoresH,BichoM,
.
HN.Statin-associatedmusclesymptoms:impactonstatintherapy—European . Sardinha LB. Effectiveness of high-intensity interval training combined with
.
AtherosclerosisSocietyConsensusPanelStatementonAssessment,Aetiology .. resistance training versus continuous moderate-intensity training combined
andManagement.EurHeartJ2015;36:1012(cid:2)1022. .. withresistancetraininginpatientswithtype2diabetes:aone-yearrandomized
.
150. LeeI-M,ShiromaEJ,LobeloF,PuskaP,BlairSN,KatzmarzykPT.Effectofphysi- . controlledtrial.DiabetesObesMetab2019;21:550(cid:2)559.
.
cal inactivity on major non-communicable diseases worldwide: an analysis of . 167.MygindND,MichelsenMM,PenaA,FrestadD,DoseN,AzizA,FaberR,Host
.
burdenofdiseaseandlifeexpectancy.Lancet2012;380:219(cid:2)229. .. N,GustafssonI,HansenPR,HansenHS,MerzBairey,Kastrup,CN,Prescott,J
151. CloostermansL,Wendel-VosW,DoornbosG,HowardB,CraigCL,Kivimaki .. E.Coronarymicrovascularfunctionandcardiovascularriskfactorsinwomen
.
M,TabakAG,JefferisBJ,RonkainenK,BrownWJ,PicavetSHSJ,Ben-ShlomoY, . withanginapectorisandnoobstructivecoronaryarterydisease:theiPOWER
.
LaukkanenJA,KauhanenJ,BemelmansWJE.Independentandcombinedeffects . Study.JAmHeartAssoc2016;5:e003064.
.
ofphysicalactivityandbodymassindexonthedevelopmentofType2diabetes .. 168.Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, Dorbala S,
.
(cid:2) a meta-analysis of 9 prospective cohort studies. Int J Behav Nutr Phys Act . BlanksteinR,DiCarliMF.Associationbetweencoronaryvasculardysfunction
.
2015;12:147. . andcardiacmortalityinpatientswithandwithoutdiabetesmellitus.Circulation
.
152. EkelundU,PallaL,BrageS,FranksPW,PetersT,BalkauB,DiazMJT,Huerta .. 2012;126:1858(cid:2)1868.
JM, Agnoli C, Arriola L, Ardanaz E, Boeing H, Clavel-Chapelon F, Crowe F, .. 169.OlsenRH,PedersenLR,JursA,SnoerM,HaugaardSB,PrescottE.Arando-
.
FagherazziG,GroopL,FonsJohnsenN,KaaksR,KhawKT,KeyTJ,deLauzon- . misedtrialcomparingtheeffectofexercisetrainingandweightlossonmicro-
.
GuillainB,MayA,MonninkhofE,NavarroC,NilssonP,NautrupOstergaardJ, . vascularfunctionincoronaryarterydisease.IntJCardiol2015;185:229(cid:2)235.
.
NoratT,OvervadK,PalliD,PanicoS,RedondoML,RicceriF,RolandssonO, .. 170.YoshinagaK,BeanlandsRSB,DekempRA,LortieM,MorinJ,AungM,McKelvie
RomagueraD,RomieuI,SanchezPerezMJ,SlimaniN,SpijkermanA,Teucher .. R,DaviesRF.Effectofexercisetrainingonmyocardialbloodflowinpatients
.
B,TjonnelandA,TravierN,TuminoR,VosW,ViglM,SharpS,LangebergC, . withstablecoronaryarterydisease.AmHeartJ2006;151:1324.e11(cid:2)8.
.
ForouhiN,RiboliE,FeskensE,WarehamNJ.Physicalactivityreducestherisk .. 171.HambrechtR,WolfA,GielenS,LinkeA,HoferJ,ErbsS,SchoeneN,Schuler
ofincidenttype2diabetesingeneralandinabdominallyleanandobesemen .. G.Effectofexerciseoncoronaryendothelialfunctioninpatientswithcoronary
.
andwomen:theEPIC-InterActStudy.Diabetologia2012;55:1944(cid:2)1952. . arterydisease.NEnglJMed2000;342:454(cid:2)460.
.
153. HjerkindKV,StenehjemJS,NilsenTIL.Adiposity, physicalactivityandriskof . 172.WingRR,BolinP,BrancatiFL,BrayGA,ClarkJM,CodayM,CrowRS,Curtis
.
diabetes mellitus: prospective data from the population-based HUNT study, .. JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW,
Norway.BMJOpen2017;7:e013142. .. HarrisonB,HazudaHP,HillJO,HortonES,HubbardVS,JakicicJM,JefferyRW,
.
154. RanaJS,LiTY,MansonJE,HuFB.Adipositycomparedwithphysicalinactivity . JohnsonKC,KahnSE,KitabchiAE,KnowlerWC,LewisCE,Maschak-CareyBJ,
.
andriskoftype2diabetesinwomen.DiabetesCare2007;30:53(cid:2)58. . MontezMG,MurilloA,NathanDM,PatricioJ,PetersA,Pi-SunyerX,Pownall
.
155. Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. .. H,ReboussinD,RegensteinerJG,RickmanAD,RyanDH,SaffordM,Wadden
.
CochraneDatabaseSystRev2006;CD002968. . TA,WagenknechtLE,WestDS,WilliamsonDF,YanovskiSZ.Cardiovascular
.
156. ZhangX,DevlinHM,SmithB,ImperatoreG,ThomasW,LobeloF,AliMK, . effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med
.
NorrisK,GrussS,BardenheierB,ChoP,GarciadeQuevedoI,MudaliarU, .. 2013;369:145(cid:2)154.
Jones CD, Durthaler JM, Saaddine J, Geiss LS, Gregg EW. Effect of lifestyle .. 173.Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC,
.
interventionsoncardiovascularriskfactorsamongadultswithoutimpairedglu- . HortonES,CastorinoK,TateDF.Physicalactivity/exerciseanddiabetes:aposi-
.
cose tolerance or diabetes: a systematic review and meta-analysis. PLoS One . tion statement of the American Diabetes Association. Diabetes Care
.
2017;12:e0176436. .. 2016;39:2065(cid:2)2079.
157. CosentinoF,GrantPJ,AboyansV,BaileyCJ,CerielloA,DelgadoV,FedericiM, .. 174.PanB,GeL,XunY-Q,ChenY-J,GaoC-Y,HanX,ZuoL-Q,ShanH-Q,Yang
.
FilippatosG,GrobbeeDE,HansenTB,HuikuriHV,JohanssonI,JuniP,Lettino . K-H,DingG-W,TianJ-H.Exercisetrainingmodalitiesinpatientswithtype2
.
M,MarxN,MellbinLG,OstgrenCJ,RoccaB,RoffiM,SattarN,SeferovicPM, .. diabetes mellitus: a systematic review and network meta-analysis. Int J Behav
Sousa-UvaM,ValensiP,WheelerDC.2019ESCGuidelinesondiabetes,pre- .. NutrPhysAct2018;15:72.
.
diabetes, and cardiovascular diseases developed in collaboration with the . 175.SigalRJ,KennyGP,BouleNG,WellsGA,Prud’hommeD,FortierM,ReidRD,
.
EASD.EurHeartJ2020;41:255(cid:2)323. . TullochH,CoyleD,PhillipsP,JenningsA,JaffeyJ.Effectsofaerobictraining,
.
158. SluikD,BuijsseB,MuckelbauerR,KaaksR,TeucherB,JohnsenNF,Tjonneland .. resistancetraining,orbothonglycemiccontrolintype2diabetes:arandom-
A, Overvad K, Ostergaard JN, Amiano P, Ardanaz E, Bendinelli B, Pala V, .. izedtrial.AnnInternMed2007;147:357(cid:2)369.
.
TuminoR,RicceriF,MattielloA,SpijkermanAMW,MonninkhofEM,MayAM, . 176.ChurchTS,BlairSN,CocrehamS,JohannsenN,JohnsonW,KramerK,Mikus .
FranksPW,NilssonPM,WennbergP,RolandssonO,FagherazziG,Boutron- . CR, Myers V, Nauta M, Rodarte RQ, Sparks L, Thompson A, Earnest CP.
. RuaultM-C,Clavel-ChapelonF,CastanoJMH,GalloV,BoeingH,NothlingsU. .. EffectsofaerobicandresistancetrainingonhemoglobinA1clevelsinpatients
Physicalactivityandmortalityinindividualswithdiabetesmellitus:aprospective .. with type 2 diabetes: a randomized controlled trial. JAMA
.
studyandmeta-analysis.ArchInternMed2012;172:1285(cid:2)1295. . 2010;304:2253(cid:2)2262.
.
159. DiabetesPreventionProgramResearchGroup.Reductionintheincidenceof .. 177.KempsH,KrankelN,DorrM,MoholdtT,WilhelmM,PaneniF,SerratosaL,
type 2 diabetes with lifestyle intervention or metformin. N Engl J Med .. EkkerSolbergE,HansenD,HalleM,GuazziM.Exercisetrainingforpatients
.
2002;346:393(cid:2)403. . withtype2diabetesandcardiovasculardisease:whattopursueandhowtodo
.
160. KnowlerWC,FowlerSE,HammanRF,ChristophiCA,HoffmanHJ,Brenneman . it. A position paper of the European Association of Preventive Cardiology
.
AT,Brown-FridayJO,GoldbergR,VendittiE,NathanDM.10-yearfollow-upof .. (EAPC).EurJPrevCardiol2019;26:709(cid:2)727.
diabetes incidence and weight loss in the Diabetes Prevention Program .. 178.UmpierreD,RibeiroPAB,KramerCK,LeitaoCB,ZucattiATN,AzevedoMJ,
.
OutcomesStudy.Lancet2009;374:1677(cid:2)1686. . GrossJL,RibeiroJP,SchaanBD.Physicalactivityadviceonlyorstructuredexer-
.
161. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, . cisetrainingandassociationwithHbA1clevelsintype2diabetes:asystematic
.
HamalainenH,HarkonenP,Keinanen-KiukaanniemiS,LaaksoM,LouherantaA, .. reviewandmeta-analysis.JAMA2011;305:1790(cid:2)1799.
.
MannelinM,PaturiM,SundvallJ,ValleTT,UusitupaM,TuomilehtoJ.Sustained . 179.FeldmanDI,Al-MallahMH,KeteyianSJ,BrawnerCA,FeldmanT,Blumenthal
.
reductionintheincidenceoftype2diabetesbylifestyleintervention:follow-up . RS,BlahaMJ.Noevidenceofanupperthresholdformortalitybenefitathigh
.
oftheFinnishDiabetesPreventionStudy.Lancet2006;368:1673(cid:2)1679. .. levelsofcardiorespiratoryfitness.JAmCollCardiol2015;65:629(cid:2)630.
162. TuomilehtoJ,LindstromJ,ErikssonJG,ValleTT,HamalainenH,Ilanne-Parikka .. 180.Hamer M, Lavoie KL, Bacon SL. Taking up physical activity in later life and
.
P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, . healthy ageing: the English longitudinal study of ageing. Br J Sports Med
.
Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle . 2014;48:239(cid:2)243.
.
among subjects with impaired glucose tolerance. N Engl J Med 2001;344: .. 181.ManiniTM,EverhartJE,PatelKV,SchoellerDA,ColbertLH,VisserM,Tylavsky
1343(cid:2)1350. .. F,BauerDC,GoodpasterBH,HarrisTB.Dailyactivityenergyexpenditureand
.
163. Hidalgo-SantamariaM,Fernandez-MonteroA,Martinez-GonzalezMA,Moreno- . mortalityamongolderadults.JAMA2006;296:171(cid:2)179.
.
Galarraga L, Sanchez-Villegas A, Barrio-Lopez MT, Bes-Rastrollo M. Exercise .. 182.StessmanJ,Hammerman-RozenbergR,CohenA,Ein-MorE,JacobsJM.Physical
intensityandincidenceofmetabolicsyndrome:theSUNProject.AmJPrevMed .. activity, function, and longevity among the very old. Arch Intern Med
.
2017;52:e95(cid:2)e101. . 2009;169:1476(cid:2)1483.
.
164. DubeJJ,AllisonKF,RoussonV,GoodpasterBH,AmatiF.Exercisedoseand . 183.SabiaS,Singh-ManouxA,Hagger-JohnsonG,CamboisE,BrunnerEJ,Kivimaki
.
insulin sensitivity: relevance for diabetes prevention. Med Sci Sports Exerc .. M.Influenceofindividualandcombinedhealthybehavioursonsuccessfulaging.
2012;44:793(cid:2)799. . CMAJ2012;184:1985(cid:2)1992.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 69 ---
ESCGuidelines 85
.
.
184. SunQ,TownsendMK,OkerekeOI,FrancoOH,HuFB,GrodsteinF.Physical . in leisure-time sport activities: position stand from the Sections of Exercise
.
activityatmidlifeinrelationtosuccessfulsurvivalinwomenatage70yearsor . Physiology and Sports Cardiology of the European Association of
.
older.ArchInternMed2010;170:194(cid:2)201. .. Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil
185. DuganSA,GabrielKP,Lange-MaiaBS,Karvonen-GutierrezC.Physicalactivity .. 2011;18:446(cid:2)458.
.
and physical function: moving and aging. Obstet Gynecol Clin North Am . 208.OrkabyAR,FormanDE.PhysicalactivityandCVDinolderadults:anexpert’s
.
2018;45:723(cid:2)736. .. perspective.ExpertRevCardiovascTher2018;16:1(cid:2)10.
186. BerkDR,HubertHB,FriesJF.Associationsofchangesinexerciselevelwith .. 209.GillespieLD,RobertsonMC, Gillespie WJ,Sherrington C,GatesS,Clemson
.
subsequentdisabilityamongseniors:a16-yearlongitudinalstudy.JGerontolA . LM, Lamb SE. Interventions for preventing falls in older people living in the
.
BiolSciMedSci2006;61:97(cid:2)102. . community.CochraneDatabaseSystRev2012;CD007146.
.
187. ThielC,VogtL,TeskyVA,MerothL,Sahlender,JakobM,Pantel,SBanzer,JW. .. 210.HamedA,BohmS,MersmannF,ArampatzisA.Follow-upefficacyofphysical
Cognitiveinterventionresponseisrelatedtohabitualphysicalactivityinolder .. exerciseinterventionsonfallincidenceandfallriskinhealthyolderadults:a
.
adults.AgingClinExpRes2012;24:47(cid:2)55. . systematicreviewandmeta-analysis.SportMed-Open2018;4:56.
.
188. LautenschlagerNT,CoxKL,FlickerL,FosterJK,vanBockxmeerFM,XiaoJ, . 211.GanseB,DegensH,DreyM,KorhonenMT,McPheeJ,MullerK,JohannesBW,
.
Greenop KR, Almeida OP. Effect of physical activity on cognitive function in .. RittwegerJ.Impact ofage, performanceandathletic eventon injuryratesin
.
older adults at risk for Alzheimer disease: a randomized trial. JAMA . master athletics (cid:2) first results from an ongoing prospective study. J
.
2008;300:1027(cid:2)1037. . MusculoskeletNeuronalInteract2014;14:148(cid:2)154.
.
189. SinkKM,EspelandMA,CastroCM,ChurchT,CohenR,DodsonJA,GuralnikJ, .. 212.Rogers NT, Marshall A, Roberts CH, Demakakos P, Steptoe A, Scholes S.
HendrieHC,JenningsJ,KatulaJ,LopezOL,McDermottMM,PahorM,ReidKF, .. Physical activity and trajectories of frailty among older adults: evidence from
.
Rushing J, Verghese J, Rapp S, Williamson JD. Effect of a 24-month physical . theEnglishLongitudinalStudyofAgeing.PLoSOne2017;12:e0170878.
.
activity intervention vs health education on cognitive outcomes in sedentary . 213.NelsonME,RejeskiWJ,BlairSN,DuncanPW,JudgeJO,KingAC,MaceraCA,
.
olderadults:theLIFErandomizedtrial.JAMA2015;314:781(cid:2)790. .. Castaneda-SceppaC.Physicalactivityandpublichealthinolderadults:recom-
190. LoprinziPD,FrithE,EdwardsMK,SngE,AshpoleN.Theeffectsofexerciseon .. mendationfromtheAmericanCollegeofSportsMedicineandtheAmerican
.
memoryfunction amongyoungtomiddle-agedadults:systematicreview and . HeartAssociation.MedSciSportsExerc2007;39:1435(cid:2)1445.
.
recommendationsforfutureresearch.AmJHealthPromot2018;32:691(cid:2)704. .. 214.Chou W-T, Tomata Y, Watanabe T, Sugawara Y, Kakizaki M, Tsuji I.
191. RobertsCK,HevenerAL,BarnardRJ.Metabolicsyndromeandinsulinresist- .. Relationshipsbetweenchangesintimespentwalkingsincemiddleageandinci-
.
ance: underlying causes and modification by exercise training. Compr Physiol . dentfunctionaldisability.PrevMed(Baltim)2014;59:68(cid:2)72.
.
2013;3:1(cid:2)58. . 215.TomataY,ZhangS,SugiyamaK,KaihoY,SugawaraY,TsujiI.Changesintime
.
192. Vigorito C,Giallauria F.Effectsofexerciseoncardiovascularperformancein .. spentwalkingandtheriskofincidentdementiainolderJapanesepeople:the
theelderly.FrontPhysiol2014;5:51. .. OhsakiCohort2006Study.AgeAgeing2017;46:857(cid:2)860.
.
193. Power GA, Dalton BH, Behm DG, Vandervoort AA, Doherty TJ, Rice CL. . 216.Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE.
.
Motor unit number estimates in masters runners: use it or lose it? Med Sci . Triggeringofsuddendeathfromcardiaccausesbyvigorousexertion.NEnglJ
.
SportsExerc2010;42:1644(cid:2)1650. .. Med2000;343:1355(cid:2)1361.
.
194. Power GA, Dalton BH, Behm DG, Doherty TJ, Vandervoort AA, Rice CL. . 217.GuazziM,ArenaR,HalleM,PiepoliMF,MyersJ,LavieCJ.2016focusedupdate:
.
Motorunitsurvivalinlifelongrunnersismuscledependent.MedSciSportsExerc . clinicalrecommendationsforcardiopulmonaryexercisetestingdataassessment
.
2012;44:1235(cid:2)1242. .. inspecificpatientpopulations.EurHeartJ2016;39:1144(cid:2)1161.
195. RubensteinLZ,JosephsonKR,TruebloodPR,LoyS,HarkerJO,PietruszkaFM, .. 218.ThompsonPD,FranklinBA,BaladyGJ,BlairSN,CorradoD,EstesNAM3rd,
.
RobbinsAS.Effectsofagroupexerciseprogramonstrength,mobility,andfalls . FultonJE,GordonNF,HaskellWL,LinkMS,MaronBJ,MittlemanMA,Pelliccia
.
amongfall-proneelderlymen.JGerontolABiolSciMedSci2000;55:M317(cid:2)21. . A,WengerNK,WillichSN,CostaF.Exerciseandacutecardiovascularevents
.
196. FrancoMR,PereiraLS,FerreiraPH.Exerciseinterventionsforpreventingfalls .. placing the risks into perspective: a scientific statement from the American
inolderpeoplelivinginthecommunity.BrJSportsMed2014;48:867(cid:2)868. .. HeartAssociationCouncilonNutrition,PhysicalActivity,andMetabolismandthe
.
197. Chodzko-ZajkoWJ,ProctorDN,Fiatarone Singh MA, Minson CT, Nigg CR, . CouncilonClinicalCardiology.Circulation2007;115:2358(cid:2)2368.
.
Salem GJ, Skinner JS. American College of Sports Medicine position stand. .. 219.PenalverJM,MoscaRS,WeitzD,PhoonCKL.Anomalousaorticoriginofcoro-
Exercise and physical activity for older adults. Med Sci Sports Exerc .. naryarteriesfromtheoppositesinus:acriticalappraisalofrisk.BMCCardiovasc
.
2009;41:1510(cid:2)1530. . Disord2012;12:83.
.
198. Crocker T, Forster A, YoungJ, Brown L,Ozer S, Smith J, GreenJ, Hardy J, . 220.GowdBMP,ThompsonPD.Isolatedmyocardialbridgingandexercise-related
.
BurnsE,GlidewellE,GreenwoodDC.Physicalrehabilitationforolderpeople .. cardiacevents.IntJSportsMed2014;35:1145(cid:2)1150.
inlong-termcare.CochraneDatabaseSystRev2013;CD004294. .. 221.Kalaga RV, Malik A, Thompson PD. Exercise-related spontaneous coronary
.
199. Bray NW, Smart RR, Jakobi JM, Jones GR. Exercise prescription to reverse . artery dissection: case report and literature review. Med Sci Sports Exerc .
frailty.ApplPhysiolNutrMetab2016;41:1112(cid:2)1116. . 2007;39:1218(cid:2)1220.
. 200. ForbesD,ThiessenEJ,BlakeCM,ForbesSC,ForbesS.Exerciseprogramsfor .. 222.Aengevaeren VL, Mosterd A, Braber TL, Prakken NHJ, Doevendans PA,
peoplewithdementia.CochraneDatabaseSystRev2013;CD006489. .. Grobbee DE, Thompson PD, Eijsvogels TMH, Velthuis BK. Relationship
.
201. LiuC-J,LathamNK.Progressiveresistancestrengthtrainingforimprovingphys- . between lifelong exercise volume and coronary atherosclerosis in athletes.
.
icalfunctioninolderadults.CochraneDatabaseSystRev2009;CD002759. .. Circulation2017;136:138(cid:2)148.
202. FragalaMS,CadoreEL,DorgoS,IzquierdoM,KraemerWJ,PetersonMD,Ryan .. 223.Shave R, Baggish A, George K, Wood M, Scharhag J, Whyte G, Gaze D,
.
ED.Resistancetrainingforolderadults:positionstatementfromtheNational . ThompsonPD.Exercise-inducedcardiactroponinelevation:evidence,mecha-
.
Strength and Conditioning Association. J Strength Cond Res . nisms,andimplications.JAmCollCardiol2010;56:169(cid:2)176.
.
2019;33:2019(cid:2)2052. .. 224.Aagaard P, Sahlen A, Braunschweig F. Performance trends and cardiac bio-
203. PahorM,GuralnikJM,AmbrosiusWT,BlairS,BondsDE,ChurchTS,Espeland .. markers in a 30-km cross-country race, 1993(cid:2)2007. Med Sci Sports Exerc
.
MA, Fielding RA, Gill TM, Groessl EJ, King AC, Kritchevsky SB, Manini TM, . 2012;44:894(cid:2)899.
.
McDermottMM,MillerME,NewmanAB,RejeskiWJ,SinkKM,WilliamsonJD. . 225.ColletJ-P,ZeitouniM,ProcopiN,HulotJ-S,SilvainJ,KerneisM,ThomasD,
.
Effectofstructuredphysicalactivityonpreventionofmajormobilitydisability .. LattucaB,BarthelemyO,Lavie-BadieY,EsteveJ-B,PayotL,BrugierD,LopesI,
.
in older adults: the LIFE study randomized clinical trial. JAMA . DialloA,VicautE,MontalescotG.Long-termevolutionofprematurecoronary
.
2014;311:2387(cid:2)2396. . arterydisease.JAmCollCardiol2019;74:1868(cid:2)1878.
.
204. Gill TM, Pahor M, Guralnik JM, McDermott MM, King AC, Buford TW, .. 226.MaronBJ,AraujoCG,ThompsonPD,FletcherGF,deLunaAB,FlegJL,Pelliccia
StrotmeyerES,NelsonME,SinkKM,DemonsJL,KashafSS,WalkupMP,Miller .. A,BaladyGJ,FurlanelloF,VanCampSP,ElosuaR,ChaitmanBR,BazzarreTL.
.
ME.Effectofstructuredphysicalactivityonpreventionofseriousfallinjuriesin . Recommendationsforpreparticipationscreeningandtheassessmentofcardio-
.
adultsaged70(cid:2)89:randomizedclinicaltrial(LIFEstudy).BMJ2016;352:i245. . vascular disease in masters athletes: an advisory for healthcare professionals
.
205. ChurchTS,EarnestCP,SkinnerJS,BlairSN.Effectsofdifferentdosesofphysi- .. from the working groups of the World Heart Federation, the International
calactivityoncardiorespiratoryfitnessamongsedentary,overweightorobese .. Federation of Sports Medicine, and the American Heart Association
.
postmenopausal women with elevated blood pressure: a randomized con- . Committee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation
.
trolledtrial.JAMA2007;297:2081(cid:2)2091. .. 2001;103:327(cid:2)334.
206. PowellKE,PaluchAE,BlairSN.Physicalactivityforhealth:Whatkind?How .. 227.Erbel R, Mohlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A,
.
much?Howintense?Ontopofwhat?AnnuRevPublicHealth2011;32:349(cid:2)365. . Dragano N, Gronemeyer D, Seibel R, Kalsch H, Brocker-Preuss M, Mann K,
.
207. Borjesson M, Urhausen A, Kouidi E, Dugmore D, Sharma S, Halle M, . SiegristJ,JockelK-H.Coronaryriskstratification,discrimination,andreclassifi-
.
Heidbu¨chel H, Bjo¨rnstad HH, Gielen S, Mezzani A, Corrado D, Pelliccia A, .. cationimprovementbasedonquantificationofsubclinicalcoronaryatheroscle-
VanheesL.Cardiovascularevaluationofmiddle-aged/seniorindividualsengaged . rosis:theHeinzNixdorfRecallStudy.JAmCollCardiol2010;56:1397(cid:2)1406.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 70 ---
86 ESCGuidelines
.
.
228. YeboahJ,McClellandRL,PolonskyTS,BurkeGL,SibleyCT,O’LearyD,CarrJJ, . 243.VerschuerenS,EskesAM,MaaskantJM,RoestAM,LatourCHM,OpReimer
.
GoffDC,GreenlandP,HerringtonDM.Comparisonofnovelriskmarkersfor . WS. The effect of exercise therapy on depressive and anxious symptoms in
.
improvementincardiovascularriskassessmentinintermediate-riskindividuals. .. patients with ischemic heart disease: a systematic review. J Psychosom Res
JAMA2012;308:788(cid:2)795. .. 2018;105:80(cid:2)91.
.
229. GreenlandP,LaBreeL,AzenSP,DohertyTM,DetranoRC.Coronaryartery . 244.Piepoli MF, Corra U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D,
.
calciumscorecombinedwithFraminghamscoreforriskpredictioninasympto- .. McGeeH,MendesM,NiebauerJ,ZwislerA-DO,SchmidJ-P.Secondarypre-
maticindividuals.JAMA2004;291:210(cid:2)215. .. ventionthroughcardiacrehabilitation:fromknowledgetoimplementation.A
.
230. SaadM,PothineniNV,ThomasJ,ParikhR,KovelamudiS,ElsayedD,NairoozR, . position paper from the Cardiac Rehabilitation Section of the European
.
Feit F. Coronary artery calcium scoring in young adults: evidence and chal- . Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc
.
lenges.CurrCardiolRep2018;20:10. .. PrevRehabil2010;17:1(cid:2)17.
231. Borjesson M, Assanelli D, Carre F, Dugmore D, Panhuyzen-Goedkoop NM, .. 245.HaykowskyM,ScottJ,EschB,SchopflocherD,MyersJ,PatersonI,Warburton
.
SeilerC,SendenJ,SolbergEE.ESCStudyGroupofSportsCardiology:recom- . D,JonesL,ClarkAM.Ameta-analysisoftheeffectsofexercisetrainingonleft
.
mendations for participation in leisure-time physical activity and competitive . ventricularremodelingfollowingmyocardialinfarction:startearlyandgolonger
.
sports for patients with ischaemic heart disease. Eur J Cardiovasc Prev Rehabil .. forgreatestexercisebenefitsonremodeling.Trials2011;12:92.
.
2006;13:137(cid:2)149. . 246.AngeliniP,CheongBY,LengeDeRosenVV,LopezJA,UribeC,MassoAH,Ali
.
232. SiricoF,FernandoF,DiPaoloF,AdamiPE,SignorelloMG,SanninoG,Bianco . SW,DavisBR,MuthupillaiR,WillersonJT.Magneticresonanceimaging-based
.
A, Cerrone A, Baioccato V, Filippi N, Ferrari U, Tuzi M, Nurzynska D, Di .. screening study in a general population of adolescents. J Am Coll Cardiol
MeglioF,CastaldoC,D’AscenziF,MontagnaniS,BiffiA.Exercisestresstestin .. 2018;71:579(cid:2)580.
.
apparentlyhealthyindividuals(cid:2)wheretoplacethefinishline?TheFerraricor- . 247.PrioriSG,Blomstrom-LundqvistC,MazzantiA,BlomN,BorggrefeM,CammJ,
.
poratewellnessprogrammeexperience.EurJPrevCardiol2019;26:731(cid:2)738. . ElliottPM,FitzsimonsD,HatalaR,HindricksG,KirchhofP,KjeldsenK,KuckK-
.
233. Borjesson M, Dellborg M, Niebauer J, LaGerche A, Schmied C, Solberg EE, .. H, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van
HalleM,AdamiE,BiffiA,CarreF,CaselliS,PapadakisM,PresslerA,Rasmusen .. VeldhuisenDJ.2015ESCGuidelinesforthemanagementofpatientswithven-
.
H,SerratosaL,SharmaS,vanBuurenF,PellicciaA.Recommendationsforpar- . tricular arrhythmias and the prevention of sudden cardiac death: The Task
.
ticipationinleisuretimeorcompetitivesportsinathletes-patientswithcoro- .. Force for the Management of Patients with Ventricular Arrhythmias and the
naryarterydisease:apositionstatementfromtheSportsCardiologySectionof .. Prevention of Sudden Cardiac Death of the European Society of Cardiology
.
the European Association of Preventive Cardiology (EAPC). Eur Heart J . (ESC).EPEuropace2015;17:1601(cid:2)1687.
.
2019;40:13(cid:2)18. . 248.LinS,TremmelJA,YamadaR,RogersIS,YongCM,TurcottR,McConnellMV,
.
234. Anderson L, Thompson DR, Oldridge N, Zwisler A-D, Rees K, Martin N, .. DashR,SchnittgerI.Anovelstressechocardiographypatternformyocardial
Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease. .. bridgewithinvasivestructuralandhemodynamiccorrelation.JAmHeartAssoc
.
CochraneDatabaseSystRev2016;CD001800. . 2013;2:e000097.
.
235. Piepoli MF, Corra U, Adamopoulos S, Benzer W, Bjarnason-Wehrens B, . 249.GraniC,BenzDC,SteffenDA,GiannopoulosAA,MesserliM,PazhenkottilAP,
.
Cupples M, Dendale P, Doherty P, Gaita D, Hofer S, McGee H,MendesM, .. GaemperliO,GebhardC,SchmiedC,KaufmannPA,BuechelRR.Sportsbehav-
.
NiebauerJ,PogosovaN,Garcia-PorreroE,RauchB,SchmidJP,GiannuzziP. . iorinmiddle-agedindividualswithanomalouscoronaryarteryfromtheoppo-
.
Secondarypreventionintheclinicalmanagementofpatientswithcardiovascu- . sitesinusofValsalva.Cardiology2018;139:222(cid:2)230.
.
lardiseases.Corecomponents,standardsandoutcomemeasuresforreferral .. 250.GraniC,BenzDC,SteffenDA,ClercOF,SchmiedC,PossnerM,VontobelJ,
anddelivery:apolicystatementfromthecardiacrehabilitationsectionofthe .. MikulicicF,GebhardC,PazhenkottilAP,GaemperliO,HurwitzS,Kaufmann
.
European Association for Cardiovascular Prevention and Rehabilitation. Eur J . PA,BuechelRR.Outcomeinmiddle-agedindividualswithanomalousoriginof
.
PrevCardiol2014;21:664(cid:2)681. . thecoronaryarteryfromtheoppositesinus:amatchedcohortstudy.EurHeart
.
236. HachamovitchR,RozanskiA,ShawLJ,StoneGW,ThomsonLEJ,FriedmanJD, .. J2017;38:2009(cid:2)2016.
HayesSW,CohenI,GermanoG,BermanDS.Impactofischaemiaandscaron .. 251.VanHareGF,AckermanMJ,EvangelistaJ-AK,KovacsRJ,MyerburgRJ,Shafer
.
the therapeutic benefit derived from myocardial revascularization vs. medical . KM,WarnesCA,WashingtonRL.Eligibilityanddisqualificationrecommenda-
.
therapyamongpatients undergoingstress-restmyocardialperfusionscintigra- .. tionsforcompetitiveathleteswithcardiovascularabnormalities:TaskForce4:
phy.EurHeartJ2011;32:1012(cid:2)1024. .. Congenital heart disease: a scientific statement from the American Heart
.
237. HoffmannU,FerencikM,UdelsonJE,PicardMH,TruongQA,PatelMR,Huang . Association and American College of Cardiology. Circulation
.
M,PencinaM,MarkDB,HeitnerJF,FordyceCB,PellikkaPA,TardifJ-C,Budoff . 2015;132:e281(cid:2)91.
.
M,NahhasG,ChowB,KosinskiAS,LeeKL,DouglasPS.Prognosticvalueof .. 252.BassoC,MaronBJ,CorradoD,ThieneG.Clinicalprofileofcongenitalcoro-
noninvasive cardiovascular testing in patients with stable chest pain: insights .. naryarteryanomalieswithoriginfromthewrongaorticsinusleadingtosudden
.
fromthePROMISEtrial(ProspectiveMulticenterImagingStudyforEvaluation . deathinyoungcompetitiveathletes.JAmCollCardiol2000;35:1493(cid:2)1501. .
ofChestPain).Circulation2017;135:2320(cid:2)2332. . 253.Finocchiaro G, Behr ER, Tanzarella G, Papadakis M, Malhotra A, Dhutia H,
. 238. NewbyDE,AdamssonPD,BerryC,BoonNA,DweckMR,TFlatherM,Forbes .. MilesC,DiembergerI,SharmaS,SheppardMN.Anomalouscoronaryartery
J,HunterA,LewisS,MacLeanS,MillsNL,NorrieJ,RoditiG,ShahASV,Timmis .. origin and sudden cardiac death: clinical and pathological insights from a
.
AD,vanBeekEJRWM.CoronaryCTangiographyand5-yearriskofmyocardial . nationalpathologyregistry.JACCClinElectrophysiol2019;5:516(cid:2)522.
.
infarction.NEnglJMed2018;379:924(cid:2)933. .. 254.Yamada R, TremmelJA, Tanaka S, Lin S, Kobayashi Y, Hollak MB, Yock PG,
239. Sousa-UvaM,NeumannF-J,AhlssonA,AlfonsoF,BanningAP,BenedettoU, .. FitzgeraldPJ,SchnittgerI,HondaY.Functionalversusanatomicassessmentof
.
ByrneRA,ColletJ-P,FalkV,HeadSJ,JuniP,KastratiA,KollerA,Kristensen . myocardialbridgingbyintravascularultrasound:impactofarterialcompression
.
SD,NiebauerJ,RichterDJ,SeferovicPM,SibbingD,StefaniniGG,Windecker . onproximalatheroscleroticplaque.JAmHeartAssoc2016;5:e001735.
.
S,YadavR,ZembalaMO.2018ESC/EACTSGuidelinesonmyocardialrevascu- .. 255.CerratoE,BarberoU,D’AscenzoF,TahaS,Biondi-ZoccaiG,OmedeP,Bianco
larization.EurJCardiothoracSurg2019;55:4(cid:2)90. .. M,Echavarria-PintoM,EscanedJ,GaitaF,VarbellaF.Whatistheoptimaltreat-
.
240. Valgimigli M, Bueno H, Byrne RA, Collet J-P, Costa F, Jeppsson A, Juni P, . mentforsymptomaticpatientswithisolatedcoronarymyocardialbridge?Asys-
.
KastratiA,KolhP,MauriL,MontalescotG,NeumannF-J,PetricevicM,RoffiM, . tematic review and pooled analysis. J Cardiovasc Med (Hagerstown)
.
StegPG,WindeckerS,ZamoranoJL.Specialarticle2017ESCfocusedupdate .. 2017;18:758(cid:2)770.
.
ondualantiplatelettherapyincoronaryarterydiseasedevelopedincollabora- . 256.Dimitriu-Leen AC, van Rosendael AR, Smit JM, van Elst T, van Geloven N,
.
tionwithEACTS.RevEspCardiol(EnglEd)2018;71:42. . MaaniittyT,JukemaJW,DelgadoV,ScholteAJHA,SarasteA,KnuutiJ,BaxJJ.
.
241. AlbaladejoP,SamamaC-M,SieP,KauffmannS,MemierV,SuchonP,ViallonA, .. Long-term prognosis of patients with intramural course of coronary arteries
DavidJS,GruelY,BellamyL,deMaistreE,RomegouxP,ThoretS,PernodG, .. assessedwithCTangiography.JACCCardiovascImaging2017;10:1451(cid:2)1458.
.
BossonJ-L.Managementofseverebleedinginpatientstreatedwithdirectoral . 257.PonikowskiP,VoorsAA,AnkerSD,BuenoH,ClelandJGF,CoatsAJS,FalkV,
.
anticoagulants: an observational registry analysis. Anesthesiology . Gonzalez-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C,
.
2017;127:111(cid:2)120. .. NihoyannopoulosP,ParissisJT,PieskeB,RileyJP,RosanoGMC,RuilopeLM,
242. BaladyGJ,WilliamsMA,AdesPA,BittnerV,ComossP,FoodyJM,FranklinB, .. RuschitzkaF,RuttenFH,vanderMeerP.2016ESCGuidelinesforthediagnosis
.
SandersonB,SouthardD.Corecomponentsofcardiacrehabilitation/secondary . andtreatmentofacuteandchronicheartfailure:TheTaskForceforthediag-
.
prevention programs: 2007 update: ascientific statement fromthe American .. nosisandtreatmentofacuteandchronicheartfailureoftheEuropeanSociety
HeartAssociationExercise,CardiacRehabilitation,andPreventionCommittee, .. ofCardiology(ESC).EurHeartJ2016;37:2129(cid:2)2200.
.
the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, . 258.PiepoliMF,DavosC,FrancisDP,CoatsAJS.Exercisetrainingmeta-analysisof
.
EpidemiologyandPrevention,andNutrition,PhysicalActivity,andMetabolism; . trialsinpatientswithchronicheartfailure(ExTraMATCH).BMJ2004;328:189.
.
andtheAmericanAssociationofCardiovascularandPulmonaryRehabilitation. .. 259.TaylorRS,WalkerS,SmartNA,PiepoliMF,WarrenFC,CianiO,O’ConnorC,
Circulation2007;115:2675(cid:2)2682. . WhellanD,KeteyianSJ,CoatsA,DavosCH,DalalHM,DracupK,Evangelista
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 71 ---
ESCGuidelines 87
.
.
L,JollyK,MyersJ,McKelvieRS,NilssonBB,PassinoC,WithamMD,YehGY, . statement from the American Heart Association Council on Clinical
.
ZwislerA-DO.Impactofexercise-basedcardiacrehabilitationinpatientswith . Cardiology and Council on Nutrition, Physical Activity, and Metabolism.
.
heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual .. Circulation2007;116:572(cid:2)584.
patient data meta-analysis of randomised trials. Eur J Heart Fail .. 277.GiulianoC,KarahaliosA,NeilC,AllenJ,LevingerI.Theeffectsofresistance
.
2018;20:1735(cid:2)1743. . trainingonmusclestrength,qualityoflifeandaerobiccapacityinpatientswith
.
260. LongL,MordiIR,BridgesC,SagarVA,DaviesEJ,CoatsAJ,DalalH,ReesK, .. chronicheartfailure(cid:2)ameta-analysis.IntJCardiol2017;227:413(cid:2)423.
SinghSJ,TaylorRS.Exercise-basedcardiacrehabilitationforadultswithheart .. 278.AlvarezP,HannawiB,GuhaA.Exerciseandheartfailure:advancingknowledge
.
failure.CochraneDatabaseSystRev2019;1:CD003331. . andimprovingcare.MethodistDebakeyCardiovascJ2016;12:110(cid:2)115.
.
261. ReesK,TaylorRS,SinghS,CoatsAJS,EbrahimS.Exercisebasedrehabilitation . 279.SadekZ,SalamiA,JoumaaWH,AwadaC,AhmaidiS,RamadanW.Bestmode
.
forheartfailure.CochraneDatabaseSystRev2004;CD003331. .. ofinspiratorymuscletraininginheartfailurepatients:asystematicreviewand
262. TaylorRS,WalkerS,SmartNA,PiepoliMF,WarrenFC,CianiO,WhellanD, .. meta-analysis.EurJPrevCardiol2018;25:1691(cid:2)1701.
.
O’ConnorC,KeteyianSJ,CoatsA,DavosCH,DalalHM,DracupK,Evangelista . 280.Smart NA, Giallauria F, Dieberg G. Efficacy of inspiratory muscle training in
.
LS,JollyK,MyersJ,NilssonBB,PassinoC,WithamMD,YehGY.Impact of . chronicheartfailurepatients:asystematicreviewandmeta-analysis.IntJCardiol
.
exercise rehabilitation onexercise capacity andquality-of-lifeinheart failure: .. 2013;167:1502(cid:2)1507.
.
individualparticipantmeta-analysis.JAmCollCardiol2019;73:1430(cid:2)1443. . 281.NetoMG,MartinezBP,ConceicaoCS,SilvaPE,CarvalhoVO.Combinedexer-
.
263. PandeyA,ParasharA,KumbhaniD,AgarwalS,GargJ,KitzmanD,LevineB, . ciseandinspiratorymuscletraininginpatientswithheartfailure:asystematic
.
DraznerM,BerryJ.Exercisetraininginpatientswithheartfailureandpreserved .. reviewandmeta-analysis.JCardiopulmRehabilPrev2016;36:395(cid:2)401.
ejection fraction: meta-analysis of randomized control trials. Circ Heart Fail .. 282.WuJ,KuangL,FuL.Effectsofinspiratorymuscletraininginchronicheartfail-
.
2015;8:33(cid:2)40. . ure patients: a systematic review and meta-analysis. Congenit Heart Dis
.
264. SagarVA,DaviesEJ,BriscoeS,CoatsAJS,DalalHM,LoughF,ReesK,SinghS, . 2018;13:194(cid:2)202.
.
TaylorRS.Exercise-basedrehabilitationforheartfailure:systematicreviewand .. 283.TeiC,HorikiriY,ParkJC,JeongJW,ChangKS,ToyamaY,TanakaN.Acute
meta-analysis.OpenHeart2015;2:e000163. .. hemodynamicimprovementbythermalvasodilationincongestiveheartfailure.
.
265. CorraU,AgostoniPG,AnkerSD,CoatsAJS,CrespoLeiroMG,deBoerRA, . Circulation1995;91:2582(cid:2)2590.
.
Harjola V-P, Hill L, Lainscak M, Lund LH, Metra M, Ponikowski P, Riley J, .. 284.AdsettJA,MudgeAM,MorrisN,KuysS,ParatzJD.Aquaticexercisetraining
SeferovicPM,PiepoliMF.Roleofcardiopulmonaryexercisetestinginclinical .. and stable heart failure: a systematic review and meta-analysis. Int J Cardiol
.
stratificationinheartfailure.ApositionpaperfromtheCommitteeonExercise . 2015;186:22(cid:2)28.
.
Physiology and Training of the Heart Failure Association of the European . 285.OmarW,PandeyA,HaykowskyMJ,BerryJD,LavieCJ.Theevolvingroleof
.
SocietyofCardiology.EurJHeartFail2018;20:3(cid:2)15. .. cardiorespiratoryfitnessandexerciseinpreventionandmanagementofheart
266. Scherr J, Wolfarth B, Christle JW, Pressler A, Wagenpfeil S, Halle M. .. failure.CurrHeartFailRep2018;15:75(cid:2)80.
.
Associations between Borg’s rating of perceived exertion and physiological . 286.EdelmannF,GelbrichG,DungenH-D,FrohlingS,WachterR,StahrenbergR,
.
measuresofexerciseintensity.EurJApplPhysiol2013;113:147(cid:2)155. . Binder L, Topper A, Lashki DJ, Schwarz S, Herrmann-Lingen C, Loffler M,
.
267. O’ConnorCM,WhellanDJ,LeeKL,KeteyianSJ,CooperLS,EllisSJ,LeiferES, .. Hasenfuss G, Halle M, Pieske B. Exercise training improves exercise capacity
.
Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, . anddiastolicfunctioninpatientswithheartfailurewithpreservedejectionfrac-
.
Schulman KA, McKelvie RS, Zannad F, Pi~na IL, for the HF-ACTION . tion: results of the Ex-DHF (exercise training in diastolic heart failure) pilot
.
Investigators. Efficacy and safety of exercise training in patients with chronic .. study.JAmCollCardiol2011;58:1780(cid:2)1791.
heart failure: HF-ACTION randomized controlled trial. JAMA .. 287.Kitzman DW, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus WE,
.
2009;301:1439(cid:2)1450. . EggebeenJ,NicklasBJ.Effectofcaloricrestrictionoraerobicexercisetraining
.
268. RognmoO,MoholdtT,BakkenH,HoleT,MolstadP,MyhrNE,GrimsmoJ, . onpeakoxygenconsumptionandqualityoflifeinobeseolderpatientswith
.
WisloffU.Cardiovascularriskofhigh-versusmoderate-intensityaerobicexer- .. heartfailurewithpreservedejectionfraction:arandomizedclinicaltrial.JAMA
ciseincoronaryheartdiseasepatients.Circulation2012;126:1436(cid:2)1440. .. 2016;315:36(cid:2)46.
.
269. EllingsenO,HalleM,ConraadsV,StoylenA,DalenH,DelagardelleC,Larsen . 288.KitzmanDW,BrubakerPH,MorganTM,StewartKP,LittleWC.Exercisetrain-
.
A-I,HoleT,MezzaniA,VanCraenenbroeckEM,VidemV,BeckersP,Christle .. ing in older patients with heart failure and preserved ejection fraction: a
JW,WinzerE,MangnerN,WoitekF,HollriegelR,PresslerA,Monk-HansenT, .. randomized,controlled,single-blindtrial.CircHeartFail2010;3:659(cid:2)667.
.
Snoer M, Feiereisen P, Valborgland T, Kjekshus J, Hambrecht R, Gielen S, . 289.AlvesAJ,RibeiroF,GoldhammerE,RivlinY,RosenscheinU,VianaJL,Duarte
.
KarlsenT,PrescottE,LinkeA.High-intensityintervaltraininginpatientswith . JA,SagivM,OliveiraJ.Exercisetrainingimprovesdiastolicfunctioninheartfail-
.
heartfailurewithreducedejectionfraction.Circulation2017;135:839(cid:2)849. .. urepatients.MedSciSportsExerc2012;44:776(cid:2)785.
270. Piepoli MF, Conraads V, Corra U, Dickstein K, Francis DP, Jaarsma T, .. 290.GaryRA,SuetaCA,DoughertyM,RosenbergB,CheekD,PreisserJ,Neelon
.
McMurrayJ,PieskeB,PiotrowiczE,SchmidJ-P,AnkerSD,SolalAC,Filippatos . V, McMurray R. Home-based exercise improves functional performance and .
GS,HoesAW,GielenS,GiannuzziP,PonikowskiPP.Exercisetraininginheart . quality of life in women with diastolic heart failure. Heart Lung
. failure: fromtheory to practice. Aconsensus document ofthe HeartFailure .. 2004;33:210(cid:2)218.
Association andtheEuropeanAssociationforCardiovascularPreventionand .. 291.SmartNA,HaluskaB,JeffriessL,LeungD.Exercisetraininginheartfailurewith
.
Rehabilitation.EurJHeartFail2011;13:347(cid:2)357. . preservedsystolicfunction:arandomizedcontrolledtrialoftheeffectsoncar-
.
271. Corra U, Piepoli MF, Carre F, Heuschmann P, Hoffmann U, Verschuren M, .. diacfunctionandfunctionalcapacity.CongestHeartFail2012;18:295(cid:2)301.
Halcox J, Giannuzzi P, Saner H, Wood D, Piepoli MF, Corra U, Benzer W, .. 292.PandeyA,GargS,KhungerM,DardenD,AyersC,KumbhaniDJ,MayoHG,de
.
Bjarnason-WehrensB,DendaleP,GaitaD,McGeeH,MendesM,NiebauerJ, . LemosJA,BerryJD.Dose-responserelationshipbetweenphysicalactivityand
.
ZwislerA-DO,SchmidJ-P.Secondarypreventionthroughcardiacrehabilitation: . riskofheartfailure:ameta-analysis.Circulation2015;132:1786(cid:2)1794.
.
physicalactivitycounsellingandexercisetraining:keycomponentsoftheposi- .. 293.AdamsV,ReichB,UhlemannM,NiebauerJ.Moleculareffectsofexercisetrain-
tionpaperfromtheCardiacRehabilitationSectionoftheEuropeanAssociation .. inginpatientswithcardiovasculardisease:focusonskeletalmuscle,endothe-
.
of Cardiovascular Prevention and Rehabilitation. Eur Heart J . lium,andmyocardium.AmJPhysiolHeartCircPhysiol2017;313:H72(cid:2)H88.
.
2010;31:1967(cid:2)1974. .. 294.Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX,
272. GaydaM,RibeiroPAB,JuneauM,NigamA.Comparisonofdifferentformsof .. TwomeyD,ElliottAD,KalmanJM,AbhayaratnaWP,LauDH,SandersP.Long-
.
exercise training in patients with cardiac disease: where does high-intensity . termeffectofgoal-directedweightmanagementinanatrialfibrillationcohort:a
.
intervaltrainingfit?CanJCardiol2016;32:485(cid:2)494. . long-termfollow-upstudy(LEGACY).JAmCollCardiol2015;65:2159(cid:2)2169.
.
273. Gomes Neto M, Duraes AR, Conceicao LSR, Saquetto MB, Ellingsen O, .. 295.Hollekim-StrandSM,BjorgaasMR,AlbrektsenG,TjonnaAE,WisloffU,Ingul
CarvalhoVO.Highintensityintervaltrainingversusmoderateintensitycontinu- .. CB. High-intensity interval exercise effectively improves cardiac function in
.
oustrainingonexercisecapacityandqualityoflifeinpatientswithheartfailure . patientswithtype2diabetesmellitusanddiastolicdysfunction:arandomized
.
with reduced ejection fraction: a systematic review and meta-analysis. Int J . controlledtrial.JAmCollCardiol2014;64:1758(cid:2)1760.
.
Cardiol2018;261:134(cid:2)141. .. 296.Angadi SS, Mookadam F, Lee CD, Tucker WJ, Haykowsky MJ, Gaesser GA.
274. Cornelis J, Beckers P, Taeymans J, Vrints C, Vissers D. Comparing exercise .. High-intensityintervaltrainingvs.moderate-intensitycontinuousexercisetrain-
.
trainingmodalitiesinheartfailure:asystematicreviewandmeta-analysis.IntJ . inginheartfailurewithpreservedejectionfraction:apilotstudy.JApplPhysiol
.
Cardiol2016;221:867(cid:2)876. .. 2015;119:753(cid:2)758.
275. ConraadsVM,BeckersPJ.Exercisetraininginheartfailure:practicalguidance. .. 297.Pathak RK, Elliott A, Middeldorp ME, Meredith M, Mehta AB, Mahajan R,
.
Heart2010;96:2025(cid:2)2031. . HendriksJML,TwomeyD,KalmanJM,AbhayaratnaWP,LauDH,SandersP.
.
276. Williams MA, Haskell WL, Ades PA, Amsterdam EA, Bittner V, Franklin . ImpactofCARDIOrespiratoryFITnessonarrhythmiarecurrenceinobeseindi-
.
BA, Gulanick M, Laing ST, Stewart KJ. Resistance exercise in individuals .. viduals with atrial fibrillation: the CARDIO-FIT Study. J Am Coll Cardiol
with and without cardiovascular disease: 2007 update: a scientific . 2015;66:985(cid:2)996.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 72 ---
88 ESCGuidelines
.
.
298. HowdenEJ,SarmaS,LawleyJS,OpondoM,CornwellW,StollerD,UreyMA, . positionstatement:recommendationsfortheindicationandinterpretationof
.
Adams-HuetB,LevineBD.Reversingthecardiaceffectsofsedentaryagingin . cardiovascular imaging in the evaluation of the athlete’s heart. Eur Heart J
.
middleage(cid:2)arandomizedcontrolledtrial:implicationsforheartfailurepre- .. 2018;39:1949(cid:2)1969.
vention.Circulation2018;137:1549(cid:2)1560. .. 320.VermaS,SiuSC.Aorticdilatationinpatientswithbicuspidaorticvalve.NEnglJ
.
299. EdelmannF,WachterR,SchmidtAG,Kraigher-KrainerE,ColantonioC,Kamke . Med2014;370:1920(cid:2)1929.
.
W,DuvinageA,StahrenbergR,DurstewitzK,LofflerM,DungenH-D,Tschope .. 321.Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM,
C,Herrmann-LingenC,HalleM,HasenfussG,GelbrichG,PieskeB.Effectof .. EidemB,EdwardsWD,SundtTM3rd,Enriquez-SaranoM.Incidenceofaortic
.
spironolactoneondiastolicfunctionandexercisecapacityinpatientswithheart . complications in patients with bicuspid aortic valves. JAMA
.
failurewithpreservedejectionfraction:theAldo-DHFrandomizedcontrolled . 2011;306:1104(cid:2)1112.
.
trial.JAMA2013;309:781(cid:2)791. .. 322.HarrisKM,TungM,HaasTS,MaronBJ.Under-recognitionofaorticandaortic
300. GivertzMM,HartleyLH,ColucciWS.Long-termsequentialchangesinexercise .. valvediseaseandtheriskforsuddendeathincompetitiveathletes.JAmColl
.
capacity and chronotropic responsiveness after cardiac transplantation. . Cardiol2015;65:860(cid:2)862.
.
Circulation1997;96:232(cid:2)237. .. 323.SpataroA,PellicciaA,RizzoM,BiffiA,MasazzaG,PigozziF.Thenaturalcourse
301. HabedankD,EwertR,HummelM,WenselR,HetzerR,AnkerSD.Changesin .. ofbicuspidaorticvalveinathletes.IntJSportsMed2008;29:81(cid:2)85.
.
exercisecapacity,ventilation,andbodyweightfollowinghearttransplantation. . 324.TzemosN,TherrienJ,YipJ,ThanassoulisG,TremblayS,JamorskiMT,Webb
.
EurJHeartFail2007;9:310(cid:2)316. . GD, Siu SC. Outcomes in adults with bicuspid aortic valves. JAMA
.
302. MandakJS,AaronsonKD,ManciniDM.Serialassessmentofexercisecapacity .. 2008;300:1317(cid:2)1325.
afterhearttransplantation.JHeartLungTransplant1995;14:468(cid:2)478. .. 325.BoraitaA,Morales-AcunaF,Marina-BreysseM,HerasM-E,CandaA,Fuentes
.
303. GrupperA,GewirtzH,KushwahaS.Reinnervationpost-hearttransplantation. . M-E, Chacon A, Diaz-Gonzalez L, Rabadan M, Parra Laca B, Perez deIsla L,
.
EurHeartJ2018;39:1799(cid:2)1806. . TunonJ.Bicuspidaorticvalvebehaviourineliteathletes.EurHeartJCardiovasc
.
304. Tucker WJ, Beaudry RI, Samuel TJ, Nelson MD, Halle M, Baggish AL, .. Imaging2019;20:772(cid:2)780.
Haykowsky MJ. Performance limitations in heart transplant recipients. Exerc .. 326.BonowRO,NishimuraRA,ThompsonPD,UdelsonJE.Eligibilityanddisqualifi-
.
SportSciRev2018;46:144(cid:2)151. . cation recommendations for competitive athletes with cardiovascular abnor-
.
305. AndersonL,NguyenTT,DallCH,BurgessL,BridgesC,TaylorRS.Exercise- .. malities:TaskForce5:Valvularheartdisease:ascientificstatementfromthe
based cardiac rehabilitation in heart transplant recipients. Cochrane Database .. American Heart Association and American College of Cardiology. Circulation
.
SystRev2017;4:CD012264. . 2015;132:e292(cid:2)e297.
.
306. EsefeldK,FrickeH,HaykowskyM,HalleM.Ultra-enduranceexerciseinaheart . 327.PellicciaA,MaronBJ,CulassoF,SpataroA,CaselliG.Athlete’sheartinwomen.
.
transplantathlete:influenceonmyocardialfunctionandbiomarkers.EurJPrev .. Echocardiographiccharacterizationofhighlytrainedelitefemaleathletes.JAMA
Cardiol2020;27:885(cid:2)887.doi:10.1177/2047487318808636.Epub2018Nov5. .. 1996;276:211(cid:2)215.
.
307. Rosenbaum AN, Kremers WK, Schirger JA, Thomas RJ, Squires RW, Allison . 328.Delling FN, Rong J, Larson MG, Lehman B, Osypiuk E, Stantchev P,
.
TG, Daly RC, Kushwaha SS, Edwards BS. Association between early cardiac . SlaugenhauptSA,BenjaminEJ,LevineRA,VasanRS.Familialclusteringofmitral
.
rehabilitationandlong-termsurvivalincardiactransplantrecipients.MayoClin .. valveprolapseinthecommunity.Circulation2015;131:263(cid:2)268.
.
Proc2016;91:149(cid:2)156. . 329.Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B,
.
308. Bachmann JM, Shah AS, DuncanMS, Greevy RAJ, Graves AJ, NiS, OoiHH, . BenjaminEJ.Prevalenceandclinicaloutcomeofmitral-valveprolapse.NEnglJ
.
Wang TJ, Thomas RJ, Whooley MA, Freiberg MS. Cardiac rehabilitation and .. Med1999;341:1(cid:2)7.
readmissions after heart transplantation. J Heart Lung Transplant .. 330.JeresatyRM.Mitralvalveprolapse:definitionandimplicationsinathletes.JAm
.
2018;37:467(cid:2)476. . CollCardiol1986;7:231(cid:2)236.
.
309. Haykowsky MJF, Riess KJ, Baggish AL. Heart transplant recipient finishes the . 331.AvierinosJ-F,GershBJ,MeltonLJ3rd,BaileyKR,ShubC,NishimuraRA,Tajik
.
118th Boston Marathon 27 years post-surgery. J Heart Lung Transplant .. AJ,Enriquez-SaranoM.Naturalhistoryofasymptomaticmitralvalveprolapsein
2014;33:1197. .. thecommunity.Circulation2002;106:1355(cid:2)1361.
.
310. HaykowskyMJ,HalleM,BaggishA.Upperlimitsofaerobicpowerandperform- . 332.BassoC,PerazzoloMarraM,RizzoS,DeLazzariM,GiorgiB,CiprianiA,Frigo
.
ance in heart transplant recipients: legacy effect of prior endurance training. .. AC, Rigato I, Migliore F, Pilichou K, Bertaglia E, Cacciavillani L, Bauce B,
Circulation2018;137:650(cid:2)652. .. CorradoD,ThieneG,IlicetoS.Arrhythmicmitralvalveprolapseandsudden
.
311. Nytrøen K, Gullestad L. Exercise after heart transplantation: an overview. . cardiacdeath.Circulation2015;132:556(cid:2)566.
.
WorldJTransplant2013;3:78(cid:2)90. . 333.DejgaardLA,SkjolsvikET,LieOH,RibeM,StokkeMK,HegbomF,Scheirlynck
.
312. RustadLA,NytrøenK,AmundsenBH,GullestadL,AakhusS.Oneyearofhigh- .. ES,GjertsenE,AndresenK,Helle-ValleTM,HoppE,EdvardsenT,HaugaaKH.
intensity interval training improves exercise capacity, but not left ventricular .. The mitral annulus disjunction arrhythmic syndrome. J Am Coll Cardiol
.
functioninstablehearttransplantrecipients:arandomisedcontrolledtrial.EurJ . 2018;72:1600(cid:2)1609. .
PrevCardiol2012;21:181(cid:2)191. . 334.Perazzolo Marra M, Basso C, De Lazzari M, Rizzo S, Cipriani A, Giorgi B,
. 313. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, .. LacognataC,RigatoI,MiglioreF,PilichouK,CacciavillaniL,BertagliaE,Frigo
LancellottiP,LansacE,RodriguezMu~nozD,RosenhekR,Sjo¨grenJ,TornosMas .. AC,BauceB,CorradoD,ThieneG,IlicetoS.Morphofunctionalabnormalities
.
P,VahanianA,WaltherT,WendlerO,WindeckerS,ZamoranoJL.2017ESC/ . ofmitralannulusandarrhythmicmitralvalveprolapse.CircCardiovascImaging
.
EACTS Guidelines forthe management of valvular heart disease. Eur Heart J .. 2016;9:e005030.
2017;38:2739(cid:2)2791. .. 335.CristinaB,SabinoI,GaetanoT,MartinaPM.Mitralvalveprolapse,ventricular
.
314. RosenhekR,RaderF,KlaarU,GabrielH,KrejcM,KalbeckD,SchemperM, . arrhythmias,andsuddendeath.Circulation2019;140:952(cid:2)964.
.
Maurer G, Baumgartner H. Outcome of watchful waiting in asymptomatic . 336.GatiS,MalhotraA,SharmaS.Exerciserecommendationsinpatientswithvalvu-
.
severemitralregurgitation.Circulation2006;113:2238(cid:2)2244. .. larheartdisease.Heart2019;105:106(cid:2)110.
315. BaumgartnerHC,HungJC-C,BermejoJ,ChambersJB,EdvardsenT,Goldstein .. 337.Caselli S, Mango F, Clark J, Pandian NG, Corrado D, Autore C, Pelliccia A.
.
S,LancellottiP,LeFevreM,MillerFJ,OttoCM.Recommendationsontheecho- . Prevalence and clinical outcome of athletes with mitral valve prolapse.
.
cardiographicassessment ofaorticvalvestenosis: afocusedupdatefromthe .. Circulation2018;137:2080(cid:2)2082.
EuropeanAssociationofCardiovascularImagingandtheAmericanSocietyof .. 338.ErmakovS,GulharR,LimL,BibbyD,FangQ,NahG,AbrahamTP,Schiller
.
Echocardiography.EurHeartJCardiovascImaging2017;18:254(cid:2)275. . NB,DellingFN.Leftventricularmechanicaldispersionpredictsarrhythmicrisk
.
316. ClavelM-A,BurwashIG,PibarotP.Cardiacimagingforassessinglow-gradient . inmitralvalveprolapse.Heart2019;105:1063(cid:2)1069.
.
severeaorticstenosis.JACCCardiovascImaging2017;10:185(cid:2)202. .. 339.GrovesPH,LewisNP,IkramS,MaireR,HallRJ.Reducedexercisecapacityin
317. MoriseAP.Exercisetestinginnonatheroscleroticheartdisease:hypertrophic .. patients with tricuspid regurgitation after successful mitral valve replacement
.
cardiomyopathy, valvular heart disease, and arrhythmias. Circulation . forrheumaticmitralvalvedisease.BrHeartJ1991;66:295(cid:2)301.
.
2011;123:216(cid:2)225. . 340.AndersenMJ,NishimuraRA,BorlaugBA.Thehemodynamicbasisofexercise
.
318. Lee JKT, Franzone A, Lanz J, Siontis GCM, Stortecky S, Grani C, Roost E, .. intoleranceintricuspidregurgitation.CircHeartFail2014;7:911(cid:2)917.
Windecker S, Pilgrim T. Early detection of subclinical myocardial damage in .. 341.Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RDi, Eggebrecht H,
.
chronicaorticregurgitationandstrategiesfortimelytreatmentofasymptomatic . EvangelistaA,FalkV,FrankH,GaemperliO,GrabenwogerM,HaverichA,Iung
.
patients.Circulation2018;137:184(cid:2)196. .. B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U,
319. Pelliccia A, Caselli S, Sharma S, Basso C, Bax JJ, Corrado D, D’Andrea A, .. SirnesPA,AllmenRSvon,VrintsCJM.2014ESCGuidelinesonthediagnosis
.
D’Ascenzi F, Di Paolo FM, Edvardsen T, Gati S, Galderisi M, Heidbuchel H, . andtreatmentofaorticdiseases:documentcoveringacuteandchronicaortic
.
NchimiA,NiemanK,PapadakisM,PisicchioC,SchmiedC,PopescuBA,Habib . diseasesofthethoracicandabdominalaortaoftheadult.TheTaskForcefor
.
G,GrobbeeD,LancellottiP.EuropeanAssociation of PreventiveCardiology .. the Diagnosis and Treatment of Aortic Diseases of the European Society of
(EAPC) and European Association of Cardiovascular Imaging (EACVI) joint . Cardiology(ESC).EurHeartJ2014;35:2873(cid:2)2926.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 73 ---
ESCGuidelines 89
.
.
342. BravermanAC,HarrisKM,KovacsRJ,MaronBJ.EligibilityandDisqualification . 360.PellicciaA,LemmeE,MaestriniV,DiPaoloFM,PisicchioC,DiGioiaG,Caselli
.
Recommendations for Competitive Athletes With Cardiovascular . S.Doessportparticipationworsentheclinicalcourseofhypertrophiccardio-
.
Abnormalities:TaskForce7:Aorticdiseases,includingMarfansyndrome:asci- .. myopathy? Clinical outcome of hypertrophic cardiomyopathy in athletes.
entificstatementfromtheAmericanHeartAssociationandAmericanCollege .. Circulation2018;137:531(cid:2)533.
.
ofCardiology.JAmCollCardiol2015;66:2398(cid:2)2405. . 361.FinocchiaroG,PapadakisM,TanzarellaG,DhutiaH,MilesC,TomeM,Behr
.
343. HiratzkaLF,BakrisGL,BeckmanJA,BersinRM,CarrVF,CaseyDEJ,EagleKA, .. ER, Sharma S,Sheppard MN.Suddendeathcan bethe first manifestation of
Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, .. hypertrophiccardiomyopathy:datafromaUnitedKingdomPathologyRegistry.
.
Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM. 2010 . JACCClinElectrophysiol2019;5:252(cid:2)254.
.
ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diag- . 362.KlempfnerR,KamermanT,SchwammenthalE,NahshonA,HayI,Goldenberg
.
nosisandmanagementofpatientswiththoracicaorticdisease:areportofthe .. I, Dov F, Arad M. Efficacy of exercise training in symptomatic patients with
AmericanCollegeofCardiologyFoundation/AmericanHeartAssociationTask .. hypertrophiccardiomyopathy:resultsofastructuredexercisetrainingprogram
.
ForceonPracticeGuidelines.Circulation2010;121:e266(cid:2)369. . inacardiacrehabilitationcenter.EurJPrevCardiol2015;22:13(cid:2)19.
.
344. Boraita A, Heras M-E, Morales F, Marina-Breysse M, Canda A, Rabadan M, . 363.Saberi S, Wheeler M, Bragg-Gresham J, Hornsby W, Agarwal PP, Attili A,
.
BarriopedroM-I,VarelaA,delaRosaA,TunonJ.Referencevaluesofaortic .. ConcannonM,DriesAM,ShmargadY,SalisburyH,KumarS,HerreraJJ,Myers
.
rootinmaleandfemalewhiteeliteathletesaccordingtosport.CircCardiovasc . J,HelmsAS,AshleyEA,DaySM.Effectofmoderate-intensityexercisetraining
.
Imaging2016;9:e005292. . onpeakoxygenconsumptioninpatientswithhypertrophiccardiomyopathy:a
.
345. IskandarA,ThompsonPD.Ameta-analysisofaorticrootsizeineliteathletes. .. randomizedclinicaltrial.JAMA2017;317:1349(cid:2)1357.
Circulation2013;127:791(cid:2)798. .. 364.SheikhN,PapadakisM,PanoulasVF,PrakashK,MillarL,AdamiP,ZaidiA,Gati
.
346. Pelliccia A, Di Paolo FM, De Blasiis E, Quattrini FM, Pisicchio C, Guerra E, . S,WilsonM,Carr-WhiteG,Tome´ MTE,BehrER,SharmaS.Comparisonof
.
CulassoF,MaronBJ.Prevalenceandclinicalsignificanceofaorticrootdilation . hypertrophic cardiomyopathy in Afro-Caribbean versus white patients in the
.
inhighlytrainedcompetitiveathletes.Circulation2010;122:698(cid:2)706. .. UK.Heart2016;102:1797(cid:2)1804.
347. GatiS,MalhotraA,SedgwickC,PapamichaelN,DhutiaH,SharmaR,ChildAH, .. 365.SorajjaP,OmmenSR,NishimuraRA,GershBJ,BergerPB,TajikAJ.Adverse
.
PapadakisM,SharmaS.Prevalenceandprogressionofaorticrootdilatationin . prognosis of patients with hypertrophic cardiomyopathy who have epicardial
.
highlytrainedyoungathletes.Heart2019;105:920(cid:2)925. .. coronaryarterydisease.Circulation2003;108:2342(cid:2)2348.
348. Benninghoven D, Hamann D, von Kodolitsch Y, Rybczynski M, Lechinger J, .. 366.AdabagAS,CaseySA,KuskowskiMA,ZenovichAG,MaronBJ.Spectrumand
.
Schroeder F, Vogler M, Hoberg E. Inpatient rehabilitation for adult patients . prognosticsignificanceofarrhythmiasonambulatoryHolterelectrocardiogram
.
with Marfan syndrome: an observational pilot study. Orphanet J Rare Dis . inhypertrophiccardiomyopathy.JAmCollCardiol2005;45:697(cid:2)704.
.
2017;12:127. .. 367.Mentias A, Raeisi-Giglou P, Smedira NG, Feng K, Sato K, Wazni O, Kanj M,
349. ThijssenCGE,BonsLR,Go¨kalpAL,VanKimmenadeRRJ,MokhlesMM,Pelliccia .. FlammSD,ThamilarasanM,PopovicZB,LeverHM,DesaiMY.Lategadolinium
.
A, Takkenberg JJM, Roos-Hesselink JW. Exercise and sports participation in . enhancementinpatientswithhypertrophiccardiomyopathyandpreservedsys-
.
patients with thoracic aortic disease: a review. Expert Rev Cardiovasc Ther . tolicfunction.JAmCollCardiol2018;72:857(cid:2)870.
.
2019;17:251(cid:2)266. .. 368.WengZ,YaoJ,ChanRH,HeJ,YangX,ZhouY,HeY.Prognosticvalueof
.
350. ItagakiR,KimuraN,ItohS,YamaguchiA,AdachiH.Acutetypeaaorticdissec- . LGE-CMRinHCM:ameta-analysis.JACCCardiovascImaging2016;9:1392(cid:2)1402.
.
tionassociatedwithasportingactivity.SurgToday2017;47:1163(cid:2)1171. . 369.Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR,
.
351. Stefani L, Galanti G, Toncelli L, Manetti P, Vono MC, Rizzo M, Maffulli N. .. GrunerC,CreanAM,RakowskiH,UdelsonJE,RowinE,LombardiM,CecchiF,
Bicuspidaorticvalveincompetitiveathletes.BrJSportsMed2008;42:31(cid:2)5;dis- .. TomberliB,SpiritoP,FormisanoF,BiaginiE,RapezziC,DeCeccoCN,Autore
.
cussion35. . C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS.
.
352. Gibson C, Nielsen C, Alex R, Cooper K, Farney M, Gaufin D, Cui JZ, van . Prognosticvalueofquantitativecontrast-enhancedcardiovascularmagneticres-
.
BreemenC,BroderickTL,Vallejo-EliasJ,EsfandiareiM.Mildaerobicexercise .. onancefortheevaluationofsuddendeathriskinpatientswithhypertrophic
blocks elastin fiber fragmentation and aortic dilatation in a mouse model of .. cardiomyopathy.Circulation2014;130:484(cid:2)495.
.
Marfansyndromeassociatedaorticaneurysm.JApplPhysiol2017;123:147(cid:2)160. . 370.IsmailTF,JabbourA,GulatiA,MallorieA,RazaS,CowlingTE,DasB,KhwajaJ,
.
353. Mas-StachurskaA,SiegertA-M,BatlleM,BlancoGorbenkoDel,Meirelles,D, .. Alpendurada FD, Wage R, Roughton M, McKenna WJ, Moon JC, Varnava A,
Rubies,T,Bonorino,C,Serra-Peinado,F,Bijnens,C,Baudin,B,Sitges,J,Mont, .. ShakespeareC,CowieMR,CookSA,ElliottP,O’HanlonR,PennellDJ,Prasad
.
M,Guasch,LEgea,EG.Cardiovascularbenefitsofmoderateexercisetraining . SK.Roleoflategadoliniumenhancementcardiovascularmagneticresonancein
.
in Marfan syndrome: insights from an animal model. J Am Heart Assoc . the risk stratification of hypertrophic cardiomyopathy. Heart
.
2017;6:pii:e006438. .. 2014;100:1851(cid:2)1858.
354. MaronBJ,DoererJJ,HaasTS,TierneyDM,MuellerFO.Suddendeathsinyoung .. 371.OlivottoI,MaronBJ,MontereggiA,MazzuoliF,DolaraA,CecchiF.Prognostic
.
competitiveathletesanalysisof1866deathsintheUnitedStates,1980(cid:2)2006. . value of systemic blood pressure response during exercise in a community- .
Circulation2009;119:1085(cid:2)1092. . basedpatientpopulationwithhypertrophiccardiomyopathy.JAmCollCardiol
. 355. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, .. 1999;33:2044(cid:2)2051.
HagegeAA,LafontA,LimongelliG,MahrholdtH,McKennaWJ,MogensenJ, .. 372.Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ.
.
Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, . Prospectiveprognosticassessmentofbloodpressureresponseduringexercise
.
TillmannsC,WatkinsH.2014ESCGuidelinesondiagnosisandmanagementof .. inpatientswithhypertrophiccardiomyopathy.Circulation1997;96:2987(cid:2)2991.
hypertrophic cardiomyopathy: the Task Force for the diagnosis and manage- .. 373.O’MahonyC,JichiF,PavlouM,MonserratL,AnastasakisA,RapezziC,BiaginiE,
.
mentofhypertrophiccardiomyopathyoftheEuropeanSocietyofCardiology . GimenoJR,LimongelliG,McKennaWJ,OmarRZ,ElliottPM.Anovelclinical
.
(ESC).EurHeartJ2014;35:2733(cid:2)2779. . riskpredictionmodelforsuddencardiacdeathinhypertrophiccardiomyopathy
.
356. MaronBJ,ChaitmanBR,AckermanMJ,Baye´sdeLunaA,CorradoD,Crosson .. (HCMrisk-SCD).EurHeartJ2014;35:2010(cid:2)2020.
JE, Deal BJ, Driscoll DJ, Estes NAM, Ara(cid:3)ujo CGS, Liang DH, Mitten MJ, .. 374.SpiritoP,AutoreC,FormisanoF,AssenzaGE,BiaginiE,HaasTS,BongioanniS,
.
MyerburgRJ,PellicciaA,ThompsonPD,TowbinJAVCS.WorkingGroupsof . SemsarianC,DevotoE,Musumeci B,LaiF,YeatesL,ConteMR,RapezziC,
.
theAmericanHeartAssociationCommitteeonExerciseCardiacRehabilitation . BoniL,MaronBJ.Riskofsuddendeathandoutcomeinpatientswithhypertro-
.
andPrevention,CouncilsonClinicalCardiologyandCardiovascularDiseasein .. phiccardiomyopathywithbenignpresentationandwithoutriskfactors.AmJ
.
theYoung.Recommendationsforphysicalactivityandrecreationalsportspar- . Cardiol2014;113:1550(cid:2)1555.
.
ticipation.Circulation2004;109:2807(cid:2)2816. . 375.MarcusFI,McKennaWJ,SherrillD,BassoC,BauceB,BluemkeDA,CalkinsH,
.
357. Maron BJ, Ackerman MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE. .. Corrado D, Cox MGPJ, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A,
TaskForce4:HCMandothercardiomyopathies,mitralvalveprolapse,myocar- .. PicardMH,ProtonotariosN,SaffitzJE,SanbornDMY,SteinbergJS,TandriH,
.
ditis,andMarfansyndrome.JAmCollCardiol2005;45:1340(cid:2)1345. . Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of
.
358. Dejgaard LA, Haland TF, Lie OH, Ribe M, Bjune T, Leren IS, Berge KE, . arrhythmogenicrightventricularcardiomyopathy/dysplasia:proposedmodifica-
.
EdvardsenT,HaugaaKH.Vigorousexerciseinpatientswithhypertrophiccardi- .. tionofthetaskforcecriteria.Circulation2010;121:1533(cid:2)1541.
omyopathy.IntJCardiol2018;250:157(cid:2)163. .. 376.MilesC,FinocchiaroG,PapadakisM,GrayB,WestabyJ,EnsamB,BasuJ,Parry-
.
359. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, . WilliamsG,PapatheodorouE,PatersonC,MalhotraA,RobertusJL,WareJS,
.
CalkinsH,EstesNAM,LinkMS,MaronBJ,MarcusF,ScheinmanM,WilkoffBL, .. Cook SA, Asimaki A, Witney A, Chis Ster I, Tome M, Sharma S, Behr ER,
ZipesDP,BerulCI,ChengA,JordaensL,LawI,LoomisM,WillemsR,BarthC, .. SheppardMN.Suddendeathandleftventricularinvolvementinarrhythmogenic
.
Broos K, Brandt C, Dziura J, Li F, Simone L, Vandenberghe K, Cannom D. . cardiomyopathy.Circulation2019;139:1786(cid:2)1797.
.
Safetyofsportsforathleteswithimplantablecardioverter-defibrillators:long- . 377.Sen-ChowdhryS,SyrrisP,PrasadSK,HughesSE,MerrifieldR,WardD,Pennell
.
term results of a prospective multinational registry. Circulation .. DJ, McKenna WJ. Left-dominant arrhythmogenic cardiomyopathy: an under-
2017;135:2310(cid:2)2312. . recognizedclinicalentity.JAmCollCardiol2008;52:2175(cid:2)2187.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 74 ---
90 ESCGuidelines
.
.
378. Corrado D, van Tintelen PJ, McKenna WJ, Hauer RNW, Anastastakis A, . 393.OrgeronGM,JamesCA,TeRieleA,TichnellC,MurrayB,BhonsaleA,Kamel
.
Asimaki A, Basso C, Bauce B, Brunckhorst C, Bucciarelli-Ducci C, Duru F, . IR, Zimmerman SL, Judge DP, Crosson J, Tandri H, Calkins H. Implantable
.
ElliottP,HamiltonRM,HaugaaKH,JamesCA,JudgeD,LinkMS,MarchlinskiFE, .. cardioverter-defibrillatortherapyinarrhythmogenicrightventriculardysplasia/
MazzantiA,MestroniL,PantazisA,PellicciaA,MarraMP,PilichouK,Platonov .. cardiomyopathy: predictors of appropriate therapy, outcomes, and complica-
.
PGA,ProtonotariosA,RampazzoA,SaffitzJE,SagunerAM,SchmiedC,Sharma . tions.JAmHeartAssoc2017;6.
.
S,TandriH,TeRieleASJM,ThieneG,TsatsopoulouA,ZarebaW,ZorziA, .. 394.Sadjadieh G, Jabbari R, Risgaard B, Olesen MS, Haunso S, Tfelt-Hansen J,
WichterT,MarcusFI,CalkinsH.Arrhythmogenicrightventricularcardiomyop- .. WinkelBG.Nationwide(Denmark)studyofsymptomsprecedingsuddendeath
.
athy:evaluationofthecurrentdiagnosticcriteriaanddifferentialdiagnosis.Eur . due to arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol
.
HeartJ2020;41:1414(cid:2)1429. . 2014;113:1250(cid:2)1254.
.
379. CalkinsH,CorradoD,MarcusF.Riskstratificationinarrhythmogenicrightven- .. 395.Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D,
tricularcardiomyopathy.Circulation2017;136:2068(cid:2)2082. .. TedfordR,RussellSD,AbrahamT,TandriH,JudgeDP,CalkinsH.Incidence
.
380. Cadrin-Tourigny J, Bosman LP, Nozza A, Wang W, Tadros R, Bhonsale A, . andpredictorsofimplantablecardioverter-defibrillatortherapyinpatientswith
.
BourfissM,FortierA,LieØH,SagunerAM,SvenssonA,AndorinA,TichnellC, . arrhythmogenicrightventriculardysplasia/cardiomyopathyundergoingimplant-
.
MurrayB,ZeppenfeldK,vandenBergMP,AsselbergsFW,WildeAAM,Krahn .. able cardioverter-defibrillator implantation for primary prevention. J Am Coll
.
AD,TalajicM,RivardL,ChelkoS,ZimmermanSL,KamelIR,CrossonJE,Judge . Cardiol2011;58:1485(cid:2)1496.
.
DP,YapS-C,vanderHeijdenJF,TandriH,JongbloedJDH,GuertinM-C,van . 396.LinkMS,LaidlawD,PolonskyB,ZarebaW,McNittS,GearK,MarcusF,Estes
.
TintelenJP,PlatonovPG,DuruF,HaugaaKH,KhairyP,HauerRNW,Calkins .. NAM 3rd. Ventricular arrhythmias in the North American multidisciplinary
H,teRieleASJM,JamesCA.Anewpredictionmodelforventriculararrhyth- .. study of ARVC: predictors, characteristics, and treatment. J Am Coll Cardiol
.
mias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J . 2014;64:119(cid:2)125.
.
2019;40:1850(cid:2)1858. . 397.PicciniJP,DalalD,RoguinA,BommaC,ChengA,PrakasaK,DongJ,Tichnell
.
381. Maupain C, Badenco N, Pousset F, Waintraub X, Duthoit G, Chastre T, .. C,JamesC,RussellS,CrossonJ,BergerRD,MarineJE,TomaselliG,CalkinsH.
HimbertC,HebertJ-L,FrankR,Hidden-LucetF,GandjbakhchE.Riskstratifica- .. Predictors of appropriate implantable defibrillator therapies in patients with
.
tion in arrhythmogenic right ventricular cardiomyopathy/dysplasia without an . arrhythmogenicrightventriculardysplasia.HeartRhythm2005;2:1188(cid:2)1194.
.
implantablecardioverter-defibrillator.JACCClinElectrophysiol2018;4:757(cid:2)768. .. 398.Saguner AM, Vecchiati A, Baldinger SH, Rueger S, Medeiros-Domingo A,
382. Kirchhof P, Fabritz L, Zwiener M, Witt H, Schafers M, Zellerhoff S, Paul M, .. Mueller-Burri AS, Haegeli LM, Biaggi P, Manka R, Luscher TF, Fontaine G,
.
AthaiT,HillerK-H,BabaHA,BreithardtG,RuizP,WichterT,LevkauB.Age- . Delacretaz E, Jenni R, Held L, Brunckhorst C, Duru F, Tanner FC. Different
.
andtraining-dependentdevelopmentofarrhythmogenicrightventricularcardi- . prognostic value of functionalright ventricular parameters inarrhythmogenic
.
omyopathy in heterozygous plakoglobin-deficient mice. Circulation .. right ventricular cardiomyopathy/dysplasia. Circ Cardiovasc Imaging
2006;114:1799(cid:2)1806. .. 2014;7:230(cid:2)239.
.
383. BenitoB,Gay-JordiG,Serrano-MollarA,GuaschE,ShiY,TardifJ-C,BrugadaJ, . 399.Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TDT,
.
NattelS,MontL.Cardiacarrhythmogenicremodelinginaratmodeloflong- . Soeparwata R, Block M, Borggrefe M, Scheld HH, Breithardt G, Bocker D.
.
termintensiveexercisetraining.Circulation2011;123:13(cid:2)22. .. Implantablecardioverter/defibrillatortherapyinarrhythmogenicrightventricu-
.
384. JamesCA,BhonsaleA,TichnellC,MurrayB,RussellSD,TandriH,TedfordRJ, . larcardiomyopathy:single-centerexperienceoflong-termfollow-upandcom-
.
JudgeDP,CalkinsH.Exerciseincreasesage-relatedpenetranceandarrhythmic . plicationsin60patients.Circulation2004;109:1503(cid:2)1508.
.
risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated .. 400.Rigato I, Bauce B, Rampazzo A, Zorzi A, Pilichou K, Mazzotti E, Migliore F,
desmosomalmutationcarriers.JAmCollCardiol2013;62:1290(cid:2)1297. .. MarraMP,LorenzonA,DeBortoliM,CaloreM,NavaA,DalientoL,Gregori
.
385. RuwaldA-C,MarcusF,EstesNAM3rd,LinkM,McNittS,PolonskyB,Calkins . D,IlicetoS,ThieneG,BassoC,CorradoD.Compoundanddigenichetero-
.
H,TowbinJA,MossAJ,ZarebaW.Associationofcompetitiveandrecreational . zygositypredictslifetimearrhythmicoutcomeandsuddencardiacdeathindes-
.
sport participation with cardiac events in patients with arrhythmogenic right .. mosomal gene-related arrhythmogenic right ventricular cardiomyopathy. Circ
ventricularcardiomyopathy:resultsfromtheNorthAmericanmultidisciplinary .. CardiovascGenet2013;6:533(cid:2)542.
.
study of arrhythmogenic right ventricular cardiomyopath. Eur Heart J . 401.GandjbakhchE,RedheuilA,PoussetF,CharronP,FrankR.Clinicaldiagnosis,
.
2015;36:1735(cid:2)1743. .. imaging,andgeneticsofarrhythmogenicrightventricularcardiomyopathy/dys-
386. Saberniak J, Hasselberg NE, Borgquist R, Platonov PG, Sarvari SI, Smith H-J, .. plasia:JACCstate-of-the-artreview.JAmCollCardiol2018;72:784(cid:2)804.
.
RibeM,HolstAG,EdvardsenT,HaugaaKH.Vigorousphysicalactivityimpairs . 402.Merner ND, Hodgkinson KA, Haywood AFM, Connors S, French VM,
.
myocardialfunctioninpatientswitharrhythmogenicrightventricularcardiomy- . Drenckhahn J-D, Kupprion C, Ramadanova K, Thierfelder L, McKenna W,
.
opathy and in mutation positive family members. Eur J Heart Fail .. Gallagher B, Morris-Larkin L, Bassett AS, Parfrey PS, Young T-L.
2014;16:1337(cid:2)1344. .. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant,
.
387. Sawant AC, Bhonsale A, te Riele ASJM, Tichnell C, Murray B, Russell SD, . lethalarrhythmicdisordercausedbyamissensemutationintheTMEM43gene. .
TandriH,TedfordRJ,JudgeDP,CalkinsH,JamesCA.Exercisehasadispropor- . AmJHumGenet2008;82:809(cid:2)821.
. tionateroleinthepathogenesisofarrhythmogenicrightventriculardysplasia/ .. 403.DhutiaH,MalhotraA,YeoTJ,SterIC,GabusV,SteriotisA,DoresH,Mellor
cardiomyopathyinpatients withoutdesmosomal mutations.JAmHeartAssoc .. G,Garc(cid:3)ıa-CorralesC,EnsamB,JayalapanV,EzzatVA,FinocchiaroG,GatiS,
.
2014;3:e001471. . PapadakisM,Tome-EstebanM,SharmaS.Inter-raterreliabilityanddownstream
.
388. Lie OH, Dejgaard LA, Saberniak J, Rootwelt C, Stokke MK, Edvardsen T, .. financial implications of electrocardiography screening in young athletes. Circ
Haugaa KH. Harmful effects of exercise intensity and exercise duration in .. CardiovascQualOutcomes2017;10:e003881.
.
patients with arrhythmogenic cardiomyopathy. JACC Clin Electrophysiol . 404.GatiS,RajaniR,Carr-WhiteGS,ChambersJB.Adultleftventricularnoncom-
.
2018;4:744(cid:2)753. . paction: reappraisal of current diagnostic imaging modalities. JACC Cardiovasc
.
389. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, .. Imaging2014;7:1266(cid:2)1275.
CalkinsH,EstesNAM,LinkMS,MaronBJ,MarcusF,ScheinmanM,WilkoffBL, .. 405.GatiS,ChandraN,BennettRL,ReedM,KervioG,PanoulasVF,GhaniS,Sheikh
.
ZipesDP,BerulCI,ChengA,LawI,LoomisM,BarthC,BrandtC,DziuraJ,Li . N,ZaidiA,WilsonM,PapadakisM,Carre´F,SharmaS.Increasedleftventricular
.
F, Cannom D. Safety of sports for athletes with implantable cardioverter- .. trabeculationinhighlytrainedathletes:doweneedmorestringentcriteriaforthe
defibrillators: results of a prospective, multinational registry. Circulation .. diagnosisofleftventricularnon-compactioninathletes?Heart2013;99:401(cid:2)408.
.
2013;127:2021(cid:2)2030. . 406.GatiS,PapadakisM,PapamichaelND,ZaidiA,SheikhN,ReedM,SharmaR,
.
390. DalalD,NasirK,BommaC,PrakasaK,TandriH,PicciniJ,RoguinA,TichnellC, . ThilaganathanB,SharmaS.Reversibledenovoleftventriculartrabeculationsin
.
JamesC,RussellSD,JudgeDP,AbrahamT,SpevakPJ,BluemkeDA,CalkinsH. .. pregnantwomen:implicationsforthediagnosisofleftventricularnoncompac-
Arrhythmogenic right ventricular dysplasia: a United States experience. .. tioninlow-riskpopulations.Circulation2014;130:475(cid:2)483.
.
Circulation2005;112:3823(cid:2)3832. . 407.ZemrakF,AhlmanMA,CapturG,MohiddinSA,Kawel-BoehmN,PrinceMR,
.
391. GuptaR,TichnellC,MurrayB,RizzoS,TeRieleA,TandriH,JudgeDP,Thiene . MoonJC,HundleyWG,LimaJAC,BluemkeDA,PetersenSE.Therelationship
.
G,BassoC,CalkinsH,JamesCA.Comparisonoffeaturesoffatalversusnonfa- .. ofleftventriculartrabeculationtoventricularfunctionandstructureovera9.5-
talcardiacarrestinpatientswitharrhythmogenicrightventriculardysplasia/car- .. yearfollow-up:theMESAstudy.JAmCollCardiol2014;64:1971(cid:2)1980.
.
diomyopathy.AmJCardiol2017;120:111(cid:2)117. . 408.CaselliS,FerreiraD,KanawatiE,DiPaoloF,PisicchioC,AttenhoferJostC,
.
392. CorradoD,CalkinsH,LinkMS,LeoniL,FavaleS,BevilacquaM,BassoC,Ward .. SpataroA,JenniR,PellicciaA.Prominentleftventriculartrabeculationsincom-
D,BorianiG,RicciR,PicciniJP,DalalD,SantiniM,BujaG,IlicetoS,EstesNAM .. petitiveathletes:aproposalforriskstratificationandmanagement.IntJCardiol
.
3rd,WichterT,McKennaWJ,ThieneG,MarcusFI.Prophylacticimplantable . 2016;223:590(cid:2)595.
.
defibrillatorinpatientswitharrhythmogenicrightventricularcardiomyopathy/ . 409.CaselliS,AttenhoferJostCH,JenniR,PellicciaA.Leftventricularnoncompac-
.
dysplasiaandnopriorventricularfibrillationorsustainedventriculartachycar- .. tiondiagnosisandmanagementrelevanttopre-participationscreeningofath-
dia.Circulation2010;122:1144(cid:2)1152. . letes.AmJCardiol2015;116:801(cid:2)808.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 75 ---
ESCGuidelines 91
.
.
410. GatiS,MerghaniA,SharmaS.Increasedleftventriculartrabeculationdoesnot . 426.PasottiM,KlersyC,PilottoA,MarzilianoN,RapezziC,SerioA,MannarinoS,
.
necessarily equate to left ventricular noncompaction in athletes. JAMA Intern . GambarinF,FavalliV,GrassoM,AgozzinoM,CampanaC,GavazziA,FeboO,
.
Med2015;175:1247. .. MariniM,LandolinaM,MortaraA,PiccoloG,ViganoM,TavazziL,ArbustiniE.
411. GatiS,SharmaS.Thedilemmasindiagnosingleftventricularnon-compactionin .. Long-termoutcomeandriskstratificationindilatedcardiolaminopathies.JAm
.
athletes.EurHeartJ2015;36:891(cid:2)893. . CollCardiol2008;52:1250(cid:2)1260.
.
412. PintoYM,ElliottPM,ArbustiniE,AdlerY,AnastasakisA,BohmM,DubocD, .. 427.Skjølsvik ET, Hasselberg NE, Dejgaard LA, Lie ØH, Andersen K, Holm T,
GimenoJ,deGrooteP,ImazioM,HeymansS,KlingelK,KomajdaM,Limongelli .. EdvardsenT,HaugaaKH.Exerciseisassociatedwithimpairedleftventricular
.
G, Linhart A, Mogensen J, Moon J, Pieper PG, Seferovic PM, Schueler S, . systolic function in patients with lamin A/C genotype. J Am Heart Assoc
.
Zamorano JL, Caforio ALP, Charron P. Proposal for a revised definition of . 2020;9:e012937.
.
dilatedcardiomyopathy,hypokineticnon-dilatedcardiomyopathy,anditsimpli- .. 428.KumarS,BaldingerSH,GandjbakhchE,MauryP,SellalJ-M,AndroulakisAFA,
cationsforclinicalpractice:apositionstatementoftheESCworkinggroupon .. WaintraubX,CharronP,RollinA,RichardP,StevensonWG,MacintyreCJ,Ho
.
myocardialandpericardialdiseases.EurHeartJ2016;37:1850(cid:2)1858. . CY,ThompsonT,VohraJK,KalmanJM,ZeppenfeldK,SacherF,TedrowUB,
.
413. Hasselberg NE, Haland TF, Saberniak J, Brekke PH, Berge KE, Leren TP, . LakdawalaNK.Long-termarrhythmicandnonarrhythmicoutcomesoflaminA/
.
EdvardsenT,HaugaaKH.LaminA/Ccardiomyopathy:youngonset,highpene- .. Cmutationcarriers.JAmCollCardiol2016;68:2299(cid:2)2307.
.
trance, and frequent need for heart transplantation. Eur Heart J . 429.vanRijsingenIAW,ArbustiniE,ElliottPM,MogensenJ,Hermans-vanAstJF,van
.
2018;39:853(cid:2)860. . derKooiAJ,vanTintelenJP,vandenBergMP,PilottoA,PasottiM,JenkinsS,
.
414. Ortiz-GengaMF,CuencaS,DalFerroM,ZorioE,Salgado-ArandaR,Climent .. RowlandC,AslamU,WildeAAM,PerrotA,PankuweitS,Zwinderman AH,
V, Padron-Barthe L, Duro-Aguado I, Jimenez-Jaimez J, Hidalgo-Olivares VM, .. CharronP,PintoYM.Riskfactorsformalignantventriculararrhythmiasinlamin
.
Garcia-Campo E, Lanzillo C, Suarez-Mier MP, Yonath H, Marcos-Alonso S, . A/C mutation carriers: a European cohort study. J Am Coll Cardiol
.
OchoaJP,SantomeJL,Garcia-GiustinianiD,Rodriguez-GarridoJL,Dominguez . 2012;59:493(cid:2)500.
.
F,MerloM,PalominoJ,PenaML,TrujilloJP,Martin-VilaA,StolfoD,MolinaP, .. 430.CaforioALP,PankuweitS,ArbustiniE,BassoC,Gimeno-BlanesJ,FelixSB,Fu
Lara-PezziE,Calvo-IglesiasFE,NofE,CaloL,Barriales-VillaR,Gimeno-Blanes .. M,HelioT,HeymansS,JahnsR,KlingelK,LinhartA,MaischB,McKennaW,
.
JR,AradM,Garcia-PaviaP,MonserratL.TruncatingFLNCmutationsareasso- . MogensenJ,PintoYM,RisticA,SchultheissH-P,SeggewissH,TavazziL,Thiene
.
ciated with high-risk dilated and arrhythmogenic cardiomyopathies. J Am Coll .. G,YilmazA,CharronP,ElliottPM.Currentstateofknowledgeonaetiology,
Cardiol2016;68:2440(cid:2)2451. .. diagnosis,management,andtherapyofmyocarditis:apositionstatementofthe
.
415. HallidayBP,ClelandJGF,GoldbergerJJ,PrasadSK.Personalizingriskstratifica- . EuropeanSocietyofCardiologyWorkingGrouponmyocardialandpericardial
.
tionforsuddendeathindilatedcardiomyopathy:thepast,present,andfuture. . diseases.EurHeartJ2013;34:2636(cid:2)2648.
.
Circulation2017;136:215(cid:2)231. .. 431.SinagraG,AnziniM,PereiraNL,BussaniR,FinocchiaroG,BartunekJ,MerloM.
416. HollowayCJ,DassS,SuttieJJ,RiderOJ,CoxP,CochlinLE,JacksonH,FastAM, .. Myocarditisinclinicalpractice.MayoClinProc2016;91:1256(cid:2)1266.
.
JohnsonAW,KaramitsosTD,NeubauerS,ClarkeK.Exercisetrainingindilated . 432.BreinholtJP,MoulikM,DreyerWJ,DenfieldSW,KimJJ,JefferiesJL,Rossano
.
cardiomyopathyimprovesrestandstresscardiacfunctionwithoutchangesin . JW, Gates CM, Clunie SK, Bowles KR, Kearney DL, Bowles NE, Towbin JA.
.
cardiachighenergyphosphatemetabolism.Heart2012;98:1083(cid:2)1090. .. Viralepidemiologicshiftininflammatoryheartdisease:theincreasinginvolve-
.
417. StolenKQ,KemppainenJ,UkkonenH,KalliokoskiKK,LuotolahtiM,Lehikoinen . ment of parvovirus B19 in the myocardium of pediatric cardiac transplant
.
P,HamalainenH,SaloT,AiraksinenKEJ,NuutilaP,KnuutiJ.Exercisetraining . patients.JHeartLungTransplant2010;29:739(cid:2)746.
.
improves biventricular oxidative metabolism and left ventricular efficiency in .. 433.YilmazA,KlingelK,KandolfR,SechtemU.Ageographicalmystery:docardio-
patientswithdilatedcardiomyopathy.JAmCollCardiol2003;41:460(cid:2)467. .. tropic viruses respect national borders? J Am Coll Cardiol 2008;52:82; author
.
418. Harmon KG, Drezner JA, Maleszewski JJ, Lopez-Anderson M, Owens D, . reply82(cid:2)83.
.
PrutkinJM,AsifIM,KlossnerD,AckermanMJ.Pathogenesesofsuddencardiac . 434.MagnaniJW,DanikHJS,DecGWJ,DiSalvoTG.Survivalinbiopsy-provenmyo-
.
death in national collegiate athletic association athletes. Circ Arrhythm .. carditis:along-termretrospectiveanalysisofthehistopathologic,clinical,and
Electrophysiol2014;7:198(cid:2)204. .. hemodynamicpredictors.AmHeartJ2006;151:463(cid:2)470.
.
419. ClaessenG,SchnellF,BogaertJ,ClaeysM,PattynN,DeBuckF,Dymarkowski . 435.SmithSC,LadensonJH,MasonJW,JaffeAS.ElevationsofcardiactroponinI
.
S,ClausP,CarreF,VanCleemputJ,LaGercheA,HeidbuchelH.Exercisecar- .. associated with myocarditis. Experimental and clinical correlates. Circulation
diacmagnetic resonance to differentiate athlete’s heartfrom structural heart .. 1997;95:163(cid:2)168.
.
disease.EurHeartJCardiovascImaging2018;19:1062(cid:2)1070. . 436.MorgeraT,DiLenardaA,DreasL,PinamontiB,HumarF,BussaniR,SilvestriF,
.
420. MillarLM,FantonZ,FinocchiaroG,Sanchez-FernandezG,DhutiaH,Malhotra . ChersevaniD,CameriniF.Electrocardiographyofmyocarditisrevisited:clinical
.
A, Merghani A, Papadakis M, Behr ER, Bunce N, Oxborough D, Reed M, .. and prognostic significance of electrocardiographic changes. Am Heart J
O’DriscollJ,TomeEstebanMT,D’SilvaA,Carr-WhiteG,WebbJ,SharmaR, .. 1992;124:455(cid:2)467.
.
SharmaS.Differentiationbetweenathlete’sheartanddilatedcardiomyopathy . 437.PinamontiB,Alberti E, Cigalotto A, Dreas L,Salvi A, Silvestri F, Camerini F. .
inathleticindividuals.Heart2020;106:1059(cid:2)1065. . Echocardiographicfindingsinmyocarditis.AmJCardiol1988;62:285(cid:2)291.
. 421. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, Morarji K, Brown .. 438.CaforioALP,CalabreseF,AngeliniA,TonaF,VinciA,BottaroS,RamondoA,
TDH,IsmailNA, Dweck MR,DiPietroE,RoughtonM,WageR,DaryaniY, .. Carturan E, Iliceto S, Thiene G, Daliento L. A prospective study of biopsy-
.
O’Hanlon R, Sheppard MN, Alpendurada F, Lyon AR, Cook SA, Cowie MR, . provenmyocarditis:prognosticrelevanceofclinicalandaetiopathogeneticfea-
.
AssomullRG,PennellDJ,PrasadSK.Associationoffibrosiswithmortalityand .. turesatdiagnosis.EurHeartJ2007;28:1326(cid:2)1333.
sudden cardiac death in patients with nonischemic dilated cardiomyopathy. .. 439.Schnell F, Claessen G, LaGerche A, Bogaert J, Lentz P-A, Claus P,Mabo P,
.
JAMA2013;309:896(cid:2)908. . Carre F, Heidbuchel H. Subepicardial delayed gadolinium enhancement in
.
422. Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ, . asymptomaticathletes:letsleepingdogslie?BrJSportsMed2016;50:111(cid:2)117.
.
Tokuda M, Daly CA, Tedrow UB, Stevenson WG, Jerosch-Herold M, .. 440.FriedrichMG,SechtemU,Schulz-MengerJ,HolmvangG,AlakijaP,CooperLT,
Ghoshhajra BB, Kwong RY. CMR quantification of myocardial scar provides .. WhiteJA,Abdel-AtyH,GutberletM,PrasadS,AletrasA,LaissyJ-P,PatersonI,
.
additiveprognosticinformationinnonischemiccardiomyopathy.JACCCardiovasc . FilipchukNG,KumarA,PauschingerM,LiuP.Cardiovascularmagneticreso-
.
Imaging2013;6:944(cid:2)954. .. nance in myocarditis: a JACC white paper. J Am Coll Cardiol
423. Masci PG, Doulaptsis C, Bertella E, Del Torto A, Symons R, Pontone G, .. 2009;53:1475(cid:2)1487.
.
BarisonA,DroogneW,AndreiniD,LorenzoniV,GripariP,MushtaqS,Emdin . 441.RadenkovicD,WeingartnerS,RickettsL,MoonJC,CapturG.T1mappingin
.
M,BogaertJ,LombardiM.Incrementalprognosticvalueofmyocardialfibrosis . cardiacMRI.HeartFailRev2017;22:415(cid:2)430.
.
inpatientswithnon-ischemiccardiomyopathywithoutcongestiveheartfailure. .. 442.NadjiriJ,NieberlerH,HendrichE,GreiserA,WillA,MartinoffS,Hadamitzky
CircHeartFail2014;7:448(cid:2)456. .. M.Performanceofnativeandcontrast-enhancedT1mappingtodetectmyocar-
.
424. PerazzoloMarraM,DeLazzariM,ZorziA,MiglioreF,ZilioF,CaloreC,Vettor . dialdamageinpatientswithsuspectedmyocarditis:ahead-to-headcomparison
.
G,TonaF,TarantiniG,CacciavillaniL,CorbettiF,GiorgiB,MiottoD,Thiene . of different cardiovascular magnetic resonance techniques. Int J Cardiovasc
.
G,BassoC,IlicetoS,CorradoD.Impactofthepresenceandamountofmyo- .. Imaging2017;33:539(cid:2)547.
cardialfibrosisbycardiacmagneticresonanceonarrhythmicoutcomeandsud- .. 443.AquaroGD,PerfettiM,CamastraG,MontiL,DellegrottaglieS,MoroC,Pepe
.
den cardiac death in nonischemic dilated cardiomyopathy. Heart Rhythm . A,TodiereG,LanzilloC,ScatteiaA,DiRomaM,PontoneG,PerazzoloMarra
.
2014;11:856(cid:2)863. .. M, Barison A, Di Bella G. Cardiac MR with late gadolinium enhancement in
425. CattinM-E,FerryA,VignaudA,MougenotN,JacquetA,WahbiK,Bertrand .. acute myocarditis with preserved systolic function: ITAMY Study. J Am Coll
.
AT,BonneG.MutationinlaminA/Csensitizesthemyocardiumtoexercise- . Cardiol2017;70:1977(cid:2)1987.
.
induced mechanical stress but has no effect on skeletal muscles in mouse. . 444.MewtonN,DernisA,BressonD,ZouaghiO,CroisilleP,FlocardE,DouekP,
.
NeuromusculDisord2016;26:490(cid:2)499. .. Bonnefoy-Cudraz E. Myocardial biomarkers and delayed enhanced cardiac
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 76 ---
92 ESCGuidelines
.
.
magneticresonancerelationshipinclinicallysuspectedmyocarditisandinsight . P,EliaDM,AntonioP,CristinaB,MaurizioS,BarbaraB,SabinoI,GaetanoT,
.
onclinicaloutcome.JCardiovascMed(Hagerstown)2015;16:696(cid:2)703. . DomenicoC.Nonischemicleftventricularscarasasubstrateoflife-threatening
.
445. GrunS,SchummJ,GreulichS,WagnerA,SchneiderS,BruderO,KispertE-M, .. ventriculararrhythmiasandsuddencardiacdeathincompetitiveathletes.Circ
HillS,OngP,KlingelK,KandolfR,SechtemU,MahrholdtH.Long-termfollow- .. ArrhythmiaElectrophysiol2016;9:e004229.
.
upofbiopsy-provenviralmyocarditis:predictorsofmortalityandincomplete . 464.AnziniM,MerloM,SabbadiniG,BarbatiG,FinocchiaroG,PinamontiB,SalviA,
.
recovery.JAmCollCardiol2012;59:1604(cid:2)1615. .. PerkanA,DiLenardaA,BussaniR,BartunekJ,SinagraG.Long-termevolution
446. SchummJ,GreulichS,WagnerA,GrunS,OngP,BentzK,KlingelK,KandolfR, .. and prognostic stratification of biopsy-proven active myocarditis. Circulation
.
BruderO,SchneiderS,SechtemU,MahrholdtH.Cardiovascularmagneticres- . 2013;128:2384(cid:2)2394.
.
onance risk stratification in patients with clinically suspected myocarditis. J . 465.ImazioM,GaitaF,LeWinterM.Evaluationandtreatmentofpericarditis:asys-
.
CardiovascMagnReson2014;16:14. .. tematicreview.JAMA2015;314:1498(cid:2)1506.
447. van de Schoor FR, Aengevaeren VL, Hopman MTE, Oxborough DL, George .. 466.ImazioM,SpodickDH,BrucatoA,TrincheroR,AdlerY.Controversialissues
.
KP,ThompsonPD, EijsvogelsTMH. Myocardial fibrosisinathletes.MayoClin . inthemanagementofpericardialdiseases.Circulation2010;121:916(cid:2)928.
.
Proc2016;91:1617(cid:2)1631. .. 467.PellicciaA,SolbergEE,PapadakisM,AdamiPE,BiffiA,CaselliS,LaGercheA,
448. Ammirati E, Moroni F, Sormani P, Peritore A, Milazzo A, Quattrocchi G, .. Niebauer J, Pressler A, Schmied CM, Serratosa L, Halle M, Van Buuren F,
.
CiprianiM,OlivaF,GiannattasioC,FrigerioM,RoghiA,CamiciPG,PedrottiP. . Borjesson M, Carre` F, Panhuyzen-Goedkoop NM, Heidbuchel H, Olivotto I,
.
Quantitativechangesinlategadoliniumenhancementatcardiacmagneticreso- . CorradoD,SinagraG,SharmaS.Recommendationsforparticipationincom-
.
nanceintheearlyphaseofacutemyocarditis.IntJCardiol2017;231:216(cid:2)221. .. petitiveandleisuretimesportinathleteswithcardiomyopathies,myocarditis,
449. Gr€aniC,EichhornC,Bie`reL,KanekoK,MurthyVL,AgarwalV,AghayevA, .. and pericarditis: position statement of the Sport Cardiology Section of the
.
SteignerM,BlanksteinR,Jerosch-HeroldM,KwongRY.Comparisonofmyo- . European Association of Preventive Cardiology (EAPC). Eur Heart J
.
cardial fibrosis quantification methods by cardiovascular magnetic resonance . 2018;40:19(cid:2)33.
.
imagingforriskstratificationofpatientswithsuspectedmyocarditis.JCardiovasc .. 468.La Gerche A, Robberecht C, Kuiperi C, Nuyens D, Willems R, de Ravel T,
MagnReson2019;21:14. .. Matthijs G, Heidbuchel H. Lower than expected desmosomal gene mutation
.
450. MatthiasH,AlexanderN,UweK,MichelN,WolfgangP,WolfgangH,Andreas . prevalenceinenduranceathleteswithcomplexventriculararrhythmiasofright
.
M, Bernhard W, Carsten T, Heinz-Peter S, Matthias P. Complication rate of .. ventricularorigin.Heart2010;96:1268(cid:2)1274.
right ventricular endomyocardial biopsy via the femoral approach. Circulation .. 469.Heidbuchel H. The athlete’s heart is a proarrhythmic heart, and what that
.
2008;118:1722(cid:2)1728. . meansforclinicaldecisionmaking.EPEuropace2018;20:1401(cid:2)1411.
.
451. YilmazA,KindermannI,KindermannM,MahfoudF,UkenaC,AthanasiadisA, . 470.DuX,DongJ,MaC.Isatrialfibrillationapreventabledisease?JAmCollCardiol
.
HillS,MahrholdtH,VoehringerM,SchieberM,KlingelK,KandolfR,BohmM, .. 2017;69:1968(cid:2)1982.
SechtemU.Comparativeevaluationofleftandrightventricularendomyocardial .. 471.MozaffarianD, FurbergCD, PsatyBM, Siscovick D. Physicalactivityandinci-
.
biopsy:differencesincomplicationrateanddiagnosticperformance.Circulation . dence of atrial fibrillation in older adults: the cardiovascular health study.
.
2010;122:900(cid:2)909. . Circulation2008;118:800(cid:2)807.
.
452. Cooper LTJ, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, .. 472.Rienstra M, Hobbelt AH, Alings M, Tijssen JGP, Smit MD, Brugemann J,
.
Menon S, Mullen GM, Jaski B, Bailey KR,, Cunningham MW, Dec GW. . GeelhoedB,TielemanRG,HillegeHL,TukkieR,VanVeldhuisenDJ,CrijnsH,
.
Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol . Van Gelder IC IR. Targeted therapy of underlying conditions improves sinus
.
2008;102:1535(cid:2)1539. .. rhythmmaintenanceinpatientswithpersistentatrialfibrillation:resultsofthe
453. Bohm P, Scharhag J, Meyer T. Data from a nationwide registry on sports- .. RACE3trial.EurHearJ2018;39:2987(cid:2)2996.
.
relatedsuddencardiacdeathsinGermany.EurJPrevCardiol2016;23:649(cid:2)656. . 473.ElliottAD,MaatmanB,EmeryMS,SandersP.Theroleofexerciseinatrialfibril-
.
454. PhillipsM,RobinowitzM,HigginsJR,BoranKJ,ReedT,VirmaniR.Suddencar- . lation prevention and promotion: finding optimal ranges for health. Heart
.
diacdeathinAirForcerecruits.A20-yearreview.JAMA1986;256:2696(cid:2)2699. .. Rhythm2017;14:1713(cid:2)1720.
455. KielRJ,SmithFE,ChasonJ,KhatibR,ReyesMP.CoxsackievirusB3myocarditis .. 474.Andersen K, Farahmand B, Ahlbom A, Held C, Ljunghall S, Michaelsson K,
.
inC3H/HeJmice:descriptionofaninbredmodelandtheeffectofexerciseon . SundstromJ.Riskofarrhythmiasin52755long-distancecross-countryskiers:a
.
virulence.EurJEpidemiol1989;5:348(cid:2)350. .. cohortstudy.EurHeartJ2013;34:3624(cid:2)3631.
456. GatmaitanBG,ChasonJL,LernerAM.Augmentationofthevirulenceofmurine .. 475.AizerA,GazianoJM,CookNR,MansonJE,BuringJE,AlbertCM.Relationof
.
Coxsackie-virus B-3 myocardiopathy by exercise. J Exp Med . vigorousexercisetoriskofatrialfibrillation.AmJCardiol2009;103:1572(cid:2)1577.
.
1970;131:1121(cid:2)1136. . 476.KwokCS,AndersonSG,MyintPK,MamasMA,LokeYK.Physicalactivityand
.
457. IlbackNG,FohlmanJ,FrimanG.ExerciseinCoxsackieB3myocarditis:effects .. incidenceofatrialfibrillation:asystematicreviewandmeta-analysis.IntJCardiol
onheartlymphocytesubpopulationsandtheinflammatoryreaction.AmHeartJ .. 2014;177:467(cid:2)476.
.
1989;117:1298(cid:2)1302. . 477.La Gerche A, Schmied CM. Atrial fibrillation in athletes and the interplay .
458. Cabinian AE, Kiel RJ, Smith F, Ho KL, Khatib R, Reyes MP. Modification of . betweenexerciseandhealth.EurHeartJ2013;34:3599(cid:2)3602.
. exercise-aggravated Coxsackie virus B3 murine myocarditis by T lymphocyte .. 478.ElosuaR,ArquerA,MontL,SambolaA,MolinaL,Garcia-MoranE,BrugadaJ,
suppressioninaninbredmodel.JLabClinMed1990;115:454(cid:2)462. .. MarrugatJ.Sportpracticeandtheriskofloneatrialfibrillation:acase-control
.
459. PellicciaA,CorradoD,BjornstadHH,Panhuyzen-GoedkoopN,UrhausenA, . study.IntJCardiol2006;108:332(cid:2)337.
.
CarreF,AnastasakisA,VanheesL,ArbustiniE,PrioriS.Recommendationsfor .. 479.MontL,SambolaA,BrugadaJ,VaccaM,MarrugatJ,ElosuaR,PareC,Azqueta
participationincompetitivesportandleisure-timephysicalactivityinindividuals .. M, Sanz G. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J
.
withcardiomyopathies,myocarditisandpericarditis.EurJCardiovascPrevRehabil . 2002;23:477(cid:2)482.
.
2006;13:876(cid:2)885. . 480.HeidbuchelH,AnneW,WillemsR,AdriaenssensB,VandeWerfF,EctorH.
.
460. MaronBJ,UdelsonJE,BonowRO,NishimuraRA,AckermanMJ,EstesNAM .. Endurancesportsisariskfactorforatrialfibrillationafterablationforatrialflut-
3rd,CooperLTJ,LinkMS,MaronMS.Eligibilityanddisqualificationrecommen- .. ter.IntJCardiol2006;107:67(cid:2)72.
.
dationsforcompetitiveathleteswithcardiovascularabnormalities:TaskForce . 481.Morseth B, Graff-Iversen S, Jacobsen BK, Jorgensen L, Nyrnes A, Thelle DS,
.
3:Hypertrophiccardiomyopathy,arrhythmogenicrightventricularcardiomyop- . VestergaardP,LochenM-L.Physicalactivity,restingheartrate,andatrialfibrilla-
.
athyandothercardiomyopathies,andmyocarditis.Ascientificstatementfrom .. tion:theTromsoStudy.EurHeartJ2016;37:2307(cid:2)2313.
.
the American Heart Association and American College of Cardiology. . 482.KawabataM,HiraoK,HorikawaT,SuzukiK,MotokawaK,SuzukiF,AzegamiK,
.
Circulation2015;132:e273(cid:2)280. . HiejimaK.SyncopeinpatientswithatrialflutterduringtreatmentwithclassIc
.
461. Gati S, Sharma S, Pennell D. The role of cardiovascular magnetic resonance .. antiarrhythmicdrugs.JElectrocardiol2001;34:65(cid:2)72.
imaging in the assessment of highly trained athletes. JACC Cardiovasc Imaging .. 483.Brembilla-PerrotB,HouriezP,BeurrierD,ClaudonO,TerrierdelaChaiseA,
.
2018;11:1327(cid:2)1339. . LouisP.Predictorsofatrialflutterwith1:1conductioninpatientstreatedwith
.
462. Enrico A, Manlio C, Claudio M, Claudia R, Daniela P, Paola S, Riccardo M, . class I antiarrhythmic drugs for atrial tachyarrhythmias. Int J Cardiol
.
MarisaV,PatriziaP,CristinaC,AntonioM,AureliaG,DanieleB,SilviaG,PG .. 2001;80:7(cid:2)15.
B., Stefania C, CS I., Cristina G, Alberto M, Valentina C, Marco M, Carlo L, .. 484.AlboniP,BottoGL,BaldiN,LuziM,RussoV,GianfranchiL,MarchiP,Calzolari
.
JenessC,PiergiuseppeA,GiovanniP,LauraS,AnnalisaT,GiuseppeDT,Carlo . M,SolanoA,BaroffioR,GaggioliG.Outpatienttreatmentofrecent-onsetatrial
.
C, Armando B, Fabrizio M, Andrea M, Antonio C, Michele S, Antonello G, .. fibrillation with the “pill-in-the-pocket” approach. N Engl J Med
Maria F,FabrizioO, CP G.,null null.Clinical presentation andoutcome ina .. 2004;351:2384(cid:2)2391.
.
contemporary cohort of patients with acute myocarditis. Circulation . 485.KirchhofP,BenussiS,KotechaD,AhlssonA,AtarD,CasadeiB,CastellaM,
.
2018;138:1088(cid:2)1099. . Diener H-C, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J,
.
463. AlessandroZ,MartinaPM,IlariaR,ManuelDL,AngelaS,AliceN,KalliopiP, .. Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron
FedericoM,StefaniaR,BenedettaG,GiorgioDC,PatrizioS,LuisS,Giampiero . Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R,
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 77 ---
ESCGuidelines 93
.
.
Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, . CorradoD.Burdenofventriculararrhythmiasat12-lead24-hourambulatory
.
Guenoun M, Hohnloser SH, Kolh P, Lip GYH, Manolis A, McMurray J, . ECGmonitoringinmiddle-agedenduranceathletesversussedentarycontrols.
.
Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, .. EurJPrevCardiol2018;25:2003(cid:2)2011.
TamargoJL,TaylorCJ,VanGelderIC,VoorsAA,WindeckerS,ZamoranoJL, .. 503.BiffiA,PellicciaA,VerdileL,FernandoF,SpataroA,CaselliS,SantiniM,Maron
.
Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation . BJ.Long-termclinicalsignificanceoffrequentandcomplexventriculartachyar-
.
developed in collaboration with EACTS. Eur J Cardiothorac Surg .. rhythmiasintrainedathletes.JAmCollCardiol2002;40:446(cid:2)452.
2016;50:e1(cid:2)e88. .. 504.PalatiniP, MaraglinoG, Sperti G,Calzavara A, Libardoni M, PessinaAC, Dal
.
486. SteffelJ,VerhammeP,PotparaTS,AlbaladejoP,AntzM,DestegheL,Haeusler . PaluC.Prevalenceandpossiblemechanismsofventriculararrhythmiasinath-
.
KG,OldgrenJ,ReineckeH,Roldan-SchillingV,RowellN,SinnaeveP,CollinsR, . letes.AmHeartJ1985;110:560(cid:2)567.
.
Camm AJ, Heidbuchel H. The 2018 European Heart Rhythm Association .. 505.LeeV,PereraD,LambiaseP.Prognosticsignificanceofexercise-inducedpre-
PracticalGuideontheuseofnon-vitaminKantagonistoralanticoagulantsin .. matureventricularcomplexes:asystematicreviewandmeta-analysisofobser-
.
patientswithatrialfibrillation.EurHeartJ2018;39:1330(cid:2)1393. . vationalstudies.HeartAsia2017;9:14(cid:2)24.
.
487. Calkins H,HindricksG,CappatoR,KimY-H, SaadEB,AguinagaL, AkarJG, . 506.LinC-Y,ChangS-L,ChungF-P,ChenY-Y,LinY-J,LoL-W,HuY-F,TuanT-C,
.
BadhwarV,BrugadaJ,CammJ,ChenP-S,ChenS-A,ChungMK,NielsenJC, .. Chao T-F, Liao J-N, Chang Y-T, Lin C-H, Allamsetty S, Walia R, Te ALD,
.
Curtis AB, Davies DW, Day JD, d’Avila A, de Groot NMSN, Di Biase L, . Yamada S, Chiang S-J, Tsao H-M, Chen S-A. Long-term outcome of non-
.
DuytschaeverM,EdgertonJR,EllenbogenKA,EllinorPT,ErnstS,FenelonG, . sustained ventricular tachycardia in structurally normal hearts. PLoS One
.
GerstenfeldEP,HainesDE,HaissaguerreM,HelmRH,HylekE,JackmanWM, .. 2016;11:e0160181.
Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, .. 507.HutchinsonMD,GarciaFC.Anorganizedapproachtothelocalization, map-
.
Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, . ping, and ablation of outflow tract ventricular arrhythmias. J Cardiovasc
.
Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, . Electrophysiol2013;24:1189(cid:2)1197.
.
ReynoldsMR,SandersP,ScanavaccaM,SchillingR,TondoC,TsaoH-M,Verma .. 508.Luebbert J, Auberson D, Marchlinski F. Premature ventricular complexes in
A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert .. apparentlynormalhearts.CardElectrophysiolClin2016;8:503(cid:2)514.
.
consensusstatementoncatheterandsurgicalablationofatrialfibrillation.Heart . 509.HaissaguerreM,NademaneeK,HociniM,ChenitiG,DuchateauJ,FronteraA,
.
Rhythm2017;14:e275(cid:2)e444. .. SacherF,DervalN,DenisA,PambrunT,DuboisR,JaisP,BenoistD,Walton
488. Calvo N, Mont L, Tamborero D, Berruezo A, Viola G, Guasch E, Nadal M, .. RD,NogamiA,CoronelR,PotseM,BernusO.Depolarizationversusrepolari-
.
AndreuD,VidalB,SitgesM,BrugadaJ.Efficacyofcircumferentialpulmonary . zationabnormalityunderlyinginferolateralJ-wavesyndromes:newconceptsin
.
vein ablation of atrial fibrillation in endurance athletes. Europace . sudden cardiac death with apparently normal hearts. Heart Rhythm
.
2010;12:30(cid:2)36. .. 2019;16:781(cid:2)790.
489. KoopmanP,NuyensD,GarwegC,LaGercheA,DeBuckS,VanCasterenL, .. 510.LeenhardtA,GlaserE,BurgueraM,NurnbergM,Maison-BlancheP,CoumelP.
.
AlzandB,WillemsR,HeidbuchelH.Efficacyofradiofrequencycatheterablation . Short-coupledvariantoftorsadedepointes.Anewelectrocardiographicentity
.
inathleteswithatrialfibrillation.Europace2011;13:1386(cid:2)1393. . in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation
.
490. AbdullaJ,NielsenJR.Istheriskofatrialfibrillationhigherinathletesthaninthe .. 1994;89:206(cid:2)215.
.
general population? A systematic review and meta-analysis. EP Europace . 511.Al-KhatibSM,StevensonWG,AckermanMJ,BryantWJ,CallansDJ,CurtisAB,
.
2009;11:1156(cid:2)1159. . DealBJ,DickfeldT,FieldME,FonarowGC,GillisAM,GrangerCB,Hammill
.
491. Sorbo MD, Buja GF, Miorelli M, Nistri S, Perrone C, Manca S, Grasso F, .. SC,HlatkyMA,JoglarJA,KayGN,MatlockDD,MyerburgRJ,PageRL.2017
Giordano GM, Nava A. [The prevalence of the Wolff-Parkinson-White syn- .. AHA/ACC/HRSguidelineformanagementofpatientswithventriculararrhyth-
.
drome in a population of 116,542 young males]. G Ital Cardiol . miasandthepreventionofsuddencardiacdeath:executivesummary.Areport
.
1995;25:681(cid:2)687. . oftheAmericanCollegeofCardiology/AmericanHeartAssociationTaskForce
.
492. SanoS,KomoriS,AmanoT,KohnoI,IshiharaT,SawanoboriT,IjiriH,Tamura .. on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm
K. Prevalence of ventricular preexcitation in Japanese schoolchildren. Heart .. 2018;15:e190(cid:2)e252.
.
1998;79:374(cid:2)378. . 512.Latchamsetty R, Bogun F. Premature ventricular complexes and premature
.
493. Timmermans C, Smeets JL, Rodriguez LM, Vrouchos G, van den Dool A, .. ventricular complex induced cardiomyopathy. Curr Probl Cardiol
Wellens HJ. Aborted sudden death in the Wolff-Parkinson-White syndrome. .. 2015;40:379(cid:2)422.
.
AmJCardiol1995;76:492(cid:2)494. . 513.Morshedi-MeibodiA,EvansJC,LevyD,LarsonMG,VasanRS.Clinicalcorre-
.
494. WaxmanMB,WaldRW,SharmaAD,HuertaF,CameronDA.Vagaltechniques . lates and prognostic significance of exercise-induced ventricular premature
.
for termination of paroxysmal supraventricular tachycardia. Am J Cardiol .. beats in the community: the Framingham Heart Study. Circulation
1980;46:655(cid:2)664. .. 2004;109:2417(cid:2)2422.
.
495. MiljoenH,EctorJ,GarwegC,SaenenJ,HuybrechtsW,SarkozyA,WillemsR . 514.SelzmanKA,GettesLS.Exercise-inducedprematureventricularbeats:should .
HH.DifferentialpresentationofAVnodalreentranttachycardiainathletesand . wedoanythingdifferently?Circulation2004;109:2374(cid:2)2375.
. non-athletes.EPEuropace2019;21:944(cid:2)949. .. 515.Zorzi A, Perazzolo Marra M, Rigato I, De Lazzari M, Susana A, Niero A,
496. ObeyesekereMN,Leong-SitP,MasselD,ManlucuJ,ModiS,KrahnAD,Skanes .. Pilichou K, Migliore F, Rizzo S, Giorgi B, De Conti G, Sarto P, Serratosa L,
.
AC,YeeR,GulaLJ,KleinGJ.Riskofarrhythmiaandsuddendeathinpatients . Patrizi G, De Maria E, Pelliccia A, Basso C, Schiavon M, Bauce B, Iliceto S,
.
with asymptomatic preexcitation: a meta-analysis. Circulation .. ThieneG,CorradoD.Nonischemicleftventricularscarasasubstrateoflife-
2012;125:2308(cid:2)2315. .. threatening ventricular arrhythmias and sudden cardiac death in competitive
.
497. Wellens HJ, Rodriguez LM, Timmermans C, Smeets JP. The asymptomatic . athletes. Circ Arrhythm Electrophysiol 2016;9:e004229. doi: 10.1161/
.
patient with the Wolff-Parkinson-White electrocardiogram. Pacing Clin . CIRCEP.116.004229.OriginallypublishedJuly7,2016.
.
Electrophysiol1997;20:2082(cid:2)2086. .. 516.Cipriani A, Zorzi A, Sarto P, Donini M, Rigato I, Bariani R, De Lazzari M,
498. GaitaF,GiustettoC,RiccardiR,MangiardiL,BruscaA.Stressandpharmaco- .. PilichouK,ThieneG,IlicetoS,BassoC,CorradoD,PerazzoloMarraM,Bauce
.
logic tests as methods to identify patients with Wolff-Parkinson-White syn- . B.Predictivevalueofexercisetestinginathleteswithventricularectopyeval-
.
dromeatriskofsuddendeath.AmJCardiol1989;64:487(cid:2)490. .. uatedbycardiacmagneticresonance.HeartRhythm2019;16:239(cid:2)248.
499. PapponeC,MangusoF,SantinelliR,VicedominiG,SalaS,PaglinoG,Mazzone .. 517.Gimeno JR, Tome-Esteban M, Lofiego C, Hurtado J, Pantazis A, Mist B,
.
P, Lang CC, Gulletta S, Augello G, Santinelli O, Santinelli V. Radiofrequency . LambiaseP,McKennaWJ,ElliottPM.Exercise-inducedventriculararrhythmias
.
ablation in children with asymptomatic Wolff-Parkinson-White syndrome. N . andriskofsuddencardiacdeathinpatientswithhypertrophiccardiomyopathy.
.
EnglJMed2004;351:1197(cid:2)1205. .. EurHeartJ2009;30:2599(cid:2)2605.
500. Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomstrom-Lundqvist C, .. 518.Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M,
.
CalkinsH,CorradoD,DeftereosSG,DillerG-P,Gomez-DoblasJJ,GorenekB, . DeSimoneL,ColtortiF,BloiseR,KeeganR,CruzFilhoFES,VignatiG,Benatar
.
Grace A, Ho SY, Kaski J-C, Kuck K-H, Lambiase PD, Sacher F, Sarquella- . A,DeLoguA.Clinicalandmolecularcharacterizationofpatientswithcatecho-
.
BrugadaG,SuwalskiP,ZazaA.2019ESCGuidelinesforthemanagementof .. laminergicpolymorphicventriculartachycardia.Circulation2002;106:69(cid:2)74.
patientswithsupraventriculartachycardia.TheTaskForceforthemanagement .. 519.Heidbuchel H, Hoogsteen J, Fagard R, Vanhees L, Ector H, Willems R, Van
.
of patients with supraventricular tachycardia of the European Society of . LierdeJ.Highprevalenceofrightventricularinvolvementinenduranceathletes
.
Cardiology(ESC).EurHeartJ2019;41:655(cid:2)720. .. withventriculararrhythmias.Roleofanelectrophysiologicstudyinriskstratifi-
501. BjornstadH,StorsteinL,MeenHD,HalsO.Ambulatoryelectrocardiographic .. cation.EurHeartJ2003;24:1473(cid:2)1480.
.
findings in top athletes, athletic students and control subjects. Cardiology . 520.Sofi F, Capalbo A, Pucci N, Giuliattini J, Condino F, Alessandri F, Abbate R,
.
1994;84:42(cid:2)50. . GensiniGF,CalifanoS.Cardiovascularevaluation,includingrestingandexercise
.
502. ZorziA,MastellaG,CiprianiA,BertonG,DelMonteA,GusellaB,NeseA, .. electrocardiography,beforeparticipationincompetitivesports:crosssectional
Portolan L, Sciacca F, Tikvina S, Tollot S, Trovato D, Iliceto S, Schiavon M, . study.BMJ2008;337:a346.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 78 ---
94 ESCGuidelines
.
.
521. HaugaaKH,LerenIS,BergeKE,BathenJ,LoennechenJP,AnfinsenO-G,Fruh . McKennaW,ZarebaW,BrugadaR,BrugadaP.Currentelectrocardiographic
.
A,EdvardsenT,KongsgardE,LerenTP,AmlieJP.Highprevalenceofexercise- . criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol
.
inducedarrhythmiasincatecholaminergicpolymorphicventriculartachycardia .. 2012;45:433(cid:2)442.
mutation-positive family members diagnosed by cascade genetic screening. .. 541.ChockalingamP,RammelooLA,PostemaPG,HrudaJ,ClurS-AB,BlomNA,
.
Europace2010;12:417(cid:2)423. . WildeAA.Fever-inducedlife-threateningarrhythmiasinchildrenharboringan
.
522. Sharma S, Drezner JA, Baggish A, Papadakis M, Wilson MG, Prutkin JM, La .. SCN5Amutation.Pediatrics2011;127:e239(cid:2)e244.doi:10.1542/peds.2010-1688.
GercheA,AckermanMJ,BorjessonM,SalernoJC,AsifIM,OwensDS,Chung .. 542.MiyazakiT,MitamuraH,MiyoshiS,SoejimaK,AizawaY,OgawaS.Autonomic
.
EH,EmeryMS,FroelicherVF,HeidbuchelH,AdamuzC,AsplundCA,Cohen . andantiarrhythmicdrugmodulationofSTsegmentelevationinpatientswith
.
G,HarmonKG,MarekJC,MolossiS,NiebauerJ,PeltoHF,PerezMV,Riding . Brugadasyndrome.JAmCollCardiol1996;27:1061(cid:2)1070.
.
NR,SaarelT,SchmiedCM,ShiponDM,SteinR,VetterVL,PellicciaA,Corrado .. 543.MizumakiK,FujikiA,TsunedaT,SakabeM,NishidaK,SugaoM,InoueH.Vagal
D. International recommendations for electrocardiographic interpretation in .. activitymodulatesspontaneousaugmentationofSTelevationinthedailylifeof
.
athletes.EurHeartJ2018;39:1466(cid:2)1480. . patientswithBrugadasyndrome.JCardiovascElectrophysiol2004;15:667(cid:2)673.
.
523. PrioriSG,SchwartzPJ,NapolitanoC,BloiseR,RonchettiE,GrilloM,Vicentini . 544.MatsuoK,KuritaT,InagakiM,KakishitaM,AiharaN,ShimizuW,TaguchiA,
.
A,SpazzoliniC,NastoliJ,BottelliG,FolliR,CappellettiD.Riskstratificationin .. SuyamaK,Kamakura S,ShimomuraK.Thecircadianpatternofthe develop-
.
thelong-QTsyndrome.NEnglJMed2003;348:1866(cid:2)1874. . mentofventricularfibrillationinpatientswithBrugadasyndrome.EurHeartJ
.
524. SyRW,vanderWerfC,ChatthaIS,ChockalingamP,AdlerA,HealeyJS,Perrin . 1999;20:465(cid:2)470.
.
M, Gollob MH, Skanes AC, Yee R, Gula LJ, Leong-Sit P, Viskin S, Klein GJ, .. 545.ProbstV,DenjoyI,MeregalliPG,AmiraultJ-C,SacherF,MansouratiJ,Babuty
Wilde AA, Krahn AD. Derivation and validation of a simple exercise-based .. D,VillainE,VictorJ,SchottJ-J,LupoglazoffJ-M,MaboP,VeltmannC,JeselL,
.
algorithm for prediction of genetic testing in relatives of LQTS probands. . ChevalierP,ClurS-AB,HaissaguerreM,WolpertC,LeMarecH,WildeAAM.
.
Circulation2011;124:2187(cid:2)2194. . Clinical aspects and prognosis of Brugada syndrome in children. Circulation
.
525. ChandraN,BastiaenenR,PapadakisM,PanoulasVF,GhaniS,DuschlJ,Foldes .. 2007;115:2042(cid:2)2048.
D,RajuH,OsborneR,SharmaS.Prevalenceofelectrocardiographicanomalies .. 546.TakigawaM,NodaT,ShimizuW,MiyamotoK,OkamuraH,SatomiK,Suyama
.
inyoungindividuals:relevancetoanationwidecardiacscreeningprogram.JAm . K,AiharaN,KamakuraS,KuritaT.Seasonalandcircadiandistributionsofven-
.
CollCardiol2014;63:2028(cid:2)2034. .. tricular fibrillation in patients with Brugada syndrome. Heart Rhythm
526. BasavarajaiahS,WilsonM,WhyteG,ShahA,BehrE,SharmaS.Prevalenceand .. 2008;5:1523(cid:2)1527.
.
significance of an isolated long QT interval in elite athletes. Eur Heart J . 547.Michowitz Y, Milman A, Sarquella-Brugada G, Andorin A, Champagne J,
.
2007;28:2944(cid:2)2949. . PostemaPG,Casado-ArroyoR,LeshemE,JuangJJM,GiustettoC,Tfelt-Hansen
.
527. JohnsonJN,AckermanMJ.Returntoplay?AthleteswithcongenitallongQT .. J, Wijeyeratne YD, Veltmann C, Corrado D, Kim S-H, Delise P, Maeda S,
syndrome.BrJSportsMed2013;47:28(cid:2)33. .. GourraudJ-B,SacherF,MaboP,TakahashiY,KamakuraT,AibaT,ConteG,
.
528. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, . Hochstadt A, Mizusawa Y, Rahkovich M, Arbelo E, Huang Z, Denjoy I,
.
DenjoyI,GuicheneyP,BreithardtG,KeatingMT,TowbinJA,BeggsAH,Brink . NapolitanoC,BrugadaR,CaloL,PrioriSG,TakagiM,BehrER,GaitaF,YanG-
.
P,WildeAA,ToivonenL,ZarebaW,RobinsonJL,TimothyKW,CorfieldV, .. X,BrugadaJ,LeenhardtA,WildeAAM,BrugadaP,KusanoKF,HiraoK,Nam
.
WattanasirichaigoonD,CorbettC,Haverkamp W,Schulze-BahrE, Lehmann . G-B,ProbstV,BelhassenB.Fever-relatedarrhythmiceventsinthemulticenter
.
MH,SchwartzK,CoumelP,BloiseR.Genotype-phenotypecorrelationinthe . survey on arrhythmic events in Brugada syndrome. Heart Rhythm
.
long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. .. 2018;15:1394(cid:2)1401.
Circulation2001;103:89(cid:2)95. .. 548.Rossenbacker T, Carroll SJ, Liu H, Kuiperi C, de Ravel TJL, Devriendt K,
.
529. Schwartz PJ, Ackerman MJ. The long QT syndrome: a transatlantic clinical . CarmelietP,KassRS,HeidbuchelH.NovelporemutationinSCN5Amanifests
.
approachtodiagnosisandtherapy.EurHeartJ2013;34:3109(cid:2)3116. . asaspectrumofphenotypesrangingfromatrialflutter,conductiondisease,and
.
530. VincentGM,SchwartzPJ,DenjoyI,SwanH,BithellC,SpazzoliniC,CrottiL, .. Brugadasyndrometosuddencardiacdeath.HeartRhythm2004;1:610(cid:2)615.
PiippoK,LupoglazoffJ-M,VillainE,PrioriSG,NapolitanoC,ZhangL.Higheffi- .. 549.Kasanuki H, Ohnishi S, Ohtuka M, Matsuda N, Nirei T, Isogai R, Shoda M,
.
cacyofbeta-blockersinlong-QTsyndrometype1:contributionofnoncompli- . Toyoshima Y, Hosoda S. Idiopathic ventricular fibrillation induced with vagal
.
ance and QT-prolonging drugs to the occurrence of beta-blocker treatment .. activity in patients without obvious heart disease. Circulation
“failures”.Circulation2009;119:215(cid:2)221. .. 1997;95:2277(cid:2)2285.
.
531. AckermanMJ,ZipesDP,KovacsRJ,MaronBJ.Eligibilityanddisqualificationrec- . 550.Arai Y, Saul JP, Albrecht P, Hartley LH, Lilly LS, Cohen RJ, Colucci WS.
.
ommendationsforcompetitiveathleteswithcardiovascularabnormalities:Task . Modulationofcardiacautonomicactivityduringandimmediatelyafterexercise.
.
Force 10: The cardiac channelopathies: a scientific statement from the .. AmJPhysiol1989;256:H132(cid:2)41.
American Heart Association and American College of Cardiology. Circulation .. 551.SmithML,HudsonDL,GraitzerHM,RavenPB.Exercisetrainingbradycardia:
.
2015;132:e326(cid:2)9. . theroleofautonomicbalance.MedSciSportsExerc1989;21:40(cid:2)44. .
532. DreznerJA,RogersKJ.Suddencardiacarrestinintercollegiateathletes:detailed . 552.DeharoJC,BongiorniMG,RozkovecA,BrackeF,DefayeP,Fernandez-Lozano
. analysis and outcomes of resuscitation in nine cases. Heart Rhythm .. I, Golzio PG, Hansky B, Kennergren C, Manolis AS, Mitkowski P, Platou ES.
2006;3:755(cid:2)759. .. Pathways for training and accreditation for transvenous lead extraction: a
.
533. BrugadaP,BrugadaJ.Rightbundlebranchblock,persistentSTsegmenteleva- . European Heart Rhythm Association position paper. Europace
.
tionandsuddencardiacdeath:adistinctclinicalandelectrocardiographicsyn- .. 2012;14:124(cid:2)134.
drome.Amulticenterreport.JAmCollCardiol1992;20:1391(cid:2)1396. .. 553.Lamas GA, Keefe JM. The effects of equitation (horseback riding) on a
.
534. BrugadaJ,CampuzanoO,ArbeloE,Sarquella-BrugadaG,BrugadaR.Present . motion responsive DDDR pacemaker. Pacing Clin Electrophysiol 1990;13:
.
status of Brugada syndrome: JACC state-of-the-art review. J Am Coll Cardiol . 1371(cid:2)1373.
.
2018;72:1046(cid:2)1059. .. 554.DeeringJA,PedersonDN.Pacemakerleadfractureassociatedwithweightlift-
535. FrustaciA,PrioriSG,PieroniM,ChimentiC,NapolitanoC,RivoltaI,SannaT, .. ing:areportoftwocases.MilMed1993;158:833(cid:2)834.
.
BellocciF,RussoMA.Cardiachistologicalsubstrateinpatientswithclinicalphe- . 555.GouldL,BetzuR,TaddeoM,JudgeJD,LeeJ.Pulsegeneratorfailuredueto
.
notypeofBrugadasyndrome.Circulation2005;112:3680(cid:2)3687. .. blunttrauma.ClinCardiol1988;11:581(cid:2)582.
536. Frustaci A, Russo MA, Chimenti C. Structural myocardial abnormalities in .. 556.GriecoJG,ScanlonPJ,PifarreR.Pacingleadfractureafteradecelerationinjury.
.
asymptomaticfamilymemberswithBrugadasyndromeandSCN5Agenemuta- . AnnThoracSurg1989;47:453(cid:2)454.
.
tion.EurHeartJ2009;30:1763. . 557.Schuger CD, Mittleman R, Habbal B, Wagshal A, Huang SK. Ventricular lead
.
537. CatalanoO,AntonaciS,MoroG,MussidaM,FrascaroliM,BaldiM,CobelliF, .. transectionandatrialleaddamageinayoungsoftballplayershortlyafterthe
BaiardiP,NastoliJ,BloiseR,MonteforteN,NapolitanoC,PrioriSG.Magnetic .. insertion of a permanent pacemaker. Pacing Clin Electrophysiol
.
resonanceinvestigationsinBrugadasyndromerevealunexpectedlyhighrateof . 1992;15:1236(cid:2)1239.
.
structuralabnormalities.EurHeartJ2009;30:2241(cid:2)2248. . 558.AltunA,ErdoganO.Pacemakerleadfailuresuggestiveofcrushinjury.Cardiol
.
538. vanHoornF,CampianME,SpijkerboerA,BlomMT,PlankenRN,vanRossum .. Rev2003;11:256.
AC,deBakkerJMT,WildeAAM,GroeninkM,,TanHL.SCN5Amutationsin .. 559.NobleSL,BurriH,SunthornH.Completesectionofpacemakerleaddueto
.
Brugada syndrome are associated with increased cardiac dimensions and . subclaviancrush.MedJAust2005;182:643.
.
reducedcontractility.PLoSOne2012;7:e42037. .. 560.ExnerDV,RothschildJM,HealS,GillisAM.Unipolarsensingincontemporary
539. BaranchukA,NguyenT,RyuMH,FemeniaF,ZarebaW,WildeAAM,Shimizu .. pacemakers:usingmyopotentialtestingtodefineoptimalsensitivitysettings.J
.
W,BrugadaP,Perez-RieraAR.Brugadaphenocopy:newterminologyandpro- . IntervCardElectrophysiol1998;2:33(cid:2)40.
.
posedclassification.AnnNoninvasiveElectrocardiol2012;17:299(cid:2)314. . 561.Jain P, Kaul U, Wasir HS. Myopotential inhibition of unipolar demand pace-
.
540. Bayes de Luna A, Brugada J, Baranchuk A, Borggrefe M, Breithardt G, .. makers:utilityofprovocativemanoeuvresinassessmentandmanagement.IntJ
Goldwasser D, Lambiase P, Riera AP, Garcia-Niebla J, Pastore C, Oreto G, . Cardiol1992;34:33(cid:2)39.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 79 ---
ESCGuidelines 95
.
.
562. HeidbuchelH,WillemsR,JordaensL,OlshanskyB,CarreF,FernandezLozano . 579.Correia JD, da Rosa EB, Silveira DB, Grapiglia CG, Canabarro ST,
.
I,WilhelmM,MussigbrodtA,HuybrechtsW,MorganJ,AnfinsenOG,PriorD, . WaterkemperR,ZenPRG,RosaRFM.Majorextracardicmalformationsamong
.
Mont L, Mairesse GH, Boveda S, Duru F, Kautzner J, Viskin S, Geelen P, .. patientswithcongenitalheartdefects.IntJCardiol2016;214:154(cid:2)156.
Cygankiewicz I, Hoffman E, Vanden LR. Intensive recreational athletes in the .. 580.LuiGK,SaidiA,BhattAB,BurchillLJ,DeenJF,EaringMG,GewitzM,GinnsJ,
.
prospective multinational ICD Sports Safety Registry: results from the . KayJD,KimYY,KovacsAH,KriegerEV,WuFM,YooS-J.Diagnosisandman-
.
Europeancohort.EurJPrevCardiol2019;26:764(cid:2)775. .. agementofnoncardiaccomplicationsinadultswithcongenitalheartdisease:a
563. Barry MJ, Edgman-Levitan S. Shared decision making (cid:2) pinnacle of patient- .. scientific statement from the American Heart Association. Circulation
.
centeredcare.NEnglJMed2012;366:780(cid:2)781. . 2017;136:e348(cid:2)e392.
.
564. Rahman B, Macciocca I, Sahhar M, Kamberi S, Connell V, Duncan RE. . 581.HackerA-L,OberhofferR,HagerA,EwertP,MullerJ.Age-relatedcardiovascu-
.
Adolescents with implantable cardioverter defibrillators:a patient and parent .. lar risk in adult patients with congenital heart disease. Int J Cardiol
perspective.PacingClinElectrophysiol2012;35:62(cid:2)72. .. 2019;277:90(cid:2)96.
.
565. OlshanskyB,AtteyaG,CannomD,HeidbuchelH,SaarelEV,AnfinsenO-G, . 582.GiannakoulasG,NtiloudiD.Acquiredcardiovasculardiseaseinadultpatients
.
ChengA,GoldMR,MussigbrodtA,PattonKK,SaxonLA,WilkoffBL,Willems .. withcongenitalheartdisease.Heart2018;104:546(cid:2)547.
R,DziuraJ,LiF,BrandtC,SimoneL,WilhelmM,LampertR.Competitiveath- .. 583.KoyakZ,HarrisL,deGrootJR,SilversidesCK,OechslinEN,BoumaBJ,Budts
.
letes with implantable cardioverter-defibrillators (cid:2) how to program? Data . W,ZwindermanAH,VanGelderIC,MulderBJM.Suddencardiacdeathinadult
.
fromtheImplantableCardioverter-DefibrillatorSportsRegistry.HeartRhythm . congenitalheartdisease.Circulation2012;126:1944(cid:2)1954.
.
2019;16:581(cid:2)587. .. 584.ZomerAC,VaartjesI,UiterwaalCSPM,vanderVeldeET,vandenMerkhof
566. AuricchioA,SchlossEJ,KuritaT,MeijerA,GerritseB,ZweibelS,AlSmadiFM, .. LFM, Baur LHB,AnsinkTJM,CozijnsenL,PieperPG,Meijboom FJ,Grobbee
.
LengCT,SternsLD.Lowinappropriateshockratesinpatientswithsingle-and . DE,MulderBJM.Circumstancesofdeathinadultcongenitalheartdisease.IntJ
.
dual/triple-chamberimplantablecardioverter-defibrillatorsusinganovelsuiteof . Cardiol2012;154:168(cid:2)172.
.
detection algorithms: PainFree SST trial primary results. Heart Rhythm .. 585.ScanlanS.ShaunWhite’sbiggestfansaretheonesthatsharehisheartcondi-
2015;12:926(cid:2)936. .. tion. USA Today, 2018. https://eu.usatoday.com/story/sports/olympics/2018/02/
.
567. TheunsDAMJ,BrouwerTF,JonesPW,AllavatamV,DonnelleyS,AuricchioA, . 13/shaun-whites-biggest-fans-ones-share-his-heart-condition/333985002/.
.
KnopsRE,BurkeMC.Prospectiveblindedevaluationofanovelsensingmeth- .. 586.LyngeTH, Jeppesen AG, Winkel BG, Glinge C, Schmidt MR, Sondergaard L,
odologydesignedtoreduceinappropriateshocksbythesubcutaneousimplant- .. RisgaardB,Tfelt-HansenJ.Nationwidestudyofsuddencardiacdeathinpeople
.
ablecardioverter-defibrillator.HeartRhythm2018;15:1515(cid:2)1522. . with congenital heart defects aged 0 to 35 years. Circ Arrhythm Electrophysiol
.
568. CammCF,JamesCA,TichnellC,MurrayB,BhonsaleA,teRieleASJM,Judge . 2018;11:e005757.
.
DP, Tandri H, Calkins H. Prevalence of atrial arrhythmias in arrhythmogenic .. 587.Tutarel O, Gabriel H, Diller G-P. Exercise: friend or foe in adult congenital
rightventriculardysplasia/cardiomyopathy.HeartRhythm2013;10:1661(cid:2)1668. .. heartdisease?CurrCardiolRep2013;15:416.
.
569. ZeitlerEP,SandersGD,SinghK,GreenfieldRA,GillisAM,WilkoffBL,Piccini . 588.vanDisselAC,BlokIM,HooglugtJ-LQ,deHaanFH,JorstadHT,MulderBJM,
.
JP,Al-KhatibSM.Singlevs.dualchamberimplantablecardioverter-defibrillators . Bouma BJ, Winter MM. Safety and effectiveness of home-based, self-selected
.
orprogrammingofimplantablecardioverter-defibrillatorsinpatientswithouta .. exercise training in symptomatic adults with congenital heart disease: a pro-
.
bradycardia pacing indication: systematic review and meta-analysis. Europace . spective,randomised,controlledtrial.IntJCardiol2019;278:59(cid:2)64.
.
2018;20:1621(cid:2)1629. . 589.EijsvogelsTMH,ThompsonPD, FranklinBA.The“extremeexercise hypoth-
.
570. Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, .. esis”:recentfindingsandcardiovascularhealthimplications.CurrTreatOptions
AguinagaL,BergerRD,CuestaA,DaubertJP,DubnerS,EllenbogenKA,Estes .. CardiovascMed2018;20:84.
.
NAM3rd,FenelonG,GarciaFC,GaspariniM,HainesDE,HealeyJS,Hurtwitz . 590.KimJH,BaggishAL.Strenuousexerciseandcardiovasculardiseaseoutcomes.
.
JL,KeeganR,KolbC,KuckK-H,MarinskisG,MartinelliM,McguireM,Molina . CurrAtherosclerRep2017;19:1.
.
LG,OkumuraK,ProclemerA,RussoAM,SinghJP,SwerdlowCD,TeoWS, .. 591.Dua JS, Cooper AR, Fox KR, Graham Stuart A. Exercise training in adults
Uribe W, Viskin S, Wang C-C, Zhang S. 2015 HRS/EHRA/APHRS/SOLAECE .. with congenital heart disease: feasibility and benefits. Int J Cardiol 2010;138:
.
expert consensus statement on optimal implantable cardioverter-defibrillator . 196(cid:2)205.
.
programmingandtesting.EPEuropace2016;18:159(cid:2)183. .. 592.DuppenN,TakkenT,HopmanMTE,tenHarkelADJ,DulferK,UtensEMWJ,
571. SinhaA-M,StellbrinkC,SchuchertA,MoxB,JordaensL,LamaisonD,GillJ, .. HelbingWA.Systematicreviewoftheeffectsofphysicalexercisetrainingpro-
.
KaplanA,MerkelyB.Clinicalexperiencewithanewdetectionalgorithmfordif- . grammesinchildrenandyoungadultswithcongenitalheartdisease.IntJCardiol
.
ferentiationofsupraventricularfromventriculartachycardiainadual-chamber . 2013;168:1779(cid:2)1787.
.
defibrillator.JCardiovascElectrophysiol2004;15:646(cid:2)652. .. 593.CordinaRL, O’MeagherS,Karmali A, Rae CL, Liess C, Kemp GJ, Puranik R,
572. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S, .. SinghN,CelermajerDS.Resistancetrainingimprovescardiacoutput,exercise
.
ZrennerB,SchmittC.Docurrentdualchambercardioverterdefibrillatorshave . capacity andtolerancetopositiveairwaypressureinFontan physiology. IntJ .
advantages over conventional single chamber cardioverter defibrillators in . Cardiol2013;168:780(cid:2)788.
. reducinginappropriatetherapies?Arandomized,prospectivestudy.JCardiovasc .. 594.DuppenN,EtnelJR,SpaansL,TakkenT,vandenBerg-EmonsRJ,BoersmaE,
Electrophysiol2001;12:134(cid:2)142. .. Schokking M, Dulfer K, Utens EM, Helbing W, Hopman MT. Does exercise
.
573. van der Linde D, Konings EEM, Slager MA, Witsenburg M, Helbing WA, . trainingimprovecardiopulmonaryfitnessanddailyphysicalactivityinchildren
.
TakkenbergJJM,Roos-HesselinkJW.Birthprevalenceofcongenitalheartdis- .. and young adults with corrected tetralogy of Fallot or Fontan circulation? A
ease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol .. randomizedcontrolledtrial.AmHeartJ2015;170:606(cid:2)614.
.
2011;58:2241(cid:2)2247. . 595.Chaix M-A, Marcotte F, Dore A, Mongeon F-P, Mondesert B, Mercier L-A,
.
574. LongmuirPE,BrothersJA,deFerrantiSD,HaymanLL,VanHareGF,Matherne . KhairyP.Risksandbenefitsofexercisetraininginadultswithcongenitalheart
.
GP,DavisCK,JoyEA,McCrindleBW.Promotionofphysicalactivityforchil- .. disease.CanJCardiol2016;32:459(cid:2)466.
drenandadultswithcongenitalheartdisease:ascientificstatementfromthe .. 596.MullerJ,AmbergerT,BergA,GoederD,RemmeleJ,OberhofferR,EwertP,
.
AmericanHeartAssociation.Circulation2013;127:2147(cid:2)2159. . HagerA.Physicalactivityinadultswithcongenitalheartdiseaseandassocia-
.
575. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. .. tionswithfunctionaloutcomes.Heart2017;103:1117(cid:2)1121.
Lifetimeprevalenceofcongenitalheartdiseaseinthegeneralpopulationfrom .. 597.BudtsW,BorjessonM,ChessaM,vanBuurenF,TrigoTrindadeP,CorradoD,
.
2000to2010.Circulation2014;130:749(cid:2)756. . HeidbuchelH,WebbG,HolmJ,PapadakisM.Physicalactivityinadolescents
.
576. InuzukaR,DillerG-P,BorgiaF,BensonL,TayELW,Alonso-GonzalezR,Silva . and adults with congenital heart defects: individualized exercise prescription.
.
M, Charalambides M, Swan L, Dimopoulos K, Gatzoulis MA. Comprehensive .. EurHeartJ2013;34:3669(cid:2)3674.
useofcardiopulmonaryexercisetestingidentifiesadultswithcongenitalheart .. 598.TakkenT,GiardiniA,ReybrouckT,GewilligM,Hovels-GurichHH,Longmuir
.
disease at increased mortality risk in the medium term. Circulation . PE,McCrindleBW,ParidonSM,HagerA.Recommendationsforphysicalactiv-
.
2012;125:250(cid:2)259. . ity,recreationsport,andexercisetraininginpaediatricpatientswithcongenital
.
577. PellicciaA,AdamiPE,QuattriniF,SqueoMR,CaselliS,VerdileL,MaestriniV, .. heart disease: a report from the Exercise, Basic & Translational Research
DiPaoloF,PisicchioC,CiardoR,SpataroA.AreOlympicathletesfreefrom .. SectionoftheEuropeanAssociation ofCardiovascularPrevention.Eur JPrev
.
cardiovascular diseases? Systematic investigation in 2352 participants from . Cardiol2012;19:1034(cid:2)1065.
.
Athens2004toSochi2014.BrJSportsMed2017;51:238(cid:2)243. .. 599.Muscogiuri G, Secinaro A, Ciliberti P, Fuqua M, Nutting A. Utility of cardiac
578. Pierpont ME, Basson CT, Benson DWJ, Gelb BD, Giglia TM, Goldmuntz E, .. magneticresonanceimaginginthemanagementofadultcongenitalheartdis-
.
McGeeG,SableCA,SrivastavaD,WebbCL.Geneticbasisforcongenitalheart . ease.JThoracImaging2017;32:233(cid:2)244.
.
defects: current knowledge: a scientific statement from the American Heart . 600.SparrowP,MerchantN,ProvostY,DoyleD,NguyenE,PaulN.CardiacMRI
.
AssociationCongenitalCardiacDefectsCommittee,CouncilonCardiovascular .. andCTfeaturesofinheritableandcongenitalconditionsassociatedwithsudden
DiseaseintheYoung.Circulation2007;115:3015(cid:2)3038. . cardiacdeath.EurRadiol2009;19:259(cid:2)270.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 80 ---
96 ESCGuidelines
.
601. SimonneauG,MontaniD,CelermajerDS,DentonCP,GatzoulisMA,Krowka .. 612.Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, Daniels CJ,
M,WilliamsPG,SouzaR.Haemodynamicdefinitionsandupdatedclinicalclassi- .. DealBJ,DearaniJA,GrootNde,DubinAM,HarrisL,JanousekJ,KanterRJ,
.
ficationofpulmonaryhypertension.EurRespirJ2019;53:1801913. . KarpawichPP,PerryJC,SeslarSP,ShahMJ,SilkaMJ,TriedmanJK,WalshEP,
.
602.MollerT,BrunH,FredriksenPM,HolmstromH,PettersenE,ThaulowE.Moderate . WarnesCA.PACES/HRSexpertconsensusstatementontherecognitionand
.
altitudeincreasesrightventricularpressureandoxygendesaturationinadolescents .. management of arrhythmias in adult congenital heart disease: developed in
withsurgicallyclosedseptaldefect.CongenitHeartDis2010;5:556(cid:2)564. .. partnership between the Pediatric and Congenital Electrophysiology
.
603. Kovacs G, Berghold A, Scheidl S, OlschewskiH. Pulmonary arterial pressure . Society (PACES) and the Heart Rhythm Society (HRS). Can J Cardiol
.
duringrestandexerciseinhealthy subjects:asystematic review.EurRespir J .. 2014;30:e1(cid:2)e63.
2009;34:888(cid:2)894. .. 613. DillerG-P,DimopoulosK,OkonkoD,LiW,Babu-NarayanSV,BrobergCS,
.
604. Augustine DX, Coates-Bradshaw LD, Willis J, Harkness A, Ring L, Grapsa J, . JohanssonB,BouzasB,MullenMJ,Poole-WilsonPA,FrancisDP,Gatzoulis
.
CoghlanG,KayeN,OxboroughD,RobinsonS,SandovalJ,RanaBS,SivaA, . MA. Exercise intolerance in adult congenital heart disease: comparative
.
NihoyannopoulosP,HowardLS,FoxK,BhattacharyyaS,SharmaV,SteedsRP, .. severity, correlates, and prognostic implication. Circulation 2005;112:
MathewT.Echocardiographicassessmentofpulmonaryhypertension:aguide- .. 828(cid:2)835.
.
line protocol from the British Society of Echocardiography. Echo Res Pract . 614.MantegazzaV,ApostoloA,HagerA.Cardiopulmonaryexercisetestinginadult
.
2018;5:G11(cid:2)G24. .. congenitalheartdisease.AnnAmThoracSoc2017;14:S93(cid:2)S101.
605. GalieN,HumbertM,VachieryJ-L,GibbsS,LangI,TorbickiA,SimonneauG, .. 615.Borg G. Perceived exertion as an indicatorof somatic stress.Scand J Rehabil
.
PeacockA,VonkNoordegraafA,BeghettiM,GhofraniA,GomezSanchezMA, . Med1970;2:92(cid:2)98. .
HansmannG,KlepetkoW,LancellottiP,MatucciM,McDonaghT,PierardLA, . 616.KempnyA,DimopoulosK,UebingA,MoceriP,SwanL,GatzoulisMA,Diller
.
TrindadePT,ZompatoriM,HoeperM.2015ESC/ERSGuidelinesforthediag- .. G-P. Reference values for exercise limitations among adults with congenital
nosisandtreatmentofpulmonaryhypertension:theJointTaskForceforthe .. heartdisease.Relationtoactivitiesofdailylife(cid:2)singlecentreexperienceand
.
diagnosisandtreatmentofpulmonaryhypertensionoftheEuropeanSocietyof . reviewofpublisheddata.EurHeartJ2012;33:1386(cid:2)1396.
.
Cardiology (ESC) and the European Respiratory Society (ERS). Eur Heart J . 617.d’UdekemY.Cardiorespiratoryfitness,nottheseverityofthecondition,dic-
. 2016;37:67(cid:2)119. .. tates late outcomes after Fontan procedures. J Am Coll Cardiol
606. Muller J, Heck PB, Ewert P, Hager A. Noninvasive screening for pulmonary .. 2017;69:2745(cid:2)2747.
.
hypertension by exercise testing in congenital heart disease. Ann Thorac Surg . 618.EvangelistaA,FlachskampfFA,ErbelR,Antonini-CanterinF,VlachopoulosC,
.
2017;103:1544(cid:2)1549. .. RocchiG,SicariR,NihoyannopoulosP,ZamoranoJ,PepiM,BreithardtO-A,
607. DimopoulosK,WortSJ,GatzoulisMA.Pulmonaryhypertensionrelatedtocon- .. Plonska-Gosciniak E. Echocardiography in aortic diseases: EAE recommenda-
.
genitalheartdisease:acallforaction.EurHeartJ2014;35:691(cid:2)700. . tionsforclinicalpractice.EurJEchocardiogr2010;11:645(cid:2)658.
.
608. GrunigE,EichstaedtC,BarberaJ-A,BenjaminN,BlancoI,BossoneE,Cittadini . 619.Ait Ali L, Pingitore A, Piaggi P, Brucini F, Passera M, Marotta M, Cadoni A,
.
A,CoghlanG,CorrisP,D’AltoM,D’AndreaA,DelcroixM,deManF,GaineS, .. PassinoC,CatapanoG,FestaP.RespiratorytraininglateafterFontaninterven-
GhioS,GibbsS,GumbieneL,HowardLS,JohnsonM,JurevicieneE,KielyDG, .. tion: impact on cardiorespiratory performance. Pediatr Cardiol
.
Kovacs G, MacKenzie A, Marra AM, McCaffrey N, McCaughey P, Naeije R, . 2018;39:695(cid:2)704.
.
OlschewskiH,Pepke-ZabaJ,ReisA,SantosM,SaxerS,TullohRM,UlrichS, . 620.MaronBJ,ShiraniJ,PoliacLC,MathengeR,RobertsWC,MuellerFO.Sudden
.
VonkNoordegraafA,PeacockAJ.ERSstatementonexercisetrainingandreha- .. death in young competitive athletes. Clinical, demographic, and pathological
bilitationinpatientswithseverechronicpulmonaryhypertension.EurRespirJ .. profiles.JAMA1996;276:199(cid:2)204.
.
2019;53:1800332. . 621.MaronBJ,HaasTS,AhluwaliaA,MurphyCJ,GarberichRF.Demographicsand
.
609. Kuijpers JM, Koolbergen DR, Groenink M, Boekholdt SM, Meijboom FJ, .. epidemiologyofsuddendeathsinyoungcompetitiveathletes:fromtheUnited
Jongbloed MRM, Hoendermis ES, Duijnhouwer AL, Mulder BJM, Bouma BJ. .. StatesNationalRegistry.AmJMed2016;129:1170(cid:2)1177.
.
Aortic dissection and prophylactic surgery in congenital heart disease. Int J . 622.Locati EH, Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Lehmann MH,
.
Cardiol2019;274:113(cid:2)116. . TowbinJA,PrioriSG,NapolitanoC,RobinsonJL,AndrewsM,TimothyK,Hall
.
610. ZhaoQ,ShiK,YangZ-G,DiaoK-Y,XuH-Y,LiuX,GuoY-K.Predictorsof .. WJ.Age-andsex-relateddifferencesinclinicalmanifestationsinpatientswith
aorticdilationinpatientswithcoarctationoftheaorta:evaluationwithdual- .. congenitallong-QT syndrome:findingsfromtheInternational LQTSRegistry.
.
sourcecomputedtomography.BMCCardiovascDisord2018;18:124. . Circulation1998;97:2237(cid:2)2244.
.
611. Loomba RS, Buelow MW, Aggarwal S, Arora RR, Kovach J, Ginde S. .. 623.MakkarRR,FrommBS,SteinmanRT,MeissnerMD,LehmannMH.Femalegen-
Arrhythmiasinadultswithcongenitalheartdisease:whatareriskfactorsfor .. derasariskfactorfortorsadesdepointesassociatedwithcardiovasculardrugs.
.
specificarrhythmias?PacingClinElectrophysiol2017;40:353(cid:2)361. . JAMA1993;270:2590(cid:2)2597.
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/1/17/5898937
by
guest
on
22
January
2026
--- Страница 81 ---
Delivering to 20+ European Countries.
To deliver the best
patient care, you
FREE CASE ANY LITTMANN® CARD IV
need the tools add code at the checkout to apply
FREECASE
to match.
SHOP NOW
™
Littmann® Cardiology IV
& Littmann® CORE Digital
Stethoscopes
LITTMANN
RATING
9/10
Keep your tools safe
with laser engraving.
LITTMANN
RATING
10+
♥☺♫★♠
FREE CASE ANY LITTMANN® CORE
add code at the checkout to apply
FREECASE
SHOP NOW
